0001574540 doc:ElPasoMedicalOfficeBuildingElPasoTXMember 2017-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20541
 
FORM 10-K
 
ý     ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 20142017

o     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from              to              
 
Commission file number: 001-36007 (Physicians Realty Trust)
Commission file number: 333-205034-01 (Physicians Realty L.P.)
 
PHYSICIANS REALTY TRUST
PHYSICIANS REALTY L.P.
(Exact Name of Registrant as Specified in Its Charter)
Maryland (Physicians Realty Trust)
Delaware (Physicians Realty L.P.)
 
46-2519850
80-0941870
(State or Other Jurisdiction
of Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
   
309 N. Water Street
Suite 500
Milwaukee, Wisconsin
 53202
(Address of Principal Executive Offices) (Zip Code)
 
(414) 367-5600
(Registrant’s telephone number, including area code)
 
Securities registered under Section 12(b) of the Act:None
RegistrantTitle of Each ClassName of Each Exchange On Which Registered
Physicians Realty TrustCommon Shares, $0.01 par valueNew York Stock Exchange
 
Securities registered under Section 12(g) of the Act: None
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. 
Physicians Realty Trust        Yes oý No oPhysicians Realty L.P.        Yes o No ý
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. 
Physicians Realty Trust        Yes o No ýPhysicians Realty L.P.        Yes o No ý
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Physicians Realty Trust        Yes oý No oPhysicians Realty L.P.        Yes ý No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). 
Physicians Realty Trust        Yes oý No oPhysicians Realty L.P.        Yes ý No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ýo
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Physicians Realty Trust
Large accelerated filer o
ýAccelerated filer o
Non-accelerated filer x
(Doo (Do not check if a smaller reporting company)
Smaller reporting company oEmerging growth company o

Physicians Realty L.P.
Large accelerated filer o     Accelerated filer o Non-accelerated filer ý (Do not check if a smaller reporting company) Smaller reporting company o Emerging growth company o


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Physicians Realty Trust      o Physicians Realty L.P. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). 
Physicians Realty Trust        Yes o No ýPhysicians Realty L.P.        Yes o No ý
 
AsThe aggregate market value of March 9, 2015, 3,640,900Physicians Realty Trust’s common units of limited partnership interest of the Registrant wereshares held by non-affiliates as of June 30, 2017 was approximately $3,154,991,308 based upon the Registrant.closing price reported for such date on the New York Stock Exchange. There is no established trading market for such units.units of Physicians Realty L.P.
As of February 23, 2018, there were 181,758,250 shares of Physicians Realty Trust’s common shares outstanding.
 
DOCUMENTS INCORPORATED BY REFERENCE


The information required by Part III of this Annual Report on Form 10-K, to the extent not set forth in this Form 10-K, is incorporated herein by reference from Physicians Realty Trust’s definitive proxy statement relating to the annual meeting of shareholders to be held on May 7, 2015, which was3, 2018, to be filed with the Securities and Exchange Commission on March 25, 2015.within 120 days after the end of the Registrant’s fiscal year ended December 31, 2017.






EXPLANATORY NOTE


Physicians Realty L.P. (the “Operating Partnership”), a Delaware limited partnership, is filing thisThis Annual Report on Form 10-K combines the Annual Reports on Form 10-K for the fiscal yearsyear ended December 31, 2014, December 31, 2013 and December 31, 2012 in connection with becoming current in its filing obligations under the Securities Exchange Act2017 of 1934, as amended (the “Exchange Act”). In addition, the Operating Partnership and Physicians Realty Trust (the “Trust”), a Maryland real estate investment trust, and the general partner of the Operating Partnership, filedPhysicians Realty L.P. (the “Operating Partnership”), a comprehensive Annual Report on Form 10-K for the fiscal year ended December 31, 2016, which included selected, unaudited quarterly financial information of the Operating Partnership for 2016 and 2015. Unless otherwise indicated, this report has been prepared as of December 31, 2014 and has not been updated since that time.

Delaware limited partnership. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “our company,” or the “Company”“Company,” and “Physicians Realty” refer to the Operating Partnership,Trust, together with its consolidated subsidiaries, including the Operating Partnership, and the historical business and operations of four healthcare real estate private equity funds, organized as limited liability companies under the laws of Delaware, managed by B.C. Ziegler & Company, that we have classified for accounting purposes as our “Predecessor” and which we sometimes refer to as the “Ziegler Funds.Funds, and references to the “Operating Partnership” mean collectively the Operating Partnership together with its consolidated subsidiaries. In this report, all references to “common shares” refer to the common shares of the Trust and references to “the“our shareholders” refer to shareholders of the common shares of the Trust, and the term “OP Units” refers to partnership interests of the Operating Partnership and the term “Series A Preferred Units” refers to Series A Participating
Redeemable Preferred Units of the Operating Partnership. As of February 23, 2018, 104,172 Series A Preferred Units were outstanding.

The Trust is a self-managed real estate investment trust (“REIT”) formed primarily to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. The Trust operates in an umbrella partnership REIT structure (“UPREIT”) in which the Operating Partnership and its subsidiaries hold substantially all of the assets. The Trust’s operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership. The Trust, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership.



The Trust conducts substantially all of its operations through the Operating Partnership. As of December 31, 2017, the Trust held a 97.1% interest in the Operating Partnership and owns no Series A Preferred Units. Apart from this ownership interest, the Trust has no independent operations.

Noncontrolling interests in the Operating Partnership, shareholders’ equity of the Trust and partners’ capital of the Operating Partnership are the primary areas of difference between the consolidated financial statements of the Trust and those of the Operating Partnership. OP Units not owned by the Trust are accounted for as limited partners’ capital in the Operating Partnership’s consolidated financial statements and as noncontrolling interests in the Trust’s consolidated financial statements. The differences between the Trust’s shareholders’ equity and the Operating Partnership’s partners’ capital are due to the differences in the equity issued by the Trust and the Operating Partnership, respectively.

The Company believes combining the Annual Reports of the Trust and the Operating Partnership, including the notes to the consolidated financial statements, into this single report results in the following benefits:

a combined report enhances investors’ understanding of the Trust and the Operating Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;
a combined report eliminates duplicative disclosure and provides a more streamlined and readable presentation, as a substantial portion of the Company’s disclosure applies to both the Trust and the Operating Partnership; and
a combined report creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.

To help investors understand the significant differences between the Trust and the Operating Partnership, this report presents the following separate sections for each of the Trust and the Operating Partnership:

the market for registrant’s common equity, related stockholder matters and issuer purchases of equity securities in Item 5 of this report;
selected financial data in Item 6 of this report;
the consolidated financial statements in Item 8 and Item 15 of this report;
certain accompanying notes to the consolidated financial statements, including Note 3 (Acquisitions and Dispositions), Note 14 (Earnings Per Share and Earnings Per Unit) and Note 16 (Quarterly Data);
controls and procedures in Item 9A of this report; and
the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this report.





PHYSICIANS REALTY TRUST AND PHYSICIANS REALTY L.P.
 
Annual Report on Form 10-K for the Year Ended December 31, 20142017

Table of Contents






Forward-Looking Statements


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
This Annual Report on Form 10-K contains forward-looking statements made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts may be forward-looking statements.statements within the meaning of the federal securities laws. In particular, statements pertaining to our capital resources, property performance and results of operations contain forward-looking statements. Likewise, all of our statements regarding anticipated growth in our funds from operations and anticipated market conditions, demographics and results of operations are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “pro forma,” “estimates” or “anticipates” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans, expectations or intentions.
 
These forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information. These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties and thus, you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods which may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:

general economic conditions;

adverse economic or real estate developments, either nationally or in the markets in whichwhere our properties are located;

our failure to generate sufficient cash flows to service our outstanding indebtedness, or our ability to pay down or refinance our indebtedness;

fluctuations in interest rates and increased operating costs;

the availability, terms and deployment of debt and equity capital, including our unsecured revolving credit facility;

our ability to make distributions toon our OP Unit holders;
common shares;

general volatility of the market price of our limited operating history;
common shares;

our increased vulnerability economically due to the concentration of our investments in healthcare properties;

our geographic concentrationsconcentration in Texas and metro Atlanta, Georgia causes us to be particularly exposed to downturns in these local economiesthe Texas economy or other changes in local real estateTexas market conditions;

changes in our business or strategy;

our dependence upon our general partner's key personnel whose continued service is not guaranteed;

our general partner's ability to identify, hire and retain highly qualified personnel in the future;


the degree and nature of our competition;

changes in governmental regulations, tax rates and similar matters;


defaults on or non-renewal of leases by tenants;

decreased rental rates or increased vacancy rates;
 
difficulties in identifying healthcare properties to acquire and completecompleting acquisitions;


competition for investment opportunities;


any adverse effects to the business, financial position or results of operations of Catholic Health Initiatives (“CHI”), or one or more of the CHI-affiliated tenants, that impact the ability of CHI-affiliated tenants to pay us rent;
our failure to successfully develop, integrate and operate acquired properties and operations;

the impact of our investment in joint ventures;


the financial condition and liquidity of, or disputes with, any joint venture and development partners with whom we may make co-investments in the future;

cybersecurity incidents could disrupt our business and result in the compromise of confidential information;

our ability to operate as a public company;

changes in accounting principles generally accepted in the United States (or GAAP)(GAAP);
 
lack of or insufficient amounts of insurance;
 
other factors affecting the real estate industry generally;

our failure to maintain our qualification as a real estate investment trust (or REIT) for U.S. federal income tax purposes;
 
limitations imposed on our business as a result ofand our general partner's compliance withability to satisfy complex rules in order for itus to qualify as a REIT for U.S. federal income tax purposes;

changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates and taxation of REITs; and
 
various other factors that may materially adversely affect us, such as:or the per share market price of our common shares, including:
 
higher market interest rates;
the number of our common shares available for future issuance or sale;
our issuance of OP Unitsequity securities or the perception that such issuance might occur;
future debt;
failure of securities analysts to publish research or reports about us or our industry; and
future offeringssecurities analysts’ downgrade of debt.our common shares or the healthcare-related real estate sector.

While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. You should not place undue reliance on any forward-looking statements, which speak only as of the date of this report. We disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes after the date of this report, except as required by applicable law. You should not place undue reliance on any forward-looking statements that are based on information currently available to us or the third parties making the forward-looking statements. For a further discussion of these and other factors that could impact our future results, performance or transactions, see “Part I, Item 1A. Risk Factors.”Factors” of this report.



3




PART I
 
ITEM 1. BUSINESS
 
Overview
 
We arePhysicians Realty Trust (the “Trust”), a self managed healthcareMaryland real estate companyinvestment trust, and Physicians Realty L.P. (the “Operating Partnership”), a Delaware limited partnership, were organized in April 2013 to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. TheUnless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “our company,” the “Company,” and “Physicians Realty” refer to the Trust, together with its consolidated subsidiaries, including the Operating Partnership, and the Ziegler Funds, and references to the “Operating Partnership” mean collectively the Operating Partnership together with its consolidated subsidiaries. We completed anour initial public offering (“IPO”) in July 2013. The Trust’s common shares are listed on the NYSE and it is included in the MSCI US REIT Index.


We had no business operations prior to the Trust's completionhave grown our portfolio of its IPO and the related formation transactions on July 24, 2013. Our Predecessor, which is not a legal entity, is comprised of the four healthcaregross real estate funds managed by B.C. Ziegler & Company (“Ziegler”) that owned directly or indirectly interests in entities that ownedinvestments from approximately $124 million at the initial properties that we acquired on July 24, 2013 in connection with completiontime of our general partner's IPO and related formation transactions.

The Trust is a self-managed Maryland real estate investment trust (“REIT”) and elected to be taxedapproximately $4.3 billion as a REIT for U.S. federal income tax purposes beginning with the short taxable year endedof December 31, 2013. The Trust’s operations are conducted through us and our wholly-owned and majority-owned subsidiaries. The Trust, as our sole general partner, controls our operations and consolidates our assets, liabilities, and results of operations. As of March 9, 2015, the Trust owned approximately 95.0% of the OP Units.

2017. As of December 31, 2014,2017, our portfolio consisted of 87280 healthcare properties located in 1930 states with approximately 3,100,70113,996,802 net leasable square feet, which were approximately 94.6%96.6% leased with a weighted average remaining lease term of approximately 9.6 years and8.3 years. As of December 31, 2017, approximately 76.5%85.1% of the net leasable square footage of our portfolio was either on campus with a hospital or other healthcare facility or strategically located and affiliated with a hospital or other healthcare delivery system or located within approximately 1/4 mile of a hospital campus.facility.

We receive a cash rental stream from these healthcare providers under our leases. Approximately 85%90.8% of the annualized base rent payments from our properties as of December 31, 20142017 are from absolute and triple-net leases, pursuant to which the tenants are responsible for all operating expenses relating to the property, including but not limited to real estate taxes, utilities, property insurance, routine maintenance and repairs, and property management. This structure helps insulate us from increases in certain operating expenses and provides morerelatively predictable cash flow. Approximately 15% of the annualized base rent payments from our properties as of December 31, 2014 are from modified gross base stop leases which allow us to pass through certain increases in future operating expenses (e.g., property tax and insurance), to tenants for reimbursement, thus protecting us from increases in such operating expenses. We seek to structure our triple-nettriple net leases to generate attractive returns on a long-term basis. Our leases typically have initial terms of five to 15 years and include annual rent escalators of approximately 1.5% to 3.0%. Our operating results depend significantly upon the ability of our tenants to make required rental payments. We believe that our portfolio of medical office buildings and other healthcare facilities will enable us to generate stable cash flows over time because of the diversity of our tenants, staggered lease expiration schedule, long-term leases, and low historical occurrence of tenants defaulting under their leases. As of December 31, 2014,2017, leases representing a percentage of our portfolio on the basis of leasable square feet will expire as follows: 
Year Portfolio Lease Expirations Portfolio Lease Expirations
2015 2.8%
2016 3.6%
2017 2.2%
MTM (1) 0.5%
2018 6.6% 2.9%
2019 6.5% 3.9%
2020 1.6% 3.6%
2021 2.4% 4.9%
2022 3.4% 4.9%
2023 5.7% 4.2%
2024 16.9% 6.2%
2025 7.3%
2026 25.6%
2027 9.7%
Thereafter 42.8% 22.9%
Total 96.6%
(1)“MTM” means month-to-month. This line also includes 4 leases which expired on December 31, 2017, representing 0.1% of portfolio leasable square feet.

We invest in real estate that is integral to providing high quality healthcare services. Our properties are typically located on a campus with a hospital or other healthcare facilities or strategically located and affiliated with a hospital or other healthcare facilities.system. We believe the impact of government programs and continuing trends in the healthcare industry create

attractive opportunities for us to invest in health care relatedhealthcare-related real estate. Our management team has significant public healthcare REIT experience and has long established relationships with physicians, hospitals and healthcare delivery system decision makers that we believe will provide quality investment and growth opportunities. Our principal investments include medical


office buildings, outpatient treatment facilities, acute and post-acute care hospitals, as well as other real estate integral to health care providers. We seek to invest in stabilized medical facility assets with initial cash yields of 6%5.0% to 10%.9.0%, although we invested in certain medical facility assets in 2017 with anticipated initial cash yields below 5.0% and we may invest in other medical facility assets with initial cash yields outside of this range. We seek to generate attractive risk-adjusted returns for our shareholders through a combination of stable and increasing dividends and potential long-term appreciation in the value of our properties and our OP Units.common shares.
 
We had no business operations prior to completion of the IPO and the related formation transactions on July 24, 2013. Our Predecessor, which is not a legal entity, is comprised of the four healthcare real estate private equity funds, organized as limited liability companies under the laws of Delaware, managed by B.C. Ziegler & Company, which we refer to as the Ziegler Funds, that owned directly or indirectly interests in entities that owned our initial properties we acquired on July 24, 2013 in connection with completion of our IPO and related formation transactions.
The Trust is a Maryland real estate investment trust and has elected to be taxed as a REIT for U.S. federal income tax purposes. We conduct our business through an umbrella partnership REIT structure in which our properties are owned by the Operating Partnership directly or through limited partnerships, limited liability companies, or other subsidiaries. The Trust is the sole general partner of the Operating Partnership and, as of February 23, 2018, owned approximately 97.1% of the partnership interests in the Operating Partnership (“OP Units”). 

Our Objectives and Growth Strategy

Overview

Our principal business objective is to provide attractive risk-adjusted returns to our OP Unit holdersshareholders through a combination of (i) sustainable and increasing rental revenue and cash flow that generate reliable, increasing dividends, and (ii) potential long-term appreciation in the value of our properties and our OP Units.common shares. Our primary strategies to achieve our business objective are to leverage our physician and hospital relationships nationwide to invest in off-market assets that maximize risk-adjusted returns to our shareholders, to invest in, own, and manage a diversified portfolio of high quality healthcare properties, and to pay careful attention to our tenants’ real estate strategies, which we believe will drive high retention, high occupancy and reliable, increasing rental revenue and cash flow.
 
We intend to grow our portfolio of high-quality healthcare properties leased to physicians, hospitals, healthcare delivery systems, and other healthcare providers primarily through acquisitions of existing healthcare facilities that provide stable revenue growth and predictable long-term cash flows. We may also selectively finance the development of new healthcare facilities through joint venture or fee arrangements with premier healthcare real estate developers. Generally, we only expect to make investments in new development properties when approximately 70% or more of the development property has been pre-leased before construction commences. We seek to invest in properties where we can develop strategic alliances with financially sound healthcare providers and healthcare delivery systems that offer need-based healthcare services in sustainable healthcare markets. We focus our investment activity on the following types of healthcare properties:

medical office buildings;
outpatient treatment and diagnostic facilities;
physician group practice clinics;
ambulatory surgery centers; and
specialty hospitals and treatment centers;
acute care hospitals; and
post-acute care hospitals and long-term care facilities.centers.
 
We believe that shifting consumer preferences, limited space in hospitals, the desire of patients and healthcare providers to limit non-essential services provided in a hospital setting, and cost considerations, among other trends, continue to drive the industry trend of performing procedures in outpatient facilities that have traditionally been performed in hospitals, such as surgeries and other invasive medical procedures. As these trends continue, we believe that demand for medical office buildings and similar healthcare properties will continue to rise, and that our investment strategy accounts for these trends.

We may invest opportunistically in life science facilities, assisted living, and independent senior living facilities and in the longer term, senior housing properties, including skilled nursing. Consistent with the intent of our general partner to qualifyTrust’s qualification as a REIT, we may also opportunistically invest in companies that provide healthcare services, and in joint venture entities with operating partners structured to comply with the REIT Investment Diversification Act of 2007 (“RIDEA”).
 


In connection with our review and consideration of healthcare real estate investment opportunities, we generally take into account a variety of market considerations, including:

whether the property is anchored by a financially-sound healthcare delivery system or whether tenants have strong affiliation to a healthcare delivery system;
the performance of the local healthcare delivery system and its future prospects;
property location, with a particular emphasis on proximity to healthcare delivery systems;
demand for medical office buildings and healthcare related facilities, current and future supply of competing properties, and occupancy and rental rates in the market;
population density and growth potential;
ability to achieve economies of scale with our existing medical office buildings and healthcare related facilities or anticipated investment opportunities; and
existing and potential competition from other healthcare real estate owners and operators.

In addition, our management team has maintained a conservative balance sheet while investing over $4.3 billion as of December 31, 2017 in real estate assets since our IPO in July 2013. For short-term purposes, we may borrow on our primary unsecured credit facility. From time to time, we replace these borrowings with long-term capital such as senior unsecured notes and equity. We selectively utilize capital market transactions in furtherance of our investment strategy, including, during 2017, the issuance by the Operating Partnership of $750.0 million of senior notes through two public debt offerings, and the raising of an additional $721.5 million of equity through two follow-on offerings and $122.5 million of equity through sales under our ATM Program (as hereinafter defined).

Business Strategy

We are focused on building and maintaining a portfolio of high-quality healthcare properties leased to physicians, hospitals, healthcare delivery systems, and other healthcare providers. Our investment strategy includes a focus on investments with the following key attributes:

We seek to invest in properties serving healthcare systems with dominant market share, high credit quality and those who are investing capital into their campuses. In particular, we seek to own off-market or selectively marketed assets with attractive demographics, economic growth, and high barriers to entry. We seek to invest in and maintain well occupied properties that we believe are critical to the delivery of healthcare.
We emphasize ensuring an appropriate and balanced mix of tenants to provide synergies within both individual buildings and the broader health system campus. Our primary tenants are healthcare systems, academic medical centers and leading physician groups. These groups typically have strong and stable financial performance. We believe this helps ensure stability in our rental income and tenant retention over time.
We seek to maintain a core, critical portfolio of properties and to build our reputation as a dedicated leading MOB owner and operator.
We seek to maintain or increase our average rental rates, and focus on actively leasing our vacant space and reducing leasing concessions.

In addition, we seek to invest in properties where we can develop strategic alliances with financially sound healthcare providers and healthcare delivery systems that offer need-based healthcare services in sustainable healthcare markets, and consider long-term relationship building when assessing acquisition potential.

Finally, we actively manage our balance sheet to maintain our investment grade credit rating, to maintain an appropriate level of leverage and to preserve financing flexibility for funding of future acquisitions. In particular, we:

Continue to maintain a high level of liquidity, including borrowing availability under our unsecured revolving credit facility.
Maintain access to multiple sources of capital, including private debt issuances, public bond offerings, public equity offerings, unsecured bank loans, and secured property level debt.
Closely monitor our existing debt maturities and average interest rates.
 

6


2017 Highlights and Other Recent Developments

Investment Activity

For the full year 2017, we completed acquisitions of 40 operating healthcare properties, 2 condominium units, and 1 parking deck, located in 15 states for an aggregate purchase price of approximately $1.37 billion. In addition, we funded $42.9 million of other investments, including the issuance of loans and buyouts of noncontrolling interests, resulting in total investments of $1.41 billion.

During 2017, we completed acquisitions of 8 healthcare properties as a result of the exercise of certain rights of first refusal by the sellers. These properties comprising approximately 1,402,872 net leasable square feet in three states for an aggregate purchase price of $677.7 million.
Since January 1, 2018, we have completed acquisitions of 2 healthcare properties for an aggregate purchase price of $98.7 million containing an aggregate of 220,140 net leasable square feet. One of these properties was partially funded by issuing an aggregate of 104,172 preferred operating partnership units valued at approximately $22.7 million on the date of issuance.

Assets Slated for Disposition

We consider 10 properties in four states, representing an aggregate of approximately 391,014 square feet of gross leasable area, to be slated for disposition as of December 31, 2017. These assets consist of five assets leased to entities who have succeeded to the interests of certain Foundation Healthcare, Inc. affiliates (“Former Foundation Assets”) and five additional properties which we believe no longer meet our core business strategy from a size, age, geography, or line of business perspective.

Capital Markets and Dividends

In August 2016, we entered into separate At Market Issuance Sales Agreements with each of KeyBanc Capital Markets Inc., Credit Agricole Securities (USA) Inc., JMP Securities LLC, Raymond James & Associates, Inc. and Stifel Nicolaus & Company, Incorporated (the “Agents”), pursuant to which we may issue and sell, from time to time, our common shares having an aggregate offering price of up to $300.0 million, through the Agents (the “ATM Program”). During the fiscal year-ended December 31, 2017, we issued and sold pursuant to the ATM Program 6,347,914 common shares at a weighted average price of $19.48 per share, resulting in net proceeds to us of approximately $122.5 million.

In March 2017, the Operating Partnership issued and sold $400.0 million in aggregate principal amount of its 4.30% Senior Notes which will mature on March 15, 2027. Our net proceeds from the offering, after deducting underwriting discounts and expenses, were approximately $396.1 million. We used the net proceeds of the public debt offering to repay a portion of the outstanding indebtedness under our unsecured revolving credit facility and for general corporate purposes, including working capital and funding acquisitions.

In March 2017, we completed a follow-on public offering of 17,250,000 common shares of beneficial interest, including 2,250,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds to us of approximately $300.8 million. We contributed the net proceeds of this offering to the Operating Partnership in exchange for 17,250,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowings under its unsecured revolving credit facility and for general corporate purposes, including working capital and funding acquisitions.

In July 2017, we completed a follow-on public offering of 21,500,000 common shares of beneficial interest, including 1,500,000 common shares issued upon partial exercise of the underwriters’ option to purchase additional shares, resulting in net proceeds to us of approximately $420.7 million. We contributed the net proceeds of this offering to the Operating Partnership in exchange for 21,500,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowings under its unsecured revolving credit facility and for general corporate purposes, including working capital and funding acquisitions.


On December 1, 2017, the Operating Partnership issued and sold $350.0 million in aggregate principal amount of its 3.95% Senior Notes which will mature on January 15, 2028. Our net proceeds from the offering, after deducting underwriting discounts and expenses, were approximately $347.0 million. We used the net proceeds of the public debt offering to repay outstanding indebtedness under our unsecured revolving credit facility and for general corporate purposes, including working capital and funding acquisitions.

The Board of Trustees authorized and the Trust declared a cash dividend of $0.225 per common share and OP Unit for the quarterly period ended March 31, 2017, which was paid on April 18, 2017 to common shareholders and OP Unit holders of record as of the close of business on April 5, 2017. The Board of Trustees authorized and the Trust declared a cash dividend of $0.23 per common share and OP Unit for the quarterly period ended June 30, 2017, which was paid on July 18, 2017 to common shareholders and OP Unit holders of record as of the close of business on July 3, 2017. The Board of Trustees authorized and the Trust declared a cash dividend of $0.23 per common share and OP Unit for the quarterly period ended September 30, 2017, which was paid on October 18, 2017 to common shareholders and OP Unit holders of record as of the close of business on October 3, 2017. The Board of Trustees authorized and the Trust declared a cash dividend of $0.23 per common share and OP Unit for the quarterly period ended December 31, 2017, which was paid on January 18, 2018 to common shareholders and OP Unit holders of record as of the close of business on January 3, 2018.

EmployeesOur Industry and Market Opportunity

AtThe nature of healthcare delivery continues to evolve due to the impact of government programs, regulatory changes and consumer preferences. We believe these changes have increased the need for capital among healthcare providers and increased pressure on these providers to integrate more efficient real estate solutions in order enhance the delivery of quality healthcare. In particular, we believe the following factors and trends are creating an attractive environment in which to invest in healthcare properties.

$3.3 Trillion Healthcare Industry Projected to Grow to $5.7 Trillion (and 19.7% of U.S. GDP) by 2026

According to the U.S. Department of Health and Human Services (“HHS”), healthcare spending accounted for 17.9% of U.S. gross domestic product (“GDP”) in 2016. The general aging of the population, driven by the Baby Boomer generation and advances in medical technology and services which increase life expectancy, are key drivers of the growth in healthcare expenditures. The anticipated continuing increase in demand for healthcare services, together with an evolving complex and costly regulatory environment, changes in medical technology and reductions in government reimbursements are expected to pressure capital-constrained healthcare providers to find cost effective solutions for their real estate needs.

We believe the demand by healthcare providers for healthcare real estate will increase as healthcare spending in the United States continues to increase. According to the Centers for Medicare & Medicaid Services’ National Health Expenditure Projections 2017-2026, national healthcare expenditures continue to rise and are projected to grow from an estimated $3.5 trillion in 2017 to $5.7 trillion by 2026, representing an average annual rate of growth of 5.5%, reaching a projected 19.7% of GDP in 2026.
Source: Centers for Medicare & Medicaid Services, Office of the Actuary


Aging Population

The aging of the U.S. population has a direct effect on the demand for healthcare as older persons generally utilize healthcare services at a rate well in excess of younger people. According to the U.S. Census Bureau, the U.S. population over 65 years of age is projected to more than double from 47.8 million to nearly 98.2 million and the 85 and older population is expected to more than triple, from 6.3 million to 19.7 million, between 2015 and 2060. Also according to the U.S. Census Bureau, the number of older Americans is growing as a percentage of the total U.S. population with the number of persons older than 65 estimated to comprise 14.9% of the total U.S. population in 2015 and projected to grow to 23.6% by 2060.

We believe that healthcare expenditures for the population over 65 years of age will continue to rise as a disproportionate share of healthcare dollars is spent on older Americans. To illustrate, in 2012 the elderly (65+ years old) represented only 14% of the population while accounting for 34% of all healthcare-related spending. We believe the older population group increasingly will require treatment and management of chronic and acute health ailments and that this increased demand for healthcare services will create a substantial need for additional medical office buildings and other facilities that serve the healthcare industry in many regions of the United States. Additionally, we believe there will likely be a focus on lowering the cost of outpatient care to support the aging U.S. population, which will continue to support medical office and outpatient facility property demand in the long term. We believe these trends will result in a substantial increase in the number of properties meeting our investment criteria.

We believe advances in medical technology will continue to enable healthcare providers to identify and treat once fatal illnesses and improve the survival rate of critically ill and injured patients who will require continuing medical care. Along with these technical innovations, the U.S. population is growing older and living longer.

Source: U.S. Census Bureau

Affordable Care Act

The Affordable Care Act (as hereinafter defined) constituted a significant overhaul of many aspects of healthcare regulations and health insurance, and created the framework for healthcare services over the near term. It required every American to have health insurance or be subjected to a tax. Those who cannot afford health insurance are offered insurance subsidies or Medicaid coverage. The U.S. Census Bureau estimated that approximately 50 million Americans did not have healthcare insurance in 2009, before the Affordable Care Act was enacted. The HHS reported that approximately 28.1 million Americans did not have health insurance in 2016. The Affordable Care Act and subsequent legislation, executive orders and events, as well as their potential impact on our business, are discussed more fully under Item I, “Business,” under the caption “Certain Government Regulations.”

We believe the increase in the number of Americans with access to health insurance will result in an increase in physician office visits and an overall rise in healthcare utilization which in turn will drive a need for expansion of medical, outpatient, and smaller specialty hospital facilities. We also believe the increased dissemination of health research through media outlets, marketing of healthcare products, and availability of advanced screening techniques and medical procedures have contributed to a more engaged population of healthcare users and has created increased demand for customized facilities providing specialized, preventive and integrative healthcare services.


We further believe the provisions of the Affordable Care Act that are designed to lower certain reimbursement amounts under Medicare and tie reimbursement levels to the quality of services provided will increase the pressure on healthcare providers to become more efficient in their business models, invest capital in their businesses, lower costs and improve the quality of care, which in turn will drive healthcare systems to monetize their real estate assets and create demand for new, modern and specialized facilities.

Clinical Care Continues to Shift to Outpatient Care

According to the American Hospital Association, procedures traditionally performed in hospitals, such as certain types of surgery, are increasingly moving to outpatient facilities driven by advances in clinical science, shifting consumer preferences, limited or inefficient space in existing hospitals, and lower costs in the outpatient environment. This continuing shift toward delivering healthcare services in an outpatient environment rather than a traditional hospital environment increases the need for additional outpatient facilities and smaller, more specialized and efficient hospitals. Studies by the Medicare Payment Advisory Commission and others have shown that healthcare is delivered more cost effectively and with higher patient satisfaction when it is provided on an outpatient basis. Increasingly, hospital admissions are reserved for the critically ill, and less critical patients are treated on an outpatient basis with recuperation in their own homes. We believe healthcare market trends toward outpatient care will continue to push healthcare services out of larger, older, inefficient hospitals and into newer, more efficient and conveniently located outpatient facilities and smaller specialized hospitals. We believe that increased specialization within the medical field is also driving demand for medical facilities designed specifically for particular specialties and that physicians want to locate their practices in medical office space that is in or adjacent to these facilities.

Impact of BBA on Outpatient Care    

Section 603 Assets: Section 603 of the Bipartisan Budget Act of 2015 (the “2015 BBA”) generally prohibits hospital outpatient departments (“HOPDs”) from charging preferential hospital outpatient department rates for Medicare patients treated in “off-campus” locations on or after January 1, 2017, potentially impacting their profitability. These preferential Medicare rates are only permitted if the hospital provides HOPD services in a building within 250 yards of the hospital’s main inpatient location, unless the hospital’s HOPD service location is grandfathered by the 2015 BBA. A hospital’s HOPD locations, and thus the legislative right to bill at the higher HOPD rates, are grandfathered in all locations in existence as of November 2, 2015, as long as the hospital was billing services in that location on a HOPD basis as of November 2, 2015 and continues to provide those services in that location. “Grandfathered” hospitals providing HOPD services in our portfolio are referred to as 603 assets in our SEC reports and other public disclosures.

We own a number of assets that will continue to be reimbursed at hospital inpatient rates, which we refer to as “603 assets” after the applicable section of the BBA. Rent derived from these 603 assets accounts for approximately 19.7% of our total portfolio annualized base rent as of December 31, 2014, we had 14 full-time employees, none2017. Depending upon the implementation of whom are subjectthe regulations, the BBA may enhance the value of these 603 assets because existing HOPDs may lose their higher reimbursements rates should they choose to a collective bargaining agreement.change locations.



Portfolio Summary
 
Please see “Item 2. Properties” for a table that summarizes our portfolio as of December 31, 2014.2017.
 
Geographic Concentration
 
As ofFor the year ended December 31, 2014,2017, approximately 41%16.4% of our total annualized base rent was derived from properties located in Texas (23%) or metro Atlanta, Georgia (18%). The Texas properties are concentrated in El Paso and Plano.Texas. 

As a result of this geographic concentration, we are particularly exposed to downturns in these local economiesthe Texas economy or other changes in local real estate market conditions. Any material change in the current payment programs or regulatory, economic, environmental, or competitive conditions in either of these areasTexas could have a disproportionate effect on our overall business results. In the event of negative economic or other changes in either of these markets,the Texas market, our business, financial condition, and results of operations, our ability to make distributions to the Trustour shareholders and the tradingmarket price of the Trust'sour common shares may be adversely affected. See each of the discussion under Item 1A, “Risk Factors,” under the caption, “EconomicEconomic and other conditions that negatively affect geographic areas in which we conduct business, and in particular Texas, and other areas to which a greater percentage of our revenue is attributed could materially adversely affect our business, results of operations, and financial condition.condition.


Customer Concentration
 
We receive substantially all of our revenue as rent payments from tenants under leases of space in our healthcare properties, with our five largest tenants based upon rental revenue representing approximately $17.2$49.4 million, or 26.1%17.4%, of the annualized base rent from our properties as of December 31, 2014.2017. No one tenant represents more than 7.1%5.6% of our total annualized rent.base rent; however, 18.7% of our total annualized base rent as of December 31, 2017 is from tenants affiliated with CHI. We have no control over the success or failure of our tenants’ businesses and, at any time, any of our tenants may experience a downturn in its business that may weaken its financial condition. Our business, financial position, or results of operation could be materially adversely affected if CHI were to experience a material adverse effect on its business, financial position, or results of operations.
 
Competition
 
We compete with many other entities engaged in real estate investment activities for acquisitions of healthcare properties, including national, regional and local operators, acquirers, and developers of healthcare-related real estate properties.properties and other investors such as private equity firms, some of whom may have greater financial resources and lower costs of capital than we do. The competition for healthcare-related real estate properties may significantly increase the price that we must pay for healthcare properties or other assets that we seek to acquire, and our competitors may succeed in acquiring those properties or assets themselves. In addition, our potential acquisition targets may find our competitors to be more attractive because they may have greater resources, may be willing to pay more for the properties or may have a more compatible operating philosophy. In particular, larger REITs that target healthcare properties may enjoy significant competitive advantages that result from, among other things, a lower cost of capital, enhanced operating efficiencies, more personnel, and market penetration and familiarity with markets. In addition, the number of entities and the amount of funds competing for suitable investment properties may increase. Increased competition would result in increased demand for the same assets and therefore increase prices paid for them. Those higher prices for healthcare properties or other assets may adversely affect our returns from our investments.

Credit Facility
Effective September 18, 2014, the credit agreement, dated as of August 29, 2013 (as amended, restated, increased, extended, supplemented or otherwise modified from time to time, the “Prior Credit Agreement”), among us, as borrower, the Trust, certain of our subsidiariesWe also face competition in leasing available MOBs and other affiliates, as guarantors, Regions Bank, as administrative agent, Regions Capital Markets, as sole lead arranger and sole book runner, andfacilities that serve the lenders party thereto, andhealthcare industry to prospective tenants. As a result, we may have to provide rent concessions, incur charges for tenant improvements, offer other inducements, or we may be unable to timely lease vacant space in our properties, all commitments provided thereunder, was terminated. All amounts due and outstanding under the Prior Credit Agreement were repaidof which may have a material adverse impact on or prior to such date.
On September 18, 2014, we, as borrower, and the Trust and certain subsidiaries and other affiliatesour results of the Trust, as guarantors, entered into a credit agreement (the “Credit Agreement”) with KeyBank National Association as administrative agent, KeyBanc Capital Markets Inc., Regions Capital Markets and BMO Capital Markets, as joint lead arrangers and joint bookrunners, Regions Capital Markets and BMO Capital Markets, as co-syndication agents, and the lenders party thereto in connection with an unsecured revolving credit facility in the maximum principal amount of $400 million. The Credit Agreement includes a swingline loan commitment for up to 10% of the maximum principal amount and provides an accordion feature allowing the Trust to increase borrowing capacity by up to an additional $350 million, subject to customary terms and conditions, resulting in a maximum borrowing capacity of $750 million. The Credit Agreement replaced the Trust’s senior secured revolving credit facility in the maximum principal amount of $200 million under the Prior Credit Agreement.


The Credit Agreement has a maturity date of September 18, 2018 and includes a one year extension option. Borrowings under the Credit Agreement bear interest on the outstanding principal amount at a rate equal to LIBOR plus 1.50% to 2.20%, depending on the consolidated leverage ratio outlined below. In addition, the Credit Agreement includes an unused fee equal to 0.15% or 0.25% per annum, which is determined by usage under the Credit Agreement.
The Credit Agreement contains financial covenants that, among other things, require compliance with leverage and coverage ratios and maintenance of minimum tangible net worth, as well as covenants that may limit our and the Trust's ability to incur additional debt or make distributions. The Trust may, at any time, voluntarily prepay any loan under the Credit Agreement in whole or in part without premium or penalty. As of December 31, 2014, the Trust was in compliance with all financial covenants.
The Credit Agreement includes customary representations and warranties by us, the Trust and each other guarantor and imposes customary covenants on us, the Trust and each other guarantor. The Credit Agreement also contains customary events of default, and if an event of default occurs and continues, we are subject to certain actions by the administrative agent, including without limitation, the acceleration of repayment of all amounts outstanding under the Credit Agreement.
The Credit Agreement provides for revolving credit loans to the Operating Partnership. Base Rate Loans, Adjusted LIBOR Rate Loans and Letters of Credit (each, as defined in the Credit Agreement) will be subject to interest rates, based upon the consolidated leverage ratio of us, the Trust, and our subsidiaries as follows:
Consolidated Leverage Ratio
Adjusted LIBOR Rate Loans
and Letter of Credit Fee
Base Rate Loans
<35%
LIBOR + 1.50%0.50%
>35% and <45%
LIBOR + 1.65%0.65%
>45% and <45%
LIBOR + 1.75%0.75%
>45% and <50%
LIBOR + 1.85%0.85%
>50% and <55%
LIBOR + 2.00%1.00%
>55%LIBOR + 2.20%1.20%
We may, at any time, voluntarily prepay any loan under the unsecured revolving credit facility in whole or in part without premium or penalty.
The unsecured revolving credit facility contains financial covenants that, among other things, require compliance with loan-to-value, leverage and coverage ratios and maintenance of minimum tangible net worth, as well as covenants that may limit our ability to incur additional debt or make distributions. The unsecured revolving credit facility also contains customary events of default. Any event of default, if not cured or waived, could result in the acceleration of any outstanding indebtedness under the unsecured revolving credit facility.
As of December 31, 2014, there were $138 million of borrowings outstanding under our unsecured revolving credit facility and $189 million available for us to borrow without adding additional properties to the unencumbered borrowing base of assets, as defined by the Credit Agreement.
As of March 9, 2015, there were no borrowings outstanding under our unsecured revolving credit facility and $327 million is available for us to borrow without adding additional properties to the unencumbered borrowing base of assets, as defined by the Credit Agreement.operations.
 
Seasonality
 
Our business has not been, and we do not expect it to become, subject to material seasonal fluctuations.
 
Employees
At December 31, 2017, we had 63 full-time employees, none of whom are subject to a collective bargaining agreement. We believe that relations with our employees are positive.

Environmental Matters
 
As an owner of real estate, we are subject to various federal, state, and local environmental laws, regulations, and ordinances and also could be liable to third parties as a result of environmental contamination or noncompliance at our properties even if we no longer own such properties. See the discussion under Item 1A, “Risk Factors,” under the caption “Environmental compliance costs and liabilities associated with owning, leasing, developing and operating our properties may affect our results of operations.”


11




Certain Government Regulations

Overview
 
Our tenants and operators are typically subject to extensive and complex federal, state, and local healthcare laws and regulations relating to fraud and abuse practices, government reimbursement, licensure, and certificate of need and similar laws governing the operation of healthcare facilities, and we expect that the healthcare industry, in general, will continue to face increased regulation and pressure in the areas of fraud, waste and abuse, cost control, healthcare management, and provision of services, among others. These regulations are wide-ranging and can subject our tenants and operators to civil, criminal and administrative sanctions. Affected tenants and operators may find it increasingly difficult to comply with this complex and evolving regulatory environment because of a relative lack of guidance in many areas as certain of our healthcare properties are subject to oversight from several government agencies and the laws may vary from one jurisdiction to another. Changes in laws and regulations, reimbursement enforcement activity and regulatory non-compliance by our tenants and operators can all have a significant effect on their operations and financial condition, which in turn may adversely impact us, as detailed below and set forth under Item 1A, “Risk Factors,” under the caption “The healthcare industry is heavily regulated, and new laws or regulations, changes to existing laws or regulations, loss of licensure, or failure to obtain licensure could adversely impact our company and result in the inability of our tenants to make rent payments to us.”

BasedIn 2017, Congress came within a single vote of repealing of the Affordable Care Act (the “ACA”) and substantially reducing funding to the Medicaid program. New legislation is likely to be introduced proposing similar changes, if not full repeal, in 2018. Beyond this, significant changes to commercial health insurance and government-sponsored insurance (i.e., Medicare and Medicaid) remain possible. Commercial and government payors are likely to continue imposing larger discounts and tighter cost controls upon operators, through changes in reimbursement rates and methodologies, discounted fee structures, the assumption by healthcare providers of all or a portion of the financial risk or otherwise. A shift toward less comprehensive health insurance coverage and increased consumer cost-sharing on information primarily provided by our tenants and operators as of December 31, 2014 we estimate that approximately 47%health expenditures could have a material adverse effect on certain of our hospitaloperators’ liquidity, financial condition, and long-term acute care hospital tenants’results of operations and, operators’ revenues were dependent on Medicare reimbursement.
in turn, their ability to satisfy their contractual obligations, including making rental payments under and otherwise complying with the terms of our leases.
The following is a discussion of certain laws and regulations generally applicable to our operators, and in certain cases, to us.
 
Healthcare Legislation

Health Reform Laws.  On March 23, 2010, President Obama signed into law the Patient Protection and Affordable Care Act of 2010 (the “Affordable Care Act”) and the Health Care and Education Reconciliation Act of 2010, which amends the Affordable Care Act (collectively with other subsequently enacted federal health care laws and regulations, the “Health Reform Laws”). The Health Reform Laws contain various provisions that may directly impact us or the operators and tenants of our properties. Some provisions of the Health Reform Laws may have a positive impact on our operators’ or tenants’ revenues, by, for example, increasing coverage of uninsured individuals, while others may have a negative impact on the reimbursement of our operators or tenants by, for example, altering the market basket adjustments for certain types of health care facilities. The Health Reform Laws also enhance certain fraud and abuse penalty provisions that could apply to our operators and tenants, in the event of one or more violations of the federal health care regulatory laws. In addition, there are provisions that impact the health coverage that we and our operators and tenants provide to our respective employees. The Health Reform Laws also provide additional Medicaid funding to allow states to carry out the expansion of Medicaid coverage to certain financially-eligible individuals beginning in 2014, and have also permitted states to expand their Medicaid coverage to these individuals since April 1, 2010, if certain conditions are met. On June 28, 2012, the United States Supreme Court upheld the individual mandate of the Health Reform Laws but partially invalidated the expansion of Medicaid. The ruling on Medicaid expansion allows states not to participate in the expansion-and to forego funding for the Medicaid expansion-without losing their existing Medicaid funding. As of December 31, 2017, 18 states have pursued this option. The participation by states in the Medicaid expansion could have the dual effect of increasing our tenants’ revenues, through new patients, but could also further strain state budgets. While the federal government paid for approximately 100% of those additional costs from 2014 to 2016, states now are expected to pay for part of those additional costs. 

Challenges to the Health Reform Laws and Potential Repeal and/or Further Reforms under Trump Administration.  Since the enactment of the Health Care Laws, there have been multiple attempts through legislative action and legal challenge to repeal or amend the Health Reform Laws, including the case that was before the U.S. Supreme Court, King v. Burwell.  Although the Supreme Court in Burwell upheld the use of subsidies to individuals in federally-facilitated health care exchanges on June 25, 2015, which ultimately did not disrupt significantly the implementation of the Health Reform Laws, we cannot predict whether other current or future efforts to repeal, amend or challenge the validity of all or part of the Health Reform

Laws will be successful, nor can we predict the impact that such a repeal, amendment or challenge would have on our operators or tenants and their ability to meet their obligations to us.

In 2017, President Trump and Congress unsuccessfully sought to repeal and replace the Affordable Care Act. On January 20, 2017, President Trump issued an Executive Order stating that it is the administration’s official policy to repeal the Affordable Care Act and instructing the Secretary of Health and Human Services and the heads of all other executive departments and agencies with authority and responsibility under the Affordable Care Act to, among other matters, delay implementation of or grant an exemption from any provision of the Affordable Care Act that would impose a fiscal burden on any state or a cost, fee, tax, penalty, or regulatory burden on individuals, families, healthcare providers, health insurers, patients, and others. On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was signed into law. The Tax Act, among other things, reduces the Affordable Care Act’s individual mandate penalty to zero beginning in 2019. The elimination of the penalties does not remove the requirement to obtain healthcare coverage; however, without penalties there effectively will be no enforcement. It is expected that Congress will continue to consider other legislation to repeal the Affordable Care Act or repeal and replace some or all elements of the Affordable Care Act.

We cannot predict the effect of either the Executive Order or the Tax Act’s 2019 repeal of the individual mandate penalty on the Affordable Care Act, or whether Congress’ attempt to repeal or repeal and replace the law will be successful. Further, we cannot predict how the Affordable Care Act might be amended or modified, either through the legislative or judicial process, and how any such modification might impact our tenants’ operations or the net effect of this law on us. If the operations, cash flows or financial condition of our operators and tenants are materially adversely impacted by any repeal or modification of the law, our revenue and operations may be materially adversely affected as well.

Fraud and Abuse Enforcement
 
There are various extremely complex federal and state laws and regulations governing healthcare providers’ relationships and arrangements and prohibiting fraudulent and abusive practices by such providers. These laws include (i) federal and state false claims acts, which, among other things, prohibit providers from filing false claims or making false statements to receive payment from Medicare, Medicaid or other federal or state healthcare programs, (ii) federal and state anti-kickback and fee-splitting statutes, including the Medicare and Medicaid anti-kickback statute, which prohibit the payment or receipt of remuneration to induce referrals or recommendations of healthcare items or services, (iii) federal and state physician self-referral laws (commonly referred to as the “Stark Law”), which generally prohibit referrals by physicians to entities with which the physician or an immediate family member has a financial relationship, (iv) the federal Civil Monetary Penalties Law, which prohibits, among other things, the knowing presentation of a false or fraudulent claim for certain healthcare services and (v) federal and state privacy laws, including the privacy and security rules contained in the Health Insurance Portability and Accountability Act of 1996, which provide for the privacy and security of personal health information. Violations of healthcare fraud and abuse laws carry civil, criminal and administrative sanctions, including punitive sanctions, monetary penalties, imprisonment, denial of Medicare and Medicaid reimbursement, and potential exclusion from Medicare, Medicaid or other federal or state healthcare programs. These laws are enforced by a variety of federal, state, and local agencies and can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or “whistleblower” actions. Many of our operators and tenants are subject to these laws, and some of them may in the future become the subject of governmental enforcement actions if they fail to comply with applicable laws.
 
Reimbursement
 
Sources of revenue for many of our tenants and operators include, among other sources, governmental healthcare programs, such as the federal Medicare program and state and Medicaid programs,program, and non-governmental payors, such as insurance carriers and HMOs. As federal and state governments focus on healthcare reform initiatives, and as the federal government and many states face significant budget deficits, efforts to reduce costs by these payors will likely continue, which may result in reduced or slower growth in reimbursement for certain services provided by some of our tenants and operators.

We cannot predict whether future Congressional proposals will seek to reduce physician reimbursements. Efforts by other payors to reduce healthcare costs are likely to continue, which may result in reductions or slower growth in reimbursement for certain services provided by some of our tenants. Further, revenue realizable under third-party payor agreements can change after examination and retroactive adjustment by payors during the claims settlement process or as a result of post-payment audits. For example, payors may disallow requests for reimbursement based on determinations that certain costs are not reimbursable or reasonable, because additional documentation is necessary or because certain services were not covered or were not medically necessary. The Healthcare Reform Laws and regulatory changes could impose further limitations on government and private payments to healthcare providers. In some cases, states have enacted or are considering enacting measures designed to reduce their Medicaid expenditures and to make changes to private healthcare insurance. In

addition, the failure of any of our tenants to comply with various laws and regulations could jeopardize their ability to continue participating in Medicare, Medicaid and other government sponsored payment programs. The financial impact on our tenants’ failure to comply with such laws and regulations could restrict their ability to make rent payments to us.
 
Healthcare Licensure and Certificate of Need
 
Certain healthcare facilities in our portfolio are subject to extensive federal, state and local licensure, certification and inspection laws, and regulations. In addition, various licenses and permits are required to dispense narcotics, operate pharmacies and laboratories, handle radioactive materials, and operate equipment. Many states require certain healthcare providers to obtain a certificate of need, which requires prior approval for the construction, expansion, and closure of certain healthcare facilities. The

approval process related to state certificate of need laws may impact some of our tenants’ and operators’ abilities to expand or change their businesses.


Available Information
 
The Trust'sOur website address is www.docreit.com.  The Trust makesWe make available, free of charge through the Investor Relations portion of itsthe website, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) as soon as reasonably practicable after the Trust or we electronically file such material with, or furnish such materialsit to, the Securities and Exchange Commission (the “SEC” or the “Commission”). Reports of beneficial ownership filed pursuant to Section  16(a) of the Exchange Act are also available on thisour website. These reports and other information are also available, free of charge, at www.sec.gov. Alternatively, the public may read and copy any materials we or the Trust file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330.
 
In addition, the Trust'sTrust’s board of trustees has established a Code of Business Conduct and Ethics that applies to the Trust'sour officers, including itsour Chief Executive Officer and President and Chief Financial Officer, its trustees, and its employees. The Code of Business Conduct and Ethics provides a statement of the Company’s policies and procedures for conducting business legally and ethically. A copy of the Code of Business Conduct and Ethics is available in the Investor Relations section of the Trust'sour website (www.docreit.com) under the tab “Governance Documents.” Any amendments to or waivers from the Code of Business Conduct and Ethics will be disclosed on the Trust'sour website. Information contained on the Trust'sour website is not part of this report.

14


ITEM 1A. RISK FACTORS
 
The following summarizes the material risks of purchasing or owning our securities. Additional unknown risks may also impair our financial performance and business operations. Our business, financial condition, and/or results of operation may be materially adversely affected by the nature and impact of these risks. In such case, the market value of our securities could be detrimentally affected, and investors may lose part or all of the value of their investment. You should carefully consider the risks and uncertainties described below.

We have grouped these risk factors into the following general categories:

Risks related to our business;
Risks related to the healthcare industry; 

Risks related to the real estate industry; 

Risks related to financings;

Risks related to our formationportfolio and structure; and 

Risks related to our general partner's qualification and operation as a REIT.
 
Risks Related To Our Business
We are recently formed and have a very limited operating history; therefore there is no assurance that we will be able to achieve our investment objectives.
We commenced operations on July 24, 2013 and have a very limited operating history. We are subject to all of the business risks and uncertainties associated with any new business, including the risk that we will not achieve our investment objectives as described in this report and that the value of your investment could decline substantially. Our financial condition and results of operations will depend on many factors, including the availability of investment opportunities, readily accessible short and long-term financing, conditions in the financial markets and economic conditions generally. There can be no assurance that we will be able to generate sufficient cash flow over time to pay our operating expenses and make distributions to shareholders.



Our real estate investments are concentrated in healthcare properties, making us more vulnerable economically than if our investments were diversified in other segments of the economy.
 
We acquire, own, manage, operate and selectively develop properties for lease primarily to physicians, hospitals, and healthcare delivery systems. We are subject to risks inherent in concentrating investments in real estate, and further from the risks resulting from a lackconcentration of diversification become even greater as a result of our business strategy to concentrate our investments in the healthcare sector. Any adverse effects that result from these risks could be more pronounced than if we diversified our investments outside of healthcare properties. Given our concentration in this sector, our tenant base is especially concentrated and dependent upon the healthcare industry generally, and any industry downturn could adversely affect the ability of our tenants to make lease payments and our ability to maintain current rental and occupancy rates. Our tenant mix could become even more concentrated if a significant portion of our tenants practice in a particular medical field or are reliant upon a particular healthcare delivery system. Accordingly, a downturn in the healthcare industry generally, or in the healthcare relatedhealthcare-related facility specifically, could adversely affect our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares.
 
Economic and other conditions that negatively affect geographic areas in which we conduct business, and in particular Texas, and other areas to which a greater percentage of our revenue is attributed could materially adversely affect our business, results of operations, and financial condition.condition.
For the year ended December 31, 2014, approximately 41% of our total annualized rent was derived from properties located in Texas (23%) and metro Atlanta, Georgia (18%).   The Texas properties are concentrated in El Paso and Plano.
As a result of these geographic concentrations, we are particularly exposed to downturns in these local economies or other changes in local real estate market conditions. Any material change in the current payment programs or regulatory, economic, environmental or competitive conditions in either of these areas could have a disproportionate effect on our overall business results. In the event of negative economic or other changes in either of these markets, our business, financial condition and results of operations, our ability to make distributions to our OP Unit holders and the trading price of our general partner's common shares may be adversely affected.
We may not realize the benefits that we anticipate from focusing on healthcare properties that are strategically aligned with a healthcare delivery system and from the relationships established through such strategic alignments.
As part of our business strategy, we focus on healthcare properties that are strategically aligned with a healthcare delivery system by (i) seeking to acquire, own, manage, and develop healthcare properties that are located on medical campuses where the underlying land is owned by a healthcare delivery system or by us, or (ii) seeking to acquire, own, manage, and develop healthcare properties located in close proximity to a healthcare delivery system or strategically aligned with a healthcare delivery system through leasing or other arrangements. We may not realize the benefits that we anticipate as a result of these strategic relationships. In particular, we may not obtain or realize increased rents, or reduced tenant turnover rates as compared to healthcare properties that are not strategically aligned. Moreover, building a portfolio of healthcare properties that are strategically aligned does not assure the success of any given property. The associated healthcare delivery system may not be successful and the strategic alignment that we seek for our healthcare properties could dissolve, and we may not succeed in replacing them. If we do not realize the benefits that we anticipate from this focus and those strategic alignments dissolve and we are not successful in replacing them, our reputation, business, financial results and prospects may be adversely affected.
Adverse economic or other conditions in the geographic markets in which we conduct business could negatively affect our occupancy levels and rental rates and therefore our operating results.

Our operating results depend upon our ability to maintain and increase occupancy levels and rental rates at our properties. Adverse economic or other conditions in the geographic markets in which we operate, including periods of economic slowdown or recession, industry slowdowns, periods of deflation, relocation of businesses, changing demographics, earthquakes and other natural disasters, fires, terrorist acts, civil disturbances or acts of war, and other man-made disasters which may result in uninsured or underinsured losses, and changes in tax, real estate, zoning, and other laws and regulations, may lower our occupancy levels and limit our ability to increase rents or require us to offer rental concessions. The failure
For the year ended December 31, 2017, approximately 1.9 million of our gross leasable area and $46.9 million of our total annualized base rent was derived from properties located in Texas (13.8% of our gross leasable area and 16.4% of our total annualized base rent). As a result of these geographic concentrations, we are particularly exposed to generate revenues sufficient to meet our cash requirements, including operating anddownturns in the Texas economy or other expenses, debt service and capital expenditures, maychanges in local real estate market conditions. Any material change in the current payment programs or regulatory, economic, environmental, or competitive conditions in Texas could have an adversea disproportionate effect on our overall business results. In the event of negative economic or other changes in any of the markets in which we conduct business, our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares.shares may be adversely affected.

Our healthcare properties and tenants face competition from nearby hospitals and other healthcare properties, and we may not realize the benefits that we anticipate from focusing on healthcare properties that are strategically aligned with a healthcare delivery system and from the relationships established through such strategic alignments. Further, we may not be able to maintain or expand our relationships with our existing and future hospital and healthcare delivery system clients.
As part of our business strategy, we focus on healthcare properties that are strategically aligned with a healthcare delivery system by (i) seeking to acquire, own, manage, and develop healthcare properties that are located on medical campuses where the underlying land is owned by a healthcare delivery system or by us, or (ii) seeking to acquire, own, manage, and develop healthcare properties located in close proximity to a healthcare delivery system or strategically aligned with a healthcare delivery system through leasing or other arrangements. We may not realize the benefits that we anticipate as a result of these strategic relationships, such as increased rents and reduced tenant turnover rates as compared to healthcare properties that are not strategically aligned. Moreover, building a portfolio of healthcare properties that are strategically aligned does not assure the success of any given property. The associated healthcare delivery system may not be successful and the strategic alignment that we seek for our healthcare properties could dissolve, and we may not succeed in replacing them. In addition, our healthcare properties, the associated healthcare delivery systems with which our healthcare properties are strategically aligned, and our tenants may be unable to compete successfully with nearby hospitals, medical practices, other healthcare properties that provide comparable services, pharmacies and other retailers that may initiate or expand healthcare clinic operations and services to compete with our tenants. Any of our properties may be materially and adversely affected if the healthcare delivery system with which it is strategically aligned is unable to compete successfully. If we do not realize the benefits that we anticipate from our business strategy and our strategic alignments dissolve and we are not successful in replacing them, our reputation, business, financial results, and prospects may be adversely affected.

The success of our business depends, to a large extent, on our current and future relationships with hospital and healthcare delivery system clients. We invest a significant amount of time to develop, maintain and be responsive to these relationships, and our relationships have helped us to secure acquisition and development opportunities, as well as other advisory, property management, and projects, with both new and existing clients. If our relationships with hospital or health system clients deteriorate, if a conflict of interest or non-compete arrangement prevents us from expanding these relationships, or if a hospital on or near whose campus one of our properties is located fails or becomes unable to meet its financial obligations, the business of our tenants could be adversely affected or our ability to secure new acquisition and development opportunities or other advisory, property management, and hospital project management projects could be adversely impacted and our professional reputation within the industry could be damaged.

Any failure, inability, or unwillingness by our tenants to pay rent or other amounts under leases could materially adversely affect our financial results; we may have difficulty finding suitable replacement tenants in the event of a tenant default or non-renewal of our leases, especially for our properties located in smaller markets.


Our portfolio of healthcare properties is leased to physicians, hospitals, healthcare delivery systems, and other healthcare providers. We cannot provide assurance that our tenants will have sufficient assets, income and access to financing to enable them to satisfy their respective obligations to us, and any failure, inability or unwillingness by our tenants to do so could adversely affect our financial results. We have had tenants pay us rent late or fail to pay rent, which has adversely affected our financial results.

We cannot predict whether our tenants will renew or extend existing leases beyond their current terms. Nearly all of our properties are subject to leases which have multi-year terms. As of December 31, 2014,2017, leases representing 2.8%, 3.6%2.9% and 2.2%3.9% of leasable square feet at our properties will expire in the 2015, 20162018 and 2017, respectively.2019, respectively, and leases representing 0.1% of leasable square feet had expired as of December 31, 2017. If any of our leases are not renewed or extended, or if a tenant defaults under the terms of its lease or becomes insolvent, we would attempt to leaserelet those spaces or properties to another tenant.other tenants or new tenants. In case of non-renewal, we generally have advance notice before expiration of the lease term to arrange for reletting or repositioning of the spaces or the properties and our tenants are required to continue to perform all of their obligations (including the payment of all rental amounts) forunder the non-renewed assetsleases until such expiration. However, following expiration of a lease term or if we exercise our right to replace a tenant in default, rental payments on the related properties could decline or cease altogether while we relet or reposition the spaces or the properties with a suitable replacement tenant.tenants. We also might not be successful in identifying suitable replacement tenants or entering into leases with new tenants on a timely basis or on terms as favorable to us as our current leases, or at all, and we may be required to fund certain expenses and obligations (e.g., real estate taxes, debt costs, and maintenance expenses) to preserve the value of, and avoid the imposition of liens on, our properties while they are being relet or repositioned. Our ability to relet or reposition our properties, or spaces within our properties, with a suitable tenanttenants could be significantly delayed or limited by state licensing, receivership, certificate of need or other laws, as well as by the Medicare and Medicaid change-of-ownership rules. We could also incur substantial additional expenses in connection with any licensing, receivership, or change-of-ownership proceedings. In addition, our ability

to locate suitable replacement tenants could be impaired by the specialized healthcare uses or contractual restrictions on use of the properties, and we may be required to spend substantial amounts to adapt the properties to other uses. Any such delays, limitations and expenses could adversely impact our ability to collect rent, obtain possession of leased properties, or otherwise exercise remedies for tenant default and could have a material adverse effect on us or cause us to take an impairment charge on a property.
 
All of these risks may be greater in smaller markets, where there may be fewer potential replacement tenants, making it more difficult to replace tenants, especially for specialized spaces, like hospital or outpatient treatment facilities located in our properties, and could have a material adverse effect on us.

We may fail to complete any pending acquisitions, whichIf the business, financial position or results of operations of CHI or one or more of our CHI-affiliated tenants suffer or are adversely affected, it could have a material adverse impacteffect on our business, financial position, or results of operations, earnings and cash flow.operations. 

As of December 31, 2017, approximately 18.7% of our total annualized base rent is from tenants affiliated with CHI.
    
From timeAlthough CHI is not a party to time, we enter into definitivenor a guarantor of the related lease agreements, to acquire healthcare propertiesit controls each of the subsidiaries and affiliates that are structured as bifurcated transactions (i.e.,parties to the master lease agreement, which was entered into in connection with the closing of the transaction does not occur attransactions. Given this control, if CHI’s business, financial position or results of operations suffer or are adversely affected, it could adversely affect CHI’s ability to provide any financial or operational support for the timesubsidiaries and affiliates it controls, which could adversely affect one or more of the signingCHI-affiliated tenants’ ability to pay rent to us. Additionally, if CHI’s business, financial position or results of operations were to suffer or its credit ratings were to be downgraded, it could cause investors to lose confidence in our ability to collect rent from the definitive agreement). The acquisition of any such properties are subjectCHI-affiliated tenants and could cause our stock price to customary closing conditions, anddecline. Moreover, there can be no assurance that those conditionsCHI’s subsidiaries and affiliates will be satisfiedhave sufficient assets, income, and access to financing to enable them to satisfy their payment obligations under their lease agreements. The inability of CHI’s subsidiaries and affiliates to meet their rent obligations could materially adversely affect our business, financial position, or thatresults of operations including our ability to pay dividends to our stockholders as required to maintain our status as a REIT. The inability of CHI’s subsidiaries and affiliates to satisfy their other obligations under their lease agreements such as the acquisitions will close on the terms that may be described or at all. Pending acquisitions, whether or not successful, require substantial timepayment of taxes, insurance, and attention from management. Furthermore, any such pending acquisitions require significant expense, including expenses for due diligence, legal and accounting fees and other costs. In the event we do not complete any pending acquisitions, these expenses will not be offset by revenues from the investments and we may have issued a significant number of additional common shares without realizing a corresponding increase in earnings and cash flow from the investments. As a result, our failure to complete pending acquisitionsutilities could have a material adverse impacteffect on the condition of the leased properties as well as on our business, financial condition,position, and results of operations. For these reasons, if CHI were to experience a material adverse effect on its business, financial position, or results of operations, our business, financial position, or results of operations could also be materially adversely affected.

Failure by CHI’s subsidiaries and affiliates to comply with the market priceterms of our general partner's common shares.
We may be unabletheir lease agreements or to successfully acquire or developcomply with the healthcare regulations to which the leased properties and expand ourCHI’s operations into neware subject could require us to find other lessees for any affected leased properties and there could be a decrease or existing markets.
We intend to explore acquisitions or developmentscessation of properties in newrental payments by CHI’s subsidiaries and existing geographic markets. These acquisitions and developments could divert management’s attention from our existing properties, andaffiliates. In such event, we may be unable to retain key employees or attract highly qualified new employees. In addition, we may not possess familiarity with the dynamics and prevailing conditions of any new geographic markets which could adversely affect our abilitylocate suitable replacement lessees willing to successfully expand into or operate within those markets. For example, new markets may have different insurance practices, reimbursementpay similar rental rates and local real estate, zoning and development regulations than those with which we are familiar. We may find ourselves more dependent on third parties in new markets because our distance could hinder our ability to directly and efficiently manage and otherwise monitor new properties in new markets. Our expansion into new markets could result in unexpected costs or delays as well as lower occupancy rates and other adverse consequences. We may not be successful in identifying suitable properties or other assets which meet our acquisition or development criteria or in consummating acquisitions or developments on satisfactory terms or at all, for a numberwhich would have the effect of reasons, including, among other things, unsatisfactory results ofreducing our due diligence investigations, failure to obtain financing for the acquisition or development on favorable terms or at all,rental revenues and our misjudgment of the value of the opportunities. We may also be unable to successfully integrate the operations of acquired properties, maintain consistent standards, controls, policies and procedures, or realize the anticipated benefits of the acquisitions within the anticipated timeframe or at all. If we are unsuccessful in expanding into new or our existing markets, it could materially adversely affect our business, financial condition andposition, or results of operations, our ability to make distributions to our OP Unit holders and the trading price of our general partner's common shares.operations.



We may not be successful in identifying and completing off-market acquisitions and other suitable acquisitions or investment opportunities, which may impede our growth and adversely affect our business, financial condition, and results of operations and our ability to make distributions to our OP Unit holders.shareholders.
 
An important component of our growth strategy is to acquire “off-market” properties before they are widely marketed by the owners. Facilities that are acquired off-market are typically more attractive to us as a purchaser because of the absence of a formal marketing process, which could lead to higher prices or other unattractive terms. If we cannot obtain off-market deal flow in the future, our ability to locate and acquire facilities at attractive prices could be adversely affected. We expect to compete with many other entities engaged in real estate investment activities for acquisitions of healthcare properties, including national, regional, and local operators, acquirers and developers of healthcare-related real estate properties.properties, and other investors such as private equity firms, some of whom may have greater financial resources and lower costs of capital than we do. The competition for healthcare-related real estate properties may significantly increase the price that we must pay for healthcare properties or other assets that we seek to acquire, and our competitors may succeed in acquiring those properties or assets themselves. In addition, our potential acquisition targets may find our competitors to be more attractive because they may have greater resources, may be willing to pay more for the properties, or may have a more compatible operating philosophy. In particular, larger REITs that target healthcare properties may enjoy significant competitive advantages that result from, among other things, a lower cost of capital, enhanced operating efficiencies, more personnel and market penetration, and familiarity with markets. In addition, the number of entities and the amount of funds competing for suitable investment properties may increase. Increased competition would result in increased demand for these assets and therefore likely would increase prices

paid for them. Those higher prices for healthcare properties or other assets may adversely affect our returns from our investments.

 During 2017, we saw an increased level of competition for healthcare properties and, as a result, an increase in prices paid for them. In turn, this has had a negative impact on the initial cash yields on potential asset acquisitions. We seek to invest in stabilized medical facility assets with initial cash yields of 5.0% to 9.0%, although we invested in certain medical facility assets in 2017 with anticipated initial cash yields below 5.0% and we may invest in other medical facility assets with initial cash yields outside of this range.

Some of our existing properties and properties we acquire in the future are and may be subject to ground lease or other restrictions on the use of the space. If we are required to undertake significant capital expenditures to procure new tenants, then our business and results of operations may suffer.

SixSeventy-eight of our properties, (Mid Coast Hospital, Valley West Hospital, Crescent City Surgical Centre, Ortho One — Columbus, Berger Medical Center, and Carmel Medical Pavilion), representing approximately 9%39.1% of our total leasable square feet and 11%36.9% of our annualized revenue based on rental payments for the month ended December 31, 2014,2017, are subject to ground leases that contain certain restrictions. These restrictions include limits on our ability to re-let our initial properties to tenants not affiliated with the healthcare delivery system that owns the underlying property, rights of purchase and rights of first offer and refusal with respect to sales of the property and limits on the types of medical procedures that may be performed. In addition, lower than expected rental rates upon re-letting could impede our growth. We may not be able to re-let space on terms that are favorable to us or at all. Further, we may be required to undertake significant capital expenditures to renovate or reconfigure space to attract new tenants. If we are unable to promptly re-let our initial properties, if the rates upon such re-letting are significantly lower than expected, or if we are required to undertake significant capital expenditures in connection with re-letting, our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares may be adversely affected.
Our healthcare properties, the associated healthcare delivery systems with which our healthcare properties are strategically aligned and our tenants may be unable to compete successfully.
Our healthcare properties and the associated healthcare delivery systems with which our healthcare properties are strategically aligned often face competition from nearby hospitals and other healthcare properties that provide comparable services. In addition, pharmacies and other retailers may initiate or expand healthcare clinic operations and services to compete with our tenants in the provision of healthcare delivery systems.  Any of our properties may be materially and adversely affected if the healthcare delivery system with which it is strategically aligned is unable to compete successfully. There are numerous factors that determine the ability of a healthcare delivery system to compete successfully, most of which are outside of our control.
Similarly, our tenants face competition from other medical practices and service providers at nearby hospitals and other healthcare properties. From time to time and for reasons beyond our control, managed care organizations may change their lists of preferred hospitals or in-network physicians. Physicians also may change hospital affiliations. If competitors of our tenants or competitors of the associated healthcare delivery systems with which our healthcare properties are strategically aligned have greater geographic coverage, improve access and convenience to physicians and patients, provide or are perceived to provide higher quality services, recruit physicians to provide competing services at their facilities, expand or improve their services or obtain more favorable managed care contracts, our tenants may not be able to successfully compete. Any reduction in rental revenues resulting from the inability of our tenants or the associated healthcare delivery systems with which our healthcare properties are strategically aligned to compete in providing medical services and/or receiving sufficient rates of reimbursement for healthcare services rendered could have an adverse effect on our business, financial condition and results of

operations, our ability to make distributions to our OP Unit holders and the trading price of our general partner's common shares.

We may in the future make investments in development projects, which may not yield anticipated returns which could directly affect our operating results and reduce the amount of funds available for distributions.
A component of our growth strategy is exploring development opportunities, some of which may arise through strategic joint ventures. In deciding whether to make an investment in a particular development, we make certain assumptions regarding the expected future performance of that property. To the extent that we consummate development opportunities, our investment in these projects will be subject to the following risks:
we may be unable to obtain financing for development projects on favorable terms or at all;
we may not complete development projects on schedule or within budgeted amounts;
we may encounter delays in obtaining or fail to obtain all necessary zoning, land use, building, occupancy, environmental and other governmental permits and authorizations, or underestimate the costs necessary to develop the property to market standards;
development or construction delays may provide tenants the right to terminate preconstruction leases or cause us to incur additional costs;
volatility in the price of construction materials or labor may increase our development costs;
hospitals or health systems may maintain significant decision-making authority with respect to the development schedule;
we may incorrectly forecast risks associated with development in new geographic regions;
tenants may not lease space at the quantity or rental rate levels projected;
demand for our development project may decrease prior to completion, including due to competition from other developments; and
lease rates and rents at newly developed properties may fluctuate based on factors beyond our control, including market and economic conditions.
If our investments in development projects do not yield anticipated returns for any reason, including those set forth above, our business, financial condition and results of operations, our ability to make distributions to our OP Unit holders and the trading price of our general partner's common shares may be adversely affected.
We may in the future make investments in joint ventures, which could be adversely affected by our lack of decision-making authority, our reliance upon our joint venture partners’ financial condition, any disputes that may arise between us and our joint venture partners and our exposure to potential losses from the actions of our joint venture partners.
We may in the future make co-investments with third parties through partnerships, joint ventures or other entities, acquiring noncontrolling interests in or sharing responsibility for the management of the affairs of a property, partnership, joint venture or other entity. Joint ventures generally involve risks not present with respect to our wholly-owned properties, including the following:
our joint venture partners may make management, financial and operating decisions with which we disagree or that are not in our best interest;
we may be prevented from taking actions that are opposed by our joint venture partners;
our ability to transfer our interest in a joint venture to a third party may be restricted;

our joint venture partners might become bankrupt or fail to fund their share of required capital contributions which may delay construction or development of a healthcare related facility or increase our financial commitment to the joint venture;
our joint venture partners may have business interests or goals with respect to the healthcare related facility that conflict with our business interests and goals which could increase the likelihood of disputes regarding the ownership, management or disposition of the healthcare related facility;

disputes may develop with our joint venture partners over decisions affecting the healthcare related facility or the joint venture which may result in litigation or arbitration that would increase our expenses and distract our officers and/or trustees from focusing their time and effort on our business and possibly disrupt the daily operations of the healthcare related facility; and
we may suffer losses as a result of the actions of our joint venture partners with respect to our joint venture investments.
Joint venture investments involve risks that may not be present with other methods of ownership. In addition to those risks identified above, our partners might at any time have economic or other business interests or goals that are or become inconsistent with our interests or goals; that we could become engaged in a dispute with our partners, which could require us to expend additional resources to resolve such disputes and could have an adverse impact on the operations and profitability of the joint venture; and that our partners may be in a position to take action or withhold consent contrary to our instructions or requests. In addition, our ability to transfer our interest in a joint venture to a third party may be restricted. In the future, in certain instances, we or our partners may have the right to trigger a buy-sell arrangement, which could cause us to sell our interest, or acquire our partners’ interest, at a time when we otherwise would not have initiated such a transaction. Our ability to acquire our partners’ interest may be limited if we do not have sufficient cash, available borrowing capacity or other capital resources. In such event, we may be forced to sell our interest in the joint venture when we would otherwise prefer to retain it. Joint ventures may require us to share decision-making authority with our partners, which could limit our ability to control the properties in the joint ventures. Even when we have a controlling interest, certain major decisions may require partner approval, such as the sale, acquisition or financing of a property.
RIDEA and operating properties.
We may invest in senior housing facilities or other properties, structured, where applicable, in compliance with RIDEA or other applicable REIT laws or regulations. If so, we will be exposed to various operational risks with respect to those operating properties that may increase our costs or adversely affect our ability to generate revenues. These risks include fluctuations in patient volume and occupancy, Medicare and Medicaid reimbursement, if applicable, and private pay rates; economic conditions; competition; federal, state, local, and industry-regulated licensure, certification and inspection laws, regulations, and standards; the availability and increases in cost of general and professional liability insurance coverage; state regulation; the availability and increases in cost of labor (as a result of unionization or otherwise) and other risks applicable to operating businesses. Any one or a combination of these factors may adversely affect our revenue and operations.
We may not be able to control our operating costs or our expenses may remain constant or increase, even if our revenue does not increase, which could cause our results of operations to be adversely affected.
Factors that may adversely affect our ability to control operating costs include the need to pay for insurance and other operating costs, including real estate taxes, which could increase over time, the need periodically to repair, renovate and re-let space, the cost of compliance with governmental regulation, including zoning and tax laws, the potential for liability under applicable laws, interest rate levels and the availability of financing. Certain costs associated with real estate investments may not be reduced even if a healthcare related facility is not fully occupied or other circumstances cause our revenues to decrease. If our operating costs increase as a result of any of the foregoing factors, our results of operations may be adversely affected.

Uninsured losses or losses in excess of our insurance coverage could adversely affect our financial condition and our cash flows.
 
We maintain comprehensive liability, fire, flood, earthquake, wind (as deemed necessary or as required by our lenders), extended coverage, and rental loss insurance with respect to our initial properties. Certain types of losses, however, may be either uninsurable or not economically insurable, such as losses due to earthquakes, riots, acts of war, or terrorism. Should an uninsured loss occur, we could lose both our investment in and anticipated profits and cash flows from a healthcare relatedhealthcare-related facility. If any such loss is insured, we may be required to pay a significant deductible on any claim for recovery of such

a loss prior to our insurer being obligated to reimburse us for the loss, or the amount of the loss may exceed our coverage for the loss. In addition, future lenders may require such insurance, and our failure to obtain such insurance could constitute a default under loan agreements. We may determine not to insure some or all of our properties at levels considered customary in our industry, and which would expose us to an increased risk of loss. As a result, our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares may be adversely affected.


Environmental compliance costs and liabilities associated with owning, leasing, developing, and operating our properties may affect our results of operations.

Under various U.S. federal, state, and local laws, ordinances, and regulations, current and prior owners and tenants of real estate may be jointly and severally liable for the costs of investigating, remediating, and monitoring certain hazardous substances or other regulated materials on or in such property. In addition to these costs, the past or present owner or tenant of a property from which a release emanates could be liable for any personal injury or property damage that results from such releases, including for the unauthorized release of asbestos-containing materials and other hazardous substances into the air, as well as any damages to natural resources or the environment that arise from such releases. These environmental laws often impose such liability without regard to whether the current or prior owner or tenant knew of, or was responsible for, the presence or release of such substances or materials. Moreover, the release of hazardous substances or materials, or the failure to properly remediate such substances or materials, may adversely affect the owner’s or tenant’s ability to lease, sell, develop, or rent such property or to borrow by using such property as collateral. Persons who transport or arrange for the disposal or treatment of hazardous substances or other regulated materials may be liable for the costs of removal or remediation of such substances at a disposal or treatment facility, regardless of whether or not such facility is owned or operated by such person.
 
Certain environmental laws impose compliance obligations on owners and tenants of real property with respect to the management of hazardous substances and other regulated materials. For example, environmental laws govern the management and removal of asbestos-containing materials and lead-based paint. Failure to comply with these laws can result in penalties or other sanctions. If we incur substantial costs to comply with these environmental laws or we are held liable under these laws,

our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares may be adversely affected.
 
Costs associated with complying with the Americans with Disabilities Act of 1990We may result in unanticipated expenses.
Under the Americans with Disabilities Act of 1990, or the ADA, all places of public accommodation are requiredbe unable to meet certain U.S. federal requirements related to access and use by disabled persons. A number of additional U.S. federal, state and local laws may also require modifications to our healthcare properties, or restrict certain further renovations of the buildings, with respect to access thereto by disabled persons. Noncompliance with the ADA could result in the imposition of fines, an award of damages to private litigants and/or an order to correct any non-complying featuremake distributions which could result in substantial capital expenditures. We have not conducted a detailed audit or investigationdecrease in the market price of our common shares.

Substantially all of our assets are held through the Operating Partnership, which holds substantially all of its properties and assets through subsidiaries. Our Operating Partnership’s cash flow is dependent upon cash distributions to determine our compliance,it by its subsidiaries, and we cannot predictin turn, substantially all of the ultimate costTrust’s cash flow is dependent upon cash distributions to it by the Operating Partnership. The creditors of compliance with the ADA or other legislation. If one or moreeach of our properties is not in compliance with the ADA or other related legislation, then we woulddirect and indirect subsidiaries are entitled to payment of that subsidiary’s obligation to them, as and when due and payable, before distributions may be requiredmade by that subsidiary to incur additional costs to bring the facility into compliance. If we incur substantial costs to comply with the ADA or other related legislation,its equity holders. Therefore, our business, financial condition and results of operations, ourOperating Partnership’s ability to make distributions to ourholders of OP Units depends on its subsidiaries’ ability first to satisfy their obligations to their creditors and then to make distributions to the Operating Partnership. Furthermore, holders of Series A Preferred Units are entitled to receive preferred distributions before payment of distributions to OP Unit holders, including the Trust. Finally, the Trust’s ability to pay dividends to holders of common shares depends upon our Operating Partnership’s ability to first satisfy its obligations to its creditors and then to make distributions to the tradingTrust.
While we expect to make regular quarterly distributions to the holders of our common shares, if sufficient cash is not available for distribution from our operations, we may have to fund distributions from working capital, borrow to provide funds for such distributions, or reduce the amount of such distributions. To the extent we borrow to fund distributions, our future interest costs would increase, thereby reducing our earnings and cash available for distributions from what they otherwise would have been. If cash available for distribution generated by our assets is less than expected, or if such cash available for distribution decreases in future periods from expected levels, our inability to make distributions could result in a decrease in the market price of our general partner's common shares may be adversely affected.
Acquiring outstanding mortgagesshares. All distributions are made at the discretion of our board of trustees. Any inability to make distributions, or other debt secured by a healthcare related facility or land suitable for development as a healthcare related facility may expose us to risks of costs and delays in acquiring the underlying property.
We may decide to acquire outstanding mortgages or other debt secured by a healthcare related facility or land suitable for development as a healthcare related facility from lenders and investors if we believe we can ultimately foreclose or otherwise acquire ownership of the underlying property in the near-term through foreclosure, deed-in-lieu of foreclosure or other means. However, if we do acquire such debt, borrowers may seek to assert various defenses to our foreclosure or other actions and we may not be successful in acquiring the underlying property on a timely basis, ormake distributions at all, in which event we could incur significant costs and experience significant delays in acquiring such properties, all of which could adversely affect our financial performance and reduce our expected returns from such investments. In addition, we may not earn a current return on such investments particularly if the mortgage or other debt that we acquire is in default.
We have now, and may havelevels in the future, exposure to contingent rent escalators, which can hinder our growth and profitability.

We receive a significant portion of our revenues by leasing our assets under long-term triple-net leases in which the rental rate is generally fixed with annual escalations. Leases in the future may contain escalators contingent upon the achievement of specified revenue parameters or based on changes in the Consumer Price Index. If, as a result of weak economic conditions or other factors, the revenues generated by our triple-net-leased properties do not meet the specified parameters or the Consumer Price Index does not increase, our growth and profitability will be hindered by these leases.

We may not be able to maintain or expand our relationships with our existing and future hospital and healthcare delivery system clients.
The success of our business depends, to a large extent, on our current and future relationships with hospital and healthcare delivery system clients. We invest a significant amount of time to develop, maintain and be responsive to these relationships, and our relationships have helped us to secure acquisition and development opportunities, as well as other advisory, property management and projects, with both new and existing clients. If our relationships with hospital or health system clients deteriorate, or if a conflict of interest or non-compete arrangement prevents us from expanding these relationships, our ability to secure new acquisition and development opportunities or other advisory, property management and hospital project management projects could be adversely impacted and our professional reputation within the industry could be damaged.
Our investments in real estate-related investments will be subject to the risks typically associated with real estate, which may have a material effect on your investment.
Our loans held for investment generally will be directly or indirectly secured by a lien on real property, or the equity interests in an entity that owns real property, that, upon the occurrence of a default on the loan, could result in our acquiring ownership ofa decrease in the property. We will not know whether the values of the properties ultimately securing our loans will remain at or above the levels existing on the dates of origination of those loans. If the values of the underlying properties decline, our risk will increase because of the lower value of the security associated with such loans. In this manner, real estate values could impact the valuesmarket price of our loan investments. Any investments in mortgage-related securities, collateralized debt obligations and other real estate-related investments (including potential investments in real property) may be similarly affected by real estate property values. Therefore, our investments will be subject to the risks typically associated with real estate.common shares.
The value of real estate may be adversely affected by a number of risks, including:
natural disasters, such as hurricanes, earthquakes and floods;
acts of war or terrorism, including the consequences of terrorist attacks, such as those that occurred on September 11, 2001;
adverse changes in national and local economic and real estate conditions;
an oversupply of (or a reduction in demand for) space in the areas where particular properties are located and the attractiveness of particular properties to prospective tenants; 

changes in governmental laws and regulations, fiscal policies and zoning ordinances and the related costs of compliance therewith and the potential for liability under applicable laws; 

costs of remediation and liabilities associated with environmental conditions affecting properties; and the potential for uninsured or underinsured property losses.
The value of each property is affected significantly by its ability to generate cash flow and net income, which in turn depends on the amount of rental or other income that can be generated net of expenses required to be incurred with respect to the property. Many expenditures associated with properties (such as property taxes, operating expenses and capital expenditures) cannot be reduced when there is a reduction in income from the properties. These factors may have a material adverse effect on the ability of the borrowers to pay their loans, as well as on the value that we can realize from assets we own or acquire.
Our investments in, or originations of, senior debt or mezzanine debt will be subject to the specific risks relating to the particular company and to the general risks of investing in real estate-related loans and securities, which may result in significant losses.

We may invest in, or originate, senior debt or mezzanine debt. These investments will involve special risks relating to the particular borrower, including its financial condition, liquidity, results of operations, business and prospects. In particular, the debt securities may not be collateralized and also may be subordinated to the entity’s other obligations. We are likely to invest in debt securities of companies that are not rated or are rated non-investment grade by one or more rating agencies. Investments that are not rated or are rated non-investment grade have a higher risk of default than investment grade rated assets and therefore may result in losses to us. We have not adopted any limit on such investments.
These investments also will subject us to the risks inherent with real estate investments referred to previously, including:
risks of delinquency and foreclosure, and risks of loss in the event thereof;

the dependence upon the successful operation of, and net income from, real property;
risks generally incident to interests in real property; and
risks specific to the type and use of a particular property.
These risks may adversely affect the value of our investments and the ability of our borrowers to make principal and interest payments in a timely manner, or at all, and could result in significant losses.

Cybersecurity incidents could disrupt our business and result in the compromise of confidential informationinformation.
 
Our business is at risk from and may be impacted by cybersecurity attacks, including attempts to gain unauthorized access to our confidential data, and other electronic security breaches. Such cyber attacks can range from individual attempts to gain unauthorized access to our information technology systems to more sophisticated security threats. While we employ a number of measures to prevent, detect and mitigate these threats, there is no guarantee such efforts will be successful in preventing a cyber attack. Cybersecurity incidents could disrupt our business and compromise confidential information and of ours and third parties, including our tenants.

We may not be able to sustain our growth rate level.

Since our inception in 2013 through December 31, 2017, our compounded annual growth rate was 120.0%. This growth rate has contributed significantly to our growth in revenue. While we expect to continue to grow through property acquisitions and investments as our asset base continues to increase, we expect our annual growth rate to decelerate in the future. Over time we may experience a decline in our growth rate as a result of various factors, including changes in the economic and other conditions in geographic markets in which we conduct business, changes in the real estate market, changes in healthcare regulations, and the competitiveness of the real estate market. Additionally, our significant growth has resulted in increased levels of responsibility for our management, who may experience additional demands related to managing our current properties portfolio.

Our ability to issue equity to expand our business will depend, in part, upon the market price of our common shares, and our failure to meet market expectations with respect to our business could negatively affect the market price of our common shares and thereby limit our ability to raise capital and our issuance of equity securities could decrease the per share market price of our common shares.
The availability of equity capital to us will depend, in part, upon the market price of our common shares which, in turn, will depend upon various market conditions and other factors that may change from time to time. Our failure to meet the market’s expectation with regard to future earnings and cash distributions would likely adversely affect the market price of our common shares and, as a result, the cost and availability of equity capital to us.
In addition, the vesting of any restricted shares granted to trustees, executive officers, and other employees under our 2013 Equity Incentive Plan, the issuance of our common shares or OP Units in connection with future property, portfolio or business acquisitions, and other issuances of our common shares may cause dilution to our shareholders and could have an

adverse effect on the per share market price of our common shares and may adversely affect the terms upon which we may be able to obtain additional capital through the sale of equity securities.

Increases in interest rates may increase our interest expense and adversely affect our cash flows, our ability to service our indebtedness and our ability to make distributions to our shareholders, and could cause our stock price to decline. Failure to hedge effectively against interest rate changes may adversely affect our results of operations.

One of the factors that influences the market price of our common shares is the dividend yield on common shares (as a percentage of the price of our common shares) relative to market interest rates. In response to the global financial crisis, the U.S. Federal Reserve took actions which resulted in low interest rates prevailing in the marketplace for a historically long period of time. Since December 2015, the U.S. Federal Reserve has raised its benchmark interest rate by a quarter of a percentage point five times to a range of 1.25% to 1.50% and is projected to raise its benchmark interest rate several times in 2018. Further increases in market interest rates may lead prospective purchasers of our common shares to expect a higher dividend yield (with a resulting decline in the market price of our common shares) and higher interest rates would likely increase our borrowing costs for both our existing and future indebtedness and potentially decrease funds available for distribution. Thus, higher market interest rates could cause the market price of our common shares to decrease.
Additionally, as of December 31, 2017, we had approximately $108.5 million of variable-rate indebtedness outstanding that has not been swapped for a fixed interest rate and we expect that more of our indebtedness in the future, including borrowings under our unsecured revolving credit facility since December 31, 2017 and thereafter, will be subject to variable interest rates. Increases in interest rates on any variable rate indebtedness will increase our interest expense, which could adversely affect our cash flow and our ability to pay distributions to our shareholders.
In certain cases, we may seek to manage our exposure to interest rate volatility by using interest rate hedging arrangements. Hedging involves risks, such as the risk that the counterparty may fail to honor its obligations under an arrangement, that the arrangements may not be effective in reducing our exposure to interest rate changes, and that a court could rule that such an agreement is not legally enforceable. In addition, we may be limited in the type and amount of hedging transactions that we may use in the future by our need to satisfy the REIT income tests under the Code. Failure to hedge effectively against interest rate changes may have an adverse effect on our business, financial condition, results of operations, our ability to make distributions to our shareholders, and the market price of our common shares.

The income from certain of our properties is dependent on the ability of our property managers to successfully manage those properties.

We depend upon the performance of our property managers to effectively manage certain of our properties and real estate assets. We do not control these third party property managers, and are accordingly subject to various risks generally associated with outsourcing of management of day-to-day activities. The income we recognize from any properties managed by third party property managers is dependent on the ability of the property manager of such property to successfully manage the property, which such property management is not within our control. Property managers generally compete with other companies in the management of properties, with respect to the quality of care provided, reputation, physical appearance of the property, and price and location, among other attributes. A property manager’s inability to successfully compete with other companies on one or more of the foregoing aspects could adversely impact our business and results of operations. Additionally, because we do not control third party property managers, any adverse events such as issues related to insufficient internal controls, cybersecurity incidents, or other adverse events may impact the income we recognize from properties managed by such third party property managers. We may be unable to anticipate such events or properly assess the magnitude of any such events because we do not control third party property managers who provide property management services to us.


20


Risks Related to the Healthcare Industry
 
The healthcare industry is heavily regulated, and new laws or regulations, changes to existing laws or regulations, loss of licensure, or failure to obtain licensure could adversely impact our company and result in the inability of our tenants to make rent payments to us.
 
The healthcare industry is heavily regulated by U.S. federal, state and local governmental authorities. Our tenants generally are subject to laws and regulations covering, among other things, licensure, certification for participation in government programs, billing for services, privacy and security of health information, and relationships with physicians and other referral sources. In addition, new laws and regulations, changes in existing laws and regulations or changes in the interpretation of such laws or regulations could negatively affect our financial condition and the financial condition of our tenants. These changes, in some cases, could apply retroactively. The enactment, timing, or effect of legislative or regulatory changes cannot be predicted.

The Affordable Care Act is changing how healthcare services are covered, delivered, and reimbursed through expanded coverage of uninsured individuals and reduced Medicare program spending. In addition, the new lawit reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement. The complexities and ramifications of the Affordable Care Act are significant and are being implemented in a phased approach which began in 2010. At this time, it isIt remains difficult to predict the full effects of the Affordable Care Act and its impact on our business, our revenues, and financial condition and those of our tenants due to the law’s complexity, lack of implementing regulations or interpretive guidance, gradual implementation, partial repeal, and possible amendment.full repeal. Further, we are unable to foresee how individuals and businesses will respond to the choices afforded them by the Affordable Care Act.Act, or the effect of any potential changes made to the Affordable Care Act or other healthcare laws and programs. The Affordable Care Act could adversely affect the reimbursement rates received by our tenants, the financial success of our tenants and strategic partners and consequently us.

On June 28,In 2012, the United States Supreme Court upheld the individual mandate of the Affordable Care Act but partially invalidated the expansion of Medicaid. The ruling on Medicaid expansion allow states not to participate in the expansion (and to forego funding for the Medicaid expansion) without losing their existing Medicaid funding. While the U.S. federal government will paypaid for approximately 100% of those additional costs from 2014 to 2016, states will benow are expected to

pay a small percentage of those additional costs beginning in 2017.costs. Because the U.S. federal government substantially funds the Medicaid expansion, it is unclear how many states ultimately will elect this option. As of January 2018, 32 states and Washington, D.C. have elected to participate in the Medicaid expansion. The participation by states in the Medicaid expansion could have the effect of increasing some of our tenants’ revenues but also could be a strain on U.S. federal government and state budgets.

On March 4, 2015,In 2017, President Trump and Congress unsuccessfully sought to repeal and replace the United States Supreme Court (“USSC”) will consider in King v. Burwell (Docket No. 14-114) whether the U.S. Internal Revenue Service may extend tax credits subsidies to health insurance purchased through exchanges established by the U.S. federal government under Section 1321 of the Patient Protection and Affordable Care Act. IfOn January 20, 2017, President Trump issued an Executive Order stating that it is the USSC rules the subsidies are not permitted byadministration’s official policy to repeal the Affordable Care Act millionsand instructing the Secretary of Americans who purchasedHealth and Human Services and the heads of all other executive departments and agencies with authority and responsibility under the Affordable Care Act to, among other matters, delay implementation of or grant an exemption from any provision of the Affordable Care Act that would impose a fiscal burden on any state or a cost, fee, tax, penalty, or regulatory burden on individuals, families, healthcare providers, health insurance coverage residinginsurers, patients, and others. On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was signed into law. The Tax Act, amongst other things, repeals the Affordable Care Act’s individual mandate penalty beginning in 34 states2019. The elimination of the penalties does not remove the requirement to obtain healthcare coverage; however, without penalties there effectively will be no enforcement. It is expected that Congress will continue to consider other legislation to repeal the Affordable Care Act or repeal and replace some or all elements of the Affordable Care Act.

We cannot predict the effect of either the Executive Order or the Tax Act’s 2019 repeal of the individual mandate penalty on the Affordable Care Act, or whether Congress’ attempt to repeal or repeal and replace the law will be successful. Further, we cannot predict how the Affordable Care Act might be amended or modified, either through the legislative or judicial process, and how any such modification might impact our tenants’ operations or the net effect of this law on us. If the operations, cash flows, or financial condition of our operators and tenants are materially adversely impacted by any repeal or modification of the law, our revenue and operations may be materially adversely affected as well.


Recent changes to healthcare laws and regulations, including to government reimbursement programs such as Medicare and reimbursement rates applicable to our current and future tenants, could defaulthave a material adverse effect on their obligation to pay for their health insurance coveragethe financial condition of our tenants and, thusconsequently, their ability to pay for health care services. Such default could adversely affect our tenants and their abilitymeet obligations to pay rent to usus.

Annual statutoryStatutory and regulatory policy changes and decisions may impact one or more specific unique providers that lease space in any of our facilities. For example, on April 1, 2014,In particular, the President signed into law the Protecting Accessfollowing recent changes to Medicare Act of 2014, which in part amendedhealthcare laws and regulations may apply to our tenants:
Recent amendments to an existing statutory moratorium on the establishment of new long-term care hospitals (“LTCH”), the establishment of new LTCH satellite facilities, and bed increases within such existing facilities, effective for the period April 1, 2014which is in effect through September 30, 2017. The present moratorium is similar to a moratorium that expired December 28, 2012, but unlike the expired moratorium, does not include any exceptions that would allow for bed increases at existing LTCHs or LTCH satellite facilities. Pursuant to the new law, limited exceptions apply to the moratorium on the establishment of new LTCHs and new LTCH satellite facilities. To qualify for the exception, a hospital or entity must have satisfied one of the following: (1) begun its qualifying period for payment as an LTCH; (2) entered into a binding written agreement with an outside, unrelated party for the actual construction, renovation, lease or demolition for an LTCH, and have expended, before April 1, 2014, at least 10 percent of the estimated cost of the project or, if less, $2.5 million; or (3) obtained a certificate of need, as may be required, in a certificate-of-need state. The Centers for Medicare and Medicaid Services (CMS) has issued a proposed rule addressing the moratorium and exceptions thereto but to date no final rule has been implemented. This law directly applies to our existing tenant, LifeCare Hospitals in each of Plano, Texas, Fort Worth, Texas and Pittsburgh, Pennsylvania facilities but does not directly31, 2017, could impact any of our existing facilities, as it only applies to the Medicare participation of facilities that are not already participating in the Medicare program as LTCHs.
The Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”) reforms Medicare payment policy for services paid under the Medicare physician fee schedule and adopts a series of policy changes affecting a wide range of providers and suppliers. MACRA repeals the sustainable growth rate (the “SGR”) formula effective January 1, 2015, and establishes a new payment framework which may impact payment rates for our tenants, including LTCHs.
The Bipartisan Budget Act of 2013 establishes new payment limits for Medicare patients discharged from an LTCH who do not meet specified criteria. For any Medicare patient who does not meet the new criteria, the LTCH will be paid a lower “site-neutral” payment rate, which may impact the financial condition of tenants affected by the lower payment rate. Additionally, new rules may cause all discharges from LTCHs to be paid at the site-neutral rate if the number of discharges for which payment is made under the site-neutral payment rate is greater than 50% of the total number of discharges from the LTCH.
The Bipartisan Budget Act of 2015 (H.R. 1314) (the “BBA”) provides changes to the requirements for providers who seek “hospital outpatient department” (“HOPD”) reimbursement under Medicare. The 2015 BBA generally requires providers who seek to qualify for HOPD to be located on the campus of the hospital that seeks such HOPD, which generally is higher than reimbursement for providers that do not qualify as HOPD providers. The BBA specifically grandfathers HOPD providers in existence as of November 2, 2015 and does not change such HOPD providers’ eligibility for HOPD reimbursement.
We have a number of existing tenants that may be reimbursed as HOPD providers and but for the grandfathering protection of the BBA, may not be eligible for HOPD reimbursement in the future. Any provider who establishes a new HOPD location after November 2, 2015 will be subject to the BBA requirements and if any such provider does not satisfy the new requirements, then such provider will be reimbursed for claims billed on or after January 1, 2017 at generally lower reimbursement levels. Failure to comply with the BBA requirements could adversely affect the ability of certain of our tenants to make rent payments to us, which may have an adverse effect on our business, financial condition, and results of operations, our ability to make distributions to our shareholders, and the market price of our common shares.
The Affordable Care Act instituted a market basket payment adjustment to LTCHs. In fiscal years 2017 through 2019, the market basket update will be reduced by 0.75%. The Affordable Care Act specifically allows these market basket reductions to result in a less than 0% payment update and payment rates that are less than the prior year. MACRA sets the annual update for fiscal year 2018 at 1% after taking into account the market basket payment reduction of 0.75% mandated by the Affordable Care Act.
These regulatory changes may have an adverse financial impact on the net operating revenues and profitability of many LTCHs for cost reporting periods beginning on or after July 1, 2016, which could have an impact on their ability to pay rent due to us.
Many states also regulate the establishment and construction of healthcare facilities and services, and the expansion of existing healthcare facilities and services through certificate of need, or CON, laws, which by way of example may include regulation of certain types of beds, medical equipment, and capital expenditures. Under such laws, the applicable state regulatory body must determine a need exists for a project before the project can be undertaken. If oneany of our tenants seeks to undertake a CON-regulated project, but isare not authorized by the applicable regulatory body to proceed with the project, the tenant wouldthese tenants could be prevented from operating in itstheir intended manner.manner and could be materially adversely affected.
FailureThe application of lower reimbursement rates to our tenants or failure to qualify for existing rates under certain exceptions, the failure to comply with these laws and regulations, or the failure to secure CON approval to undertake a desired project could adversely affect our tenants’ ability to make rent payments to us which may have an adverse effect on our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares.

Adverse trends in healthcare provider operations may negatively affect our lease revenues and our ability to make distributions to our OP Unit holders.shareholders.
The healthcare industry is currently experiencing, among other things:
changes in the demand for and methods of delivering healthcare services;
changes in third party reimbursement methods and policies;
consolidation and pressure to integrate within the healthcare industry through acquisitions and joint ventures; and
increased scrutiny of billing, referral and other practices by U.S. federal and state authorities.


These factors may adversely affect the economic performance of some or all of our tenants and, in turn, our lease revenues, which may have a material adverse effect on our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares.


Reductions in reimbursement from third party payors, including Medicare and Medicaid, could adversely affect the profitability of our tenants and hinder their ability to make rent payments to us or renew their lease.
 
Sources of revenue for our tenants typically include the U.S. federal Medicare program, state Medicaid programs, private insurance payors and health maintenance organizations. Healthcare providers continue to face increased government and private payor pressure to control or reduce healthcare costs and significant reductions in healthcare reimbursement, including reduced reimbursements and changes to payment methodologies under the Affordable Care Act. The Congressional Budget Office, or CBO, estimates the reductions required by the Affordable Care Act over the next ten years will include $415 billion in cuts to Medicare fee-for-service payments, the majority of which will come from hospitals, and that some hospitals will become insolvent as a result of the reductions. In some cases, private insurers rely upon all or portions of the Medicare payment systems to determine payment rates which may result in decreased reimbursement from private insurers.
 
The slowdown in the United States economy has negatively affected state budgets, thereby putting pressure on states to decrease spending on state programs including Medicaid. The need to control Medicaid expenditures may be exacerbated by the potential for increased enrollment in state Medicaid programs due to unemployment and declines in family incomes. Historically, states have often attempted to reduce Medicaid spending by limiting benefits and tightening Medicaid eligibility requirements. Many states have adopted, or are considering the adoption of, legislation designed to enroll Medicaid recipients in managed care programs and/or impose additional taxes on hospitals to help finance or expand the states’ Medicaid systems. Potential reductions to Medicaid program spending in response to state budgetary pressures could negatively impact the ability of our tenants to successfully operate their businesses.
 
Efforts by payors to reduce healthcare costs will likely continue which may result in reductions or slower growth in reimbursement for certain services provided by some of our tenants. A reduction in reimbursements to our tenants from third party payors for any reason could adversely affect our tenants’ ability to make rent payments to us which may have a material adverse effect on our businesses, financial condition and results of operations, our ability to make distributions to our OP Unit holdersshareholders and the tradingmarket price of our general partner's common shares.

Our tenants and our company are subject to fraud and abuse laws, the violation of which by a tenant may jeopardize the tenant’s ability to make rent payments to us.
 
There are various federal and state laws prohibiting fraudulent and abusive business practices by healthcare providers who participate in, receive payments from, or are in a position to make referrals in connection with government-sponsored healthcare programs, including the Medicare and Medicaid programs. Our lease arrangements with certain tenants may also be subject to these fraud and abuse laws.
These laws include without limitation:
the Federal Anti-Kickback Statute, which prohibits, among other things, the offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, the referral of any federal or state healthcare program patients;

the Federal Physician Self-Referral Prohibition (commonly called the “Stark Law”), which, subject to specific exceptions, restricts physicians who have financial relationships with healthcare providers from making referrals for designated health services for which payment may be made under Medicare or Medicaid programs to an entity with which the physician, or an immediate family member, has a financial relationship;

the False Claims Act, which prohibits any person from knowingly presenting false or fraudulent claims for payment to the federal government, including under the Medicare and Medicaid programs;

the Civil Monetary Penalties Law, which authorizes the Department of Health and Human Services to impose monetary penalties for certain fraudulent acts; and

state anti-kickback, anti-inducement, anti-referral and insurance fraud laws which may be generally similar to, and potentially more expansive than, the federal laws set forth above.

Violations of these laws may result in criminal and/or civil penalties that range from punitive sanctions, damage assessments, penalties, imprisonment, denial of Medicare and Medicaid payments, and/or exclusion from the Medicare and Medicaid programs. In addition, the Affordable Care Act clarifies that the submission of claims for items or services generated in violation of the Anti-Kickback Statute constitutes a false or fraudulent claim under the False Claims Act. The federal

government has taken the position, and some courts have held, that violations of other laws, such as the Stark Law, can also be a violation of the False Claims Act. Additionally, certain laws, such as the False Claims Act, allow for individuals to bring whistleblower actions on behalf of the government for violations thereof. Imposition of any of these penalties upon one of our tenants or strategic partners could jeopardize that tenant’s ability to operate or to make rent payments or affect the level of occupancy in our healthcare properties, which may have a material adverse effect on our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares. Further, we enter into leases and other financial relationships with healthcare delivery systems that are subject to or impacted by these

laws. We also have other investors who are healthcare providers in certain of our subsidiaries that own our healthcare properties. If any of our relationships, including those related to the other investors in our subsidiaries, are found not to comply with these laws, we and our physicianhealthcare provider investors may be subject to civil and/or criminal penalties.
 
Our healthcare-related tenants may be subject to significant legal actions that could subject them to increased operating costs and substantial uninsured liabilities, which may affect their ability to pay their rent payments to us, and we could be subject to healthcare industry violations.
 
As is typical in the healthcare industry, our tenants may often become subject to claims that their services have resulted in patient injury or other adverse effects. Many of these tenants may have experienced an increasing trend in the frequency and severity of professional liability and general liability insurance claims and litigation asserted against them. The insurance coverage maintained by these tenants may not cover all claims made against them nor continue to be available at a reasonable cost, if at all. In some states, insurance coverage for the risk of punitive damages arising from professional liability and general liability claims and/or litigation may not, in certain cases, be available to these tenants due to state law prohibitions or limitations of availability. As a result, these types of tenants of our healthcare properties and healthcare-related facilities operating in these states may be liable for punitive damage awards that are either not covered or are in excess of their insurance policy limits.
 
We also believe that there has been, and will continue to be, an increase in governmental investigations of certain healthcare providers, particularly in the area of Medicare/Medicaid false claims, as well as an increase in enforcement actions resulting from these investigations. Insurance is not available to cover such losses. Any adverse determination in a legal proceeding or governmental investigation, any settlements of such proceedings, or investigations in excess of insurance coverage, whether currently asserted or arising in the future, could have a material adverse effect on a tenant’s financial condition. If a tenant is unable to obtain or maintain insurance coverage, if judgments are obtained or settlements reached in excess of the insurance coverage, if a tenant is required to pay uninsured punitive damages, or if a tenant is subject to an uninsurable government enforcement action or investigation, the tenant could be exposed to substantial additional liabilities, which may affect the tenant’s ability to pay rent, which in turn could have a material adverse effect on our business, financial condition, and results of operations, our ability to pay distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares. We could also be subject to costly government investigations or other enforcement actions which could have a material adverse effect on our business, financial condition, and results of operations, our ability to pay distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares.
 
Risks Related to the Real Estate Industry
 
Our operating performance is subject to risks associated with the real estate industry.
 
Real estate investments are subject to various risks and fluctuations and cycles in value and demand, many of which are beyond our control. Certain events may decrease cash available for distributions as well as the value of our initial properties. These events include, but are not limited to:

vacancies or our inability to rent space on favorable terms, including possible market pressures to offer tenants rent abatements, tenant improvements, early termination rights, or tenant-favorable renewal options;
inability to collect rent from tenants;
competition from other real estate investors with significant capital, including other real estate operating companies, REITs, and institutional private equity or other investment funds;
reductions in the level of demand for healthcare properties and changes in the demand for certain healthcare-related properties;
increases in the supply of medical office space;

increases in expenses associated with our real estate operations, including, but not limited to, insurance costs, third party management fees, energy prices, real estate assessments, and other taxes and costs of compliance with laws, regulations and governmental policies, and restrictions on our ability to pass such expenses on to our tenants; and
changes in, and changes in interpretation or enforcement of, laws, regulations, and governmental policies associated with real estate, including, without limitation, health, safety, environmental, real estate and zoning and tax laws, increases in real property tax rates and taxation of REITs, governmental fiscal policies, and the ADA.

In addition, periods of economic slowdown or recession, such as the recent U.S. economic downturn, rising interest rates or declining demand for real estate, or the public perception that any of these events may occur, could result in a general decline in rents or an increased incidence of defaults under existing leases. If we cannot operate our properties to meet our financial expectations, our business, financial condition, results of operations, cash flow, per share tradingmarket price of the general partner'sour common shares, and ability to satisfy our debt service obligations and to make distributions to our OP Unit holdersshareholders could be adversely affected.


Illiquidity of real estate investments could significantly impede our ability to respond to adverse changes in the performance of any of our properties.
 
Because real estate investments are relatively illiquid, our ability to promptly sell one or more of our properties in response to changing economic, financial, and investment conditions is limited. The real estate market is affected by many factors, such as general economic conditions, availability of financing, interest rates, and other factors, including supply and demand, that are beyond our control. We cannot predict whether we will be able to sell any of our properties for the price or on the terms set by us or whether any price or other terms offered by a prospective purchaser would be acceptable to us. We also cannot predict the length of time needed to find a willing purchaser and to close the sale of any of our properties. We may be required to expend funds to correct defects or to make improvements before a property can be sold. We cannot assure you that we will have funds available to correct those defects or to make those improvements.
 
In acquiring a property, we may agree to transfer restrictions that materially restrict us from selling that property for a period of time or impose other restrictions, such as a limitation on the amount of debt that can be placed on that property. These transfer restrictions would impede our ability to sell a property even if we deem it necessary or appropriate. These facts and any others that would impede our ability to respond to adverse changes in the performance of our properties may have an adverse effect on our business, financial condition, results of operations, or ability to make distributions to our OP Unit holdersshareholders and the tradingmarket price of the general partner'sour common shares.
 
Uncertain market conditions could cause us to sell our healthcare properties at a loss in the future.
 
We intend to hold our various real estate investments until such time as we determine that a sale or other disposition appears to be advantageous to achieve our investment objectives. The Trust'sOur senior management team and itsthe Trust’s board of trustees may exercise their discretion as to whether and when to sell a healthcare related facility, and we will have no obligation to sell our buildings at any particular time. We generally intend to hold our healthcare properties for an extended period of time, and we cannot predict with any certainty the various market conditions affecting real estate investments that will exist at any particular time in the future. Because of the uncertainty of market conditions that may affect the future disposition of our healthcare properties, we may not be able to sell our properties at a profit in the future or at all. In addition, if we are unable to access the capital markets for financing in the future, we may need to sell some of our properties to raise capital. We may incur prepayment penalties in the event that we sell a property subject to a mortgage earlier than we otherwise had planned. Additionally, we could be forced to sell healthcare properties at inopportune times which could result in us selling the affected property at a substantial loss. Accordingly, the extent to which youwe will receivepay cash distributions and realize potential appreciation on our real estate investments will, among other things, be dependent upon fluctuating market conditions. Any inability to sell a healthcare property could adversely impact our ability to make debt payments and our ability distributions to our OP Unit holders.shareholders.
 
Our assets may be subject to impairment charges.
 
We will periodically evaluate our real estate investments and other assets for impairment indicators. The judgment regarding the existence of impairment indicators is based upon factors such as market conditions, tenant performance, and legal structure. For example, the termination of a lease by a major tenant may lead to an impairment charge. If we determine that an impairment has occurred, we would be required to make an adjustment to the net carrying value of the asset, which could have an adverse effect on our results of operations in the period in which the impairment charge is recorded. We recognizedrecorded a $0.3

$1.0 million impairment loss on a vacant medical office building in Pickerington, Ohio, and a $1.5 million impairment loss on a medical office building in Lansing, Michigan. Both properties are vacant. The fair market value of the Ohio property was determined based on an accepted arms-length offer to purchase the property and the fair market value of the Lansing, Michigan property was determined by a third party valuation firm. For both properties, the impairment was assessed because the property’s carrying amount exceeded its estimated fair value.Port Charlotte, Florida during 2017.


Our investments in, or originations of, mezzanine and term loans will be subject to specific risks relating to the particular company, and our loan assets will involve greater risks of loss than senior loans secured by income-producing properties.
 
WeAs of December 31, 2017, we have originatedten mezzanine loans and two mezzanineterm loans outstanding, and in the future, we may originate further mezzanine loans orloans. These investments involve special risks relating to the particular borrower, including its financial condition, liquidity, results of operations, business, and prospects. We may also originate other real estate-related investments which take the form of subordinated loans secured by second mortgages on the underlying property or loans secured by a pledge of the ownership interests of either the entity owning the property or a pledge of the ownership interests of the entity

that owns the interest in the entity owning the property.property or other properties. These types of assets involve a higher degree of risk than long-term senior mortgage lending secured by income producing real property, because the loan may become unsecured as a result of foreclosure by the senior lender and because it is in second position and there may not be adequate equity in the property. In the event of a bankruptcy of the entity providing the pledge of its ownership interests as security, we may not have full recourse to the assets of such entity, or the assets of the entity may not be sufficient to satisfy such mezzanine loan. If a borrower defaults on a mezzanine loan or debt senior to our loan, or in the event of a borrower bankruptcy, such mezzanine loan will be satisfied only after the senior debt. We may be unable to enforce guaranties of payment and/or performance given as security for some mezzanine loans. As a result, we may not recover some or all of our initial expenditure. Mezzanine and term loans may partially finance the construction of real estate projects and so involve additional risks inherent in the construction process, such as adherence to budgets and construction schedules. In addition, mezzanine and term loans may have higher loan-to-value ratios than conventional mortgage loans, resulting in less equity in the property and increasing the risk of loss of principal. Significant losses related to our mezzanine and term loans would result in operating losses for us and may limit our ability to make distributions to our OP Unit holders.shareholders.
 
Risks Related to Financings
 
Required payments of principal and interest on borrowings may leave us with insufficient cash to operate our properties or to pay the distributions currently contemplated or necessary for the Trust to qualify as a REIT and may expose us to the risk of default under our debt obligations.

We historically borrow on our unsecured revolving credit facility to acquire properties. Then, as market conditions dictate, we have issued equity or long-term fixed rate debt to repay borrowings under our unsecured revolving credit facility. We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited. 

As of December 31, 2014,2017, we had approximately $78.1$186.7 million of mortgage debt on individual properties. During January 2015, we have assumed an additional $5.8properties and approximately $330.0 million of mortgage debtborrowings outstanding under our unsecured credit facility. In addition, in connection with a property acquisition.January 2016, August 2016, March 2017 and December 2017 we issued and sold $150.0 million, $75.0 million, $400.0 million, and $350.0 million, respectively, aggregate principal amount of senior notes. We expect to incur additional debt in the future. We do not anticipate that our internally generated cash flow will be adequate to repay our existing indebtedness upon maturity, and, therefore, we expect to repay our indebtedness through refinancings and future offerings of equity and debt securities, either of which we may be unable to secure on favorable terms or at all. Our level of debt and the limitations imposed upon us by our debt agreements could have adverse consequences, including the following:
 
our cash flow may be insufficient to meet our required principal and interest payments;
we may be unable to borrow additional funds as needed or on favorable terms, including to make acquisitions;
we may be unable to refinance our indebtedness at maturity or the refinancing terms may be less favorable than the terms of our original indebtedness;
because a portion of our debt bears, or is expected to bear, interest at variable rates, an increase in interest rates could materially increase our interest expense;
we may fail to effectively hedge against interest rate volatility;
we may be forced to dispose of one or more of our properties, possibly on disadvantageous terms if we are able to do so at all;
after debt service, the amount available for distributions to our OP Unit holders is reduced;
our leverage could place us at a competitive disadvantage compared to our competitors who have less debt;

we may experience increased vulnerability to economic and industry downturns, reducing our ability to respond to changing business and economic conditions;
we may default on our obligations and the lenders or mortgagees may foreclose on our properties that secure their loans and receive an assignment of rents and leases;

we may violate financial covenants contained in our various loan documents which would cause a default on our obligations, giving lenders various remedies, including increased interest rates, foreclosure, and liability for additional expenses;

we may inadvertently violate non-financial restrictive covenants in our loan documents, such as covenants that require us to maintain the existence of entities, maintain insurance policies and provide financial statements, which would entitle the lenders to accelerate our debt obligations; and
our default under any of our mortgage loans with cross-default or cross-collateralization provisions could result in default on other indebtedness and result in the foreclosures of other properties.
The realization of any or all of these risks may have an adverse effect on our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares.
 
As of December 31, 2017, we had approximately $330.0 million of borrowings outstanding under our unsecured credit facility (including the term loan feature of our unsecured credit facility), during 2016 and 2017, we issued an aggregate of $975.0 million of debt, and in January 2018 we issued 104,172 Series A Preferred Units of the Operating Partnership (“Series A Preferred Units”), all of which is senior to our common shares upon liquidation, and we may in the future make offerings of debt or preferred equity securities which may be senior to our common shares for purposes of dividend distributions or upon liquidation, any of which may materially adversely affect the per share market price of our common shares.
As of December 31, 2017, there were approximately $330.0 million of borrowings outstanding under our unsecured credit facility (including the term loan feature of our unsecured credit facility), and during 2016 and 2017, we issued $975.0 million of aggregate principal amount of senior notes. In January 2018, we issued 104,172 Series A Preferred Units. In the future, we may attempt to increase our capital resources by making additional offerings of debt or equity securities (or causing the Operating Partnership to issue debt securities), including medium-term notes, senior or subordinated notes, and classes or series of preferred shares. Upon liquidation, holders of our debt securities and preferred shares and lenders with respect to other borrowings will be entitled to receive our available assets prior to distribution to the holders of our common shares. Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences, and privileges more favorable than those of our common shares and may result in dilution to owners of our common shares. Holders of our common shares are not entitled to preemptive rights or other protections against dilution. Our preferred shares would have a preference on liquidating distributions or a preference on dividend payments that could limit our ability pay dividends or other distributions to the holders of our common shares. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, or nature of our future offerings. Thus, our shareholders bear the risk that our future offerings could reduce the per share market price of our common shares and dilute their interest in us.

The derivative instruments that we may use to hedge against interest rate fluctuations may not be successful in mitigating our risks associated with interest rates and could reduce the overall returns on our shareholders’ investment.

We may use derivative instruments to hedge exposure to changes in interest rates on certain of our variable rate loans, but no hedging strategy can protect us completely. We cannot assure our shareholders that our hedging strategy and the derivatives that we use will adequately offset the risk of interest rate volatility or that our hedging of these transactions will not result in losses. Any settlement charges incurred to terminate unused derivative instruments may result in increased interest expense, which may reduce the overall return on our investments. These instruments may also generate income that may not be treated as qualifying REIT income for purposes of the 75% or 95% REIT income tests.

We rely upon external sources of capital to fund future capital needs, and, if we encounter difficulty in obtaining such capital, we may not be able to make future acquisitions necessary to grow our business or meet maturing obligations.
 
In order for the Trust to qualify as a REIT under the Internal Revenue Code it isof 1986, as amended (the “Code”), we are required, among other things, to distribute each year to itsour shareholders at least 90% of itsour taxable income, without regard to the deduction for dividends paid and excluding net capital gain. Because of this distribution requirement, we may not be able to fund all of our future capital needs from cash retained from operations, including capital needed to make investments and to satisfy or refinance maturing obligations. As a result, we expect to rely upon external sources of capital, including debt and equity financing, to fund future capital needs. If we are unable to obtain needed capital on satisfactory terms or at all, we may not be able to make the investments needed to expand our business or to meet our obligations and commitments as they mature. Our access to capital will depend upon a number of factors over which we have little or no control, including general stock and bond market conditions and investor interest, the market’s perception of our current and potential future earnings, analyst reports about us and the REIT industry, cash distributions and the market price of our general partner's common shares.shares, and other factors such as governmental regulatory action and changes in REIT tax laws. We may not be in a position to take advantage of attractive investment opportunities for growth if we are unable to access the capital markets on a timely basis on favorable terms. Moreover, additional equity offerings may result in substantial dilution of our shareholders’ interests, and additional debt

financing may substantially increase our leverage, either of which could cause the per share price of our common shares to decline.
 
We couldIf we become highly leveraged in the future, becausethe resulting increase in outstanding debt could adversely affect our organizational documents contain no limitations onability to make debt service payments, to pay our anticipated distributions, and to make the amount of debt that we may incur.distributions required to qualify as a REIT.
 
As of December 31, 2014,2017, our indebtedness represented approximately 26.6%35.8% of our total assets. However, our organizational documents contain no limitations on the amount of indebtedness that we may incur. We could alter the balance between our total outstanding indebtedness and the value of our properties at any time. If we become more highly leveraged, the resulting increase in outstanding debt could adversely affect our ability to make debt service payments, to pay our anticipated distributions, and to paymake the distributions required to our OP Unit holders.qualify as a REIT. The occurrence of any of the foregoing risks could adversely affect our business, financial condition, and results of operations, our ability to make distributions to our OP Unit holdersshareholders, and the tradingmarket price of our general partner's common shares.
 
IncreasesWe are subject to covenants in interest ratesour debt agreements that may increaserestrict or limit our interest expenseoperations and adversely affect our cash flowsacquisitions and our abilityfailure to servicecomply with the covenants in our indebtedness and to make distributions to our OP Unit holders.
As of December 31, 2014, we had approximately $142.4 million of variable-rate indebtedness outstanding that has not been swapped fordebt agreements could have a fixed interest rate and we expect that more of our indebtedness in the future, including borrowings under our unsecured revolving credit facility since December 31, 2014 and thereafter, will be subject to variable interest rates. Increases in interest rates on any variable rate indebtedness will increase our interest expense, which could adversely affect our cash flow and our ability to pay distributions.
Failure to hedge effectively against interest rate changes may adversely affect our results of operations.

In certain cases, we may seek to manage our exposure to interest rate volatility by using interest rate hedging arrangements. Hedging involves risks, such as the risk that the counterparty may fail to honor its obligations under an arrangement, that the arrangements may not be effective in reducing our exposure to interest rate changes and that a court could rule that such an agreement is not legally enforceable. In addition, we may be limited in the type and amount of hedging transactions that we may use in the future by the Trust's need to satisfy the REIT income tests under the Code. Failure to hedge effectively against interest rate changes may have anmaterial adverse effectimpact on our business, financial condition, results of operations, and financial condition.

The terms of the instruments governing our existing indebtedness require us to comply with a number of customary financial and other covenants, such as maintaining certain leverage and coverage ratios and minimum tangible net worth requirements. Our continued ability to incur additional debt and to conduct business in general is subject to our compliance with these covenants, which limit our operational flexibility. Breaches of these covenants could result in defaults under the instruments governing the applicable indebtedness, in addition to any other indebtedness cross-defaulted against such instruments. Any such default could have a material adverse impact on our business, results of operations, and financial condition or our ability to make distributions to our OP Unit holdersshareholders.

A downgrade in our credit ratings could materially adversely affect our business and financial condition.

Our credit rating and the trading pricecredit ratings assigned to our debt securities could change based upon, among other things, our results of operations and financial condition. These ratings are subject to ongoing evaluation by credit rating agencies, and any rating could be changed or withdrawn by a rating agency in the future if, in its judgment, circumstances warrant such action.

If any of the credit rating agencies that have rated our general partner's common shares.

Our ability to issue equity to expandsecurities downgrades or lowers its credit rating, or if any credit rating agency indicates that it has placed any such rating on a “watch list” for a possible downgrade or lowering, or otherwise indicates that its outlook for that rating is negative, such action could have a material adverse effect on our business will depend,costs and availability of funding, which could in part, uponturn have a material adverse effect on our financial condition, results of operations, cash flows, the market price of our general partner'ssecurities, and our ability to satisfy our debt service obligations, among other obligations.

If securities analysts do not publish research or reports about our industry or if they downgrade our common shares and our failure to meet market expectations with respect to our business could negatively affector the healthcare-related real estate sector, the market price of our general partner's common shares and thereby limit our ability to raise capital.could decline.
 
The availability of equity capital to us will depend,market for our common shares depends in part upon the marketresearch and reports that industry or financial analysts publish about us and our industry. We have no control over these analysts. Furthermore, if one or more of the analysts who do cover us downgrades our shares or our industry, or the stock of any of our competitors, the price of our general partner's common shares could decline. If one or more of these analysts ceases coverage of our company, we could lose attention in the market which in turn will depend upon various market conditions and other factors that may change from time to time, including:
the extent of investor interest;
our general partner's ability to satisfy the distribution requirements applicable to REITs;

the general reputation of REITs and the attractiveness of their equity securities in comparison to other equity securities, including securities issued by other real estate-based companies;
our financial performance and that of our tenants;
analyst reports about the Trust and the REIT industry;
general stock and bond market conditions, including changes in interest rates on fixed income securities, which may lead prospective purchasers of our general partner's common shares to demand a higher annual yield from future distributions;
a failure to maintain or increase our dividends to our OP Unit holders, which is dependent in part upon increased revenue from additional acquisitions and rental increases; and
other factors such as governmental regulatory action and changes in REIT tax laws.
Our failure to meet the market’s expectation with regard to future earnings and cash distributions would likely adversely affect the market price of our general partner's common shares and, as a result, the cost and availability of equity capital to us.
Increases in market interest rates may have an adverse effect on the trading prices of our general partner's common shares as prospective purchasers of our general partner's common shares may expect a higher dividend yield and as an increased cost of borrowing may decrease our funds available for distribution.
One of the factors that influences the trading prices of our general partner's common shares is the dividend yield on the common shares (as a percentage of the price of the common shares) relative to market interest rates. An increase in market interest rates, which are currently at low levels relative to historical rates, may lead prospective purchasers of our general partner's common shares to expect a higher dividend yield (with a resulting decline in the trading prices of the common shares) and higher interest rates would likely increase our borrowing costs and potentially decrease funds available for distribution. Thus, higher market interest rates could cause the market price of our general partner's common shares to decrease.decline.

Risks Related to Our Portfolio and Structure
  
We didhave no direct operations and rely upon funds received from the Operating Partnership to meet our obligations.
The Trust conducts substantially all of its operations through the Operating Partnership. As of February 23, 2018, the Trust owned approximately 97.1% of the OP Units and apart from this ownership interest, the Trust does not use third party appraisals of our initial properties to determine the consideration paid in the formation transactions.have any independent operations. As a result, the value ofTrust relies upon distributions from the consideration paid forOperating Partnership to pay any distributions that the Trust might declare on the Trust’s common shares. We also rely upon distributions from the Operating Partnership to the Trust to meet our initial properties inobligations, including tax liability on taxable income allocated to the formation transactions may exceed their aggregate fair market value.
We did not use third party appraisals or obtain any independent third party valuations or fairness opinions in establishingTrust from the consideration paid for our initial properties contributed to us in connection with our formation transactions. We

issued OP Units and assumed certain indebtedness secured by the initial properties in exchange for the contribution of the initial properties. The total value of the consideration issued in exchange for the contribution of ownership interests in the initial properties may have exceeded the fair market value of such assets. Upon a sale of any of the initial properties, we may not realize the value that we attributed to such property at the time of the Trust's IPO.
We may have assumed unknown liabilities in connection with the formation transactions which could result in unexpected liabilities and expenses.
As part of the acquisition of our initial properties, we received certain assets or interests in certain assets subject to existing liabilities, some of which may be unknown to us. Unknown liabilitiesOperating Partnership (which might include liabilities for cleanup or remediation of undisclosed environmental conditions, claims of tenants, vendors or other persons dealing with the entities prior to this report (including those that had not been asserted or threatened prior to this report), tax liabilities, and accrued but unpaid liabilities incurred in the ordinary course of business. Our recourse with respect to such liabilities may be limited. Depending upon the amount or nature of such liabilities, our business, financial condition and results of operations, our ability to make distributions to our OP Unit holdersthe Trust not equal to the tax on such allocated taxable income). Shareholders’ claims will consequently be structurally subordinated to all existing and future liabilities and obligations (whether or not for borrowed money) of the Operating Partnership and its subsidiaries. Therefore, in the event of bankruptcy, liquidation or reorganization of

the Trust, claims of the Trust’s shareholders will be satisfied only after all of the Trust’s and the trading price of our general partner's common shares may be adversely affected.
Our title insurance policies may not cover all title defects.
Each of our properties is insured by a title insurance policy. We did not, however, obtain new owner’s title insurance policiesOperating Partnership’s and its subsidiaries’ liabilities and obligations have been paid in connection with the acquisition of all of our initial properties in the formation transactions. In some instances, these title insurance policies are effective as of the time of the initial acquisition or later refinancing of the relevant property by the prior owner of such property. For such properties, it is possible that there may be title defects that have arisen since such acquisition or refinancing for which we will have no title insurance coverage. If there were a material title defect related to any of our properties that is not adequately covered by a title insurance policy, we could lose some or all of our capital invested in and our anticipated profits from such property.
We did not obtain new Phase I environmental site assessments for our initial properties in connection with our formation transactions, and the assessments our Predecessor obtained before their acquisition of these properties do not provide assurance that we will not be exposed to environmental liabilities at our initial properties.
We did not obtain new Phase I environmental site assessments with respect to all of our initial properties in connection with the formation transactions. No assurances can be given that any of the prior Phase I environmental site assessments previously obtained by the prior owner identify all environmental conditions impacting the properties because material environmental conditions may have developed since the Phase I environmental site assessments were conducted. The Phase I environmental site assessments are also of limited scope and do not include comprehensive asbestos, lead-based paint or lead in drinking water assessments. Therefore, the initial properties developed earlier than 1989 may contain such hazardous substances. Comprehensive mold and radon assessments also were not conducted and some of the initial properties were identified in areas with radon levels above action levels for residential buildings by the Environmental Protection Agency. We also cannot guarantee that a prior owner or tenant of our initial properties or that an adjacent property owner has not created a material environmental condition that is unknown to us or that there are no other unknown material environmental conditions as to any one or more of our initial properties. There also exists the risk that material environmental conditions, liabilities or compliance concerns may arise in the future. The realization of any or all of these risks may have an adverse effect on our business, financial condition and results of operations, our ability to make distributions to our OP Unit holders and the trading price of our general partner's common shares.
We are an “emerging growth company,” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our general partner's common shares less attractive to investors.
The Jumpstart Our Business Startups Act, or the “JOBS Act” contains provisions that, among other things, relax certain reporting requirements for “emerging growth companies,” including certain requirements relating to accounting standards and compensation disclosure. We are classified as an emerging growth company. For as long as we are an emerging growth company, which may be up to five full fiscal years, we may take advantage of exemptions from various reporting and other requirements that are applicable to other public companies that are not emerging growth companies, including the requirements to:
provide an auditor’s attestation report on management’s assessment of the effectiveness of our system of internal control over financial reporting pursuant to Section 404;

comply with any new or revised financial accounting standards applicable to public companies until such standards are also applicable to private companies;
comply with any new requirements adopted by the Public Company Accounting Oversight Board, or the PCAOB, requiring mandatory audit firm rotation or a supplement to the auditor’s report in which the auditor would be required to provide additional information about the audit and the financial statements of the issuer;
comply with any new audit rules adopted by the PCAOB after April 5, 2012 unless the SEC determines otherwise;
provide certain disclosure regarding executive compensation required of larger public companies; or
hold shareholder advisory votes on executive compensation.
We cannot predict if investors will find our general partner's common shares less attractive because we will not be subject to the same reporting and other requirements as other public companies. If some investors find our general partner's common shares less attractive as a result, there may be a less active trading market for our general partner's common shares, the per share trading price of our general partner's common shares could decline and may be more volatile.
We expect that we will no longer be an emerging growth company next year.

We will be subject to the requirements of the Sarbanes-Oxley Act of 2002.
As long as we remain an emerging growth company, we will be permitted to gradually comply with certain of the on-going reporting and disclosure obligations of public companies pursuant to the Sarbanes-Oxley Act of 2002. See “Part I, Item 1A. Risk Factors — We are an ‘emerging growth company,’ and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our general partner's common shares less attractive to investors.”
However, after we are no longer an emerging growth company under the JOBS Act, management will be required to deliver a report that assesses the effectiveness of our internal controls over financial reporting, pursuant to Section 302 of the Sarbanes-Oxley Act. Section 404 of the Sarbanes-Oxley Act may require our auditors to deliver an attestation report on the effectiveness of our internal controls over financial reporting in conjunction with their opinion on our audited financial statements as of December 31 subsequent to the period covered by this report. Substantial work on our part is required to implement appropriate processes, document the system of internal control over key processes, assess their design, remediate any deficiencies identified and test their operation. This process is expected to be both costly and challenging. We cannot give any assurances that material weaknesses will not be identified in the future in connection with our compliance with the provisions of Section 302 and 404 of the Sarbanes-Oxley Act. The existence of any material weakness would preclude a conclusion by management and our independent auditors that we maintained effective internal control over financial reporting. Our management may be required to devote significant time and expense to remediate any material weaknesses that may be discovered and may not be able to remediate any material weakness in a timely manner. The existence of any material weakness in our internal control over financial reporting could also result in errors in our financial statements that could require us to restate our financial statements, cause us to fail to meet our reporting obligations and cause investors to lose confidence in our reported financial information, all of which could lead to a decline in the per share trading price of our general partner's common shares.full.
 
Our business could be harmed if key personnel terminate their employment with us or if we are unsuccessful in integrating new personnel into our operations.

Our success depends, to a significant extent, on the continued services of Mr. Thomas, theour President and Chief Executive Officer of our general partner,Officer; Mr. Theiler, theour Executive Vice President and Chief Financial Officer ofOfficer; Mr. Taylor, our general partner, Mr. Sweet, the Executive Vice President and Chief Investment Officer of our general partner,– Investments; Mr. Lucey, theour Senior Vice President—PrincipalPresident – Chief Accounting and Reporting Officer of our general partner,Administrative Officer; Mr. Theine, theour Senior Vice President of Asset and Investment Management of our general partner andManagement; Mr. Page, theour Senior Vice President and General Counsel ofCounsel; and Mr. Klein, our general partner. The Trust doesSenior Vice President – Investments and Deputy Chief Investment Officer. We do not maintain key person life insurance on any of theseour officers. Our ability to continue to acquire and develop healthcare properties depends upon the significant relationships that the Trust'sour senior management team has developed over time.many years.
 
Although the Trust has entered into employment agreements with Messrs. Thomas, Theiler, Sweet,Taylor, Lucey, Theine, Page, and Page,Klein, we cannot provide any assurance that any of them will remain employed by the Trust. TheOur ability to retain theour senior

management team, or to attract suitable replacements should any member of the senior management team leave, is dependent on the competitive nature of the employment market. The loss of services of, or the failure to successfully integrate one or more new members of, theour senior management team could adversely affect our business and our prospects.
 
Our useThe Trust’s declaration of OP Units as currency to acquire properties could result in shareholder dilutiontrust restricts the ownership and transfer of our general partner's shareholders and/or limit our ability to sell such properties,outstanding shares of beneficial interest which could have a material adverse effect on us.
We may continue to acquire some properties or portfolios of properties through tax deferred contribution transactions in exchange for OP Units, which may result in shareholder dilution. This acquisition structure may have the effect of among other things, reducing the amountdelaying, deferring, or preventing a transaction or change of tax depreciation we could deduct over the tax lifecontrol of our company.
In order for us to qualify as a REIT, no more than 50% of the acquired properties, and may require that we agree to protect the contributors’ ability to defer recognition of taxable gain through restrictions on our ability to disposevalue of the acquired propertiesTrust’s outstanding shares of beneficial interest may be owned, beneficially or constructively, by five or fewer individuals at any time during the allocationlast half of partnership debteach taxable year other than our initial REIT taxable year. Subject to certain exceptions, the contributors to maintain their tax bases. These restrictions could limit our ability to sell properties at a time,Trust’s declaration of trust prohibits any shareholder from owning beneficially or on terms, that would be favorable absent such restrictions.
Conflictsconstructively more than 9.8% in value or number of interest could arise as a resultshares, whichever is more restrictive, of the outstanding shares of any class or series of our UPREIT structure.
Conflictsshares of beneficial interest, could arise in the future as a result of the relationships between us and our affiliates, on the one hand, andalthough the Trust on the other. The Trust's trusteeshas granted, and officers have duties to the Trust under applicable Maryland law in connection with their management of the Trust. At the same time, the Trust, as our general partner, has fiduciary duties to us and our limited partners under Delaware law in connection with the management of our business. The Trust's duties, as our general partner, to us and our limited partners may come into conflict with the duties of the trustees and officers to the Trust.

Unless otherwise provided for in the relevant partnership agreement, Delaware law generally requires a general partner of a Delaware limited partnership to adhere to fiduciary duty standards under which it owes its limited partners the highest duties of good faith, fairness and loyalty and which generally prohibits such general partner from taking any action or engaging in any transaction as to which it has a conflict of interest.
Additionally, our partnership agreement expressly limits the Trust's liability by providing that the Trust, as our general partner, and its trustees and officers are not be liable or accountable in damages to us, our limited partners or assignees for errors in judgment, mistakes of fact or law or for any act or omission if the Trust or its trustees or officers acted in good faith. In addition, we are required to indemnify the Trust, its affiliates and each of its respective officers and trustees, to the fullest extent permitted by applicable law against any and all losses, claims, damages, liabilities (whether joint or several), expenses (including, without limitation, attorneys’ fees and other legal fees and expenses), judgments, fines, settlements and other amounts arising from any and all claims, demands, actions, suits or proceedings, civil, criminal, administrative or investigative, that relate to our operations, provided that we will not indemnify any such person for (1) acts or omissions committed in bad faith or that were the result of active and deliberate dishonesty, (2) any transaction for which such person received an improper personal benefit in money, property or services, or (3) in the case of a criminal proceeding, the person had reasonable cause to believe the act or omission was unlawful.
The provisions of Delaware law that allow the common law fiduciary duties of a general partner to be modified by a partnership agreement have not been resolved in a court of law, and we have not obtained an opinion of counsel covering the provisions set forth in our partnership agreement that purport to waive or restrict the Trust's fiduciary duties that would be in effect under common law were it not for our partnership agreement.
We may change our business, investment and financing strategies without the Trust's shareholders' approval.

We may change our business, investment and financing strategies without a vote of, or notice to, the Trust's shareholders, which could result in our making investments and engaging in business activities that are different from, and possibly riskier than, the investments and businesses described in this report. In particular, a change in our investment strategy, including the manner in which we allocate our resources across our portfolio or the types of assets in which we seek to invest, may increase our exposure to real estate market fluctuations. In addition, we may in the future increasegrant, a waiver from the useownership limitations. The constructive ownership rules under the Code are complex and may cause the outstanding shares owned by a group of leverage at timesrelated individuals or entities to be deemed to be constructively owned by one individual or entity. As a result, the acquisition of less than 9.8% of our outstanding shares of any class or series by an individual or entity could cause that individual or entity to own constructively in excess of 9.8% of the outstanding shares of any class or series of our shares of beneficial interest and in amounts that we, in our discretion, deem prudent, and such decision would notto be subject to approvalthe Trust’s declaration of trust’s ownership limit. The Trust’s declaration of trust also prohibits, among other prohibitions, any person from owning our shares of beneficial interest that would result in our being “closely held” under Section 856(h) of the Trust's shareholders. Furthermore,Code or otherwise cause us to fail to qualify as a REIT. Any attempt to own or transfer shares of our beneficial interest in violation of these restrictions may result in the shares being automatically transferred to a charitable trust or may be void. The share ownership restrictions of the Code for REITs and the 9.8% share ownership limit and other restrictions on ownership and transfer of our shares contained in the Trust’s declaration of trust may inhibit market activity in our shares of beneficial interest and restrict our business combination opportunities.

Certain provisions of Maryland law could inhibit changes of control, which may discourage third parties from conducting a tender offer or seeking other change of control transactions that could involve a premium price for our common shares or that our shareholders otherwise believe to be in their best interests.

Certain provisions of the Maryland General Corporation Law, or MGCL, applicable to Maryland real estate investment trusts may have the effect of inhibiting a third party from making a proposal to acquire the Trust (and, indirectly, the Operating Partnership) or of impeding a change of control under circumstances that otherwise could provide the Trust’s common shareholders with the opportunity to realize a premium over the then-prevailing market price of such shares, including:

“business combination” provisions that, subject to limitations, prohibit certain business combinations between us and an “interested shareholder” (defined generally as any person who beneficially owns 10% or more of the voting power of our shares or an affiliate or associate of ours who was the beneficial owner, directly or indirectly, of 10% or more of the voting power of our shares at any time within the two-year period immediately prior to the date in question) or an affiliate thereof for five years after the most recent date on which the shareholder becomes an interested shareholder, and thereafter imposes certain minimum price and/or supermajority shareholder voting requirements on these combinations; and

“control share” provisions that provide that holders of “control shares” of our Trust (defined as shares that, when aggregated with all other shares controlled by the shareholder, entitle the shareholder to exercise one of three increasing ranges of voting power in electing trustees) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of issued and outstanding “control shares,” subject to certain exceptions) have no voting rights with respect to their control shares, except to the extent approved by our shareholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares.

Pursuant to the statute, the Trust’s board of trustees has by resolution exempted any business combination between us and any other person from the business combination provisions of the MGCL, provided that the business combination is first approved by the board of trustees (including a majority of trustees who are not affiliates or associates of such person). In addition, the Trust’s bylaws contain a provision exempting any and all acquisitions of our shares from the control share provisions of the MGCL. However, the board of trustees may at any time alter or repeal the resolution exempting certain businesses from the business combination provisions of the MGCL and we may determineat any time amend or eliminate the provision of our bylaws exempting acquisitions of our shares from the control share provisions of the MGCL.
Certain provisions of the MGCL permit the board of trustees, without shareholder approval and regardless of what is currently provided in the Trust’s declaration of trust or bylaws, to implement certain corporate governance provisions with respect to the Trust, some of which (for example, a classified board) are not currently applicable to us. If implemented, these provisions may have the effect of limiting or precluding a third party from making an unsolicited acquisition proposal for us or of delaying, deferring, or preventing a change in control of us under circumstances that healthcare properties do not offerotherwise could provide our common shareholders with the potential for attractive risk-adjusted returns for an investment strategy. Changesopportunity to realize a premium over the then current market price. Pursuant to our strategies with regardsdeclaration of trust, we have elected to be subject to the foregoingprovisions of Title 3, Subtitle 8 of the MGCL relating to the filling of vacancies on our board of trustees.
We could adversely affectincrease the number of authorized shares, classify and reclassify unissued shares, and issue shares without shareholder approval.
The Trust’s board of trustees, without shareholder approval, has the power under the Trust’s declaration of trust to amend our financial condition, resultsdeclaration of operationstrust to increase or decrease the aggregate number of shares or the number of shares of any class or series of the Trust that we are authorized to issue, and to authorize us to issue authorized but unissued common shares or preferred shares. In addition, under the declaration of trust, the board of trustees has the power to classify or reclassify any unissued common or preferred shares into one or more classes or series of shares and set or change the preference, conversion or other rights, voting powers, restrictions, limitations as to dividends and other distributions, qualifications or terms or conditions of redemption for such newly classified or reclassified shares. As a result, we may issue series or classes of common shares or preferred shares with preferences, dividends, powers, and rights, voting or otherwise, that are senior to, or otherwise conflict with, the rights of holders of our abilitycommon shares. Although the board of trustees has no such intention at the present time, it could establish a class or series of preferred shares that could, depending on the terms of such class or series, delay, defer, or prevent a transaction or a change of control that might involve a premium price for our common shares or that our shareholders otherwise believe to make distributions to our OP Unit holders.be in their best interests.

Certain provisions in ourthe partnership agreement of the Operating Partnership may delay or prevent unsolicited acquisitions of us.
 

Provisions in ourthe partnership agreement of the Operating Partnership may delay, or make more difficult, unsolicited acquisitions of us or changes of our control. These provisions could discourage third parties from making proposals involving an unsolicited acquisition of us or change of our control, although some Trust shareholders might consider such proposals, if made, desirable. These provisions include, among others:

redemption rights;
a requirement that the Trust may not be removed as ourthe general partner of the Operating Partnership without itsour consent;
transfer restrictions on OP Units;
the Trust'sTrust’s ability, as our general partner, in some cases, to amend ourthe partnership agreement and to cause usthe Operating Partnership to issue units with terms that could delay, defer, or prevent a merger or other change of control of usthe Trust or the Operating Partnership without the consent of ourthe limited partners; and

the right of ourthe limited partners to consent to direct or indirect transfers of the general partnership interest, including as a result of a merger or a sale of all or substantially all of our assets, in the event that such transfer requires approval by the Trust'sour common shareholders.
 
The Trust'sTrust’s declaration of trust and bylaws, Maryland law, and ourthe partnership agreement of the Operating Partnership also contain other provisions that may delay, defer, or prevent a transaction or a change of control that might involve a premium price for the Trust'sour common shares or that the Trust'sour shareholders otherwise believe to be in their best interest.
 
We may issue additional OP Units to third parties without the consent of the Trust's shareholders, which would reduce the Trust's ownership percentage in us and could have a dilutive effect on the amount of distributions we make to the Trust and, therefore, the amount of distributions the Trust can make to its shareholders.
As of December 31, 2014, the Trust owned 94.1% of our outstanding OP Units. We may, in connection with our acquisition of properties or otherwise, issue additional OP Units to third parties. Such issuances would reduce the Trust's ownership percentage in us and could affect the amount of distributions made by us to the Trust and, therefore, the amount of distributions the Trust can make to its shareholders. The Trust's shareholders do not directly own OP Units, and thus, do not have any voting rights with respect to any such issuances or other of our partnership level activities.

Risks Related to our General Partner'sOur Qualification and Operation as a REIT
 
Our general partner's complianceIf we fail to qualify as a REIT in any taxable year, we will face serious tax consequences that would substantially reduce funds available for distributions to our shareholders.
Since our formation, the Trust has been organized and has operated in such a manner as to qualify for taxation as a REIT under the U.S. federal income tax laws, and we intend to continue to operate in such a manner, but no assurances can be given that we will operate in a manner so as to qualify or remain qualified as a REIT.
Failure to qualify as a REIT, or failure to remain qualified as a REIT, would cause us to be taxed as a regular corporation, which would substantially reduce funds available for distributions to our shareholders. If we fail to qualify as a REIT in any taxable year, we would face serious tax consequences that will substantially reduce the funds available for distributions to our shareholders because:

we would not be allowed a deduction for dividends paid to shareholders in computing our taxable income and would be subject to U.S. federal income tax at regular corporate rates;
we could possibly be subject to increased state and local taxes; and
unless we are entitled to relief under certain U.S. federal income tax laws, we could not re-elect REIT status until the fifth calendar year after the year in which we failed to qualify as a REIT.
In addition, if the Trust fails to qualify as a REIT, we will no longer be required to make distributions. As a result of all these factors, the Trust’s failure to qualify as a REIT could impair our ability to expand our business and raise capital, and it would adversely affect the value of our shares of beneficial interest.
Failure to make required distributions would subject us to U.S. federal corporate income tax.
The Trust intends to operate in a manner so as to qualify as a REIT for U.S. federal income tax purposes. In order to qualify as a REIT, we generally are required to distribute at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gain, each year to our shareholders. To the extent that we satisfy this distribution requirement, but distribute less than 100% of our REIT taxable income, we will be subject to U.S. federal corporate income tax on our undistributed taxable income. In addition, we will be subject to a 4% nondeductible excise tax if the actual amount that we pay out to our shareholders in a calendar year is less than a minimum amount specified under the Code.
Complying with REIT requirements may cause us to forego otherwise attractive opportunities or liquidate otherwise attractive investments.
 
To qualify as a REIT for federal income tax purposes, our general partnerwe must continually satisfy tests concerning, among other things, the sources of itsour income, the nature and diversification of itsour assets, the amounts it distributeswe distribute to itsour shareholders, and the ownership of itsour shares of beneficial interest. In order to enable our general partner to meet these tests, we may be required to forego investments we might otherwise make. Thus, our general partner's compliance with the REIT requirements may hinder our performance.

In particular, we must ensure that at the end of each calendar quarter, at least 75% of the value of our assets consists of cash, cash items, government securities, and qualified real estate assets. The remainder of our investment in securities (other than government securities, securities of TRSs, and qualified real estate assets) generally cannot include more than 10% of the outstanding voting securities of any one issuer or more than 10% of the total value of the outstanding securities of any one issuer. In addition, in general, no more than 5% of the value of our assets (other than government securities, securities of TRSs, and qualified real estate assets) can consist of the securities of any one issuer, and no more than 20% of the value of our total assets can be represented by the securities of one or more TRSs. Further, debt instruments that do not otherwise qualify as real estate assets issued to us by publicly offered REITs will be treated as qualified real estate assets for purposes of the asset test,

but no more than 25% of the value of our total assets may be represented by such debt instruments. If our general partner failswe fail to comply with certain of these requirements at the end of any calendar quarter, itwe must correct these failuresthe failure within 30 days after the end of the calendar quarter or qualify for certain statutory relief provisions to avoid losing itsour REIT qualification and suffering adverse tax consequences. As a result, we may be required to liquidate otherwise attractive investments. These actions could have the effect of reducing our income and amounts available for distribution to our OP Unit holders.shareholders.

The prohibited transactions tax may limit our ability to dispose of our properties.
A REIT’s net income from prohibited transactions is subject to a 100% tax. In general, prohibited transactions are sales or other dispositions of property other than “foreclosure property,” held primarily for sale to customers in the ordinary course of business. We may be subject to the prohibited transactions tax equal to 100% of net gain upon a disposition of real property. Although a safe harbor to the characterization of the sale of real property by a REIT as a prohibited transaction is available, we cannot assure you that we can comply with the safe harbor or that we will avoid owning property that may be characterized as held primarily for sale to customers in the ordinary course of business. Consequently, we may choose not to engage in certain sales of our properties or may conduct such sales through any TRS that we may form, which would be subject to federal and state income taxation.
Any ownership of a TRS we may form in the future will be subject to limitations and our transactions with a TRS will cause us to be subject to a 100% penalty tax on certain income or deductions if those transactions are not conducted on arm’s-length terms.
Overall, for taxable years beginning after December 31, 2017, no more than 20% of the value of a REIT’s assets may consist of stock or securities of one or more TRSs. In addition, the Code also imposes a 100% excise tax on certain transactions between a TRS and its parent REIT that are not conducted on an arm’s-length basis, including “redetermined TRS service income” relating to gross income of a TRS attributable to services provided to, or on behalf of, the REIT (less the deductions properly allocable thereto) to the extent the amount of such income (less such deductions) would be increased on distribution, apportionment, or allocation under Code Section 482. We will monitor the value of our respective investments in any TRS that we may form for the purpose of ensuring compliance with TRS ownership limitations and will structure our transactions with any TRS on terms that we believe are arm’s-length to avoid incurring a 100% excise tax on such transactions. There can be no assurance, however, that we will be able to comply with the 20% limitation or avoid application of the 100% excise tax.
If we fail to qualifyleases of our properties are not respected as a partnershiptrue leases for federal income tax purposes, our general partnerwe would ceasefail to qualify as a REIT and suffer other adverse consequences.
We believe that we will be treated as a partnership for federal income tax purposes. As a partnership, we will notwould be subject to federalhigher taxes and have less cash available for distribution to our shareholders.
To qualify as a REIT, we must satisfy two gross income tax on our income. Instead, eachtests, under which specified percentages of our partners willgross income must be allocated,derived from certain sources, such as “rents from real property.” Rents paid to the Operating Partnership by third party lessees and any TRS lessee that we may be requiredform in the future pursuant to pay tax with respect to, its sharethe leases of our properties will constitute substantially all of our gross income. We cannot assure you, however, thatIn order for such rent to qualify as “rents from real property” for purposes of the IRS will not challenge our statusgross income tests, the leases must be respected as a partnership or any other subsidiary partnership in which we own an interest as a partnershiptrue leases for federal income tax purposes and not be treated as service contracts, joint ventures, or that a court wouldsome other type of arrangement. If our leases are not sustain such a challenge. If the IRS were successful in treating us or any such other subsidiary partnershiprespected as an entity taxable as a corporationtrue leases for federal income tax purposes, our general partnerwe would fail to meet certain

of the tests applicable to REITs and, accordingly, it would likely cease to qualify as a REIT. Also,

Dividends payable by REITs do not qualify for the reduced tax rates available for some dividends.
The maximum tax rate applicable to “qualified dividend income” payable to U.S. shareholders that are taxed at individual rates is 23.8%. Dividends payable by REITs, however, generally are not eligible for the reduced rates on qualified dividend income. The more favorable rates applicable to regular corporate qualified dividends could cause investors who are taxed at individual rates to perceive investments in REITs to be relatively less attractive than investments in the stocks of non-REIT corporations that pay dividends, which could adversely affect the value of the shares of REITs, including our failurecommon shares.
We may be subject to adverse legislative or regulatory tax changes that could reduce the market price of our common shares.
At any time, the U.S. federal income tax laws governing REITs or the failureadministrative interpretations of those laws may be amended. We cannot predict when or if any new U.S. federal income tax law, regulation, or administrative interpretation, or any amendment to any existing U.S. federal income tax law, regulation, or administrative interpretation, will be adopted, promulgated or become effective and any such law, regulation, or interpretation may take effect retroactively. We and our

shareholders could be adversely affected by any such change in the U.S. federal income tax laws, regulations, or administrative interpretations.

On December 22, 2017 the Tax Cuts and Jobs Act was signed into law. The Tax Cuts and Jobs Act makes significant changes to the U.S. federal income tax rules for taxation of individuals and corporations, generally effective for taxable years beginning after December 31, 2017. In addition to reducing corporate and non-corporate tax rates, the Tax Cuts and Jobs Act eliminates or restricts various deductions. Most of the changes applicable to individuals are temporary and apply only to taxable years beginning after December 31, 2017 and before January 1, 2026. The Tax Cuts and Jobs Act makes numerous large and small changes to the tax rules that do not affect REITs directly but may affect our subsidiary partnershipsshareholders and may indirectly affect us.

While the changes in the Tax Cuts and Jobs Act generally appear to qualify as a partnership could causebe favorable with respect to REITs, the extensive changes to non-REIT provisions in the Code may have unanticipated effects on us or such partnership to become subject to federal and state corporate incomeour stockholders. Moreover, Congressional leaders have recognized that the process of adopting extensive tax which would reduce significantly thelegislation in a short amount of cash availabletime without hearings and substantial time for debt servicereview is likely to have led to drafting errors, issues needing clarification, and for distributionunintended consequences that will have to our OP Unit holders.be reviewed in subsequent tax legislation. At this point, it is not clear when Congress will address these issues or when the Internal Revenue Service will be able to issue administrative guidance on the changes made in the Tax Cuts and Jobs Act.

ITEM 1B. UNRESOLVED STAFF COMMENTS
 
Not applicable.None.




33


ITEM 2. PROPERTIES
 
PropertiesGeographic Diversification/Concentration

The following table below sets forthlists the states in which our properties are located and provides certain information regarding the 87 properties in our portfolioportfolio’s geographic diversification/concentration as of December 31, 2014:
2017:
PROPERTY 
PROPERTY
TYPE
 
PROPERTY
LOCATION
 
YEAR
BUILT
 
%
OWNED
 
NET
LEASABLE
SQUARE
FOOTAGE
 
%
LEASED
 
ANNUALIZED
BASE RENT(1)
(thousands)
 
ANNUALIZED
BASE RENT PER
LEASED SQUARE
FOOT
 
HEALTHCARE
DELIVERY
SYSTEM
AFFILIATION
 
PRINCIPAL
TENANTS
         
  
  
  
  
 INITIAL PROPERTIES (2)
Arrowhead Commons Medical Office Building Phoenix, AZ 2,004,000 100.0% 12,800
 85.0% $261
 $24.00
 N/A Paseo Family Physicians
Aurora Medical Office Building Medical Office Building Green Bay, WI 2,010,000 100.0% 9,112
 100.0% $191
 $20.96
 Aurora Health Care Aurora Health Care
Austell Medical Office Building Medical Office Building Atlanta, GA 1,971,000 100.0% 14,598
 78.5% $183
 $15.97
 Northside Hospital Northside Hospital
Canton Medical Office Building Medical Office Building Atlanta, GA 1,994,000 51.0% 38,098
 100.0% $817
 $21.44
 Northside Hospital Northside Hospital
Decatur Medical Office Building Medical Office Building Atlanta, GA 1,974,000 100.0% 13,300
 100.0% $357
 $26.84
 N/A Georgia Urology, P.A.
El Paso Medical Office Building Medical Office Building El Paso, TX 1,987,000 100.0% 21,777
 100.0% $374
 $17.17
 HCA HCA—Del Sol Medical Center
Farmington Professional Pavilion Medical Office Building Detroit, MI 1,972,000 100.0% 21,338
 57.5% $189
 $15.40
 Botsford Hospital Botsford Hospital, Farmington Dermatology
Firehouse Square Medical Office Building Milwaukee, WI 2,002,000 100.0% 17,265
 100.0% $393
 $22.76
 Aurora Health Care Aurora Health Care
Hackley Medical Center Medical Office Building Grand Rapids, MI 1,968,000 100.0% 44,089
 85.9% $682
 $18.00
 Trinity Health Hackley Hospital, Port City Pediatrics
Ingham Regional Medical Center Medical Office Building Lansing, MI 1,994,000 100.0% 26,783
 % 
 $
 N/A N/A
MeadowView Professional Center Medical Office Building Kingsport, TN 2,005,000 100.0% 64,200
 100.0% $1,539
 $23.97
 Holston Medical Group Holston Medical Group
Mid Coast Hospital Medical Office Building Medical Office Building Portland, ME 2,008,000 66.3% 44,677
 100.0% $1,205
 $26.97
 Mid Coast Hospital Mid Coast Hospital
New Albany Professional Building Medical Office Building Columbus, OH 2,000,000 100.0% 17,213
 75.1% $177
 $13.69
 N/A Rainbow Pediatrics
Northpark Trail Medical Office Building Atlanta, GA 2,001,000 100.0% 14,223
 37.4% $66
 $12.39
 N/A Georgia Urology, P.A.
Remington Medical Commons Medical Office Building Chicago, IL 2,008,000 100.0% 37,240
 75.7% $704
 $24.98
 Adventist Fresenius Dialysis, Gateway Spine and Pain
Stonecreek Family Health Center Medical Office Building Columbus, OH 1,996,000 100.0% 20,329
 % 
 $
 N/A N/A
Summit Healthplex Medical Office Building Atlanta, GA 2,002,000 100.0% 67,333
 100.0% $1,720
 $25.54
 Piedmont Georgia Bone and Joint, Piedmont Hospital
Valley West Hospital Medical Office Building Medical Office Building Chicago, IL 2,007,000 100.0% 38,717
 96.1% $779
 $20.93
 Kish Health System Valley West Hospital, Midwest Orthopedics
INITIAL PROPERTIES TOTAL/WEIGHTED AVERAGE        
 523,092
 82.6% $9,637
 $22.31
    
Completed Acquisitions Since the IPO (3)
21st Century Radiation Oncology Centers — Sarasota Medical Office Building Sarasota, FL 1,975,000 100.0% 21,400
 100.0% $660
 $30.84
 21st Century Oncology 21st Century Oncology
21st Century Radiation Oncology Centers - Venice Medical Office Building Venice, FL 1,987,000 100.0% 10,100
 100.0% $345
 $34.16
 21st Century Oncology 21st Century Oncology
21st Century Radiation Oncology Centers - Engelwood Medical Office Building Engelwood, FL 1,992,000 100.0% 7,000
 100.0% $213
 $30.43
 21st Century Oncology 21st Century Oncology
State Number of Properties 
GLA (1)
(square feet)
 Percent of GLA 
Annualized Base Rent (2)
(thousands)
 Percent of Annualized Base Rent
Alabama 11
 509,501
 3.6% $9,825
 3.4%
Arizona 13
 733,791
 5.2% 15,751
 5.5%
Arkansas 8
 283,440
 2.0% 4,401
 1.5%
Colorado 5
 129,620
 1.0% 2,753
 1.0%
Connecticut 1
 72,022
 0.5% 1,705
 0.6%
Florida 24
 470,914
 3.4% 12,066
 4.2%
Georgia 23
 1,289,838
 9.2% 27,457
 9.6%
Illinois 4
 187,673
 1.3% 3,575
 1.3%
Indiana 22
 1,039,767
 7.4% 18,283
 6.4%
Kentucky 12
 976,620
 7.0% 16,028
 5.6%
Louisiana 3
 150,777
 1.1% 5,680
 2.0%
Maine 1
 44,677
 0.3% 1,298
 0.5%
Maryland 3
 166,594
 1.2% 3,782
 1.3%
Michigan 8
 447,794
 3.2% 9,713
 3.4%
Minnesota 18
 662,416
 4.7% 13,143
 4.6%
Mississippi 2
 97,294
 0.7% 2,466
 0.9%
Missouri 2
 69,184
 0.5% 1,851
 0.6%
Montana 3
 185,085
 1.3% 5,194
 1.8%
Nebraska 13
 979,303
 7.0% 17,304
 6.1%
New Mexico 2
 53,029
 0.4% 1,376
 0.5%
New York 13
 613,496
 4.4% 14,242
 5.0%
North Carolina 1
 29,422
 0.2% 634
 0.2%
North Dakota 8
 434,215
 3.1% 7,612
 2.7%
Ohio 12
 650,319
 4.6% 13,225
 4.6%
Oklahoma 1
 52,000
 0.4% 480
 0.2%
Pennsylvania 11
 407,911
 3.0% 5,518
 1.9%
Tennessee 11
 534,725
 3.8% 10,149
 3.6%
Texas 29
 1,930,348
 13.8% 46,850
 16.4%
Washington 10
 589,141
 4.2% 7,994
 2.8%
Wisconsin (3) 6
 205,886
 1.5% 5,315
 1.8%
Total 280
 13,996,802
 100.0% $285,670
 100.0%
(1)“GLA” means gross leasable area.
(2)Annualized base rent is calculated by multiplying (a) base rental payments for the month ended December 31, 2017, by (b) 12.
(3)Excludes leases related to the Company’s 108,843 square foot corporate office building.


21st Century Radiation Oncology Centers — Port Charlotte Medical Office Building Port Charlotte, FL 1,996,000 100.0% 8,395
 100.0% $255
 $30.38
 21st Century Oncology 21st Century Oncology
Central Ohio Neurosurgical Surgeons Medical Office Medical Office Building Columbus, OH 2,007,000 100.0% 38,891
 100.0% $818
 $21.03
 N/A CONS
Crescent City Surgical Centre Hospital New Orleans, LA 2,010,000 100.0% 60,000
 100.0% $3,090
 $51.50
 Crescent City Surgical Centre Crescent City Surgical Centre
Eagles Landing Family Practice Medical Office Building Medical Office Building McDonough, GA 2,007,000 100.0% 17,733
 100.0% $403
 $22.73
 N/A Eagles Landing Family Practice
Eagles Landing Family Practice Medical Office Building Medical Office Building Jackson, GA 2,006,000 100.0% 14,269
 100.0% $324
 $22.71
 N/A Eagles Landing Family Practice
Eagles Landing Family Practice Medical Office Building Medical Office Building Conyers, GA 2,008,000 100.0% 18,014
 100.0% $409
 $22.70
 N/A Eagles Landing Family Practice
Eagles Landing Family Practice Medical Office Building Medical Office Building McDonough, GA 2,010,000 100.0% 18,695
 100.0% $424
 $22.68
 N/A Eagles Landing Family Practice
East El Paso Medical Office Building Medical Office Building El Paso, TX 2,004,000 99.0% 41,007
 100.0% $591
 $14.41
 Foundation Healthcare Inc. EEPPMC Partners, LLC
East El Paso Surgical Hospital Hospital El Paso, TX 2,004,000 99.0% 77,000
 100.0% $3,381
 $43.91
 Foundation Healthcare Inc. East El Paso Physicians Medical Center, LLC
Foundation San Antonio Surgical Hospital Hospital San Antonio, TX 2,007,000 100.0% 45,954
 100.0% $2,300
 $50.05
 Foundation Healthcare Inc. Foundation Bariatric Hospital of San Antonio, L.L.C
Foundation San Antonio Healthplex Medical Office Building San Antonio, TX 2,007,000 100.0% 22,832
 100.0% $602
 $26.37
 Foundation Healthcare Inc. Foundation Healthcare Inc.
Foundation Surgical Affiliates Medical Office Building Medical Office Building Oklahoma City, OK 2,004,000 99.0% 52,000
 100.0% $1,273
 $24.48
 Foundation Healthcare Inc. Foundation Surgical Affiliates
Great Falls Ambulatory Surgery Center Medical Office Building Great Falls, MT 1,999,000 100.0% 12,636
 100.0% $346
 $27.38
 N/A Great Falls Clinic Surgery Center LLC
LifeCare LTACH — Fort Worth Post-Acute Hospital Fort Worth, TX 1,985,000 100.0% 80,000
 100.0% $2,200
 $27.50
 LifeCare Hospitals LifeCare Holdings, LLC
LifeCare LTACH — Pittsburgh Post-Acute Hospital Pittsburgh, PA 1,987,000 100.0% 154,910
 100.0% $1,040
 $6.71
 LifeCare Hospitals LifeCare Holdings, LLC
LifeCare Plano LTACH Post-Acute Hospital Plano, TX 1,987,000 100.0% 75,442
 100.0% $1,457
 $19.31
 LifeCare Hospitals LifeCare Holdings, LLC
Peachtree Dunwoody Medical Center Medical Office Building Atlanta, GA 1,987,000 100.0% 131,368
 94.7% $3,651
 $29.34
 Northside Northside Hospital
Pensacola Medical Office Building Medical Office Building Pensacola, FL 2,012,000 100.0% 20,319
 100.0% $609
 $29.97
 N/A N/A
South Bend Orthopaedics Medical Office Building Medical Office Building Mishawaka, IN 2,007,000 100.0% 45,198
 100.0% $1,195
 $26.44
 N/A South Bend Orthopaedics
PinnacleHealth Medical Office Building Medical Office Building Harrisburg, PA 1,990,000 100.0% 27,601
 100.0% $614
 $22.25
 Pinnacle Health Hospitals Pinnacle Health Hospitals
Pinnacle Health Medical Office Building Medical Office Building Carlisle, PA 2,002,000 100.0% 10,485
 100.0% $265
 $25.27
 Pinnacle Health Hospitals Pinnacle Health Hospitals
Grenada Medical Complex Medical Office Building Grenada, MS 1,975,000 100.0% 52,941
 94.7% $1,071
 $21.36
 N/A N/A
Mississippi Ortho Medical Office Building Medical Office Building Jackson, MS 1,987,000 100.0% 44,269
 100.0% $1,319
 $29.80
 N/A N/A
Carmel Medical Pavilion Medical Office Building Carmel, IN 1,993,000 100.0% 28,572
 100.0% $350
 $12.25
 St. Vincent’s St. Vincent’s
Renaissance Ambulatory Surgery Center Medical Office Building Oshkosh, WI 2,007,000 100.0% 24,622
 100.0% $703
 $28.55
 ThedaCare ThedaCare
Presbyterian Medical Plaza Medical Office Building Monroe, NC 2,008,000 100.0% 29,422
 100.0% $611
 $20.77
 Novant Novant
Summit Urology Medical Office Building Bloomington, IN 1,996,000 100.0% 15,946
 100.0% $386
 $24.21
 N/A Surgicare, LLC
500 Landmark Medical Office Building Bloomington, IN 2,000,000 100.0% 65,000
 100.0% $1,319
 $20.29
 N/A Premier Healthcare
550 Landmark Medical Office Building Bloomington, IN 2,000,000 100.0% 15,000
 100.0% $282
 $18.80
 N/A Premier Healthcare
574 Landmark Medical Office Building Bloomington, IN 2,004,000 100.0% 10,000
 100.0% $187
 $18.70
 N/A Premier Healthcare

Carlisle II MOB Medical Office Building Carlisle, PA 1,996,000 100.0% 13,245
 100.0% $251
 $18.95
 Carlisle Regional Medical Center Carlisle Regional Medical Center
Surgical Institute of Monroe Medical Office Building Monroe, MI 2,010,000 100.0% 24,500
 100.0% $480
 $19.59
 ProMedica The Surgical Institute of Monroe Ambulatory Surgery Center
The Oaks @ Lady Lake Medical Office Building Lady Lake, FL 2,011,000 100.0% 27,992
 100.0% $739
 $26.40
 Munroe Regional Health System Munroe Regional Health System
Mansfield ASC Medical Office Building Mansfield, TX 2,010,000 100.0% 15,662
 100.0% $633
 $40.42
 N/A Baylor Surgicare
Eye Center of Southern Indiana Medical Office Building Bloomington, IN 1,995,000 100.0% 32,096
 100.0% $883
 $27.51
 N/A Eye Center of Southern Indiana
Wayne State Medical Office Building Troy, MI 1,986,000 100.0% 176,000
 100.0% $3,168
 $18.00
 Wayne State University Physician Group Wayne State University Physician Group
Zangmeister Medical Office Building Columbus, OH 2,007,000 100.0% 109,667
 100.0% $2,555
 $23.30
   Mid Ohio Oncology
Ortho One - Columbus Medical Office Building Columbus, OH 2,009,000 100.0% 75,873
 100.0% $1,463
 $19.28
 N/A Orthopedic One
Ortho One - Westerville Medical Office Building Columbus, OH 2,007,000 100.0% 19,876
 100.0% $382
 $19.22
 N/A Orthopedic One
Berger Medical Center Medical Office Building Columbus, OH 2,007,000 100.0% 31,528
 77.7% $509
 $20.78
 Berger Hospital Berger Hospital
El Paso - Lee Trevino Medical Office Building El Paso, TX 1,983,000 100.0% 75,484
 92.8% $1,092
 $15.59
 N/A EPOSG Clinic
El Paso - Murchison Hospital El Paso, TX 1,970,000 100.0% 86,971
 100.0% $2,310
 $26.56
 N/A El Paso Specialty Hospital, EPOSG Clinic
El Paso - Kenworthy Medical Office Building El Paso, TX 1,983,000 100.0% 16,245
 73.6% $457
 $38.23
 N/A EPOSG Clinic
Pinnacle - 32 Northeast Medical Office Building Harrisburg, PA 1,994,000 100.0% 19,110
 100.0% $364
 $19.05
 Pinnacle Health Systems Pinnacle Health Systems
Pinnacle - 4518 Union Deposit Medical Office Building Harrisburg, PA 2,000,000 100.0% 39,009
 89.5% $651
 $18.65
 Pinnacle Health Systems Pinnacle Health Systems
Pinnacle - 4520 Union Deposit Medical Office Building Harrisburg, PA 1,997,000 100.0% 10,200
 100.0% $162
 $15.88
 Pinnacle Health Systems Tristan Associates
Pinnacle - 240 Grandview Medical Office Building Harrisburg, PA 1,980,000 100.0% 19,446
 100.0% $370
 $19.03
 Pinnacle Health Systems Pinnacle Health Systems
Pinnacle - Market Place Way Medical Office Building Harrisburg, PA 2,004,000 100.0% 30,000
 100.0% $332
 $11.07
 Pinnacle Health Systems Pinnacle Health Systems
CRHS - 2000 10th Avenue Medical Office Building Columbus, GA 1,989,000 100.0% 40,341
 83.2% $471
 $14.04
 Columbus Regional Health System Columbus Regional Health System
CRHS - 1942 North Avenue Medical Office Building Columbus, GA 1,971,000 100.0% 6,808
 100.0% $94
 $13.81
 Columbus Regional Health System Columbus Regional Health System
CRHS - 920 18th Street Medical Office Building Columbus, GA 1,982,000 100.0% 6,055
 100.0% $89
 $14.70
 Columbus Regional Health System Columbus Regional Health System
CRHS - 1900 10th Avenue Medical Office Building Columbus, GA 1,976,000 100.0% 50,930
 94.2% $740
 $15.43
 Columbus Regional Health System Columbus Regional Health System
CRHS - 1800 10th Avenue Medical Office Building Columbus, GA 1,980,000 100.0% 38,650
 100.0% $626
 $16.20
 Columbus Regional Health System Columbus Regional Health System
CRHS - 705 17th Street Medical Office Building Columbus, GA 1,994,000 100.0% 44,995
 82.8% $646
 $17.35
 Columbus Regional Health System Columbus Regional Health System
CRHS - 615 19th Street Medical Office Building Columbus, GA 1,976,000 100.0% 9,048
 100.0% $95
 $10.50
 Columbus Regional Health System Columbus Regional Health System
CRHS - 1968 North Avenue Medical Office Building Columbus, GA 1,966,000 100.0% 3,952
 100.0% $
 $
 N/A N/A
CRHS - 633 19th Street Medical Office Building Columbus, GA 1,972,000 100.0% 11,315
 71.2% $112
 $13.90
 Columbus Regional Health System Columbus Regional Health System
CRHS - 500 18th Street Medical Office Building Columbus, GA 1,982,000 100.0% 15,877
 71.8% $143
 $12.54
 Columbus Regional Health System Columbus Regional Health System

CRHS - 2200 Hamilton Road Medical Office Building Columbus, GA 1,992,000 100.0% 17,805
 84.9% $254
 $16.81
 Columbus Regional Health System Columbus Regional Health System
CRHS - 1810 Stadium Drive Medical Office Building Columbus, GA 1,999,000 100.0% 27,620
 65.2% $255
 $14.15
 Columbus Regional Health System Columbus Regional Health System
Carle Danville MOB Medical Office Building Danville, IL 2,007,000 100.0% 46,663
 100.0% $622
 $13.33
 N/A Carle Foundation
Middletown Medical - 111 Maltese Medical Office Building Middletown, NY 1,988,000 100.0% 27,264
 100.0% $710
 $26.04
 N/A Middletown Medical
Middletown Medical - 2 Edgewater Medical Office Building Middletown, NY 1,992,000 100.0% 8,162
 100.0% $212
 $25.97
 N/A Middletown Medical
Napoleon Medical Office Building Medical Office Building New Orleans, LA 1,974,000 100.0% 65,775
 88.9% $1,251
 $21.40
 Oschner Health System N/A
West TN Bone & Joint - Physicians Drive Medical Office Building Jackson, TN 1,991,000 100.0% 23,900
 100.0% $454
 $19.00
 N/A West TN Bone & Joint Clinic
West TN Bone & Joint Medical Office Building Jackson, TN 1,996,000 100.0% 12,524
 100.0% $257
 $20.52
 N/A Jackson Ophthalmology ASC
COMPLETED PROPERTIES TOTAL WEIGHTED AVERAGE        
 2,577,609
 97.1% $56,525
 $22.59
    
Portfolio Total/Weighted Average        
 3,100,701
 94.6% $66,162
 $22.55
    
In the opinion of management, each of our properties is adequately covered by insurance. We currently have no plans for material renovations or other capital improvements at, or developments of, any of our properties.
Scheduled Lease Expirations
 
The following table provides a summary of lease expirations for our properties owned as of December 31, 20142017, for the periods indicated.
NUMBER
OF
LEASES
EXPIRING
 
NET
RENTABLE
SQUARE FEET
 
PERCENTAGE OF
NET RENTABLE
SQUARE FEET
 
ANNUALIZED
RENT(1)
(thousands)
 
PERCENTAGE
OF
ANNUALIZED
RENT
 
ANNUALIZED
RENT LEASED
SQUARE FOOT(2)
201529
 86,971
 2.8% $1,795
 2.7% $20.64
201628
 110,075
 3.6% 2,425
 3.7% $22.03
201721
 68,298
 2.2% 1,647
 2.5% $24.11
Expiration (1) Number of Leases Expiring GLA Percent of GLA 
Annualized Base Rent (2)
(thousands)
 Percent of Annualized Base Rent Annualized Base Rent Leased per Square Foot (3)
201827
 203,922
 6.6% 4,306
 6.5% $21.12
 115
 412,406
 2.9% 8,266
 2.9% $20.04
201925
 202,606
 6.5% 4,057
 6.1% $20.02
 105
 539,574
 3.9% 11,939
 4.2% 22.13
202013
 49,028
 1.6% 969
 1.5% $19.76
 116
 498,110
 3.6% 10,548
 3.7% 21.18
202111
 73,855
 2.4% 1,784
 2.7% $24.16
 160
 688,399
 4.9% 14,709
 5.1% 21.37
202211
 106,611
 3.4% 2,669
 4.0% $25.03
 106
 684,229
 4.9% 16,300
 5.7% 23.82
202317
 178,001
 5.7% 3,941
 6.0% $22.14
 87
 594,185
 4.2% 13,023
 4.6% 21.92
202445
 523,238
 16.9% 10,017
 15.1% $19.14
 87
 862,954
 6.2% 17,524
 6.1% 20.31
2025 132
 1,027,311
 7.3% 24,384
 8.5% 23.74
2026 126
 3,576,886
 25.6% 71,566
 25.1% 20.01
2027 78
 1,362,904
 9.7% 27,181
 9.5% 19.94
Thereafter58
 1,328,091
 42.8% 32,517
 49.1% $24.48
 104
 3,199,457
 22.9% 69,153
 24.2% 21.61
Month to month(4)2
 3,323
 0.1% 35
 0.1% $10.53
 44
 73,781
 0.5% 1,077
 0.4% 14.60
Vacant
 166,682
 5.4% 
 
 
 
 476,606
 3.4% 
 
 
           
Total/ Weighted average287
 3,100,701
 100.0% $66,162
 100.0% $21.34
Total / Weighted average 1,260
 13,996,802
 100.0% $285,670
 100.0% $21.13
(1)Excludes leases related to the Company’s 108,843 square foot corporate office building.
(2)Annualized base rent is calculated by multiplying (a) base rental payments for the month ended December 31, 2017, by (b) 12.
(1)
(3)
Annualized base rent is calculated by multiplying (a) base rental payments for the month ended December 31, 2014, by (b) 12.
(2)Annualized rent per leased square foot is calculated by dividing (a) annualized base rent as of December 31, 2017, by (b) square footage under commenced leases as of December 31, 2017.
(4)Includes 4 leases which expired on December 31, 2017, representing 0.1% of portfolio leasable square feet.

Tenants
As of December 31, 2017, our properties were 96.6% leased. No single tenant accounted for more than 5.6% of our total annualized base rent or 4.3% of total base revenue as of December 31, 2017; however, 18.7% of our total annualized base rent as of December 31, 2014, by (b) square footage under commenced leases as of December 31, 2014.2017 is from tenants affiliated with CHI.


Tenants

As of December 31, 2014, our properties were 94.6% leased. No single tenant accounts for more than 7.1% of our total annualized rent as of December 31, 2014.
The following table sets forth certain information about the 10 largest tenants in our portfolio based on total annualized base rent as of December 31, 2014.
2017.
Tenant 
# of
Properties
 
Property
Location
 Leased SF 
% Leased
GLA
 
Annualized Base
Rent(1)
(thousands)
 
% of Portfolio
Annualized
Rent(2)
LifeCare 3 TX, PA 310,352
 10.0% $4,697
 7.1%
East El Paso Physicians Medical Center 1 TX 77,000
 2.5% $3,381
 5.1%
Wayne State University Physician Group 1 MI 176,000
 5.7% $3,168
 4.8%
Crescent City Surgical Centre 1 LA 60,000
 1.9% $3,090
 4.7%
Foundation Hospital of San Antonio, LLC 2 TX 68,786
 2.2% $2,902
 4.4%
Northside Hospital 3 GA 88,003
 2.8% $2,242
 3.4%
Mid Ohio Oncology 1 OH 98,325
 3.2% $2,233
 3.4%
Pinnacle Health 6 PA 105,199
 3.4% $2,011
 3.0%
Columbus Regional Health System 9 GA 125,189
 4.0% $1,909
 2.9%
Premier Healthcare 3 IN 90,000
 2.9% $1,788
 2.7%
Tenant 
# of
Properties
 Leased GLA % GLA 
Annualized Base
Rent (1)
(thousands)
 
% of Portfolio
Annualized
Rent
CHI - Nebraska 13 893,098
 6.4% $15,906
 5.6%
CHI - KentuckyOne Health 11 744,101
 5.3% 13,120
 4.6%
Baylor Scott and White Health 2 268,639
 1.9% 7,402
 2.6%
US Oncology 6 256,988
 1.8% 6,706
 2.4%
CHI - St. Alexius (ND) 7 362,284
 2.6% 6,239
 2.2%
Northside Hospital (GA) 4 329,249
 2.4% 6,018
 2.1%
HonorHealth (AZ) 6 243,482
 1.7% 5,768
 2.0%
CHI - Franciscan (Seattle - Tacoma) 8 329,754
 2.4% 5,594
 2.0%
Great Falls Hospital (MT) 3 185,085
 1.3% 5,194
 1.8%
LifeCare 3 310,352
 2.2% 5,021
 1.8%
Total 63 3,923,032
 28.0% $76,968
 27.1%
(1)
Calculated for each tenant as the monthly contracted base rent per the terms of such tenant’s lease, as of December 31, 2017, multiplied by 12.
(1)Calculated for each tenant as the monthly contracted base rent per the terms of such tenant’s lease, as of December 31, 2014, multiplied by 12.
(2)Calculated as annualized base rent for such tenant as of December 31, 2014 divided by annualized base rent for the total portfolio as of December 31, 2014.
 
Before entering into a lease and during the lease term, we seek to manage our exposure to significant tenant credit issues. In most instances, we seek to obtain tenant financial information, including credit reports, financial statements, and tax returns. Where appropriate, we seek to obtain financial commitments in the form of letters of credit, and security deposits, or personal guarantees from tenants. On an ongoing basis, we monitor accounts receivable and payment history for both tenants and properties and seek to identify any credit concerns as quickly as possible. In addition, we keep in close contact with our tenants in an effort to identify and address negative changes to their businesses prior to such adverse changes affecting their ability to pay rent to us.
 
Ground Leases

We lease the land upon which six78 of our properties (Mid Coast Hospital, Valley West Hospital, Crescent City Surgical Centre, Ortho One — Columbus, Berger Medical Center, and Carmel Medical Pavilion),are built, representing approximately 9%39.1% of our total leasable square feet and 11%36.9% of our annualized base revenue for the year endedas of December 31, 2014, are subject to2017. The ground leases that containsubject these properties to certain restrictions. These restrictions include limits onmay limit our ability to re-let such facilities to tenants not affiliated with the healthcare delivery system that owns the underlying land, andland. Restrictions may also include rights of first offer and refusal with respect to sales of the propertyproperties and limits onmay limit the types of medical procedures that may be performed.performed at the facilities.

ITEM 3. LEGAL PROCEEDINGS

From time to time, we are party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of our business. We are not currently a party, as plaintiff or defendant, to any legal proceedings which, individually or in the aggregate, would be expected to have a material effect on our business, financial condition or results of operations if determined adversely to us.
 
ITEM 4.MINE SAFETY DISCLOSURES
 
Not applicable.



36


PART II
 
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

There is no established public trading market for our OP Units.Physicians Realty Trust

The Trust’s common shares are traded on the New York Stock Exchange (“NYSE”) under the symbol “DOC.” As of March 9, 2015, weFebruary 23, 2018, the Trust had 116 holders260 registered shareholders of record of our OP Units (includingfor the Trust) and 73,509,407 OP Units outstanding, of which 69,868,507 were held by the Trust.Trust’s common shares.
 
The following table sets forth, for the periods indicated, the distributions paidhigh and low sale prices of the Trust’s common shares for the fiscal years ended December 31, 2016 and 2017, respectively, as reported on the NYSE, and the dividends declared by us to holders of OP Unitsthe Trust with respect to those periods.
2013 Dividends (1) 
Third quarter (commencing July 19, 2013 to September 30, 2013) $0.18
(2)
Fourth quarter $0.225
(3)
2016 High Low Dividends (1) 
First quarter $18.90
 $15.41
 $0.225
(2)
Second quarter $21.36
 $17.83
 $0.225
(3)
Third quarter $22.03
 $19.73
 $0.225
(4)
Fourth quarter $21.45
 $17.12
 $0.225
(5)
2014 Dividends (1) 
2017 High Low Dividends (1) 
First quarter $0.225
(4) $20.19
 $18.18
 $0.225
(6)
Second quarter $0.225
(5) $21.85
 $18.75
 $0.230
(7)
Third quarter $0.225
(6) $20.41
 $17.38
 $0.230
(8)
Fourth quarter $0.225
(7) $19.03
 $17.25
 $0.230
(9)
(1)Dividend information is for dividends declared with respect to that quarter.
(2)On March 18, 2016, the Trust declared a cash dividend of $0.225 per share for the quarterly period ended March 31, 2016. The dividend was paid on April 18, 2016 to common shareholders and OP Unit holders of record on April 1, 2016.
(3)On June 23, 2016, the Trust declared a cash dividend of $0.225 per share for the quarterly period ended June 30, 2016. The dividend was paid on July 18, 2016 to common shareholders and OP Unit holders of record on July 5, 2016.
(4)On September 26, 2016, the Trust declared a cash dividend of $0.225 per common share for the quarterly period ended September 30, 2016. The dividend was paid on October 18, 2016 to common shareholders and OP Unit holders of record on October 6, 2016.
(5)On December 22, 2016, the Trust declared a cash dividend of $0.225 per share for the quarter ending December 31, 2016. The dividend was paid on January 18, 2017 to common shareholders and OP Unit holders of record on January 5, 2017.
(6)On March 17, 2017, the Trust declared a cash dividend of $0.225 per share for the quarterly period ended March 31, 2017. The dividend was paid on April 18, 2017 to common shareholders and OP Unit holders of record on April 5, 2017.
(7)On June 12, 2017, the Trust declared a cash dividend of $0.230 per share for the quarterly period ended June 30, 2017. The dividend was paid on July 18, 2017 to common shareholders and OP Unit holders of record on July 3, 2017.
(8)On September 21, 2017, the Trust declared a cash dividend of $0.230 per share for the quarterly period ended September 30, 2017. The dividend was paid on October 18, 2017 to common shareholders and OP Unit holders of record on October 3, 2017.
(9)On December 21, 2017, the Trust declared a cash dividend of $0.230 per share for the quarterly period ended December 31, 2017. The dividend was paid on January 18, 2018 to common shareholders and OP Unit holders of record on January 3, 2018.
(1)Dividend information is for dividends declared with respect to that quarter.
(2)On September 30, 2013, the Trust declared an initial, prorated quarterly dividend of $0.18 per share for the partial quarterly period from July 19, 2013 (the date of the Trust's IPO) through September 30, 2013, which was equivalent to a full quarterly dividend of $0.225 per share. The dividend was paid on November 1, 2013 to common shareholders and OP Unit holders of record on October 18, 2013, with the exception of the OP Units issued in the acquisition of Crescent City Surgical Centre.
(3)On December 30, 2013, the Trust declared a cash dividend of $0.225 per share for the quarter ending December 31, 2013. The dividend was paid on February 7, 2014 to common shareholders and OP Unit holders of record on January 24, 2014.
(4)On March 27, 2014, the Trust declared a cash dividend of $0.225 per share for the quarterly period ended March 31, 2014. The dividend was paid on April 25, 2014 to common shareholders and OP Unit holders of record on April 18, 2014.
(5)On June 26, 2014, the Trust declared a cash dividend of $0.225 per share for the quarterly period ended June 30, 2014. The dividend was paid on August 1, 2014 to common shareholders and OP Unit holders of record on July 18, 2014.
(6)On September 26, 2014, the Trust declared a cash dividend of $0.225 per common share for the quarterly period ended September 30, 2014. The dividend was paid on October 30, 2014 to common shareholders and OP Unit holders of record on October 17, 2014.
(7)On December 30, 2014, the Trust declared a cash dividend of $0.225 per share for the quarter ending December 31, 2014. The dividend was paid on February 6, 2015 to common shareholders and OP Unit holders of record on January 23, 2015.

It has been the Trust'sTrust’s policy to declare quarterly dividends to its shareholders so as to comply with applicable provisions of the Code governing REITs. The declaration and payment of quarterly dividends remains subject to the review and approval of the Board of Trustees.

Physicians Realty L.P.

There is no established public market for the OP Units or Series A Preferred Units. As of February 23, 2018, there were no holders of record and 187,396,618 OP Units outstanding, 181,932,401 of which were held by the Trust. As of February 23, 2018, there were 104,172 Series A Preferred Units outstanding. The following table sets forth, for the periods

indicated, the distributions paid by the Operating Partnership to holders of its Series A Preferred Units and OP Units with respect to those periods.
2016 Distributions 
First quarter $0.225
Second quarter $0.225
Third quarter $0.225
Fourth quarter $0.225
2017 Distributions 
First quarter $0.225
Second quarter $0.230
Third quarter $0.230
Fourth quarter $0.230

All distributions paid by the Operating Partnership were declared and paid at the same time as dividends that were distributed by the Trust to common shareholders, except that holders of Series A Preferred Units received a 5% cumulative annual return.

It has been the Operating Partnership’s policy to declare quarterly distributions so as to allow the Trust to comply with applicable provisions of the Code governing REITs. The declaration and payment of quarterly distributions remains subject to the review and approval of the Trust’s Board of Trustees.


Stock Performance Graph
This performance graph shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any filing of Physicians Realty Trust under the Securities Act or the Exchange Act.

The graph below compares the cumulative total return of our common shares, the Standard & Poor’s 500, and the MSCI US REIT Index (RMS), from July 19, 2013 (the date of our IPO) through December 31, 2017. The comparison assumes $100 was invested on July 19, 2013 in our common shares and in each of the foregoing indexes and assumes reinvestment of dividends, as applicable. The MSCI US REIT Index consists of equity REITs that are included in the MSCI US Investable Market 2500 Index, except for specialty equity REITS that do not generate a majority of their revenue and income from real estate rental and leasing operations. We have included the MSCI US REIT Index because we joined the MSCI US REIT Index in November 2014 and therefore we believe that it is representative of the industry in which we compete and is relevant to an assessment of our performance.
  Period Ending
Index 7/19/2013 12/31/2013 12/31/2014 12/31/2015 12/31/2016 12/31/2017
Physicians Realty Trust $100.00
 $112.34
 $156.36
 $167.80
 $197.82
 $196.89
Standard & Poor’s 500 $100.00
 $110.29
 $125.39
 $127.13
 $142.33
 $173.40
MSCI US REIT (RMS) $100.00
 $91.70
 $119.56
 $122.57
 $133.11
 $139.86

Recent Sales of Unregistered Securities


None.From time to time, the Operating Partnership issues OP Units to the Trust, as required by the Partnership Agreement, to reflect additional issuances of common shares by the Trust and to preserve equitable ownership ratios.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers


None.The following table sets forth information relating to repurchases of our common shares of beneficial interest and OP Units during the three months ended December 31, 2017:



ISSUER PURCHASES OF EQUITY SECURITIES


Period (a) Total Number of Shares (or Units) Purchased (b) Average Price Paid per Share (or Unit) (c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
October 1, 2017 - October 31, 2017 8,265
(1)$17.57
 N/A
 N/A
November 1, 2017 - November 30, 2017 
 
 N/A
 N/A
December 1, 2017 - December 31, 2017 
 
 N/A
 N/A
Total 8,265
 $17.57
 
 
(1)Represents OP Units redeemed by holders in exchange for common shares of the Trust.

ITEM 6. SELECTED FINANCIAL DATA
 
The following selected financial data should be read together with the discussion under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and the consolidated and combined financial statements and related notes thereto included elsewhere in this report.

We had no business operations prior to completion of the Trust's IPO and the formation transactions on July 24, 2013. As a result, theThe balance sheet data as of December 31, 2012 reflects the financial condition of the Predecessor2017, 2016, 2015, 2014, and the balance sheet data as of December 31, 2013 and 2014 reflects our financial condition. References in theThe notes to the consolidated and combined financial statements refer, unless the context indicates otherwise, to Physicians Realty L.P.the Company for the period July 24, 2013, the date of completion of the IPO and the related formation transactions, through December 31, 2014,2017, and to the Predecessor for all prior periods.

Our Predecessor which is not a legal entity, is comprised of the four healthcare real estate private equity funds, organized as limited liability companies under the laws of Delaware, managed by B.C. Ziegler & Company, which we refer to as the Ziegler Funds, that owned directly or indirectly interests in entities that owned theour initial properties that we acquired on July 24, 2013 in connection with completion of the Trust'sour IPO and related formation transactions.


Physicians Realty Trust and Predecessor
 Year Ended December 31,
(in thousands, except per share data)2017 2016 2015 2014 2013 (1)
Statement of Operations Data 
  
  
    
Revenues: 
  
  
    
Rental revenues$259,673
 $186,301
 $103,974
 $46,397
 $13,565
Expense recoveries75,425
 45,875
 21,587
 5,871
 3,234
Interest income on real estate loans and other8,486
 8,858
 3,880
 1,066
 246
Total revenues343,584
 241,034
 129,441
 53,334
 17,045
Expenses: 
  
  
    
Interest expense47,008
 23,864
 10,636
 6,907
 4,295
General and administrative22,957
 18,397
 14,908
 11,440
 3,214
Operating expenses97,035
 65,999
 31,026
 10,154
 4,650
Depreciation and amortization125,159
 86,589
 45,471
 16,731
 5,107
Acquisition expenses16,744
 14,778
 14,893
 10,897
 1,938
Management fees
 
 
 
 475
Impairment loss965
 
 
 1,750
 
Total expenses309,868
 209,627
 116,934
 57,879
 19,679
Income (loss) before equity in income of unconsolidated entities and gain (loss) on sale of investment properties33,716
 31,407
 12,507
 (4,545) (2,634)
Equity in income of unconsolidated entities183
 115
 104
 95
 
Gain (loss) on sale of investment properties5,874
 
 130
 32
 (2)
Net income (loss)39,773
 31,522
 12,741
 (4,418) (2,636)
Net (income) loss attributable to noncontrolling interests:         
Predecessor
 
 
 
 576
Operating Partnership(1,136) (825) (576) 695
 470
Partially owned properties (2)(491) (716) (377) (314) (71)
Net income (loss) attributable to controlling interest38,146
 29,981
 11,788
 (4,037) (1,661)
Preferred distributions(731) (1,857) (1,189) 
 
Net income (loss) attributable to common shareholders$37,415
 $28,124
 $10,599
 $(4,037) $(1,661)
Net income (loss) per share:         
Basic$0.23
 $0.22
 $0.15
 $(0.12) $(0.13)
Diluted$0.23
 $0.22
 $0.15
 $(0.12) $(0.13)
Dividends and distributions declared per common share and OP Unit$0.915
 $0.900
 $0.900
 $0.900
 $0.410
          
Balance Sheet Data (as of end of period): 
  
  
    
Assets: 
  
  
    
Net real estate investments$4,045,388
 $2,767,624
 $1,579,483
 $773,650
 $227,539
Cash and cash equivalents2,727
 15,491
 3,143
 15,923
 56,478
Tenant receivables, net9,966
 9,790
 2,977
 1,324
 837
Other assets106,302
 95,187
 53,283
 15,806
 5,901
Total assets$4,164,383
 $2,888,092
 $1,638,886
 $806,703
 $290,755
Liabilities and Equity: 
  
  
    
Credit facility$324,394
 $643,742
 $389,375
 $134,144
 $
Notes payable966,603
 224,330
 
 
 
Mortgage debt186,471
 123,083
 94,240
 77,091
 40,716
Accounts payable11,023
 4,423
 644
 700
 836
Dividends and distributions payable43,804
 32,179
 20,783
 16,548
 5,681
Accrued expenses and other liabilities56,405
 42,287
 24,473
 6,140
 2,685
Acquired lease intangible, net15,702
 9,253
 5,950
 2,871
 
Total liabilities1,604,402
 1,079,297
 535,465
 237,494
 49,918
Redeemable noncontrolling interest – Series A Preferred Units (2016 and 2015) and partially owned properties12,347
 26,477
 26,960
 
 
Total shareholders’ equity2,473,172
 1,738,451
 1,021,132
 534,730
 204,904
Total noncontrolling interests74,462
 43,867
 55,329
 34,479
 35,933
Total liabilities and equity$4,164,383
 $2,888,092
 $1,638,886
 $806,703
 $290,755
(1)Because our IPO and the formation transactions were completed on July 24, 2013 and we had no operations prior to completion of our IPO, the results of operations, for the year ended December 31, 2013 reflect the results of operations of the Predecessor from January 1, 2013 through July 23, 2013 and of the Company from July 24, 2013 through December 31, 2013.
(2)An adjustment of $0.3 million and $0.1 million was required for net income attributable to redeemable noncontrolling interests for the year ended December 31, 2017 and December 31, 2016, respectively. No such adjustment was required for the year ended December 31, 2015.


Physicians Realty L.P. and Predecessor
(In thousands, except share and per share data)
Year Ended December 31,Year Ended December 31,
2014 2013 (1) 
Predecessor
2012
Statement of Operations Data: 
  
  
(in thousands, except per unit data)2017 2016 2015 2014 2013 (1)
Statement of Operations Data 
  
  
    
Revenues: 
  
  
 
  
  
    
Rental revenues$46,397
 $13,565
 $9,821
$259,673
 $186,301
 $103,974
 $46,397
 $13,565
Expense recoveries5,871
 3,234
 3,111
75,425
 45,875
 21,587
 5,871
 3,234
Interest income on real estate loans and other1,066
 246
 137
8,486
 8,858
 3,880
 1,066
 246
Total revenues53,334
 17,045
 13,069
343,584

241,034

129,441

53,334
 17,045
Expenses: 
  
  
 
  
  
    
Interest expense6,907
 4,295
 4,538
47,008
 23,864
 10,636
 6,907
 4,295
General and administrative11,440
 3,214
 362
22,957
 18,397
 14,908
 11,440
 3,214
Operating expenses10,154
 4,650
 4,758
97,035
 65,999
 31,026
 10,154
 4,650
Depreciation and amortization16,731
 5,107
 4,150
125,159
 86,589
 45,471
 16,731
 5,107
Impairment losses1,750
 
 937
Acquisition expenses10,897
 1,938
 
16,744
 14,778
 14,893
 10,897
 1,938
Management fees
 475
 951

 
 
 
 475
Impairment loss965
 
 
 1,750
 
Total expenses57,879
 19,679
 15,696
309,868

209,627

116,934

57,879
 19,679
Loss before equity in income of unconsolidated entity, gain (loss) on sale of investment properties, discontinued operations, and noncontrolling interests:(4,545) (2,634) (2,627)
Equity in income of unconsolidated entity95
 
 
Income (loss) before equity in income of unconsolidated entities and gain (loss) on sale of investment properties33,716

31,407

12,507

(4,545) (2,634)
Equity in income of unconsolidated entities183
 115
 104
 95
 
Gain (loss) on sale of investment properties32
 (2) (228)5,874
 
 130
 32
 (2)
Net loss from continuing operations(4,418) (2,636) (2,855)
Discontinued Operations 
  
  
Loss from discontinued operations
 
 (198)
Gain on sale of discontinued investment properties
 
 1,519
Income from discontinued operations
 
 1,321
Net loss(4,418) $(2,636) $(1,534)
Less: net loss attributable to Predecessor
 576
  
Less: net income attributable to noncontrolling interest — partially owned properties(314) (71)  
Net loss attributable to common unitholders$(4,732) $(2,131)  
Net income (loss)39,773

31,522

12,741

(4,418) (2,636)
Net (income) loss attributable to noncontrolling interests:         
Predecessor
 
 
 
 576
Partially owned properties (2)(491) (716) (377) (314) (71)
Net income (loss) attributable to controlling interest39,282

30,806

12,364

(4,732) (2,131)
Preferred distributions(731) (1,857) (1,189) 
 
Net income (loss) attributable to common unitholders$38,551

$28,949

$11,175

$(4,732) $(2,131)
Net income (loss) per unit:         
Basic$0.23
 $0.22
 $0.15
 $(0.12) $(0.13)
Diluted$0.23
 $0.22
 $0.15
 $(0.12) $(0.13)
Dividends and distributions declared per common unit$0.915
 $0.900
 $0.900
 $0.900
 $0.410
         
Balance Sheet Data (as of end of period): 
  
  
 
  
  
    
Assets: 
  
  
 
  
  
    
Net real estate investments$773,650
 $227,539
 $99,897
$4,045,388
 $2,767,624
 $1,579,483
 $773,650
 $227,539
Cash and cash equivalents15,923
 56,478
 2,614
2,727
 15,491
 3,143
 15,923
 56,478
Tenant receivables, net1,324
 837
 682
9,966
 9,790
 2,977
 1,324
 837
Other assets15,806
 5,901
 3,292
106,302
 95,187
 53,283
 15,806
 5,901
Total assets$806,703
 $290,755
 $106,485
$4,164,383

$2,888,092

$1,638,886

$806,703
 $290,755
Liabilities and Equity 
  
  
Credit Facility$134,144
 $
 $
Liabilities and Capital: 
  
  
    
Credit facility$324,394
 $643,742
 $389,375
 $134,144
 $
Notes payable966,603
 224,330
 
 
 
Mortgage debt77,091
 40,716
 83,382
186,471
 123,083
 94,240
 77,091
 40,716
Accounts payable to related parties
 
 1,530
Accounts payable700
 836
 802
11,023
 4,423
 644
 700
 836
Distributions payable16,548
 5,681
 
Dividends and distributions payable43,804
 32,179
 20,783
 16,548
 5,681
Accrued expenses and other liabilities6,140
 2,685
 1,674
56,405
 42,287
 24,473
 6,140
 2,685
Acquired lease intangible, net2,871
 
 
15,702
 9,253
 5,950
 2,871
 
Total liabilities237,494
 49,918
 87,388
1,604,402

1,079,297

535,465

237,494
 49,918
Total unitholders’ capital and predecessor equity568,457
 240,214
 19,068
Noncontrolling interest752
 623
 29
Total liabilities and capital/equity$806,703
 $290,755
 $106,485
Redeemable noncontrolling interest – Series A Preferred Units (2016 and 2015) and partially owned properties12,347
 26,477
 26,960
 
 
Total partners’ capital2,547,016
 1,781,593
 1,066,583
 568,457
 240,214
Noncontrolling interest - partially owned properties618
 725
 9,878
 752
 623
Total liabilities and capital$4,164,383

$2,888,092

$1,638,886

$806,703
 $290,755
(1)Because the formation transactions were completed on July 24, 2013 and we had no operations prior to completion of the Trust’s IPO, the results of operations, for the year ended December 31, 2013 reflect the results of operations of the Predecessor from January 1, 2013 through July 23, 2013 and of the Company from July 24, 2013 through December 31, 2013.
(2)An adjustment of $0.3 million and $0.1 million was required for net income attributable to redeemable noncontrolling interests for the year ended December 31, 2017 and December 31, 2016, respectively. No such adjustment was required for the year ended December 31, 2015.

(1)         Because the Trust's IPO and the formation transactions were completed on July 24, 2013 and we had no operations prior to completion of the IPO, the results of operations for the year ended December 31, 2013 reflect the results of operations of the Predecessor Ziegler Funds from January 1, 2013 through July 23, 2013 and of the Trust from July 24, 2013 through December 31, 2013.
42




ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The following discussion should be read in conjunction with our financial statements, including the notes to those statements, included elsewhere in this report, and the Section entitled “Cautionary Statement Regarding Forward-Looking Statements” in this report. As discussed in more detail in the Section entitled “Cautionary Statement Regarding Forward-Looking Statements,” this discussion contains forward-looking statements which involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements. Factors that might cause those differences include those discussed in “Part I, Item 1. Business” and“Part I, Item 1A. Risk Factors”and elsewhere in this report.
 
Overview
 
We are a self-managed healthcare real estate company organized in April 2013 to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. We invest in real estate that is integral to providing high quality healthcare services. Our properties are typically located on a campus with a hospital or other healthcare facilities or strategically located and affiliated with a hospital or other healthcare facilities. We believe the impact of government programs and continuing trends in the healthcare industry create attractive opportunities for us to invest in healthcare related real estate. In particular, we believe the demand for healthcare will continue to increase as a result of the aging population as older persons generally utilize healthcare services at a rate well in excess of younger people. Our management team has significant public healthcare REIT experience and has long establishedlong-established relationships with physicians, hospitals, and healthcare delivery system decision makers that we believe will provide quality investment and growth opportunities. Our principal investments include medical office buildings, outpatient treatment facilities, acute and post-acute care hospitals, as well as other real estate integral to health carehealthcare providers. During 2017, we saw an increased level of competition for healthcare properties and, as a result, an increase in prices paid for them. In turn, this has had a negative impact on the initial cash yields on potential asset acquisitions.We seek to invest in stabilized medical facility assets with initial cash yields of 6%5.0% to 10%.9.0%, although we invested in certain medical facility assets in 2017 with anticipated initial cash yields below 5.0% and we may invest in other medical facility assets with initial cash yields outside of this range. We seek to generate attractive risk-adjusted returns for the Trust and itsour shareholders through a combination of stable and increasing dividends and potential long-term appreciation in the value of our properties and the Trust'sour common shares.

We have entered into an unsecured credit facilitygrown our portfolio of gross real estate investments from approximately $124 million at the time of our IPO in the maximum principal amount of $400 million and intendJuly 2013 to use borrowings under the facility to finance future acquisitions and developments, fund tenant improvements, leasing commissions to third parties, capital expenditures, provide for working capital and for other general corporate purposes. The unsecured credit facility includes a swingline loan commitment for up to 10% of the maximum principal amount and provides an accordion feature allowing us to increase borrowing capacity by up to an additional $350 million, subject to customary terms and conditions, resulting in a maximum borrowing capacity of $750 million. Asapproximately $4.3 billion as of December 31, 2014, we had approximately $78.1 million of mortgage indebtedness outstanding secured by first mortgages on certain2017. Since the date of our propertiesIPO through to December 31, 2017, our compounded annual growth rate was 120.0%. While we expect to continue to grow through property acquisitions and $138.0 million of outstanding borrowings underinvestments as our unsecured credit facility.asset base continues to increase, our growth rate decelerated in 2017 and we expect our annual growth rate to decelerate in the future.

As of December 31, 2014,2017, our portfolio consisted of 87280 healthcare properties located in 1930 states with approximately 3,100,70113,996,802 net leasable square feet, which were approximately 94.6%96.6% leased with a weighted average remaining lease term of approximately 9.6 years and8.3 years. As of December 31, 2017, approximately 76.5%85.1% of the net leasable square footage of our portfolio was either on campus with a hospital or other healthcare facility or strategically located and affiliated with a hospital or other healthcare delivery system or located within approximately 1/4 mile of a hospital campus.facility.


As of December 31, 2017, leases representing a percentage of our portfolio on the basis of leasable square feet will expire as follows:
Year (1) Portfolio Lease Expirations
MTM (2) 0.5%
2018 2.9%
2019 3.9%
2020 3.6%
2021 4.9%
2022 4.9%
2023 4.2%
2024 6.2%
2025 7.3%
2026 25.6%
2027 9.7%
Thereafter 22.9%
Total 96.6%
(1)“MTM” means month-to-month.
(2)Includes 4 leases which expired on December 31, 2017, representing 0.1% of portfolio leasable square feet.

We receive a cash rental stream from these healthcare providers under our leases. Approximately 85%90.8% of the annualized base rent payments from our properties as of December 31, 20142017 are from absolute and triple-net leases, pursuant to which the tenants are responsible for all operating expenses relating to the property, including but not limited to real estate taxes, utilities, property insurance, routine maintenance and repairs, and property management. This structure helps insulate us from increases in certain operating expenses and provides more predictable cash flow.

Approximately 15%7.0% of the annualized base rent payments from our properties as of December 31, 20142017 are from modified gross base stop leases which allow us to pass through certain increases in future operating expenses (e.g., property tax and insurance), to tenants for reimbursement, thus protecting us from increases in such operating expenses. We seek to structure our triple-net leases to generate attractive returns on a long-term basis. Our leases typically have initial terms of five5 to 15 years and include annual rent escalators of approximately 1.5% to 3.0%. Our operating results depend significantly upon the ability of our tenants to make required rental payments. We believe that our portfolio of medical office buildings and other healthcare facilities will enable us to generate stable cash flows over time because of the diversity of our tenants, staggered lease expiration schedule, long-term leases, and low historical occurrence of tenants defaulting under their leases. As of December 31, 2014, leases representing a percentage of

We intend to grow our portfolio of high-quality healthcare properties leased to physicians, hospitals, healthcare delivery systems and other healthcare providers primarily through acquisitions of existing healthcare facilities that provide stable revenue growth and predictable long-term cash flows. We may also selectively finance the development of new healthcare facilities through joint venture or fee arrangements with premier healthcare real estate developers. Generally, we only expect to make investments in new development properties when approximately 70% or more of the development property has been pre-leased before construction commences. We seek to invest in properties where we can develop strategic alliances with financially sound healthcare providers and healthcare delivery systems that offer need-based healthcare services in sustainable healthcare markets. We focus our investment activity on the basisfollowing types of leasable square feet will expirehealthcare properties:

medical office buildings;
outpatient treatment and diagnostic facilities;
physician group practice clinics;
ambulatory surgery centers; and
specialty hospitals and treatment centers.

We believe that shifting consumer preferences, limited space in hospitals, the desire of patients and healthcare providers to limit non-essential services provided in a hospital setting, and cost considerations, among other trends, continue to drive the industry trend of performing procedures in outpatient facilities that have traditionally been performed in hospitals, such as follows:

Year Portfolio Lease Expirations
2015 2.8%
2016 3.6%
2017 2.2%
2018 6.6%
2019 6.5%
2020 1.6%
2021 2.4%
2022 3.4%
2023 5.7%
2024 16.9%
Thereafter 42.8%
The Trust completed its IPO in July 2013, pursuant to which it issued an aggregate of 11,753,597 common shares, including shares issued upon exercise of the underwriters’ overallotment option,surgeries and received approximately $123.8 million of net proceeds. The Trust contributed the net proceeds of the IPO to us in exchangeother invasive medical procedures. As these trends continue, we believe that demand for 11,753,597 OP Units. Simultaneously with the closing of the IPO, we completed a series of related formation transactions pursuant to which we acquired 19 medical office buildings locatedand similar healthcare properties will continue to rise, and that our investment strategy accounts for these trends.

We may invest opportunistically in ten states with approximately 524,048 net leasable square feet in exchange for 2,744,000 OP Units,life science facilities, assisted living, and the assumption of approximately $84.3 million of debt related to such properties. We used the net proceeds of the IPO to repay approximately $36.9 million of such debt, to purchase the 50% interestindependent senior living facilities and in the Arrowhead Common property not owned by the Ziegler Funds for approximately $850,000, after whichlonger term, senior housing properties, including skilled nursing. Consistent with our qualification as a REIT, we became the 100% owner ofmay also

opportunistically invest in companies that property,provide healthcare services, and to pay certain expenses related to the assumption of debt. In addition, at the completion of the IPO, we entered into a shared services agreement with Ziegler pursuant to which Ziegler provides office space, IT support, accounting support and other services to the Trust and us in exchange for an annual fee. On July 31, 2014, we entered into the First Amendment to Shared Services Agreement with Ziegler, which amended certain terms of the Shared Services Agreement. Among other things, the First Amendment reduced the shared services to be provided by Ziegler, the term of the shared services agreement, and the monthly fee to be paid by the Trust for the remainder of the term. In consideration of these changes, the Trust was obligated to make a one-time payment to Ziegler in the amount of $1,800,000, which could be paid in cash or in unrestricted common shares, as determined by the Trust in its sole discretion. On August 19, 2014, the Trust made the amendment payment by issuing 124,913 common shares to Ziegler.
Following completion of the IPO and related formation transactions through December 31, 2013, we completed the acquisitions of eight healthcare properties located in six states containing an aggregate of 377,295 net leasable square feet for an aggregate of approximately $136.4 million using proceeds from the IPO, borrowings under our former senior secured revolving credit facility and issuance of OP Units. One of the eight healthcare property acquisitions was the Crescent City Surgical Centre in New Orleans, Louisiana, which was acquired in September 2013 for approximately $37.5 million. As partial payment of the purchase price for the property, we issued an aggregate of 954,877 OP Units to the sellers of that property valued at approximately $11.5 million. Also, during 2013, we acquired approximately 40% and 35% of the joint venture interests we did not ownentities with respectoperating partners, structured to two of our existing properties, which resulted in our 100% ownership of those properties.comply with RIDEA.
On December 11, 2013, the Trust completed a follow-on public offering of 9,545,000 common shares of beneficial interest, including 1,245,000 shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds of approximately $103.1 million. The Trust contributed the net proceeds of this offering to us in exchange for 9,545,000 OP Units, and we used the net proceeds of the public offering to repay borrowings under our former senior secured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.
On May 27, 2014, the Trust completed a follow-on public offering of 12,650,000 common shares of beneficial interest, including 1,650,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds of approximately $149.9 million. The Trust contributed the net proceeds of this offering to us in exchange for 12,650,000 OP Units, and we used the net proceeds of the public offering to repay borrowings under our former senior secured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.

On August 4, 2014, the Trust filed a shelf registration statement on Form S-3 with the Commission, allowing the Trust to offer up to $900 million of an indeterminate amount of common shares, preferred shares, convertible preferred shares, debt securities, convertible debt securities or other types of securities, from time to time (the “Shelf Registration Statement”). The Commission declared the Shelf Registration Statement effective on August 19, 2014.

On August 19, 2014, we and the Trust entered into separate At Market Issuance Sales Agreements (the “Sales Agreements”) with each of MLV & Co. LLC, KeyBanc Capital Markets Inc., JMP Securities LLC, and RBC Capital Markets, LLC (the “Agents”), pursuant to which the Trust may issue and sell common shares having an aggregate offering price of up to $150 million, from time to time, through the Agents pursuant to the Shelf Registration Statement (the “ATM Program”). In accordance with the Sales Agreements, the Trust may offer and sell its common shares through any of the Agents, from time to time, by any method deemed to be an “at-the-market offering” as defined in Rule 415 under the Securities Act, which includes sales made directly on the NYSE, or other existing trading market, or sales made to or through a market maker. With the Trust's express written consent, sales also may be made in negotiated transactions or any other method permitted by law. The common shares are registered under the Securities Act pursuant to the Shelf Registration Statement, and are being offered pursuant to a prospectus dated August 19, 2014, as supplemented by a prospectus supplement dated August 19, 2014, filed with the Commission pursuant to Rule 424(b) of the Securities Act. During 2014, the Trust sold 3,576,010 common shares pursuant to the ATM Program, at a weighted average price of $15.54 per share resulting in total proceeds of approximately $55.6 million, before $0.8 million in commissions. As of March 9, 2015, the Trust sold 247,397 common shares during 2015 pursuant to the ATM Program, at a weighted average price of $16.96 per share resulting in total proceeds of approximately $4.2 million, before $55,696 in commissions. As March 9, 2015, the Trust has $90.2 million remaining available under the ATM Program.
On September 12, 2014, the Trust completed a follow-on public offering of 10,925,000 common shares of beneficial interest, including 1,425,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds of approximately $145.7 million. The Trust contributed the net proceeds of this offering to us in exchange for 10,925,000 OP Units, and we used the net proceeds of the public offering to repay borrowings under our former senior secured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.
The Trust was included in the MSCI US REIT Index at the close of business on November 25, 2014.
On December 2, 2014, the Trust adopted a Dividend Reinvestment and Share Purchase Plan (the “DRIP”). Under the DRIP:
Existing shareholders may purchase additional common shares by reinvesting all or a portion of the dividends paid on their common shares and by making optional cash payments of not less than $50 and up to a maximum of $10,000 per month.
New investors may join the DRIP by making an initial investment of not less than $1,000 and up to a maximum of $10,000.
Once enrolled in the DRIP, participants may authorize electronic deductions from their bank account for optional cash payments to purchase additional shares.
The DRIP is administered by the Trust's transfer agent, Computershare Trust Company, N.A. The Trust's common shares sold under the DRIP will be newly issued or purchased in the open market, as further described in the DRIP. As of March 9, 2015, the Trust has issued 2,540 common shares under the DRIP.
On December 30, 2014, the Trust's Board of Trustees authorized and the Trust declared a cash distribution of $0.225 per common share and common OP Unit for the quarterly period ended December 31, 2014. The distribution was paid on February 6, 2015 to common shareholders and OP Unit holders of record as of the close of business on January 23, 2015.

During 2014, we completed acquisitions of 61 operating healthcare properties located in 15 states for an aggregate purchase price of approximately $543.4 million as summarized below:

Property(1) Location 
Acquisition
Date
 
Purchase
Price
 (in thousands)
Foundation San Antonio Surgical Hospital(2) San Antonio, TX February 19, 2014 $25,556
Eagles Landing Family Practice 4 MOBs(2) Atlanta, GA February 19, 2014 20,800
21st Century Oncology 4 MOBs(3)
 Sarasota, FL February 26, 2014 17,486
Foundation San Antonio MOB(3) San Antonio, TX February 28, 2014 6,800
Peachtree Dunwoody MOB(3) Atlanta, GA February 28, 2014 36,726
LifeCare LTACH(2) Fort Worth, TX March 28, 2014 27,160
LifeCare LTACH(2) Pittsburgh, PA March 28, 2014 12,840
Pinnacle Health Cardiology Portfolio 2 MOBs (3) Carlisle & Wormleyburg, PA April 22, 2014 9,208
South Bend Orthopedic MOB (3) South Bend, IN April 30, 2014 14,900
Grenada Medical Complex MOB (3) Grenada, MS April 30,2014 7,100
Mississippi Sports Medicine and Orthopaedics Center MOB (2)(4) Jackson, MS May 23, 2014 16,700
Carmel Medical Pavilion MOB (3)(5) Carmel, IN May 28, 2014 4,664
Summit Urology MOB (2) Bloomington, IN June 30, 2014 4,783
Renaissance Center (3) Oshkosh, WI June 30, 2014 8,500
Presbyterian Medical Plaza MOB (3) Monroe, NC June 30, 2014 7,750
Landmark Medical Portfolio (Premier) 3 MOBs (2)(6) Bloomington, IN July 1, 2014 23,837
Carlisle II MOB (3) Carlisle, PA July 25, 2014 4,500
Surgical Institute of Monroe ASC (2) Monroe, MI July 28, 2014 6,000
The Oaks Medical Building MOB (3) Lady Lake, FL July 31, 2014 10,600
Baylor Surgicare ASC — Mansfield (3) Mansfield, TX September 2, 2014 8,500
Eye Center of Southern Indiana (2)(7) Bloomington, IN September 5, 2014 12,174
Wayne State Medical Center and MOB (2) Troy, MI September 10, 2014 46,500
El Paso Portfolio (specialty surgical hospital and 2 MOBs) (3)(8) El Paso, TX September 30, 2014 46,235
The Mark H. Zangmeister Center (3) Columbus, OH September 30, 2014 36,600
Berger Medical Center (3) Orient, OH September 30, 2014 6,785
Orthopedic One 2 MOBs (3) Columbus & Westerville, OH September 30, 2014 24,500
Pinnacle Health Portfolio 5 MOBs (3) Harrisburg, PA October 29, 2014 23,100
Columbus Regional Health Portfolio 12 MOBs (3) Columbus Regional Health Portfolio 1 MOB (3) Columbus, GA & Phenix City, AL November 20, 2014 27,997
Middletown Medical 2 MOBs (2) Middletown, NY November 26, 2014 14,399
Carle Danville Clinic MOB (3) Danville, IL November 26, 2014 10,300
Napoleon Medical Building MOB (3) New Orleans, LA December 18, 2014 10,500
West Tennessee Bone & Joint 1 MOB 1 ASC (2) Jackson, TN December 30, 2014 9,936
       
Total     $543,436

(1)“MOB” means medical office building, “LTACH” means long-term acute care hospital and “ASC” means ambulatory surgical center.
(2)We accounted for these acquisitions as asset acquisitions and capitalized $1.7 million of total acquisition costs to the basis of the properties.
(3)We accounted for these acquisitions as business combinations pursuant to the acquisition method and expensed total acquisition costs of $10.9 million.
(4)We partially funded the purchase price of these acquisitions by issuing a total of 147,659 OP Units valued at approximately $1.9 million in the aggregate on the date of issuance.

(5)We partially funded the purchase price of these acquisitions by issuing a total of 96,099 OP Units valued at approximately $1.2 million in the aggregate on the date of issuance.
(6)We partially funded the purchase price of these acquisitions by issuing a total of 576,040 OP Units valued at approximately $8.3 million in the aggregate on the date of issuance.
(7)We partially funded the purchase price of these acquisitions by issuing a total of 272,191 OP Units valued at approximately $4.0 million in the aggregate on the date of issuance.
(8)We partially funded the purchase price of these acquisitions by issuing a total of 950,324 OP Units valued at approximately $13.2 million in the aggregate on the date of issuance.
In 2014, we originated two mezzanine loans. On January 2, 2014, we completed a $6.9 million mezzanine loan to affiliates controlled by MedProperties Holdings, LLC, a Dallas, Texas based private investor in medical facilities (“MedProperties”). The mezzanine loan is secured by MedProperties’ ownership interest in two special purpose entities that own a surgical hospital located in San Antonio, Texas and an inpatient rehabilitation facility located in Scottsdale, Arizona. The mezzanine loan has a five year, interest-only term and bears interest at a rate of 9.0% per annum. As part of the consideration for providing the mezzanine loan, we have an option to acquire the property at a formula purchase price during year four of the mezzanine loan based on a fixed capitalization rate.
On November 26, 2014, we made an $8.6 million term loan to fund the renovations and additions of two re-purposed buildings in Jacksonville, Florida. Upon completion of the expansion and renovations, the properties will be approximately 40,000 square feet in the aggregate. Upon completion of the construction of the buildings and them becoming fully occupied, which we expect to occur in the second half of 2015, we have the option to purchase the buildings. The term loan bears interest at a rate of 9.0%.
We have grown our portfolio of gross real estate investments from approximately $124 million at the time of the Trust's IPO in July 2013 to approximately $819 million as of December 31, 2014.
We did not conduct business operations prior to completion of the IPO on July 24, 2013, therefore, the financial information herein for periods prior to July 24, 2013 reflects the operations of the four healthcare real estate funds managed by Ziegler, which we refer to as the Ziegler Funds or the Predecessor, from whom we acquired the equity interests in the 19 properties that constituted our initial properties upon completion of the IPO and formation transactions. We determined the Ziegler Funds to be our accounting predecessor. The financial information herein since July 24, 2013 reflect our operations since completion of the IPO and formation transactions.

The Trust is a Maryland real estate investment trust and elected to be taxed as a REIT for U.S. federal income tax purposes beginning with the short taxable year ended December 31, 2013. The Trust conducts itspurposes. We conduct our business through an UPREIT structure in which itsour properties are owned by usour Operating Partnership directly or through limited partnerships, limited liability companies, or other subsidiaries. The Trust is ourthe sole general partner of our Operating Partnership and, as of March 9, 2015,December 31, 2017, owned approximately 95.0%97.1% of the OP Units. As of February 23, 2018, we have 181,758,250 common shares outstanding.

2017 Investment Activity

During 2017, we completed acquisitions of 40 operating healthcare properties, 2 condominium units, and 1 parking deck, located in 15 states for an aggregate purchase price of approximately $1.37 billion. In addition, we funded $42.9 million of other investments, including the issuance of loans and buyouts of noncontrolling interests, resulting in total investments of $1.41 billion. Acquisitions are detailed in Note 3 to our consolidated financial statements included in Item 8 to this report.

Of the acquisitions completed during 2017, we acquired 8 healthcare properties as a result of the exercise of certain rights of first refusal, comprising approximately 1,402,872 net leasable square feet in three states for an aggregate purchase price of $677.7 million.

In addition, we completed several key financing transactions during fiscal year 2017, which are summarized under the heading “Liquidity and Capital Resources” below.

Recent Developments
 
On December 21, 2017, the Trust’s Board of Trustees authorized and we declared a cash distribution of $0.230 per common share and OP Unit for the quarterly period ended December 31, 2017. The distribution was paid on January 2015 Follow-on Public Offering
On January 21, 2015, the Trust completed a follow-on public offering18, 2018 to common shareholders and OP Unit holders of 18,975,000 common shares of beneficial interest, including 2,475,000 common shares issued upon exerciserecord as of the underwriters’ overallotment option, resulting in net proceedsclose of approximately $297.2 million. The Trust contributed the net proceeds of this offering to us in exchange for 18,975,000 OP Units, and we used the net proceeds of the public offering to repay borrowings under our unsecured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.business on January 3, 2018.

2015 Property Acquisitions2018 Investment Activity
 
Since January 1, 2015,December 31, 2017, we have completed six acquisitions of 162 healthcare properties located in six statesfor an aggregate purchase price of $98.7 million containing an aggregate of 610,084220,140 net leasable square feet and disposed of one property for $1.4 million, resulting in no gain or loss. In addition, the Operating Partnership funded a $2.0 million loan through a separate transaction, resulting in aggregate investment activity of $100.7 million. Property acquisitions subsequent to January 1, 2018 are summarized below.
Property   Location Acquisition
Date
 
Investment
 (in thousands)
Hazelwood Medical Commons(1)  Maplewood, MN January 9, 2018 $70,702
Lee's Hill Medical Plaza   Fredericksburg, VA January 23, 2018 28,000
Loan Investment   Pensacola, FL February 16, 2018 2,000
        $100,702
(1)The Company partially funded the purchase price of this acquisition by issuing a total of 104,172 Preferred OP Units valued at approximately $22.7 million in the aggregate on the date of issuance.

Assets Slated for Disposition

We consider 10 properties in four states, representing an aggregate of approximately $172.0 million391,014 square feet of gross leasable area, to be slated for disposition as summarized below.
Columbus Regional Health Portfolio.  On January 23, 2015,of December 31, 2017. These assets consist of five assets leased to entities who have succeeded to the interests of certain Foundation Healthcare, Inc. affiliates (“Former Foundation Assets”) and five additional properties which we closed on the final buildingbelieve no longer meet our core business strategy from a size, age, geography, or line of business perspective. No assurance can be made, however, that any or all of the previously announced $34.5 million portfolioproperties will be sold, that the Company will receive the anticipated consideration for the sale of 13 on-campus medical office facilities located in Columbus, Georgia. This last building is an approximately 37,995 square foot facility and is 100% leasedany or all of the properties, or as to the Columbus Clinic, a large multi-specialty physician group, and is attached to Columbus Regional Health’s midtown hospital. The purchase price for the building was $6.5 million.

Methodist Sports Medicine. On January 28, 2015, we completed the acquisitiontiming of an approximately 38,000 square foot orthopedic complex comprised of three medical office buildings in Greenwood, Indiana. The orthopedic complex is 100% occupied. As part of the transaction, approximately 420,963 OP Units were issued, which comprised an approximately $7.3 million portion of the purchase price for the properties.

Minnesota Portfolio. During January and February 2015, we closed on the $116.3 million Minnesota portfolio:
We entered into and closed a contribution agreement (the “Contribution Agreement”) with Minnetonka Medical Building, LLC, an affiliate of The Davis Group (“MMB”), and another investor also associated with The Davis Group (together with MMB, the “Contributors”), to acquire a medical office building in Minnetonka, Minnesota (the “Minnetonka MOB”) in exchange for approximately $16.3 million in cash and approximately $9.7 million payable in newly designated Series A Participating Redeemable Preferred Units of our Operating Partnership (the “Series A Preferred Units”). Pursuant to the Contribution Agreement, Mark Davis acquired a less than 1% minority interest in the property holding entity that we acquired. The Minnetonka MOB has approximately 63,500 square feet, and is 100% occupied by North Memorial Healthcare, a comprehensive health care system, on a long-term triple-net lease. Holders of the Series A Preferred Units issued in connection with the acquisition of the Minnetonka MOB are entitled to certain redemption rights under our partnership agreement which allow them to cause us to redeem the Series A Preferred Units in exchange for cash, or at the Trust's option, for the Trust's common shares, pursuant to a formula provided in our partnership agreement and currently on an approximately one-for-12.65 basis. Approximately 44,685 Series A Preferred Units were issued in the transaction to acquire the Minnetonka MOB. The investors in the Series A Preferred Units have agreed not cause us to redeem their Series A Preferred Units prior to February 5, 2016.
We entered into and closed purchase andany such sale or contribution agreements with other affiliates of The Davis Group and investors associated with The Davis Group to acquire six medical office facilities located in the Minneapolis-St. Paul Metropolitan area and one additional medical office facility located in Jamestown, North Dakota. The Davis Group acquired or retained a less than 1% minority interest in five property holding entities that otherwise were wholly acquired by us.sales.

In the aggregate the portfolio is approximately 362,654 square feet, and is 98% leased.
45
The Series A Preferred Units and OP Units issued in connection with the property acquisitions described above were issued (a) in private placements in reliance on Section 4(2) of the Securities Act and the rules and regulations promulgated thereunder and (b) to “accredited investors” within the meaning of Rule 501 of Regulation D under the Securities Act.
Indianapolis South Portfolio. On February 13, 2015, we closed the acquisition of four medical office buildings in Greenwood, Indiana for a purchase price of approximately $17.2 million. The medical office buildings contain approximately 118,934 square feet in the aggregate and are 81.0% leased.
Bridgeport Medical Center. On February 27, 2015, we closed the acquisition of a medical office building in Lakewood, Washington for a purchase price of approximately $13.8 million. The medical office building contains approximately 31,074 square feet and is 100% leased.
Baylor Cancer Center. On February 27, 2015, we closed the acquisition of a medical office building in Dallas, Texas for a purchase price of approximately $8.2 million. The medical office building contains approximately 21,427 square feet and is 100% leased.
We expect to acquire between $500 million to $700 million of real estate during 2015.
Second Amended and Restated Partnership Agreement
On February 5, 2015, we entered into a Second Amended and Restated Agreement of Limited Partnership (the “Partnership Agreement”) which provides for the designation and issuance of the newly designated Series A Preferred Units. The Series A Preferred Units will have priority over all other partnership interests with respect to distributions and liquidation. In addition, the Series A Preferred Units will be redeemable at the option of the holders on or after the one year anniversary of their issuance, which redemption obligation may be satisfied, at the the Trust's option, in cash or the Trust's common shares.

Appointment of General Counsel
On January 8, 2015, the Trust announced that Bradley D. Page would join the Trust as Senior Vice President and General Counsel, effective February 2, 2015. Mr. Page reports directly to the Trust's President and Chief Executive Officer, John T. Thomas. In connection with his appointment, the Trust granted an award of 17,401 restricted common shares to Mr. Page.

Mr. Page served as a shareholder and, most recently, as President of Milwaukee-based Davis & Kuelthau, s.c. until his resignation to accept this position with our general partner. He joined Davis and Kuelthau in 1995, where he represented businesses in all areas of commercial real estate, commercial lending, corporate and construction transactions. Mr. Page’s private practice included acquisition, development, leasing and sales of healthcare, retail, office, multifamily and industrial properties including our company. He has extensive experience negotiating contracts, leases, organizational documents, real estate documents, financing documents and other agreements with national retail tenants, healthcare providers, financial institutions, municipalities, and owners of real property. Mr. Page is a graduate of the University of Wisconsin Law School, with a B.B.A. from the University of Michigan.
Amendment to Mr. Sweet’s Employment Agreement
On February 19, 2015, the Trust and Mr. Sweet entered into an Amended and Restated Employment Agreement, effective January 1, 2015 (the “Amended Employment Agreement”). The Amended Employment Agreement extends Mr. Sweet’s service as Executive Vice President and Chief Investment Officer until January 1, 2017. Then, Mr. Sweet will be employed as a consultant to the Trust until January 1, 2018.
The Amended Employment Agreement amends and restates the first amended and restated Employment Agreement between the Trust and Mr. Sweet, dated May 6, 2014. Under the Amended Employment Agreement, until January 1, 2017, Mr. Sweet will receive a base salary of $245,000 per annum and will be eligible to receive an annual bonus of $50,000 to $100,000 based upon performance goals as established by the Trust's board of trustees or the compensation, nominating and governance committee of the Trust's board of trustees. For 2015 and 2016, Mr. Sweet also will be eligible to receive a one-time award of restricted share units under the Trust's 2013 Equity Incentive Plan for that number of underlying common shares that has a fair market value of at least $500,000, subject to vesting in 2017. When employed as a consultant between January 1, 2017 and January 1, 2018, Mr. Sweet will receive a consulting fee of $75,000 per annum.


Components of Our Revenues, Expenses, and Cash Flow
 
The financial information of our Predecessor, the Ziegler Funds, prior to completion of the IPO, reflects a different structure than our operations following the inception of operations upon completion of the Trust's IPO and as a result, the results of operations of the Predecessor and our results since our inception of operations may not be comparable. While the financial presentation of revenues pursuant to the leases at the properties in our initial portfolio and certain expenses, such as depreciation and amortization, are substantially consistent for the Predecessor and for us, the expense structure of our company since completion of the Trust's IPO and the formation transactions differs from the historical expense structure of the Predecessor. During the periods of financial information for the Predecessor, the Ziegler Funds had no direct employees and paid a fixed annual management fee to Ziegler, which managed the operations of the Ziegler Funds. By contrast, as a self-managed REIT, the Trust does not pay management fees to third parties (other than to third party property management companies with respect to certain of our properties) but rather the Trust pays cash and other forms of compensation to its officers and employees, who also manage our operations. In addition, as a public reporting company, the Trust has incurred and expects to continue to incur certain expenses, such as legal and accounting expenses relating to SEC reporting and other matters that were not incurred historically by the Predecessor, which was not a public reporting company.

Revenues
 
Revenues consist primarily of the rental revenues and property operating expense recoveries we collect from tenants pursuant to our leases. Additionally, we recognize certain cash and non-cash revenues. These cash and non-cash revenues are highlighted below.
 
Rental revenues. Rental revenues represent rent under existing leases that is paid by our tenants, straight-lining of contractual rents, and below-market lease amortization reduced by lease inducements and above-market lease amortization.
 
Expense recoveries. recoveries. Certain of our leases require our tenants to make estimated payments to us to cover their proportional share of operating expenses, including but not limited to real estate taxes, property insurance, routine maintenance

and repairs, utilities, and property management expenses. We collect these estimated expenses and are reimbursed by our tenants for any actual expenses in excess of our estimates or reimburse tenants if our collected estimates exceed our actual operating expenses. The net reimbursed operating expenses are included in revenues as expense recoveries.
 
We have certain tenants with absolute net leases. Under these lease agreements, the tenant is responsible for operating and building expenses. For absolute net leases, we do not recognize operating expense or expense recoveries.

Interest income on real estate loans and other. Represents interest income on a mezzanine loan,loans, term loan and changeloans, notes receivable, income generated on tenant improvements, changes in the fair value of derivative liability.liabilities, and other. Interest income on the loans are recognizedrecorded as earned based on the terms of the loans subject to evaluation of collectability risks.
We have implemented Accounting Standards Codification (ASC) 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. All of the changes in the fair market values of our derivative instruments are recorded in the consolidated and combined statements of operations.


Expenses

Expenses consist primarily of interest expense, general and administrative costs associated with operating our properties, operating expenses of our properties, depreciation and amortization, and costs we incur to acquire properties.
 
Interest expense.We recognize the interest expense we incur on our borrowings as interest expense. Additionally, we incur amortization expense for charges such as legal fees, commitment fees, and arrangement fees that reflect costs incurred with arranging certain debt financings. We generally recognize these costs over the term of the respective debt instrument for which the costs were incurred as a component of interest expense.
 
General and administrative. General and administrative expenses include certain expenses such as compensation, accounting, legal, and other professional fees as well as certain other administrative and travel costs, and expenses related to bank charges, franchisesfranchise taxes, corporate filing fees, exchange listing fees, officer and trustee insurance costs, and other costs associated with the Trust's status asbeing a public company. In addition, effective upon completion of the Trust's IPO, we entered into a Shared Services Agreement with Ziegler with respect to certain overhead expenses. On July 31, 2014, we entered into the First Amendment to Shared Services Agreement with Ziegler, which amended certain terms of the Shared Services Agreement. Among other things, the First Amendment reduced the shared services to be provided by Ziegler, the term of the shared services agreement, and the monthly fee to be paid by the Trust for the remainder of the term. In consideration of these changes, the Trust was obligated to make a one-time payment to Ziegler in the amount of $1,800,000, which could be paid in cash or in unrestricted common shares, as determined by the Trust in its sole discretion. On August 19, 2014, the Trust made the amendment payment by issuing 124,913 common shares to Ziegler. The fees paid under the Shared Services Agreement are included in general and administrative expenses.
 
Operating Expenses.Operating expenses include property operating expenses such as real estate taxes, property insurance, routine maintenance and repairs, utilities, and third party property management expenses, some of which are reimbursed to us by tenants under the terms of triple-nettriple net leases.
 
Depreciation and amortization. We incur depreciation and amortization expense on all of our long-lived assets. This non-cash expense is designed under generally accepted accounting principles, or GAAP, to reflect the economic useful lives of our assets.

Acquisition expenses.Acquisition costs are costs we incur in pursuing and closing property acquisitions accounted for as business combinations. These costs include legal, accounting, valuation, other professional or consulting fees, and the compensation of certain employees who dedicate substantially all of their time to acquisition related job functions. We account for acquisition-related costs as expenses in the period in which the costs are incurred and the services are received.
 
Management fees. Ziegler and another subsidiary of the Ziegler Companies, Inc. historically charged a management fee to the Ziegler Funds. These management fees were discontinued in connection with the acquisition of our initial properties upon completion of the IPO and the formation transactions.

Equity in income of unconsolidated entity. entities. We recognize our 40% share of earnings and losses from the entity that owns the land under Crescent City Surgical Centre. During 2017 we had a 43% voting interest in the entity Desert Cove MOB, of which we bought the remaining interest on December 18, 2017. The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting.


Gain or loss on sale of investment properties. Upon the sale of investment properties, gains or losses are recorded based upon the difference between the disposal sale price and the net book value of the asset.

Cash Flow
 
Cash flows from operating activities. Cash flows from operating activities are derived largely from net income by adjusting our revenues for those amounts not collected in cash during the period in which the revenue is recognized and for cash collected that was billed in prior periods or will be billed in future periods. Net income is further adjusted by adding back expenses charged in the period that is not paid for in cash during the same period. We expect to make our distributions based largely from cash provided by operations.

Cash flows from investing activities. Cash flows from investing activities consist of cash that is used during a period for making new investments and capital expenditures, offset by cash provided from sales of real estate investments.
 
Cash flows from financing activities. Cash flows from financing activities consist of cash we receive from debt and equity financings. This cash provides the primary basis for investments in new properties and capital expenditures. While we may invest a portion of our cash from operations into new investments, as a result of the distribution requirements to maintain the Trust'sour REIT status, it is likely that additional debt or equity financings will finance the majority of our investment activity. Cash used in financing activities consists of repayment of debt and distributions paid to ourshareholders and OP Unit holders.

Results of Operations
Overview
As described above, following the completion of the IPO and the formation transactions, our structure and operations differ from the historical structure and operations of the Ziegler Funds. For this and other reasons set forth in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” we do not believe that the Predecessor’s historical results of operations are indicative of our future operating results.
 
Year Ended December 31, 20142017 compared to the Year Ended December 31, 20132016.
The Operating Partnership commenced operations on July 24, 2013. The 2013 results disclosed in this report include our results from July 24, 2013 through September 30, 2013, combined with the results of the Predecessor from January 1, 2013 through July 23, 2013.

The following table summarizes our results of operations for the yearyears ended December 31, 20142017 and 20132016 (in thousands):

2014 2013 Change %2017 2016 Change %
Revenues: 
  
  
  
 
  
  
  
Rental revenues$46,397
 $13,565
 $32,832
 242.0
$259,673
 $186,301
 $73,372
 39.4
Expense recoveries5,871
 3,234
 2,637
 81.5
75,425
 45,875
 29,550
 64.4
Interest income on real estate loans and other1,066
 246
 820
 333.3
8,486
 8,858
 (372) (4.2)
Total revenues53,334
 17,045
 36,289
 212.9
343,584
 241,034
 102,550
 42.5
Expenses: 
  
  
  
 
  
  
  
Interest expense6,907
 4,295
 2,612
 60.8
47,008
 23,864
 23,144
 97.0
General and administrative11,440
 3,214
 8,226
 255.9
22,957
 18,397
 4,560
 24.8
Operating expenses10,154
 4,650
 5,504
 118.4
97,035
 65,999
 31,036
 47.0
Depreciation and amortization16,731
 5,107
 11,624
 227.6
125,159
 86,589
 38,570
 44.5
Acquisition expenses10,897
 1,938
 8,959
 462.3
16,744
 14,778
 1,966
 13.3
Management fee
 475
 (475) (100.0)
Impairment loss1,750
 
 1,750
 NM
965
 
 965
 NM
Total expenses57,879
 19,679
 38,200
 194.1
309,868
 209,627
 100,241
 47.8
Loss before equity in income of unconsolidated entity and gain (loss) on sale of investment properties:(4,545) (2,634) (1,911) 72.6
Equity in income of unconsolidated entity95
 
 95
 NM
Gain (loss) on sale of investment properties32
 (2) 34
 NM
Net loss$(4,418) $(2,636) $(1,782) 67.6
Income before equity in income of unconsolidated entities and gain on sale of investment properties:33,716
 31,407
 2,309
 7.4
Equity in income of unconsolidated entities183
 115
 68
 59.1
Gain on sale of investment properties5,874
 
 5,874
 NM
Net income$39,773
 $31,522
 $8,251
 26.2
NM = Not Meaningful

Revenues
 
Total revenues increased $36.3$102.6 million, or 212.9%42.5%, for the year ended December 31, 20142017 as compared to the year ended December 31, 2013.2016. An analysis of selected revenues follows.
 
Rental revenues. Rental revenues increased $32.8$73.4 million, or 242.0%39.4%, from $13.6$186.3 million for the year ended December 31, 20132016 to $46.4$259.7 million for the year ended December 31, 2014.2017. The increase in rental revenues primarily resulted

from our 20142017 and 20132016 acquisitions which resulted in additional rental revenue of $23.4$35.4 million and $9.8$48.9 million, respectively. Revenues for the year ended December 31, 2017 were partially offset by declines in rental income recognized at the Kennewick medical office building located in Kennewick, Washington (the “Kennewick MOB”) of $7.4 million and at certain of our buildings formerly occupied by Foundation Healthcare of $2.7 million.

Expense recoveries. Expense recoveries increased $2.6$29.6 million, or 81.5%64.4%, for the year ended December 31, 20142017 as compared to the year ended December 31, 2013.2016. The increase in expense recoveries primarily resulted from our 20142017 and 20132016 acquisitions which resulted in additional expense recoveries of $2.5$12.1 million and $0.2$16.7 million, respectively.
 
Interest income on real estate loans and other.Interest income on real estate loans and other increased $0.8decreased $0.4 million for the year ended December 31, 20142017 as compared to the year ended December 31, 2013. The increase was2016. Loan transactions completed during the resultprior twelve months resulted in $2.0 million of a $0.7increased interest revenue, while other income decreased $1.6 million increaserelative to the prior year due to the mezzanine loan transaction completed on January 2, 2014 and an increase of $0.2 million of other income, which was partially offset by a $0.1 million decrease in the gain from the change in fair valuepayoff of a derivative liability.real estate loan, and interest income from note receivables decreased $0.8 million which relates to a note that was paid off during January 2017.
 
Expenses
 
Total expenses increased by $38.2$100.2 million, or 194.1%47.8%, for the year ended December 31, 20142017 as compared to the year ended December 31, 2013.2016. An analysis of selected expenses follows.
 
Interest expense. Interest expense for the year ended December 31, 20142017 was $6.9$47.0 million compared to $4.3$23.9 million for the year ended December 31, 2013,2016, representing an increase of $2.6$23.1 million, or 60.8%97.0%. The $2.6An increase of $15.5 million resulted from the issuance of our March 2017 and December 2017 public debt offerings, an increase of $3.8 million resulted from borrowings under the term loan provision of our unsecured credit facility, an increase of $2.2 million was the result of a $1.9 millionan increase in interest ondue to new mortgage debt, and $2.3an increase of $2.0 million resultingresulted from outstanding balances, non-use fees and amortizationthe issuance of deferred financing costs on our revolving line of credit, partially offset by a $1.5 million decrease in interest on mortgage debt due to the repayment of $36.9 million of mortgage notes payable in connection with the formation transactions using proceeds from our IPO and $0.1 million decrease relating to a mortgage re-finance and debt pay-downs.2016 senior notes.


General and administrative. General and administrative expenses increased $8.2$4.6 million or 255.9%24.8%, from $3.2$18.4 million during the year ended December 31, 20132016 to $11.4$23.0 million during the year ended December 31, 2014.2017. The increase includedis attributable to increased salaries and benefits, of $3.8 million (includingincluding non-cash share compensation of $1.5 million),$1.1 million, increased office expenditures of $1.1 million, increased professional fees of $1.3$1.1 million, and other administrative costsincreased travel expenditures of $3.1 million (including one-time Amendment Payment of $1.8 million to Ziegler).$0.5 million.
 
Operating expenses. Operating expenses increased $5.5$31.0 million or 118.4%47.0%, from $4.7$66.0 million during the year ended December 31, 20132016 to $10.2$97.0 million during the year ended December 31, 2014.2017. The increase in operating expenseis primarily resulted fromdue to our 20142017 and 20132016 property acquisitions which resulted in additional operating expenseexpenses of $5.2$13.5 million and $0.3$21.4 million, respectively.respectively, partially offset by a reduction in operating expenses associated with the previously existing portfolio.
 
Depreciation and amortization. Depreciation and amortization increased $11.6$38.6 million, or 227.6%44.5%, from $5.1$86.6 million during the year ended December 31, 20132016 to $125.2 million during the year ended December 31, 2017. The increase is due to our 2017 and 2016 property acquisitions which resulted in additional depreciation and amortization of $18.8 million and $22.0 million, respectively, partially offset by a reduction in depreciation and amortization associated with the previously existing portfolio.
Acquisition expenses. Acquisition expenses increased $2.0 million, or 13.3%, from $14.8 million during the year ended December 31, 2016 to $16.7 million during the year ended December 31, 2014. The increase in depreciation and amortization primarily resulted from our 2014 and 2013 acquisitions which resulted in additional depreciation and amortization of $8.0 million and $3.1 million, respectively.
Acquisition expenses. Acquisition expenses increased $9.0 million or 462.3%, from $1.9 million during2017. During the year endedtwelve month periods ending December 31, 2013 to $10.9 million for the year ended December 31, 2014. During the year ended December 31, 20142017 and 2013,2016, we acquired $322.8 million$1.2 billion and $132.4$735.8 million, respectively, of real estate that were considered business combinations and as such, the related acquisition costs were expensed.

Impairment loss. We recognizedThe Company recorded a $1.8$1.0 million impairment loss on twoone medical office buildings purchased by the Predecessorbuilding for the year ended December 31, 2014.2017. No such impairment loss was recorded for the year ended December 31, 2013.2016.

Management fees. The Predecessor incurred $0.5 million of management fees in the year ended December 31, 2013. We do not incur these management fees. No management fees were incurred by us in the year ended December 31, 2014.
Equity in income of unconsolidated entity.The change in equity in income from unconsolidated entity for the year ended December 31, 2014 was $0.1 million. The increase2016 compared to the year ended December 31, 2017 is the result of the acquisition of a 40% ownership interest in the entity that owns the land under Crescent City Surgical Centre for $1.3 million on February 21, 2014.not significant.
 
Gain (loss) on sale of investment properties.On September 19, 2014,April 7, 2017, the TrustCompany sold a 2,000four properties with 80,292 net leasable square foot medical office building condominium unitfeet located in FloridaGeorgia for approximately $0.3$18.2 million, recording a gain of $5.2 million. During 2013, weOn December 18, 2017, the Company sold a 4,000one property with 20,939 net leasable square foot medical office building condominium unitfeet located in FloridaNebraska for approximately $0.5$2.5 million, recording a gain of $0.7 million. We did not dispose of any properties during the year ended December 31, 2016.



48


Year Ended December 31, 20132016 compared to the Year Ended December 31, 2012
The Operating Partnership commenced operations on July 24, 2013. The 2013 results disclosed in this report include our results from July 24, 2013 through September 30, 2013, combined with the results of the Predecessor from January 1, 2013 through July 23, 2013.2015.
  
The following table summarizes our results of operations for the yearyears ended December 31, 20132016 and 20122015 (in thousands):

2013 2012 Change %2016 2015 Change %
Revenues: 
  
  
  
 
  
  
  
Rental revenues$13,565
 $9,821
 $3,744
 38.1
$186,301
 $103,974
 $82,327
 79.2
Expense recoveries3,234
 3,111
 123
 4.0
45,875
 21,587
 24,288
 112.5
Interest income on real estate loans and other246
 137
 109
 79.6
8,858
 3,880
 4,978
 128.3
Total revenues17,045
 13,069
 3,976
 30.4
241,034
 129,441
 111,593
 86.2
Expenses: 
  
  
  
 
  
 

 

Interest expense4,295
 4,538
 (243) (5.4)23,864
 10,636
 13,228
 124.4
General and administrative3,214
 362
 2,852
 787.8
18,397
 14,908
 3,489
 23.4
Operating expenses4,650
 4,758
 (108) (2.3)65,999
 31,026
 34,973
 112.7
Depreciation and amortization5,107
 4,150
 957
 23.1
86,589
 45,471
 41,118
 90.4
Acquisition expenses1,938
 
 1,938
 NM
14,778
 14,893
 (115) (0.8)
Management fee475
 951
 (476) (50.1)
Impairment loss
 937
 (937) (100.0)
Total expenses19,679
 15,696
 3,983
 25.4
209,627
 116,934
 92,693
 79.3
Loss before loss on the sale of investment properties and discontinued operations:(2,634) (2,627) (7) (0.3)
Loss on the sale of investment properties(2) (228) 226
 (99.1)
Discontinued operations: 
  
  
  
Loss from operations
 (198) 198
 (100.0)
Income before equity in income of unconsolidated entities and gain on sale of investment properties:31,407
 12,507
 18,900
 151.1
Equity in income of unconsolidated entities115
 104
 11
 10.6
Gain on sale of investment properties
 1,519
 (1,519) (100.0)
 130
 (130) NM
Income from discontinued operations
 1,321
 (1,321) (100.0)
Net loss$(2,636) $(1,534) $(1,102) 71.8
Net income$31,522
 $12,741
 $18,781
 147.4
NM = Not Meaningful

Revenues

Total revenues increased $4.0$111.6 million, or 30.4%86.2%, for the year ended December 31, 20132016 as compared to the Predecessor’s year ended December 31, 2012.2015. An analysis of selected revenues follows. 

Rental revenues. Rental revenues increased $3.7$82.3 million, or 38.1%79.2%, from $9.8$104.0 million for the year ended December 31, 20122015 to $13.6$186.3 million for the year ended December 31, 2013.2016. The increase in rental revenues primarily resulted from eight propertyour 2016 and 2015 acquisitions which closed in the third and fourth quarters of 2013 and resulted in an additional $3.6rental revenue of $52.1 million in revenueand $31.3 million, respectively. 

Expense recoveries. Expense recoveries increased $24.3 million, or 112.5%, for the year ended December 31, 2013. The remaining increase was the result of contract rent increases and new leases within the initial 19 properties.
Expense recoveries.    Expense recoveries increased $0.1 million, or 4.0%, from $3.1 million for2016 as compared to the year ended December 31, 2012 to $3.2 million for the year ended December 31, 2013, due primarily to an2015. The increase in property related operating expensesexpense recoveries primarily resulted from our 2016 and 2015 acquisitions which are reimbursed to us by tenants under our triple-net leases.resulted in additional expense recoveries of $14.0 million and $10.2 million, respectively. 

Interest income on real estate loans and other. other. Interest income on real estate loans and other increased $0.1$5.0 million for the year ended December 31, 20132016 as compared to the year ended December 31, 2012. The increase was2015. Loan transactions completed during 2016 resulted in $1.9 million of increased interest revenue, while other income increased $2.9 million relative to 2015 due to the resultbuyout of a mark to market gain on interest rate swap.purchase option ($2.1 million) and the write-off of an expired contingent liability ($0.8 million).

Expenses

Total expenses increased by $4.0$92.7 million, or 25.4%79.3%, for the year ended December 31, 20132016 as compared to the Predecessor’s year ended December 31, 2012.2015. An analysis of selected expenses follows. 


Interest expense. Interest expense for the year ended December 31, 20132016 was $4.3$23.9 million compared to $4.5$10.6 million for the Predecessor for the year ended December 31, 2012,2015, representing a decreasean increase of $0.2$13.2 million, or 5.4%124.4%. The decreaseAn increase of $0.2$7.9 million resulted from the issuance of our senior notes, an increase of $3.5 million resulted from borrowings under the term loan provision of our unsecured credit facility, an increase of $1.0 million resulted from the amortization deferred financing fees on our credit facility, and an increase of $0.9 million was the result of a decrease in interest on mortgage debt of $0.9 million due to the repayment of $36.9 million of mortgage notes payable in connection with the formation transactions using proceeds from the Trust's IPO and partially offset by an increase in interest expense of $0.5 million resulting from outstanding balances, non-use fees and amortization ofon new mortgage debt.

deferred financing costs on our revolving line of credit. Also, partially offset by the accelerated amortization of deferred financing costs due to mortgage re-financings of $0.2 million.
General and administrative. General and administrative expenses increased $2.9$3.5 million or 787.8%23.4%, from $0.4$14.9 million during the year ended December 31, 20122015 to $3.2$18.4 million during the year ended December 31, 2013.2016. The increase was the result of the Trust's operations as a public company since completion of its IPO on July 24, 2013. The increases included salaries and benefits of $1.5$2.0 million (including non-cash share compensation of $0.4$0.8 million), professional feesincreased office expenditures of $1.0 million, office start-up costs of $0.2$0.7 million, and other administrative costsincreased travel expenditures of $0.2$0.3 million.

Operating expenses.expenses. Operating expenses decreased $0.1increased $35.0 million or 2.3%112.7%, from $4.8$31.0 million during the year ended December 31, 20122015 to $4.7$66.0 million during the year ended December 31, 2013,2016. The increase is primarily due primarily to a decreaseour 2016 and 2015 property acquisitions which resulted in bad debt expenseadditional operating expenses of $0.2$19.8 million partially offset by an increase in property tax expense of $0.1 million.and $11.8 million, respectively. 

Depreciation and amortization.Depreciation and amortization increased $1.0$41.1 million, or 23.1%90.4%, from $4.1$45.5 million during the year ended December 31, 20122015 to $5.1$86.6 million during the year ended December 31, 2013.2016. The increase is due to our 2016 and 2015 property acquisitions which resulted in additional depreciation and amortization was primarily from eight acquisitions which closed in the thirdof $24.5 million and fourth quarters of 2013 and resulted in an additional $1.1$15.1 million, in depreciation and amortization for the year ended December 31, 2013.respectively. 

Acquisition expenses.expenses. Acquisition expenses were $1.9decreased $0.1 million, for the year ended December 31, 2013. The Predecessor did not incur any acquisition expenses in the year ended December 31, 2012. During fiscal 2013, we acquired $132.4 million of real estate following completion of the IPO on July 24, 2013.
Management fees.    The Predecessor incurred $1.0 million of management fees in the year ended December 31, 2012, compared to $0.5 million of management fees incurred by the Predecessor through July 23, 2013 in the year ended December 31, 2013. No management fees were incurred by us subsequent to the IPO.
Impairment losses.     There were no impairment losses recorded in the year ended December 31, 2013. The Predecessor recorded an impairment loss of $0.9or 0.8%, from $14.9 million during the year ended December 31, 2012. Impairment losses are not a recurring expense as we periodically assess the carrying value of real estate investments and related intangible assets against the estimated fair value of the property.
Loss on sale of investment properties.  We incurred a loss of $0.022015 to $14.8 million on the sale of a medical office building condominium unit at the Summerfield Square property during the year ended December 31, 2013. Total proceeds2016. During the twelve month periods ending December 31, 2016 and 2015, we acquired $735.8 million and $779.2 million, respectively, of real estate that were considered business combinations and as such, the salerelated acquisition costs were $0.5 million. Duringexpensed.

Equity in income of unconsolidated entities. The change in equity income from unconsolidated entities for the year ended December 31, 2012, the Predecessor incurred a loss of $0.2 million on the sale of a condominium unit at the Summerfield Square property. Total proceeds on the sale were $0.3 million. We have 2,000 square feet remaining in the Summerfield Square property.
Income from discontinued operations.    There were no discontinued operations in2015 compared to the year ended December 31, 2013. In fiscal 2012,2016 is not significant. 

Gain on sale of properties. On March 26, 2015, the Predecessor recorded income from discontinued operations and recognizedCompany sold a 20,329 square foot medical office building located in Ohio for approximately $1.6 million, resulting in an insignificant loss. On July 31, 2015, the Company sold a 26,783 square foot medical office building located in Michigan for approximately $1.5 million, recording a gain onof $0.1 million. We did not dispose of any properties during the sale of two properties totaling $1.5 million.year ended December 31, 2016.

Cash Flows
 
Year Ended December 31, 20142017 compared to the Year Ended December 31, 2013 (In2016 (in thousands):
.
 2014 2013
Net cash provided by operating activities$13,295
 $1,168
Net cash used in investing activities(518,810) (126,443)
Net cash provided by financing activities464,960
 179,139
(Decrease) increase in cash and cash equivalents$(40,555) $53,864
 2017 2016
Cash provided by operating activities$180,471
 $127,197
Cash used in investing activities(1,302,638) (1,262,816)
Cash provided by financing activities1,109,403
 1,147,967
Increase (decrease) in cash and cash equivalents$(12,764) $12,348
 
Cash flows from operating activities. Cash flows provided by operating activities was $13.3$180.5 million during the yeartwelve months ended December 31, 20142017 compared to cash flow provided by operating activities of $1.2$127.2 million during the yeartwelve months ended December 31, 2013,2016, representing an increase of $12.1$53.3 million. This change is primarily attributable to the increased operating cash flows resulting from the acquisition of 61 healthcare properties in 2014.our 2017 and 2016 acquisitions.


Cash flows from investing activities. Cash flows used in investing activities was $518.8 million$1.30 billion during the yeartwelve months ended December 31, 20142017 compared to cash flows used in investing activities of $126.4 million$1.26 billion during the yeartwelve months ended December 31, 2013,2016, representing a change of $392.4$39.8 million. The increase in cash flows used in investing activities was primarily attributable to a $375.4our $31.8 million increase in 2014 acquisitions comparedacquisition activity over the prior year and cash used to 2013, fundingfund real estate loans and notes totaling $28.9 million. These were partially offset by $20.4 million in proceeds on sale of two loans for $15.4 million, and $0.9 million increase in capital expenditures on investment properties.property.
 
Cash flows from financing activities. Cash flows provided by financing activities was $465.0 million$1.11 billion during the yeartwelve months ended December 31, 20142017 compared to cash flows provided by financing activities of $179.1 million$1.15 billion during the yeartwelve months ended December 31, 2013,2016, representing an increasea decrease of $285.5$38.6 million. The increase2017 activity was primarily attributable to an increasesales of $124.5 millionour common shares, resulting in net proceeds from follow-on public offerings, net increaseof $844.7 million, $927.0 million of proceeds and payments onfrom the credit facility, borrowings of $138.0and $743.1 million increase of $26.4 million in proceeds from our issuance of mortgage debt and a decrease of $35.3 million of payments on mortgage debt,senior notes. These were partially offset by an increasethe $1.2 billion of $28.8payoffs on our credit facility and $143.1 million of dividends and distributions paid, a $7.6 million increase in purchase of OP Units, and an increase of $2.5 million of debt issuance costs on our credit facility.paid.
 

Year Ended December 31, 20132016 compared to Year Ended December 31, 2012 (In2015 (in thousands):.
 2013 2012
Cash provided by operating activities$1,168
 $3,513
Cash (used in)/provided by investing activities(126,443) 13,527
Cash provided by/(used in) financing activities179,139
 (16,358)
Increase in cash and cash equivalents$53,864
 $682
 2016 2015
Net cash provided by operating activities$127,197
 $59,352
Net cash used in investing activities(1,262,816) (799,716)
Net cash provided by financing activities1,147,967
 727,584
Increase (decrease) in cash and cash equivalents$12,348
 $(12,780)

Cash flows from operating activities.activities. Cash flows provided by operating activities was $1.2$127.2 million during the yeartwelve months ended December 31, 20132016 compared to cash flow provided by operating activities of the Predecessor of $3.5$59.4 million during the yeartwelve months ended December 31, 2012,2015, representing a decreasean increase of $2.3$67.8 million. This change wasis primarily attributable to a $1.1 million decrease in net loss, a $1.8 million decrease in related party accounts payablethe increased operating cash flows resulting from our 2016 and a $2.0 million increase in other assets, partially offset by a $1.5 million increase in gain on sale of investment property and a $1.0 million decrease in impairment loss.2015 acquisitions. 

Cash flows from investing activities.activities. Cash flows used in investing activities was $126.4$1.26 billion during the twelve months ended December 31, 2016 compared to cash flows used in investing activities of $799.7 million during the yeartwelve months ended December 31, 2013 compared to cash flow provided by investing activities of the Predecessor of $13.5 million during the year ended December 31, 2012,2015, representing a change of $139.9$463.1 million. The increase in cash flows used in investing activities was primarily attributable to our $492.3 million increase in acquisition activity over the acquisition of eight properties for $125.7 millionprior year, partially offset by reductions in 2013cash used to fund real estate loans and a $14.1 million decrease in proceeds from the Predecessor’s sale of property in fiscal 2012.notes totaling $32.7 million.
 
Cash flows from financing activities.activities. Cash flows provided by financing activities was $179.1 million$1.15 billion during the yeartwelve months ended December 31, 20132016 compared to cash flows used inprovided by financing activities for the Predecessor of $16.4$727.6 million during the yeartwelve months ended December 31, 2012,2015, representing an increase of $195.5$420.4 million. The increase2016 activity was primarily attributable to $135.2sales of our common shares, resulting in net proceeds of $766.8 million, in$1.18 billion of proceeds from the Trust's IPO, $109.8credit facility, and $225.0 million in proceeds from the Trust's December 2013 public offering,our issuance of senior notes. These were partially offset by $27.7the $925.0 million of payoffs on our credit facility and $104.9 million of dividends paid.

Non-GAAP Financial Measures
This report includes Funds From Operations (FFO), Normalized FFO, Normalized Funds Available For Distribution (FAD), Net Operating Income (NOI), Cash NOI, Same-Store Cash NOI, Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) and Adjusted EBITDA, which are non-GAAP financial measures. For purposes of Item 10(e) of Regulation S-K promulgated under the Securities Act, a non-GAAP financial measure is a numerical measure of a company’s historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in increased debt repayments, $12.3 millionthe most directly comparable financial measure calculated and presented in IPOaccordance with GAAP in the statement of operations, balance sheet, or statement of cash flows (or equivalent statements) of the company, or includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable financial measure so calculated and presented. As used in this report, GAAP refers to generally accepted accounting principles in the United States of America. Pursuant to the requirements of Item 10(e) of Regulation S-K promulgated under the Securities Act, we have provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.


Funds From Operations (FFO) and Normalized FFO

We believe that information regarding FFO is helpful to shareholders and potential investors because it facilitates an understanding of the operating performance of our properties without giving effect to real estate depreciation and amortization, which assumes that the value of real estate assets diminishes ratably over time. We calculate FFO in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”). NAREIT defines FFO as net income or loss (computed in accordance with GAAP) before noncontrolling interests of holders of OP units, excluding preferred distributions, gains (or losses) on sales of depreciable operating property, impairment write-downs on depreciable assets, plus real estate related depreciation and amortization (excluding amortization of deferred financing costs). Our FFO computation may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition or that interpret the NAREIT definition differently than we do. The GAAP measure that we believe to be most directly comparable to FFO, net income, includes depreciation and amortization expenses, gains or losses on property sales, impairments, and noncontrolling interests. In computing FFO, we eliminate these items because, in our view, they are not indicative of the results from the operations of our properties. To facilitate a clear understanding of our historical operating results, FFO should be examined in conjunction with net income (determined in accordance with GAAP) as presented in our financial statements. FFO does not represent cash generated from operating activities in accordance with GAAP, should not be considered to be an alternative to net income or loss (determined in accordance with GAAP) as a measure of our liquidity, and is not indicative of funds available for our cash needs, including our ability to make cash distributions to shareholders.
We use Normalized FFO, which excludes from FFO net change in fair value of derivative financial instruments, acquisition expenses, acceleration of deferred financing costs, and $6.7 millionother normalizing items. However, our use of the term Normalized FFO may not be comparable to that of other real estate companies as they may have different methodologies for computing this amount. Normalized FFO should not be considered as an alternative to net income or loss (computed in December 2013 public offering costs.accordance with GAAP), as an indicator of our financial performance or of cash flow from operating activities (computed in accordance with GAAP), or as an indicator of our liquidity, nor is it indicative of funds available to fund our cash needs, including its ability to make distributions. Normalized FFO should be reviewed in connection with other GAAP measurements.

The following is a reconciliation from the Trust’s net income, the most direct financial measure calculated and presented in accordance with GAAP, to FFO and Normalized FFO (in thousands, except per share data):
 Year Ended December 31,
 2017 2016
Net income$39,773
 $31,522
Earnings per share - diluted$0.23
 $0.22
    
Net income$39,773
 $31,522
Net income attributable to noncontrolling interests - partially owned properties(491) (716)
Preferred distributions(731) (1,857)
Depreciation and amortization expense125,022
 86,501
Depreciation and amortization expense - partially owned properties(531) (683)
Gain on the sale of investment properties(5,874) 
Impairment loss965
 
FFO applicable to common shares and OP Units$158,133
 $114,767
FFO per common share and OP Unit$0.94
 $0.88
Net change in fair value of derivative150
 (240)
Acquisition expenses16,744
 14,778
Net change in fair value of contingent consideration(472) (840)
Normalized FFO applicable to common shares and OP Units$174,555
 $128,465
Normalized FFO per common share and OP Unit$1.04
 $0.98
  
  
Weighted average number of common shares and OP Units outstanding168,231,299
 130,446,893


Normalized Funds Available for Distribution (FAD)

We use Normalized FAD, a non-GAAP measure, which excludes from Normalized FFO non-cash compensation expense, straight-line rent adjustments, amortization of acquired above- or below-market leases and assumed debt, amortization of deferred financing costs, amortization of lease inducements, and recurring capital expenditures related to tenant improvements and leasing commissions, and includes cash payments from seller master leases and rent abatement payments. Other REITs or real estate companies may use different methodologies for calculating Normalized FAD, and accordingly, our computation may not be comparable to those reported by other REITs. Although our computation of Normalized FAD may not be comparable to that of other REITs, we believe Normalized FAD provides a meaningful supplemental measure of our performance due to its frequency of use by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. Normalized FAD should not be considered as an alternative to net income or loss attributable to controlling interest (computed in accordance with GAAP) or as an indicator of our financial performance. Normalized FAD should be reviewed in connection with other GAAP measurements.

The following is a reconciliation from the Trust’s Normalized FFO to Normalized FAD (in thousands):
  Year Ended December 31,
  2017 2016
Net income $39,773
 $31,522
Normalized FFO applicable to common shares and OP Units $174,555
 $128,465
     
Normalized FFO applicable to common shares and OP Units $174,555
 $128,465
Non-cash share compensation expense 5,073
 3,920
Straight-line rent adjustments (16,202) (16,226)
Amortization of acquired above/below-market leases/assumed debt 3,596
 2,778
Amortization of lease inducements 1,309
 892
Amortization of deferred financing costs 2,299
 2,325
TI/LC and recurring capital expenditures (15,319) (8,087)
Seller master lease and rent abatement payments 973
 1,032
Normalized FAD applicable to common shares and OP Units $156,284
 $115,099

Net Operating Income (NOI) and Cash NOI
NOI is a non-GAAP financial measure that is defined as net income or loss, computed in accordance with GAAP, generated from our total portfolio of properties before general and administrative expenses, acquisition expenses, depreciation and amortization expense, interest expense, net change in the fair value of derivative financial instruments, gain or loss on the sale of investment properties, and impairment losses. We believe that NOI provides an accurate measure of operating performance of our operating assets because NOI excludes certain items that are not associated with management of the properties. Our use of the term NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing this amount.
Cash NOI is a non-GAAP financial measure which excludes from NOI straight-line rent adjustments, amortization of acquired above- and below-market leases, and other non-cash and normalizing items. Other non-cash and normalizing items include items such as the amortization of lease inducements, and payments received from seller master leases and rent abatements. We believe that Cash NOI provides an accurate measure of the operating performance of our operating assets because it excludes certain items that are not associated with management of the properties. Additionally, we believe that Cash NOI is a widely accepted measure of comparative operating performance in the real estate community. Our use of the term Cash NOI may not be comparable to that of other real estate companies, as such other companies may have different methodologies for computing this amount.


The following is a reconciliation from the Trust’s net income, the most direct financial measure calculated and presented in accordance with GAAP, to NOI, and Cash NOI (in thousands):
 Year Ended December 31,
 2017 2016
Net income$39,773
 $31,522
General and administrative22,957
 18,397
Acquisition expenses16,744
 14,778
Depreciation and amortization125,159
 86,589
Interest expense47,008
 23,864
Net change in the fair value of derivative150
 (240)
Gain on the sale of investment properties(5,874) 
Impairment loss965
 
NOI$246,882
 $174,910
  
  
NOI$246,882
 $174,910
Straight-line rent adjustments(16,202) (16,226)
Amortization of acquired above/below-market leases/assumed debt3,596
 2,778
Amortization of lease inducements1,309
 892
Seller master lease and rent abatement payments973
 1,032
Change in fair value of contingent consideration(472) (840)
Cash NOI$236,086
 $162,546

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) and Adjusted EBITDA
We define EBITDA as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, and net change in the fair value of derivative financial instruments. We define Adjusted EBITDA as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, net change in the fair value of derivative financial instruments, acquisition expenses, non-cash share compensation, change in fair value of contingent consideration, and other normalizing items. We consider EBITDA and Adjusted EBITDA important measures because they provide additional information to allow management, investors, and our current and potential creditors to evaluate and compare our core operating results and our ability to service debt.

The following is a reconciliation from the Trust’s net income, the most direct financial measure calculated and presented in accordance with GAAP, to EBITDA and Adjusted EBITDA (in thousands):
 Year Ended December 31,
 2017 2016
Net income$39,773
 $31,522
Depreciation and amortization125,159
 86,589
Interest expense47,008
 23,864
Net change in fair value of derivatives150
 (240)
EBITDA$212,090
 $141,735
Acquisition expenses16,744
 14,778
Non-cash share compensation expense5,074
 3,920
Change in fair value of contingent consideration(472) (840)
Impairment loss965
 
Adjusted EBITDA$234,401
 $159,593

54


Liquidity and Capital Resources
 
Our short-term liquidity requirements consist primarily of operating and interest expenses and other expenditures directly associated with our properties, including:
 
property expenses;
interest expense and scheduled principal payments on outstanding indebtedness;
general and administrative expenses; and
capital expenditures for tenant improvements and leasing commissions.
 
In addition, we will require funds for future distributions expected to be paid to our common shareholders and OP Unit holders.holders in our Operating Partnership.


As of December 31, 2014,2017, we had a total of $16.0$2.7 million of cash and cash equivalents and $189.0$753.0 million of near-term availability on our unsecured revolving credit facility. Also,Our primary sources of cash include rent we had an additional $73.0 million of availabilitycollect from our tenants, borrowings under our unsecured revolving credit facility, asand financings of December 31, 2014 which is subject to customary property underwriting standards.debt and equity securities. We believe that our existing cash and cash equivalents, cash flow from operating activities, and borrowings available under our unsecured revolving credit facility will be adequate to fund any existing contractual obligations to purchase properties and other obligations through the next twelve months. However, because of the 90% distribution requirement under the REIT tax rules under the Code, applicable to the Trust, we may not be able to fund all of our future capital needs from cash retained from operations, including capital needed to make investments and to satisfy or refinance maturing obligations. As a result, we expect to rely upon external sources of capital, including debt and equity financing, to fund future capital needs. If we are unable to obtain needed capital on satisfactory terms or at all, we may not be able to make the investments needed to expand our business or to meet our obligations and commitments as they mature. We will rely upon external sources of capital to fund future capital needs, and, if we encounter difficulty in obtaining such capital, we may not be able to make future acquisitions necessary to grow our business or meet maturing obligations.

Our long-term liquidity needs consist primarily of funds necessary to pay for acquisitions, recurring and non-recurring capital expenditures, and scheduled debt maturities. We expect to satisfy our long-term liquidity needs through cash flow from operations, unsecured borrowings, issuances of equity and debt securities, and, in connection with acquisitions of additional properties, the issuance of OP Units or issuances by the Trust of its equity securities,our Operating Partnership, and proceeds from select property dispositions and joint venture transactions.

Our ability to access capital in a timely and cost-effective manner is essential to the success of our business strategy as it affects our ability to satisfy existing obligations, including repayment of maturing indebtedness, and to make future investments and acquisitions. Factors such as general market conditions, interest rates, credit ratings on our debt and equity securities, expectations of our potential future earnings and cash distributions, and the market price of our common shares, each of which are beyond our control and vary or fluctuate over time, all impact our access to and cost of capital. In particular, to the extent interest rates continue to rise, we may experience a decline in the market price of our common shares, which may impact our decision to conduct equity offerings for capital raising purposes. We will likely also experience higher borrowing costs as interest rates rise, which may also impact our decisions to incur additional indebtedness or to engage in transactions for which we may need to fund through borrowing.

We expect to continue to utilize equity and debt financings to support our future growth and investment activity. For the twelve months ended December 31, 2017, we raised $750.0 million in senior unsecured notes, and decreased the outstanding balance on our primary unsecured revolving credit facility to $80.0 million. A summary of our key financing activities during fiscal year 2017 is included below.

We also continuously evaluate opportunities to finance future investments. New investments are generally funded from temporary borrowings under our primary unsecured credit facility and the proceeds from financing transactions such as those discussed above. Our investments generate cash from net operating income and principal payments on loans receivable. Permanent financing for future investments, which generally replaces funds drawn under our primary unsecured credit facility, has historically been provided through a combination of the issuance of debt and equity securities and the incurrence or assumption of secured debt.

We intend to invest in additional properties as suitable opportunities arise and adequate sources of financing are available. We are currently are evaluating additional potential investments consistent with the normal course of our business. There can be no assurance as to whether or when any portion of these investments will be completed. Our ability to complete investments is subject to a number of risks and variables, including our ability to negotiate mutually agreeable terms with

sellers and our ability to finance the investment. We may not be successful in identifying and consummating suitable acquisitions or investment opportunities, which may impede our growth and negatively affect our results of operations and may result in the use of a significant amount of managementmanagement’s resources. We expect that future investments in properties will depend on and will be financed by, in whole or in part, our existing cash, borrowings, including under our unsecured revolving credit facility, or the proceeds from additional issuances of OP Unitsequity or issuances by the Trust of common or preferred shares or otherdebt securities.
 
On August 4, 2014,While we intend to sell the Trust filed10 assets slated for disposition for other business reasons, we currently do not expect to sell any of our properties to meet our liquidity needs, although we may do so in the Shelf Registration Statementfuture.

We intend either to repay in full at maturity the mortgage notes payable that have maturity balloon payments or to refinance such notes if we are able to obtain favorable terms and conditions.
We currently are in compliance with the Commission, which the Commission declared effectiveall debt covenants on August 19, 2014.our outstanding indebtedness.
Credit Facility
 
On August 19, 2014, weJune 10, 2016, the Operating Partnership, as borrower, and the Trust entered into separate At Market Issuance Sales Agreements (the “Sales Agreements”) with each of MLV & Co. LLC, KeyBanc Capital Markets Inc., JMP Securities LLC,an amended and RBC Capital Markets, LLC (the “Agents”), pursuant to which the Trust may issue and sell common shares having an aggregate offering price of up to $150 million, from time to time, through the Agents pursuant to the Shelf Registration Statement (the “ATM Program”). In accordance with the Sales Agreements, the Trust may offer and sell its common shares through any of the Agents, from time to time, by any method deemed to be an “at-the-market offering” as defined in Rule 415 under the Securities Act, which includes sales made directly on the NYSE, or other existing trading market, or sales made to or through a market maker. With the Trust's express written consent, sales also may be made in negotiated transactions or any other method permitted by law. The common shares are registered under the Securities Act pursuant to the Shelf Registration Statement, and are being offered pursuant to a prospectus dated August 19, 2014, as supplemented by a prospectus supplement dated August 19, 2014, filed with the Commission pursuant to Rule 424(b) of the Securities Act. During 2014, the Trust sold 3,576,010 common shares pursuant to the ATM Program, at a weighted average price of $15.54 per share resulting in total proceeds of approximately $55.6 million, before $0.8 million in commissions. As of March 9, 2015, the Trust sold 247,397 common shares during 2015 pursuant to the ATM Program, at a weighted average price of $16.96 per share resulting in total proceeds of approximately $4.2 million, before $55,696 in commissions. As of March 9, 2015, the Trust has $90.2 million remaining available under the ATM Program.
On September 12, 2014, the Trust completed a follow-on public offering of 10,925,000 common shares of beneficial interest, including 1,425,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds of approximately $145.7 million. The Trust contributed the net proceeds of this offering to us in exchange for 10,925,000 OP Units, and we used the net proceeds of the public offering to repay borrowings under our former senior secured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.
On January 21, 2015, the Trust completed a follow-on public offering of 18,975,000 common shares of beneficial interest, including 2,475,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds of approximately $297.2 million. The Trust contributed the net proceeds of this offering to us in exchange for

18,975,000 OP Units, and we used the net proceeds of the public offering to repay borrowings under our unsecured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.

Effective September 18, 2014, therestated Credit Agreement dated as of August 29, 2013 (as amended, restated, increased, extended, supplemented or otherwise modified from time to time, the “Prior Credit Agreement”), among us, as borrower, the Trust, and certain of our subsidiaries and other affiliates, as guarantors, Regions Bank, as administrative agent, Regions Capital Markets, as sole lead arranger and sole book runner, and the lenders party thereto, and all commitments provided thereunder, were terminated. All amounts due and outstanding under the Prior Credit Agreement were repaid on or prior to such date.
On September 18, 2014, we, as borrower, the Trust and certain of our subsidiaries and other affiliates, as guarantors, entered into a Credit Agreement (the “Credit Agreement”) with KeyBank National Association, as administrative agent, KeyBanc Capital Markets Inc., RegionsBMO Capital Markets, and BMO Capital Markets,Citizens Bank N.A., as joint lead arrangers and joint bookrunners, Regionsco-book runners, BMO Capital Markets and BMO Capital Markets,Citizens Bank N.A., as co-syndication agents, and the lenders party thereto in connection with(the “Credit Agreement”) which increased the maximum principal amount available under an unsecured revolving credit facility in the maximum principal amount of $400from $750 million to $850 million. The Credit Agreement contains a 7-year term loan feature allowing us to borrow in a single drawing up to $250 million, increasing the borrowing capacity to an aggregate $1.1 billion. The Credit Agreement also includes a swingline loan commitment for up to 10% of the maximum principal amount and provides an accordion feature allowing us to increase borrowing capacity by up to an additional $350$500 million, subject to customary terms and conditions, resulting in a maximum borrowing capacity of $750 million. The Credit Agreement replaced our senior secured revolving credit facility in$1.6 billion.

On July 7, 2016, the maximum principal amount of $200Operating Partnership borrowed $250.0 million under the Prior7-year term loan feature of the Credit Agreement. Borrowings under the term loan feature of the Credit Agreement bear interest on the outstanding principal amount at a rate which is determined by the Trust’s credit rating, currently equal to LIBOR + 1.80%. The Trust simultaneously entered into a pay-fixed receive-variable rate swap for the full borrowing amount, fixing the LIBOR component of the borrowing rate to 1.07%, for an all-in fixed rate of 2.87%. Both the borrowing and pay-fixed receive-variable swap have a maturity date of June 10, 2023.

The Credit Agreement has a maturity date of September 18, 20182020 and includes a one-year extension option. Borrowings under the Credit Agreement bear interest on the outstanding principal amount at aan adjusted LIBOR rate, equal to LIBOR plus 1.50% to 2.20% dependingwhich is based on the consolidated leverage ratio. In addition,Trust’s investment grade rating under the Credit Agreement. As of December 31, 2017, the Trust had an investment grade rating from Moody’s of Baa3 and from S&P of BBB- and as such, borrowings under the revolving credit facility of the Credit Agreement accrued interest on the outstanding principal at a rate of LIBOR plus 1.20%. The Credit Agreement includes an unuseda facility fee equal to 0.15% or 0.25% per annum, which is also determined by usage under the Credit Agreement. Any additional indebtedness incurred or issued by us may be secured or unsecured, may have a short, medium, or long term fixed or variable interest rate and may be subject to other terms and conditions. We may also enter into financing arrangements on terms that we might not otherwise accept if we were in need of liquidity and had limited options.Trust’s investment grade rating.
 
The Credit Agreement contains financial covenants that, among other things, require compliance with leverage and coverage ratios and maintenance of minimum tangible net worth, as well as covenants that may limit our and the Trust’s ability to incur additional debt or make distributions. We may, at any time, voluntarily prepay any revolving or swingline loan under the Credit Agreement in whole or in part without premium or penalty. Prepayments of term borrowings require payment of premiums of up to 2.0% of the amount of prepayment, dependent on date of such prepayment. As of December 31, 2014,2017, we were in compliance with all financial covenants.

The Credit Agreement includes customary representations and warranties by us the Trust and each other guarantor and imposes customary covenants on us, the Trust and each other guarantor.us. The Credit Agreement also contains customary events of default, and if an event of default occurs and continues, we arethe Operating Partnership is subject to certain actions by the administrative agent, including without limitation, the acceleration of repayment of all amounts outstanding under the Credit Agreement.


The Credit Agreement provides for revolving credit and term loans to the Operating Partnership. Base Rate Loans, Adjusted LIBOR Rate Loans, and Letters of Credit (each, as defined in the Credit Agreement) will be subject to interest rates, based upon the Trust’s investment grade rating as follows:
Credit Rating 
Margin for Revolving Loans: Adjusted LIBOR Rate Loans
and Letter of Credit Fee
 Margin for Revolving Loans: Base Rate Loans 
Margin for Term Loans: Adjusted LIBOR Rate Loans
and Letter of Credit Fee
 Margin for Term Loans: Base Rate Loans
At Least A- or A3 LIBOR + 0.85% % LIBOR + 1.40% 0.40%
At Least BBB+ or Baa1 LIBOR + 0.90% % LIBOR + 1.45% 0.45%
At Least BBB or Baa2 LIBOR + 1.00% 0.10% LIBOR + 1.55% 0.55%
At Least BBB- or Baa3 LIBOR + 1.20% 0.20% LIBOR + 1.80% 0.80%
Below BBB- or Baa3 LIBOR + 1.55% 0.60% LIBOR + 2.25% 1.25%
As of December 31, 2017, there were $80.0 million of borrowings outstanding under our unsecured revolving credit facility and $250.0 million of borrowings outstanding under the term loan feature of the Credit Agreement. As of December 31, 2017, the Company has issued a letter of credit for $17.0 million with no outstanding balance. As defined by the Credit Agreement, as of December 31, 2017, the Trust had $753.0 million of near-term availability on our unsecured revolving credit facility without adding additional properties to the unencumbered borrowing base of assets.

Senior Notes

Senior Notes Issued in 2016

On January 7, 2016, the Operating Partnership issued and sold $150.0 million aggregate principal amount of senior notes, comprised of (i) $15.0 million aggregate principal amount of 4.03% Senior Notes, Series A, due January 7, 2023, (ii) $45.0 million aggregate principal amount of 4.43% Senior Notes, Series B, due January 7, 2026, (iii) $45.0 million aggregate principal amount of 4.57% Senior Notes, Series C, due January 7, 2028, and (iv) $45.0 million aggregate principal amount of 4.74% Senior Notes, Series D, due January 7, 2031. On August 11, 2016, the note agreement for these notes was amended to make certain changes to its terms, including certain changes to affirmative covenants, negative covenants and definitions contained therein. Interest on each respective series of the January 2016 Senior Notes is payable semi-annually. The proceeds of the Notes were used to repay borrowings under our unsecured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.

On August 11, 2016, the Operating Partnership issued and sold $75.0 million aggregate principal amount of senior notes, comprised of (i) $25.0 million aggregate principal amount of 4.09% Senior Notes, Series A, due August 11, 2025, (ii) $25.0 million aggregate principal amount of 4.18% Senior Notes, Series B, due August 11, 2026, and (iii) $25.0 million aggregate principal amount of 4.24% Senior Notes, Series C, due August 11, 2027. Interest on each respective series of the August 2016 Senior Notes is payable semi-annually.

The note agreements covering the notes described above contain covenants that are substantially similar to those contained in the Credit Agreement, including financial covenants that require compliance with leverage and coverage ratios and maintenance of minimum tangible net worth, as well as other affirmative and negative covenants that may limit, among other things, our ability to incur additional debt, make distributions or investments, incur liens and sell, transfer or dispose of assets. The note agreements also include customary representations and warranties and customary events of default substantially similar to those contained in the Credit Agreement.
2027 Senior Notes

On March 7, 2017, the Operating Partnership issued $400.0 million in aggregate principal amount of 4.30% Senior Notes due March 15, 2027 (the “2027 Senior Notes”) in a public offering (the “March Debt Offering”) through underwriters for whom J.P. Morgan Securities LLC, Credit Agricole Securities (USA) Inc., and Jefferies LLC acted as representatives (the “Representatives”) pursuant to an underwriting agreement, dated March 2, 2017 (the “Underwriting Agreement”), among the Operating Partnership, the Trust, and the Representatives.

The 2027 Senior Notes were registered under the Securities Act on the Trust’s and the Operating Partnership’s automatic shelf registration statement on Form S-3ASR (File No. 333-216214), filed with the Commission on February 24, 2017.


The 2027 Senior Notes began accruing interest on March 7, 2017 and began paying interest semi-annually beginning September 15, 2017. The 2027 Senior Notes were sold at an issue price of 99.68% of their face value, before the underwriters’ discount. Our net proceeds from the offering, after deducting underwriting discounts and expenses, were approximately $396.1 million. We currently do not expectused the net proceeds of the March Debt Offering to repay a portion of the outstanding indebtedness under our unsecured revolving credit facility and for general corporate purposes, including working capital and funding acquisitions.

The 2027 Senior Notes are subject to customary events of default, which may result in the accelerated maturity of the 2027 Senior Notes.

2028 Senior Notes

On December 1, 2017, the Operating Partnership issued $350.0 million in aggregate principal amount of 3.95% Senior Notes due January 15, 2028 (the “2028 Senior Notes”) in a public offering (the “December Debt Offering”) through underwriters for whom J.P. Morgan Securities LLC, Credit Agricole Securities (USA) Inc., and Jefferies LLC acted as representatives (the “Representatives”) pursuant to an underwriting agreement, dated November 28, 2017 (the “Underwriting Agreement”), among the Operating Partnership, the Trust, and the Representatives.

The 2028 Senior Notes were registered under the Securities Act on the Trust’s and the Operating Partnership’s automatic shelf registration statement on Form S-3ASR (File No. 333-216214), filed with the Commission on February 24, 2017.

The 2028 Senior Notes began accruing interest on December 1, 2017 and will begin paying interest semi-annually on July 15, 2018. The 2028 Senior Notes were sold at an issue price of 99.78% of their face value, before the underwriters’ discount. The net proceeds of the Offering were approximately $347.0 million, after deducting the underwriting discount and estimated offering expenses of the Trust and the Operating Partnership. We used the net proceeds of the December Debt Offering (i) to repay outstanding indebtedness under its unsecured revolving credit facility and (ii) for general corporate purposes, including, without limitation, working capital and investment in real estate.

The 2028 Senior Notes are subject to customary events of default, which may result in the accelerated maturity of the 2028 Senior Notes.

Senior Notes Summary

As of December 31, 2017, we had $975.0 million aggregate principal amount of senior notes issued and outstanding by the Operating Partnership, as follows: (i) $15.0 million aggregate principal amount of 4.03% Senior Notes, Series A, due January 7, 2023, (ii) $45.0 million aggregate principal amount of 4.43% Senior Notes, Series B, due January 7, 2026, (iii) $45.0 million aggregate principal amount of 4.57% Senior Notes, Series C, due January 7, 2028, (iv) $45.0 million aggregate principal amount of 4.74% Senior Notes, Series D, due January 7, 2031, (v) $25.0 million aggregate principal amount of 4.09% Senior Notes, Series A, due August 11, 2025, (vi) $25.0 million aggregate principal amount of 4.18% Senior Notes, Series B, due August 11, 2026, (vii) $25.0 million aggregate principal amount of 4.24% Senior Notes, Series C, due August 11, 2027, (viii) $400.0 million aggregate principal amount of 4.30% Senior Notes, due March 15, 2027, and (ix) $350.0 million aggregate principal amount of 3.95% Senior Notes due January 15, 2028.

The Senior Notes are the senior unsecured indebtedness of the Operating Partnership and rank equally in right of payment with all of the Operating Partnership’s existing and future senior unsecured indebtedness. As a result, the Senior Notes effectively are subordinated in right of payment to all of the Operating Partnership’s existing and future secured indebtedness (to the extent of the value of the collateral securing such indebtedness), and all mortgages, preferred equity, and indebtedness and other liabilities, whether secured or unsecured, of the Operating Partnership’s subsidiaries. The Operating Partnership’s obligations under the Senior Notes are fully and unconditionally guaranteed by the Trust.

The note agreements covering the notes contain covenants that are substantially similar to those contained in the Credit Agreement, including financial covenants that require compliance with leverage and coverage ratios and maintenance of minimum tangible net worth, as well as other affirmative and negative covenants that may limit, among other things, our ability to incur additional debt, make distributions or investments, incur liens and sell, transfer, or dispose of assets. The note agreements also include customary representations and warranties and customary events of default substantially similar to those contained in the Credit Agreement.

Follow-on Equity Offerings

In March 2017, the Trust completed a follow-on public offering of 17,250,000 common shares of beneficial interest, including 2,250,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds to it of approximately $300.8 million. The Trust contributed the net proceeds of this offering to the Operating Partnership in exchange for 17,250,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowings under its unsecured revolving credit facility and for general corporate purposes, including working capital and funding acquisitions.

In July 2017, the Trust completed a follow-on public offering of 21,500,000 common shares of beneficial interest, including 1,500,000 common shares issued upon partial exercise of the underwriters’ overallotment option, resulting in net proceeds to it of approximately $420.7 million. The Trust contributed the net proceeds of this offering to the Operating Partnership in exchange for 21,500,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowings under its unsecured revolving credit facility and for general corporate purposes, including working capital and funding acquisitions.
ATM Program

On August 5, 2016, the Trust and the Operating Partnership entered into separate At Market Issuance Sales Agreements (the “2016 Sales Agreements”) with each of KeyBanc Capital Markets Inc., Credit Agricole Securities (USA) Inc., JMP Securities LLC, Raymond James & Associates, Inc., and Stifel Nicolaus & Company, Incorporated (the “2016 Agents”), pursuant to which the Trust may issue and sell, from time to time, its common shares having an aggregate offering price of up to $300 million, through the Agents (the “2016 ATM Program”). The offering of the common shares from time to time were registered pursuant to the Trust’s Registration Statement on Form S-3ASR (File No. 333-205034), which became automatically effective upon filing with the Commission on June 17, 2015, as amended by Post-Effective Amendment No. 1 to the Registration Statement on Form S-3ASR, filed by the Trust with the Commission on January 19, 2016. In accordance with the 2016 Sales Agreements, the Trust may offer and sell its common shares through any of our propertiesthe 2016 Agents, from time to meet our liquidity needs, althoughtime, by any method deemed to be an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended, which includes sales made directly on the NYSE or other existing market, or sales made to or through a market maker. With the Trust’s express written consent, sales also may be made in negotiated transactions or any other method permitted by law.

During 2017, the Trust’s issuance and sale of common shares pursuant to the 2016 ATM Program is as follows (in thousands, except common shares and price): 
 2017
 
Common
shares sold
 
Weighted
average price
 
Net
proceeds
Quarterly period ended March 31
 $
 $
Quarterly period ended June 304,150,000
 20.07
 82,440
Quarterly period ended September 30
 
 
Quarterly period ended December 312,197,914
 18.39
 40,011
Year ended December 316,347,914
 $19.48
 $122,451

As of February 23, 2018, we have $168.2 million remaining available under the 2016 ATM Program.

Dividend Reinvestment and Share Purchase Plan

On December 2, 2014, we adopted a Dividend Reinvestment and Share Purchase Plan (the “DRIP”). Under the DRIP:

existing shareholders may do sopurchase additional common shares by reinvesting all or a portion of the dividends paid on their common shares and by making optional cash payments of not less than $50 and up to a maximum of $10,000 per month;
new investors may join the DRIP by making an initial investment of not less than $1,000 and up to a maximum of $10,000; and
once enrolled in the future.DRIP, participants may authorize electronic deductions from their bank account for optional cash payments to purchase additional shares.

We intend to refinance at maturity
The DRIP is administered by our transfer agent, Computershare Trust Company, N.A. Our common shares sold under the mortgage notes payable thatDRIP will be newly issued or purchased in the open market, as further described in the DRIP. As of February 23, 2018, we have balloon payments at maturity.issued 47,633 common shares under the DRIP since its inception.

We currently are in compliance with all debt covenants in our outstanding indebtedness.
Critical Accounting Policies

Our consolidated and combined financial statements are prepared in conformity with GAAP, which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated and combined financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Set forth below is a summary of our accounting policies that we believe are critical to the preparation of our consolidated and combined financial statements.
Principles of Consolidation and Combination
Concurrently with the completion of the IPO, we entered into a series of contribution transactions with the Ziegler Funds acquiring 19 properties that comprise our initial properties, as well as certain operating assets and liabilities.
We did not conduct business operations prior to completion of the IPO on July 24, 2013, so the financial information herein for periods prior to July 24, 2013 reflects the operations of the Ziegler Funds, from whom we acquired the equity

interests in the 19 properties that constituted our initial portfolio upon completion of the IPO and formation transactions. We determined the Ziegler Funds to be our accounting Predecessor. The financial information herein since July 24, 2013 reflect the operations of Physicians Realty L.P. since completion of the IPO and formation transactions.

Our Predecessor, which is not a legal entity, is comprised of the four Ziegler Funds that owned directly or indirectly interests in entities that owned our initial 19 properties. Upon completion of the IPO and formation transactions, we acquired the interests in these entities from the Ziegler Funds. The combined historical data for our Predecessor is not indicative of our financial position or results of operations.
The accompanying consolidated and combined financial statements include the accounts of all controlled subsidiaries and joint ventures. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the consolidated and combined statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation and combination.
We consider ourselves to control an entity under ASC Topic 810 Consolidation (“ASC 810”), if we are the majority owner of and have voting control over such entity. We also assess control through means other than voting rights (“variable interest entities” or “VIEs”) and determine which business entity is the primary beneficiary of the VIE. A VIE is broadly defined as an entity where either the equity investors as a group, if any, do not have a controlling financial interest or the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. We consolidate VIEs when it is determined that we are the primary beneficiary of the VIE at either the date we became involved with the variable interest entity or upon the occurrence of a reconsideration event.
Real Estate Investment Properties and Identified Intangible Assets
We are required to make subjective assessments of the useful lives of our properties for purposes of determining the amount of depreciation to record on an annual basis with respect to our investments in real estate. These assessments have a direct impact on our net income because if we were to shorten the expected useful lives of our investments in real estate we would depreciate such investments over fewer years, resulting in more depreciation expense and lower net income on an annual basis. Real estate investment properties and identified intangible assets are carried at cost, net of accumulated depreciation and amortization. Medical office buildings are depreciated over their estimated useful lives ranging up to 50 years using the straight-line method. Tenant improvements and in-place leases are amortized over the lease life of the in-place leases or the tenant’s respective lease term. Cost of maintenance and repairs are charged to expense when incurred.
We periodically assess the carrying value of real estate investments and related intangible assets in accordance with ASC Topic 360, Property, Plant & Equipment (“ASC 360”) to determine if facts and circumstances exist that would suggest that the recorded amount of an asset might be impaired or that the estimated useful live should be modified. In the event impairment in value occurs and a portion of the carrying amount of the real estate investment will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the real estate investment and related intangibles to their estimated fair value. The estimated fair value of our real estate investments is determined by use of a number of customary industry standard methods that include discounted cash flow modeling using appropriate discount and capitalization rates and/or estimated cash proceeds received upon the anticipated disposition of the asset from market comparables. Estimates of future cash flows is based on a number of factors including the historical operating results, leases in place, known trends, and other market or economic factors affecting the real estate investment. The evaluation of anticipated cash flows is subjective and is based on assumptions regarding future occupancy, lease rates and capital requirements that could differ materially from actual results. If our anticipated holding periods change or estimated cash flows decline based on market conditions or other unforeseen factors, impairment may be recognized. Long-lived assets to be disposed of are recorded at the lower of carrying value or fair value less costs to sell.
Revenue
We recognize rental revenues in accordance with ASC 840, Leases (“ASC 840”). ASC 840 requires that rental revenue and adjustments relating to lease inducements and above and below market leases, be recognized on a straight-line basis over the term of the lease when collectability is reasonably assured. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue for amounts more or less than amounts currently due from tenants. Amounts recognized in excess of amounts currently due are included in other assets on the consolidated balance sheets. If we determine the collectability of straight-line rents is not reasonable assured, we limit future recognition to amounts contractually owed and, where appropriate, establish an allowance for estimated losses.

Expense recoveries related to tenant reimbursement for real estate taxes, insurance, and other operating expenses are recognized as expense recoveries revenue in the period the applicable expenses are incurred. The reimbursements are recognized at gross, as we are generally the primary obligor with respect to real estate taxes and purchasing goods and services from third party suppliers, and have discretion in selecting the supplier, and bear the credit risk.
We have certain tenants with absolute net leases. Under these lease agreements, the tenant is responsible for operating and building expenses. For absolute net leases, we do not recognize expense recoveries.


Lease Accounting

We, as lessor, make a determination with respect to each of our leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. We believe all of our leases should be accounted for as operating leases. Payments received under operating leases are accounted for in the consolidated and combined statements of operationsincome as rental revenue for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators, adjustments relating to amortization of lease inducements above and below market leases.above/below-market leases, and rent abatements. Assets subject to operating leases are reported as real estate investments in the consolidated balance sheets.

Substantially all of our leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

Purchase of Investment Properties

A property acquired not subject to an existing lease is treated as an asset acquisition and recorded at its purchase price, inclusive of acquisition costs, allocated between the acquired tangible assets and assumed liabilities, including identified intangible assets and liabilities, based upon their relative fair values at the date of acquisition. A property acquired with an existing lease is accounted for as a business combination pursuant to the acquisition method in accordance with ASC Topic 805, Business Combinations (“ASC 805”), and assets acquired and liabilities assumed, including identified intangible assets and liabilities, are recorded at fair value.
 
The determination of fair value involves the use of significant judgment and estimation. The Trust makesWe make estimates of the fair value of the tangible and intangible acquired assets and assumed liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence and may include the assistance of a third party appraiser. We estimate the fair value of buildings acquired on an as-if-vacant basis and depreciate the building value over its estimated remaining life. We determine the allocated value of other fixed assets, such as site improvements, based upon the replacement cost and depreciatesdepreciate such value over the assets’ estimated remaining useful lives as determined at the applicable acquisition date. The fair value of land is determined either by considering the sales prices of similar properties in recent transactions or based on internal analyses of recently acquired and existing comparable properties within the our portfolio.
 
In recognizingrecording identified intangible assets and liabilities in connection with a business combination, the value of above-or-below marketabove- or below-market leases is estimated based on the present value (using an interest rate which reflected the risks associated with the leases acquired) of the difference between contractual amounts to be received pursuant to the leases and management’s estimate of market lease rates measured over a period equal to the estimated remaining term of the lease. The capitalized above-market or below-market lease intangibles are amortized as a reduction or addition to rental income over the estimated remaining term of the respective leases.
 
In determining the value of in-place leases and tenant relationships, management considers current market conditions and costs to execute similar leases in arriving at an estimate of the carrying costs during the expected lease-up period from vacant to existing occupancy. In estimating carrying costs, management includes real estate taxes, insurance, other operating expenses, estimates of lost rental revenue during the expected lease-up periods, and costs to execute similar leases, including leasing commissions, tenant improvements, legal, and other related costs based on current market demand. The values assigned to in-place leases and tenant relationships are amortized over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.
 

The values assigned to all lease intangible assets and liabilities are amortized over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.
 
We calculate the fair value of any long-term debt assumed by discounting the remaining contractual cash flows on each instrument at the current market rate for those borrowings, which we approximate based on the rate at which it would

expect be expected to incur a replacement instrument on the date of acquisition, and recognize any fair value adjustments related to long-term debt as effective yield adjustments over the remaining term of the instrument.
 
Based on these estimates, we recognize the acquired assets and assumed liabilities at their estimated fair values, which generally are determined using Level 3 inputs, such as market rental rates, capitalization rates, discount rates, or other available market data. Initial valuations are subject to change until the information is finalized, no later than 12 months from the acquisition date. We expense transaction costs associated with acquisitions accounted for as business combinations in the period incurred.
Real Estate Investment Properties and Identified Intangible Assets
We are required to make subjective assessments of the useful lives of our properties for purposes of determining the amount of depreciation to record on an annual basis with respect to our investments in real estate. These assessments have a direct impact on our net income because if we were to shorten the expected useful lives of our investments in real estate we would depreciate such investments over fewer years, resulting in more depreciation expense and lower net income on an annual basis. Real estate investment properties and identified intangible assets are carried at cost, net of accumulated depreciation and amortization. Medical office buildings are depreciated over their estimated useful lives, ranging up to 50 years, using the straight-line method. Tenant improvements and in-place leases are amortized over the lease life of the in-place leases or the tenant’s respective lease term. Cost of maintenance and repairs are charged to expense when incurred.
We periodically assess the carrying value of real estate investments and related intangible assets in accordance with ASC Topic 360, Property, Plant & Equipment (“ASC 360”), to determine if facts and circumstances exist that would suggest that the recorded amount of an asset might be impaired or that the estimated useful life should be modified. In the event impairment in value occurs and a portion of the carrying amount of the real estate investment will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the real estate investment and related intangibles to their estimated fair value. The estimated fair value of our real estate investments is determined by use of a number of customary industry standard methods that include discounted cash flow modeling using appropriate discount and capitalization rates and/or estimated cash proceeds received upon the anticipated disposition of the asset from market comparables. Estimates of future cash flows is based on a number of factors including the historical operating results, leases in place, known trends, and other market or economic factors affecting the real estate investment. The evaluation of anticipated cash flows is subjective and is based on assumptions regarding future occupancy, lease rates, and capital requirements that could differ materially from actual results. If our anticipated holding periods change or estimated cash flows decline based on market conditions or other unforeseen factors, impairment may be recorded. Long-lived assets to be disposed of are recorded at the lower of carrying value or fair value less estimated costs to sell.
Revenue
We recognize rental revenues in accordance with ASC 840, Leases (“ASC 840”). ASC 840 requires that rental revenue and adjustments relating to lease inducements and above- and below-market leases, be recognized on a straight-line basis over the term of the lease when collectability is reasonably assured. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue for amounts more or less than amounts currently due from tenants. Amounts recognized in excess of amounts currently due are included in other assets on the consolidated balance sheets. If we determine the collectability of straight-line rents is not reasonably assured, we limit future recognition to amounts contractually owed and, where appropriate, establish an allowance for estimated losses.
Expense recoveries related to tenant reimbursement for real estate taxes, insurance, and other operating expenses are recognized as expense recoveries revenue in the period the applicable expenses are incurred. The reimbursements are recognized at gross, as we are generally the primary obligor with respect to real estate taxes and purchasing goods and services from third party suppliers, have discretion in selecting the supplier, and bear the credit risk.
We have certain tenants with absolute net leases. Under these lease agreements, the tenant is responsible for operating and building expenses. For absolute net leases, we do not recognize expense recoveries.


Use of Estimates
 
The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated and combined financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are made for the valuation of real estate and related intangibles, valuation of financial instruments, impairment assessments, and fair value assessments with respect to purchase price allocations. Actual results could differ from those estimates.
 
Jumpstart Our Business Startups Act of 2012REIT Qualification Requirements
 
The Jumpstart Our Business Startups Act of 2012, or JOBS Act, permits us, as an “emerging growth company,” to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We have elected to “opt out” of this provision and, as a result, we will be required to comply with new or revised accounting standards as required when they are adopted. The decision to opt out of the extended transition period under the JOBS Act is irrevocable.
REIT Qualification Requirements of our General Partner

Our general partner is subject to a number of operational and organizational requirements necessary to qualify and maintain itsour qualification as a REIT. If the Trust failswe fail to qualify as a REIT or failsfail to remain qualified as a REIT in any taxable year, itsour income would be subject to federal income tax at regular corporate rates and potentially increased state and local taxes and itwe could incur substantial tax liabilities which could have an adverse impact upon our results of operations, liquidity, and distributions to our OP Unit holders.
Real Estate Taxes
As owner of our properties, we are ultimately liable for the real estate taxes on our properties. Pursuant to our triple-net lease agreements, tenants generally are responsible, directly or indirectly, for the payment of all real estate taxes assessed on our properties, which are subject to triple-net leases.
Credit Facility
Effective September 18, 2014, the Prior Credit Agreement, and all commitments provided thereunder, were terminated. All amounts due and outstanding under the Prior Credit Agreement were repaid on or prior to such date.
On September 18, 2014, we, as borrower, the Trust and certain of our subsidiaries and other affiliates, as guarantors, entered into the Credit Agreement with KeyBank National Association as administrative agent, KeyBanc Capital Markets Inc., Regions Capital Markets and BMO Capital Markets, as joint lead arrangers and joint bookrunners, Regions Capital Markets and BMO Capital Markets, as co-syndication agents, and the lenders party thereto in connection with an unsecured revolving credit facility in the maximum principal amount of $400 million. The Credit Agreement includes a swingline loan commitment for up to 10% of the maximum principal amount and provides an accordion feature allowing the Trust to increase borrowing capacity by up to an additional $350 million, subject to customary terms and conditions, resulting in a maximum borrowing capacity of $750 million. The Credit Agreement replaced the Trust’s senior secured revolving credit facility in the maximum principal amount of $200 million under the Prior Credit Agreement.
The Credit Agreement has a maturity date of September 18, 2018 and includes a one year extension option. Borrowings under the Credit Agreement bear interest on the outstanding principal amount at a rate equal to LIBOR plus 1.50% to 2.20% depending on the consolidated leverage ratio. In addition, the Credit Agreement includes an unused fee equal to 0.15% or 0.25% per annum, which is determined by usage under the Credit Agreement.

The Credit Agreement contains financial covenants that, among other things, require compliance with leverage and coverage ratios and maintenance of minimum tangible net worth, as well as covenants that may limit our and the Trust’s ability to incur additional debt or make distributions. The Trust may, at any time, voluntarily prepay any loan under the Credit Agreement in whole or in part without premium or penalty. As of December 31, 2014, the Trust was in compliance with all financial covenants.
The Credit Agreement includes customary representations and warranties by us, the Trust and each other guarantor and imposes customary covenants on us, the Trust and each other guarantor. The Credit Agreement also contains customary events of default, and if an event of default occurs and continues, we are subject to certain actions by the administrative agent, including without limitation, the acceleration of repayment of all amounts outstanding under the Credit Agreement.
The Credit Agreement provides for revolving credit loans to us. Base Rate Loans, Adjusted LIBOR Rate Loans and Letters of Credit (each, as defined in the Credit Agreement) will be subject to interest rates, based upon the consolidated leverage ratio of us, our subsidiaries and the Trust, as follows:
Consolidated Leverage Ratio
Adjusted LIBOR Rate Loans
and Letter of Credit Fee
Base Rate Loans
<35%
LIBOR + 1.50%0.50%
>35% and <45%
LIBOR + 1.65%0.65%
>45% and <45%
LIBOR + 1.75%0.75%
>45% and <50%
LIBOR + 1.85%0.85%
>50% and <55%
LIBOR + 2.00%1.00%
>55%LIBOR + 2.20%1.20%
shareholders.
 
Off-Balance Sheet Arrangements
 
As of December 31, 2014,2017, we had no off-balance sheet debt.
 
Contractual Obligations
 
The following table summarizes our material contractual payment obligations and commitments as of December 31, 2014: 2017:
   Payments by Period (in thousands)
 Total 
Less than 1
Year
 2016 - 2017 2018 - 2019 
2020 and
 Thereafter
Principal payments(1)$216,105
 $1,864
 $38,171
 $159,006
 $17,064
Interest payments—fixed rate debt(1)13,700
 3,832
 5,972
 2,770
 1,126
Interest payments—variable rate debt(1)9,061
 2,471
 4,868
 1,722
 
Ground lease payments30,750
 1,426
 2,922
 3,085
 23,317
Total$269,616
 $9,593
 $51,933
 $166,583
 $41,507
   By Period (in thousands)
 Total 
Less than 1
Year
 2019-2020 2021-2022 2023 and Thereafter
Principal (1)$1,491,679
 $54,775
 $154,753
 $33,426
 $1,248,725
Interest – fixed rate debt (1)460,308
 47,500
 103,813
 100,607
 208,388
Interest – variable rate debt (1)21,441
 7,967
 13,474
 
 
Ground leases and other operating leases132,203
 2,678
 5,153
 5,148
 119,224
Total$2,105,631
 $112,920
 $277,193
 $139,181
 $1,576,337
(1)
Obligations shown represent 100% of debt service and do not reflect joint venture interests.
(1)Payments shown above represent 100% of debt service and does not reflect joint venture interests.
 
Inflation
 
Historically, inflation has not had a significant impact on the operating performance of our properties. Many of our lease agreements contain provisions designed to mitigate the adverse impact of inflation. These provisions include clauses that enable us to receive payment of increased rent pursuant to escalation clauses which generally increase rental rates during the terms of the leases. These escalation clauses often provide for fixed rent increases or indexed escalations (based upon changes in the consumer price index or other measures). However, some of these contractual rent increases may be less than the actual rate of inflation. Most of our lease agreements also require the tenant to pay an allocable share of operating expenses, including common area maintenance costs, real estate taxes, and insurance. This requirement reduces our exposure to increases in these costs and operating expenses resulting from inflation.


Seasonality
 
Our business has not been and we do not expect it to become subject to material seasonal fluctuations.



62



ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our future income, cash flows, and fair values relevant to financial instruments are dependent upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. We use certain derivative financial instruments to manage, or hedge, interest rate risks related to our borrowings. We do not use derivatives for trading or speculative purposes and only enter into contracts with major financial institutions based upon their credit rating and other factors. When the Company has derivative instruments embedded in other contracts, it records them either as an asset or a liability measured at their fair value unless they qualify for a normal purchase or normal sale exception. Our derivative instrument consists solelyinstruments consist of anfive interest rate swap that is not traded on an exchange and is recorded on the consolidated balance sheet at its fair value.swaps. See Note 2 (Summary of Significant Accounting Policies) and Note 7 (Derivatives) to our consolidated and combined financial statements included in Item 8 to this report.
Anreport for further detail on our interest rate swap is a contractual agreement entered into by two counterparties under which each agrees to make periodic payments to the other for an agreed period of time based on a notional amount of principal. Under the most common form of interest rate swap, known from our perspective as a floating-to-fixed interest rate swap, a series of floating, or variable, rate payments on a notional amount of principal is exchanged for a series of fixed interest rate payments on such notional amount.swaps.
No assurance can be given that any future hedging activities by us will have the desired beneficial effect on our results of operations or financial condition.
The variable rate component of our consolidated indebtedness at December 31, 2014 is LIBOR based. Assuming no increase in the amount of our variable rate debt, if LIBOR were to increase by 100 basis points, interest expense on our variable rate debt at December 31, 2014, would increase by approximately $1.4 million annually, and if LIBOR were to decrease by 100 basis points, interest expense on our variable rate debt at December 31, 2014, would decrease by approximately $1.4 million annually.

Interest risk amounts are our management’s estimates and were determined by considering the effect of hypothetical interest rates on our consolidated financial instruments. These analyses do not consider the effect of any change in overall economic activity that could occur in that environment. Further, in the event of a change of that magnitude, we may take actions to further mitigate our exposure to the change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, these analyses assume no changes in our financial structure.

Fixed Interest Rate Debt

As of December 31, 2017, our consolidated fixed interest rate debt totaled $1.1 billion, which represented 76.0% of our total consolidated debt, excluding the impact of interest rate swaps. On July 7, 2016, we entered into a pay-fixed receive-variable rate swap for the full $250.0 million borrowing amount of our term loan borrowings, fixing the LIBOR component of the borrowing rate to 1.07%, for an all-in fixed rate of 2.87%. Both the borrowing and pay-fixed receive-variable swap have a maturity date of June 10, 2023.
Assuming the effects of the interest rate swap agreement we entered into on July 7, 2016 relating to our unsecured debt, our fixed interest rate debt would represent 92.7% of our total consolidated debt. Interest rate fluctuations on our fixed interest rate debt will generally not affect our future earnings or cash flows unless such instruments mature or are otherwise terminated. However, interest rate changes could affect the fair value of our fixed interest rate debt.

As of December 31, 2017, the fair value and the carrying value of our consolidated fixed interest rate debt were approximately $1.1 billion. The fair value estimate of our fixed interest rate debt was estimated using a discounted cash flow analysis utilizing rates we would expect to pay for debt of a similar type and remaining maturity if the loans were originated on December 31, 2017. As we expect to hold our fixed interest rate debt instruments to maturity, based on the underlying structure of the debt instrument, and the amounts due under such instruments are limited to the outstanding principal balance and any accrued and unpaid interest, we do not expect that market fluctuations in interest rates, and the resulting change in fair value of our fixed interest rate debt instruments, would have a significant impact on our operating cash flows.

Variable Interest Rate Debt

As of December 31, 2017, our consolidated variable interest rate debt totaled $358.5 million, which represented 24.0% of our total consolidated debt. Assuming the effects of the interest rate swap agreement we entered into on July 7, 2016 relating to our unsecured debt, our variable interest rate debt would represent 7.3% of our total consolidated debt. Interest rate changes on our variable rate debt could impact our future earnings and cash flows, but would not significantly affect the fair value of such debt. As of December 31, 2017, we were exposed to market risks related to fluctuations in interest rates on $108.5 million of consolidated borrowings. Assuming no increase in the amount of our variable rate debt, if LIBOR were to change by 100 basis points, interest expense on our variable rate debt as of December 31, 2017 would change by approximately $1.1 million annually.

Derivative Instruments

As of December 31, 2017, we had five outstanding interest rate swaps that were designated as cash flow hedges of interest rate risk, with a total notional amount of $250.0 million. See Note 7 (Derivatives) within our consolidated financial statements for further detail on our interest rate swaps. We are exposed to credit risk of the counterparty to our interest rate swap agreements in the event of non-performance under the terms of the agreements. If we were not able to replace these swaps in the event of non-performance by the counterparty, we would be subject to variability of the interest rate on the amount outstanding under our debt that is fixed through the use of the swaps.


Indebtedness
 
As of December 31, 2014,2017, we had total consolidated indebtedness of approximately $216.1 million.$1.5 billion. The weighted average interest rate on our consolidated indebtedness was 2.92%3.93% (based on the 30-day LIBOR rate as of December 31, 2014,2017, of 0.164%1.49%). As of December 31, 2014,2017, we had approximately $142.4$108.5 million, or approximately 65.9%7.3%, of our outstanding long-term debt exposed to fluctuations in short-term interest rates.

The following table sets forth certain information with respect to our consolidated indebtedness outstanding as of December 31, 2014.
2017 (in thousands):
(in thousands)  Principal 
Fixed/Floating
Rate
 Rate Maturity
Unsecured Revolving Credit Facility $138,000
 Floating LIBOR + 1.50%
 9/18/2018
Canton Medical Office Building(1) 6,207
 Fixed 5.94% 6/6/2017
Firehouse Square 2,765
 Fixed 6.58% 9/6/2017
Hackley Medical Center 5,397
 Fixed 5.93% 1/6/2017
MeadowView Professional Center 10,409
 Fixed 5.81% 6/6/2017
Mid Coast Hospital Medical Office Building(2) 7,869
 Fixed 4.82%(3)5/16/2016
Remington Medical Commons 4,399
 Floating LIBOR + 2.75%
 9/28/2017
Valley West Hospital Medical Office Building 4,879
 Fixed 4.83% 12/1/2020
Oklahoma City, OK Medical Office Building 7,647
 Fixed 4.71% 1/10/2021
Crescent City Surgical Center 18,750
 Fixed 5.00% 1/23/2019
San Antonio, TX Hospital 9,783
 Fixed 5.00%(4)6/26/2022
Total $216,105
    
  
  Principal 
Fixed/Floating
Rate
 Rate Maturity
Senior Unsecured Revolving Credit Facility $80,000
 Floating LIBOR + 1.20%
 9/18/2020
Senior Unsecured Term Loan (1) 250,000
 Fixed 2.87% 6/10/2023
Senior Unsecured Notes        
January 2016 - Series A 15,000
 Fixed 4.03% 1/7/2023
January 2016 - Series B 45,000
 Fixed 4.43% 1/7/2026
January 2016 - Series C 45,000
 Fixed 4.57% 1/7/2028
January 2016 - Series D 45,000
 Fixed 4.74% 1/7/2031
August 2016 - Series A 25,000
 Fixed 4.09% 8/11/2025
August 2016 - Series B 25,000
 Fixed 4.18% 8/11/2026
August 2016 - Series C 25,000
 Fixed 4.24% 8/11/2027
March 2017 Notes 400,000
 Fixed 4.30% 3/15/2027
December 2017 Notes 350,000
 Fixed 3.95% 1/15/2028
Peachtree Parking Deck 17,000
 Fixed 3.00% 1/5/2020
Mid Coast Hospital Medical Office Building (2) 7,009
 Floating LIBOR + 2.25%
 5/16/2018
Valley West Hospital Medical Office Building 4,531
 Fixed 4.83% 12/1/2020
Oklahoma City, OK Medical Office Building 7,101
 Fixed 4.71% 1/10/2021
Crescent City Surgical Center 18,750
 Fixed 5.00% 1/23/2019
San Antonio, TX Hospital 7,691
 Fixed 5.00% 6/26/2022
Savage Medical Office Building 5,449
 Fixed 5.50% 2/1/2022
St. Luke's Cornwall MOB 9,500
 Floating LIBOR + 3.25%
 2/26/2018
Columbia MOB 12,000
 Floating LIBOR + 3.25%
 3/21/2018
Honor Health - Scottsdale Hospital 10,000
 Fixed 5.41% 7/2/2018
St. Vincent Fishers Medical Center 44,000
 Fixed 4.00% 1/10/2020
CareMount Medical- Lake Katrine 26,039
 Fixed 4.63% 11/6/2024
Gwinnett Physicians Center 17,610
 Fixed 4.83% 12/1/2022
Total principal 1,491,680
    
  
Unamortized deferred financing cost (7,808)      
Unamortized discount (6,663)      
Unamortized fair value adjustment 259
    
  
Total $1,477,468
    
  

(1)Our borrowings under the term loan feature of our Credit Agreement bear interest at a rate which is determined by our credit rating, currently equal to LIBOR + 1.80%. We have entered into a pay-fixed receive-variable interest rate swap, fixing the LIBOR component of this rate at 1.07%, resulting in an effective interest rate of 2.87%.
(2)We own a 66.3% interest in the joint venture that owns this property. Debt shown in this schedule is the full amount of the mortgage indebtedness on this property.



(1) We own a 51.0% interest in the joint venture that owns this property. Debt shown in this schedule is the full amount of the mortgage indebtedness on this property.
64

(2) We own a 66.3% interest in the joint venture that owns this property. Debt shown in this schedule is the full amount of the mortgage indebtedness on this property.

(3) This loan bears interest at a rate of LIBOR + 2.75%. We have entered into an interest rate swap to effectively fix the rate on this loan at 4.82% through the date of maturity.
(4) This loan bears interest at a fixed rate of 5.00% until July 2018, then the interest rate is the higher of the prime rate plus 1.75% or 5.00%.



ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Index to Consolidated Financial Statements
Physicians Realty L.P. and Predecessor Page
   
Firm  
 
 
   
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting
 
Financial Statements of Physicians Realty Trust
Financial Statements of Physicians Realty L.P.
Notes for Physicians Realty Trust and Physicians Realty L.P.




65


Report of Independent Registered Public Accounting Firm
The PartnersTo the Shareholders and the Board of Trustees of Physicians Realty L.P.Trust
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheetsheets of Physicians Realty L.P.Trust (the “Operating Partnership”“Company”) as of December 31, 2014,2017 and 2016, the related consolidated statements of operations, changes in capitalincome, comprehensive income, shareholders’ equity and cash flows for each of the year then ended. Our audit also includedthree years in the period ended December 31, 2017, and the related notes and financial statement schedule listedincluded in the Index at Item 15(a)15 (collectively referred to as the “financial statements”). TheseIn our opinion, the financial statements and schedule arepresent fairly, in all material respects, the responsibilityfinancial position of the Operating Partnership’s management. Our responsibility is to express an opinion on these financial statementsCompany at December 31, 2017 and schedule based on our audit.2016, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2017, in conformity with U.S. generally accepted accounting principles.
We conducted our auditalso have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States). We were not engaged to perform an audit of (PCAOB), the Operating Partnership’s internal control over financial reporting. Our audit included consideration ofCompany’s internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Operating Partnership’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Physicians Realty L.P. at December 31, 2014, and the consolidated results of its operations and its cash flows for the year then ended, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
/s/ Ernst & Young LLP
Chicago, Illinois
February 24, 2017


Report of Independent Registered Public Accounting Firm


To the General and Limited Partners of
Physicians Realty L.P.
Milwaukee, Wisconsin


We have audited the accompanying consolidated and combined balance sheets of Physicians Realty L.P. (the “Partnership”)as of December 31, 2013,2017, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and the related consolidated and combined statements of operations, shareholders' equity and cash flowsour report dated March 1, 2018 expressed an unqualified opinion thereon.
Basis for each year in the two year period ended December 31, 2013. Opinion
These consolidated and combined financial statements are the responsibility of the Partnership’sCompany’s management. Our responsibility is to express an opinion on these consolidated and combinedthe Company’s financial statements based on our audits.

We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated and combined financial statements are free of material misstatement. Anmisstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Ernst & Young LLP
We have served as the Company’s auditor since 2014.
Chicago, Illinois
March 1, 2018


66


Report of Independent Registered Public Accounting Firm
To the Partners of Physicians Realty L.P.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Physicians Realty L.P. (the “Company”) as of December 31, 2017 and 2016, the related consolidated statements of income, comprehensive income, changes in capital and cash flows for each of the three years in the period ended December 31, 2017, and the related notes and financial statement schedule included in the Index at Item 15 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2017, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit includes considerationto obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supportingregarding the amounts and disclosures in the consolidated and combined financial statements, assessingstatements. Our audits also included evaluating the accounting principles used and significant estimates made by management, andas well as evaluating the overall presentation of the financial statement presentation.statements. We believe that our audits provide a reasonable basis for our opinion.


/s/ Ernst & Young LLP
We have served as the Company’s auditor since 2017.
Chicago, Illinois
March 1, 2018

67


Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Trustees of Physicians Realty Trust

Opinion on Internal Control over Financial Reporting
We have audited Physicians Realty Trust’s internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, the consolidated and combined financial statements referred to above present fairly,Physicians Realty Trust (the Company) maintained, in all material respects, theeffective internal control over financial position of Physicians Realty L.P.reporting as of December 31, 2013,2017, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of Physicians Realty Trust at December 31, 2017 and 2016, the resultsrelated consolidated statements of their operationsincome, comprehensive income, shareholders’ equity and their cash flows for each yearof the three years in the two year period ended December 31, 2013,2017, and the related notes and financial statement schedule included in conformitythe Index at Item 15 and our report dated March 1, 2018 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting include in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of the financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, generally acceptedand that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the United Statescompany; and (3) provide reasonable assurance regarding prevention or timely detection of America.unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ PlanteErnst & Moran, PLLCYoung LLP
Chicago, Illinois
February 24, 2017March 1, 2018



68


Physicians Realty Trust
Consolidated Balance Sheets
(in thousands, except share and per share data)
 December 31, 2017 December 31, 2016
ASSETS 
  
Investment properties: 
  
Land and improvements$217,695
 $189,759
Building and improvements3,568,858
 2,402,643
Tenant improvements23,056
 14,133
Acquired lease intangibles458,713
 301,462
 4,268,322

2,907,997
Accumulated depreciation(300,458) (181,785)
Net real estate property3,967,864

2,726,212
Real estate loans receivable76,195
 39,154
Investment in unconsolidated entities1,329
 2,258
Net real estate investments4,045,388

2,767,624
Cash and cash equivalents2,727
 15,491
Tenant receivables, net9,966
 9,790
Other assets106,302
 95,187
Total assets$4,164,383

$2,888,092
LIABILITIES AND EQUITY 
  
Liabilities: 
  
Credit facility$324,394
 $643,742
Notes payable966,603
 224,330
Mortgage debt186,471
 123,083
Accounts payable11,023
 4,423
Dividends and distributions payable43,804
 32,179
Accrued expenses and other liabilities56,405
 42,287
Acquired lease intangibles, net15,702
 9,253
Total liabilities1,604,402

1,079,297
    
Redeemable noncontrolling interest - Series A Preferred Units (2016) and partially owned properties12,347
 26,477
    
Equity: 
  
Common shares, $0.01 par value, 500,000,000 common shares authorized, 181,440,051 and 135,966,013 common shares issued and outstanding as of December 31, 2017 and December 31, 2016, respectively1,814
 1,360
Additional paid-in capital2,772,823
 1,920,644
Accumulated deficit(315,417) (197,261)
Accumulated other comprehensive income13,952
 13,708
Total shareholders’ equity2,473,172

1,738,451
Noncontrolling interests: 
  
Operating Partnership73,844
 43,142
Partially owned properties618
 725
Total noncontrolling interests74,462

43,867
Total equity2,547,634

1,782,318
Total liabilities and equity$4,164,383

$2,888,092

The accompanying notes are an integral part of these consolidated financial statements.

69


Physicians Realty Trust
Consolidated Statements of Income
(in thousands, except share and per share data)
 December 31,
 2017 2016 2015
Revenues: 
  
  
Rental revenues$259,673
 $186,301
 $103,974
Expense recoveries75,425
 45,875
 21,587
Interest income on real estate loans and other8,486
 8,858
 3,880
Total revenues343,584

241,034

129,441
Expenses: 
  
  
Interest expense47,008
 23,864
 10,636
General and administrative22,957
 18,397
 14,908
Operating expenses97,035
 65,999
 31,026
Depreciation and amortization125,159
 86,589
 45,471
Acquisition expenses16,744
 14,778
 14,893
Impairment loss965
 
 
Total expenses309,868

209,627

116,934
Income before equity in income of unconsolidated entities and gain on sale of investment properties:33,716
 31,407
 12,507
Equity in income of unconsolidated entities183
 115
 104
Gain on sale of investment properties5,874
 
 130
Net income39,773

31,522
 12,741
Net income attributable to noncontrolling interests:     
Operating Partnership(1,136) (825) (576)
Partially owned properties (1)(491) (716) (377)
Net income attributable to controlling interest38,146

29,981
 11,788
Preferred distributions(731) (1,857) (1,189)
Net income attributable to common shareholders$37,415
 $28,124
 $10,599
Net income per share: 
  
  
Basic$0.23
 $0.22
 $0.15
Diluted$0.23
 $0.22
 $0.15
Weighted average common shares: 
  
  
Basic163,123,109
 126,143,114
 72,750,724
Diluted168,231,299
 130,466,893
 76,792,073
Dividends and distributions declared per common share and OP unit$0.915
 $0.900
 $0.900
(1)An adjustment of $0.3 million and $0.1 million was required for net income attributable to redeemable noncontrolling interests for the year ended December 31, 2017 and December 31, 2016, respectively. No such adjustment was required for the year ended December 31, 2015.

The accompanying notes are an integral part of these consolidated financial statements.


70


Physicians Realty Trust
Consolidated Statements of Comprehensive Income
(in thousands)
 December 31,
 2017 2016 2015
Net income$39,773
 $31,522
 $12,741
Other comprehensive income:     
Change in fair value of interest rate swap agreements, net244
 13,708
 
Total other comprehensive income244
 13,708
 
Comprehensive income40,017
 45,230
 12,741
Comprehensive income attributable to noncontrolling interests - Operating Partnership(1,143) (1,162) (576)
Comprehensive income attributable to noncontrolling interests - partially owned properties(491) (716) (377)
Comprehensive income attributable to common shareholders$38,383

$43,352

$11,788

The accompanying notes are an integral part of these consolidated financial statements.


71


Physicians Realty Trust
Consolidated Statements of Equity
(in thousands)
 
Par
Value
 
Additional
Paid in
Capital
 
Accumulated
Deficit
 Accumulated Other Comprehensive Income 
Total
Shareholders’
Equity
 
Operating
Partnership
Noncontrolling
interest
 
Partially
Owned
Properties
Noncontrolling
Interest
 
Total 
Noncontrolling
Interests
 
Total
Equity
Balance at January 1, 2015$508
 $586,019
 $(51,797) $
 $534,730
 $33,727
 $752
 $34,479
 $569,209
Net proceeds from sale of common shares361
 544,756
 
 
 545,117
 
 
 
 545,117
Restricted share award grants, net1
 3,191
 (284) 
 2,908
 
 
 
 2,908
Purchase of OP Units
 
 
 
 
 (1,088) 
 (1,088) (1,088)
Conversion of OP Units
 171
 
 
 171
 (171) 
 (171) 
Dividends/distributions declared
 
 (67,542) 
 (67,542) (3,344) 
 (3,344) (70,886)
Preferred distributions
 
 (1,189) 
 (1,189) 
 
 
 (1,189)
Issuance of OP Units in connection with acquisition
 
 
 
 
 10,973
 
 10,973
 10,973
Contributions
 
 
 
 
 
 8,962
 8,962
 8,962
Distributions
 
 
 
 
 
 (213) (213) (213)
Change in market value of Redeemable Noncontrolling Interest in Operating Partnership
 (73) 
 
 (73) 
 
 
 (73)
Net income
 
 11,788
 
 11,788
 576
 377
 953
 12,741
Adjustment for Noncontrolling Interests ownership in Operating Partnership
 (4,778) 
 
 (4,778) 4,778
 
 4,778
 
Balance at December 31, 2015870
 1,129,286
 (109,024) 
 1,021,132
 45,451
 9,878
 55,329
 1,076,461
Net proceeds from sale of common shares473
 766,368
 
 
 766,841
 
 
 
 766,841
Restricted share award grants, net1
 4,893
 (460) 
 4,434
 
 
 
 4,434
Purchase of OP Units
 
 
 
 
 (3,671) 
 (3,671) (3,671)
Conversion of OP Units6
 11,613
 
 
 11,619
 (11,619) 
 (11,619) 
Dividends/distributions declared
 
 (115,901) 
 (115,901) (3,106) 
 (3,106) (119,007)
Preferred distributions
 
 (1,857) 
 (1,857) 
 
 
 (1,857)
Issuance of common shares and OP Units in connection with acquisitions10
 17,069
 
 
 17,079
 6,869
 (100) 6,769
 23,848
Contributions
 
 
 
 
 
 50
 50
 50
Distributions
 
 
 
 
 
 (543) (543) (543)
Change in market value of Redeemable Noncontrolling Interest in Operating Partnership
 (245) 
 
 (245) 
 
 
 (245)
Reclassification of Noncontrolling Interest - partially owned properties
 
 
 
 
 
 (8,514) (8,514) (8,514)
Buyout of Noncontrolling Interests - partially owned property
 53
 
 
 53
 
 (664) (664) (611)
Change in fair value of interest rate swap agreements
 
 
 13,708
 13,708
 
 
 
 13,708
Net income
 
 29,981
 
 29,981
 825
 618
 1,443
 31,424
Adjustment for Noncontrolling Interests ownership in Operating Partnership
 (8,393) 
 
 (8,393) 8,393
 
 8,393
 
Balance at December 31, 20161,360

1,920,644

(197,261)
13,708
 1,738,451
 43,142

725
 43,867
 1,782,318
Net proceeds from sale of common shares451
 844,218
 
 
 844,669
 
 
 
 844,669
Restricted share award grants, net2
 4,103
 (284) 
 3,821
 
 
 
 3,821
Purchase of OP Units
 
 
 
 
 (3,886) 
 (3,886) (3,886)
Conversion of OP Units1
 929
 
 
 930
 (930) 
 (930) 
Dividends/distributions declared
 
 (153,970) 
 (153,970) (4,867) 
 (4,867) (158,837)
Preferred distributions
 
 (731) 
 (731) 
 
 
 (731)
Issuance of OP Units in connection with acquisitions
 
 
 
 
 44,259
 
 44,259
 44,259
Contributions
 
 
 
 
 
 47
 47
 47
Distributions
 
 
 
 
 
 (321) (321) (321)
Buyout of Noncontrolling Interests - partially owned properties
 (2,800) 
 
 (2,800) 719
 (24) 695
 (2,105)
Change in fair value of interest rate swap agreements and redeemable equity - property
 
 (1,317) 244
 (1,073) 
 
 
 (1,073)
Net income
 
 38,146
 
 38,146
 1,136
 191
 1,327
 39,473
Adjustment for Noncontrolling Interests ownership in Operating Partnership
 5,729
 
 
 5,729
 (5,729) 
 (5,729) 
Balance at December 31, 2017$1,814

$2,772,823

$(315,417)
$13,952

$2,473,172

$73,844

$618

$74,462

$2,547,634

The accompanying notes are an integral part of these consolidated financial statements.

72


Physicians Realty Trust
Consolidated Statements of Cash Flows
(in thousands)
 Year Ended December 31,
 2017 2016 2015
Cash Flows from Operating Activities: 
  
  
Net income$39,773
 $31,522
 $12,741
Adjustments to reconcile net income to net cash provided by operating activities 
  
  
Depreciation and amortization125,159
 86,589
 45,471
Amortization of deferred financing costs2,299
 2,325
 1,373
Amortization of lease inducements and above/below-market lease intangibles5,083
 3,906
 2,577
Straight-line rental revenue/expense(16,202) (16,226) (9,000)
Amortization of unsecured bond discount277
 
 
Amortization of above-market assumed debt(178) (236) (173)
Gain on sale of investment properties(5,874) 
 (130)
Equity in income of unconsolidated entities(183) (115) (104)
Distribution from unconsolidated entities210
 82
 106
Change in fair value of derivatives150
 (240) (166)
Provision for bad debts123
 2,310
 69
Non-cash share compensation6,695
 5,672
 3,798
Net change in fair value of contingent consideration(472) (840) 
Impairment on investment properties965
 
 
Change in operating assets and liabilities: 
  
  
Tenant receivables(2,988) (10,058) (2,836)
Other assets(533) (19,230) (2,630)
Accounts payable6,600
 3,779
 (56)
Accrued expenses and other liabilities19,567
 37,957
 8,312
Net cash provided by operating activities180,471

127,197

59,352
Cash Flows from Investing Activities: 
  
  
Proceeds on sales of investment properties20,397
 
 3,039
Acquisition of investment properties, net(1,268,442) (1,240,438) (752,807)
Acquisition of non-controlling interests(8,469) (4,690) 
Escrowed cash—acquisition deposits/earnest deposits(1,280) (1,157) 2,000
Capital expenditures on existing investment properties(23,243) (11,304) (4,988)
Pay down of contingent consideration(156) (483) (999)
Real estate loans receivable(39,063) (10,207) (22,359)
Note receivable
 
 (20,545)
Repayment of real estate loan receivable4,711
 11,336
 
Repayment of note receivable16,423
 4,118
 
Leasing commissions(1,449) (1,034) (579)
Lease inducements(2,067) (8,957) (2,478)
Net cash used in investing activities(1,302,638)
(1,262,816)
(799,716)
Cash Flows from Financing Activities: 
  
  
Net proceeds from sale of common shares844,669
 766,841
 545,117
Proceeds from credit facility borrowings927,000
 1,181,000
 620,000
Payment on credit facility borrowings(1,248,000) (925,000) (363,000)
Proceeds from issuance of mortgage debt61,000
 39,500
 
Proceeds from issuance of senior unsecured notes743,060
 225,000
 
Principal payments on mortgage debt(41,503) (10,232) (2,022)
Debt issuance costs(1,589) (4,816) (3,105)
Dividends paid - shareholders(143,108) (104,908) (63,720)
Distributions to noncontrolling interest - Operating Partnership(4,388) (3,162) (3,216)
Preferred distributions paid - OP Unit holder(600) (1,508) (563)
Contributions to noncontrolling interest47
 
 
Distributions to noncontrolling interest - partially owned properties(748) (543) (213)
Payments of employee taxes for withheld stock based compensation shares(2,590) (778) (606)
Purchase of Series A Preferred Units(19,961) (9,756) 
Purchase of OP Units(3,886) (3,671) (1,088)
Net cash provided by financing activities1,109,403

1,147,967

727,584
Net (decrease) increase in cash and cash equivalents(12,764) 12,348
 (12,780)
Cash and cash equivalents, beginning of year15,491
 3,143
 15,923
Cash and cash equivalents, end of year$2,727

$15,491

$3,143
Supplemental disclosure of cash flow information - interest paid during the year$38,781
 $17,151
 $9,550
Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements and redeemable equity - property$244
 $13,708
 $
Supplemental disclosure of noncash activity - assumed debt$43,989
 $
 $18,690
Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions$44,978
 $6,769
 $40,376
Supplemental disclosure of noncash activity - contingent consideration$765
 $156
 $2,718
The accompanying notes are an integral part of these consolidated financial statements.

73


Physicians Realty L.P.
Consolidated Balance Sheets
(Inin thousands, except share and per share data)
 December 31, 2017 December 31, 2016
ASSETS 
  
Investment properties:   
Land and improvements$217,695
 $189,759
Building and improvements3,568,858
 2,402,643
Tenant improvements23,056
 14,133
Acquired lease intangibles458,713
 301,462
 4,268,322
 2,907,997
Accumulated depreciation(300,458) (181,785)
Net real estate property3,967,864
 2,726,212
Real estate loans receivable76,195
 39,154
Investment in unconsolidated entities1,329
 2,258
Net real estate investments4,045,388
 2,767,624
Cash and cash equivalents2,727
 15,491
Tenant receivables, net9,966
 9,790
Other assets106,302
 95,187
Total assets$4,164,383
 $2,888,092
LIABILITIES AND CAPITAL   
Liabilities:   
Credit facility$324,394
 $643,742
Notes payable966,603
 224,330
Mortgage debt186,471
 123,083
Accounts payable11,023
 4,423
Dividends and distributions payable43,804
 32,179
Accrued expenses and other liabilities56,405
 42,287
Acquired lease intangibles, net15,702
 9,253
Total liabilities1,604,402
 1,079,297
    
Redeemable noncontrolling interest - Series A Preferred Units (2016) and partially owned properties12,347
 26,477
    
Capital:   
Partners’ capital:   
General partners’ capital, 181,440,051 and 135,966,013 units issued and outstanding as of December 31, 2017 and 2016, respectively2,459,220
 1,724,743
Limited partners’ capital, 5,364,632 and 3,436,207 units issued and outstanding as of December 31, 2017 and 2016, respectively73,844
 43,142
Accumulated other comprehensive income13,952
 13,708
Total partners’ capital2,547,016
 1,781,593
Noncontrolling interest - partially owned properties618
 725
Total capital2,547,634
 1,782,318
Total liabilities and capital$4,164,383
 $2,888,092

The accompanying notes are an integral part of these consolidated financial statements.


74


Physicians Realty L.P.
Consolidated Statements of Income
(in thousands, except unit and per unit data)
 December 31,
 2017 2016 2015
Revenues: 
  
  
Rental revenues$259,673
 $186,301
 $103,974
Expense recoveries75,425
 45,875
 21,587
Interest income on real estate loans and other8,486
 8,858
 3,880
Total revenues343,584
 241,034
 129,441
Expenses:     
Interest expense47,008
 23,864
 10,636
General and administrative22,957
 18,397
 14,908
Operating expenses97,035
 65,999
 31,026
Depreciation and amortization125,159
 86,589
 45,471
Acquisition expenses16,744
 14,778
 14,893
Impairment loss965
 
 
Total expenses309,868
 209,627
 116,934
Income before equity in income of unconsolidated entities and gain on sale of investment property33,716
 31,407
 12,507
Equity in income of unconsolidated entities183
 115
 104
Gain on sale of investment properties5,874
 
 130
Net income39,773
 31,522
 12,741
Net income attributable to noncontrolling interests - partially owned properties (1)(491) (716) (377)
Net income attributable to controlling interest39,282
 30,806
 12,364
Preferred distributions(731) (1,857) (1,189)
Net income attributable to common unitholders$38,551
 $28,949
 $11,175
Net income per common unit:     
Basic$0.23
 $0.22
 $0.15
Diluted$0.23
 $0.22
 $0.15
Weighted average common units:     
Basic167,963,076
 129,835,209
 76,459,218
Diluted168,231,299
 130,466,893
 76,792,073
Distributions declared per common unit$0.915
 $0.900
 $0.900
(1)An adjustment of $0.3 million and $0.1 million was required for net income attributable to redeemable noncontrolling interests for the year ended December 31, 2017 and December 31, 2016, respectively. No such adjustment was required for the year ended December 31, 2015.

The accompanying notes are an integral part of these consolidated financial statements.


75


Physicians Realty L.P.
Consolidated Statements of Comprehensive Income
(in thousands)
 
December 31,
2014
 
December 31,
2013
ASSETS 
  
Investment properties: 
  
Land and improvements$79,334
 $26,088
Building and improvements644,086
 193,184
Tenant improvements5,614
 5,458
Acquired lease intangibles72,985
 31,236
 802,019

255,966
Accumulated depreciation(45,569) (28,427)
Net real estate property756,450

227,539
Real estate loans receivable15,876
 
Investment in unconsolidated entity1,324
 
Net real estate investments773,650

227,539
Cash and cash equivalents15,923
 56,478
Tenant receivables, net1,324
 837
Other assets15,806
 5,901
Total assets$806,703

$290,755
LIABILITIES AND CAPITAL 
  
Liabilities: 
  
Credit facility$134,144
 $
Mortgage debt77,091
 40,716
Accounts payable700
 836
Distributions payable16,548
 5,681
Accrued expenses and other liabilities6,140
 2,685
Acquired lease intangibles, net2,871
 
Total liabilities237,494

49,918
Capital: 
  
Partners' capital:

 

General partner's capital, 50,640,863 and 21,548,597 units issued and outstanding as of December 31, 2014 and 2013, respectively534,730
 204,904
Limited partners' capital, 3,190,339 and 3,698,877 units issued and outstanding as of December 31, 2014 and 2013, respectively.33,727
 35,310
Total partners' capital568,457

240,214
Noncontrolling interests - partially owned properties752
 623
Total capital569,209

240,837
Total liabilities and capital$806,703

$290,755
 December 31,
 2017 2016 2015
Net income$39,773
 $31,522
 $12,741
Other comprehensive income:     
Change in fair value of interest rate swap agreements, net244
 13,708
 
Total other comprehensive income244
 13,708
 
Comprehensive income40,017
 45,230
 12,741
Comprehensive income attributable to noncontrolling interests - partially owned properties(491) (716) (377)
Comprehensive income attributable to common unitholders$39,526
 $44,514
 $12,364

The accompanying notes are an integral part of these consolidated financial statements.


76


Physicians Realty L.P.
Consolidated Statements of Changes in Capital
(in thousands)
 General Partner Limited Partner Accumulated Other Comprehensive Income 
Total
Partners’ Capital
 
Partially
Owned
Properties
Noncontrolling
Interest
 
Total
Partners’ Capital
Balance at January 1, 2015$534,730
 $33,727
 $
 $568,457
 $752
 $569,209
Net proceeds from sale of Trust common shares and issuance of common units545,117
 
 
 545,117
 
 545,117
Trust restricted share award grants, net2,908
 
 
 2,908
 
 2,908
Purchase of OP Units
 (1,088) 
 (1,088) 
 (1,088)
Conversion of OP Units171
 (171) 
 
 
 
OP Units - distributions(67,542) (3,344) 
 (70,886) 
 (70,886)
Preferred distributions(1,189) 
 
 (1,189) 
 (1,189)
Issuance of OP Units in connection with acquisition
 10,973
 
 10,973
 
 10,973
Contributions
 
 
 
 8,962
 8,962
Distributions
 
 
 
 (213) (213)
Change in market value of Redeemable Limited Partners(73) 
 
 (73) 
 (73)
Net income11,788
 576
 
 12,364
 377
 12,741
Adjustments for Limited Partners ownership in Operating Partnership(4,778) 4,778
 
 
 
 
Balance at December 31, 20151,021,132
 45,451
 
 1,066,583
 9,878
 1,076,461
Net proceeds from sale of Trust common shares and issuance of common units766,841
 
 
 766,841
 
 766,841
Trust restricted share award grants, net4,434
 
 
 4,434
 
 4,434
Purchase of OP Units
 (3,671) 
 (3,671) 
 (3,671)
Conversion of OP Units11,619
 (11,619) 
 
 
 
OP Units - distributions(115,901) (3,106) 
 (119,007) 
 (119,007)
Preferred distributions(1,857) 
 
 (1,857) 
 (1,857)
Issuance of OP Units in connection with acquisition17,079
 6,869
 
 23,948
 (100) 23,848
Contributions
 
 
 
 50
 50
Distributions
 
 
 
 (543) (543)
Change in market value of Redeemable Limited Partners(245) 
 
 (245) 
 (245)
Reclassification of Noncontrolling Interest - partially owned properties
 
 
 
 (8,514) (8,514)
Buyout of Noncontrolling Interest - partially owned properties53
 
 
 53
 (664) (611)
Change in fair value of interest rate swap agreements
 
 13,708
 13,708
 
 13,708
Net income29,981
 825
 
 30,806
 618
 31,424
Adjustments for Limited Partners ownership in Operating Partnership(8,393) 8,393
 
 
 
 
Balance at December 31, 20161,724,743
 43,142
 13,708
 1,781,593
 725
 1,782,318
Net proceeds from sale of Trust common shares and issuance of common units844,669
 
 
 844,669
 
 844,669
Trust Restricted share award grants, net3,821
 
 
 3,821
 
 3,821
Purchase of OP Units
 (3,886) 
 (3,886) 
 (3,886)
Conversion of OP Units930
 (930) 
 
 
 
OP Units - distributions(153,970) (4,867) 
 (158,837) 
 (158,837)
Preferred distributions(731) 
 
 (731) 
 (731)
Issuance of OP Units in connection with acquisition
 44,259
 
 44,259
 
 44,259
Contributions
 
 
 
 47
 47
Distributions
 
 
 
 (321) (321)
Buyout of Noncontrolling Interest - partially owned properties(2,800) 719
 
 (2,081) (24) (2,105)
Change in fair value of interest rate swap agreements and redeemable equity - property(1,317) 
 244
 (1,073) 
 (1,073)
Net income38,146
 1,136
 
 39,282
 191
 39,473
Adjustments for Limited Partners ownership in Operating Partnership5,729
 (5,729) 
 
 
 
Balance at December 31, 2017$2,459,220
 $73,844
 $13,952
 $2,547,016
 $618
 $2,547,634
 
The accompanying notes are an integral part of these consolidated and combined financial statements.




77


Physicians Realty L.P. and Predecessor
Consolidated and Combined Statements of OperationsCash Flows
(In thousands, except unit and per unit data)
in thousands)
 December 31,
 2014 2013 
Predecessor
 2012
Revenues: 
  
  
Rental revenues$46,397
 $13,565
 $9,821
Expense recoveries5,871
 3,234
 3,111
Interest income on real estate loans and other1,066
 246
 137
Total revenues53,334

17,045

13,069
Expenses: 
  
  
Interest expense6,907
 4,295
 4,538
General and administrative11,440
 3,214
 362
Operating expenses10,154
 4,650
 4,758
Depreciation and amortization16,731
 5,107
 4,150
Acquisition expenses10,897
 1,938
 
Management fees
 475
 951
Impairment loss1,750
 
 937
Total expenses57,879

19,679

15,696
Loss before equity in income of unconsolidated entity, gain (loss) on sale of investment properties and discontinued operations(4,545) (2,634) (2,627)
      
Equity in income of unconsolidated entity95
 
 
Gain (loss) on sale of investment properties32
 (2) (228)
Loss from continuing operations(4,418)
(2,636)
(2,855)
Discontinued operations: 
  
  
Loss from operations on discontinued investment properties
 
 (198)
Gain on sale of discontinued investment properties
 
 1,519
Income from discontinued operations
 
 1,321
Net loss$(4,418)
$(2,636)
$(1,534)
Less: Net loss attributable to Predecessor
 576
  
Less: Net income attributable to noncontrolling interests — partially owned properties(314) (71)  
Net loss attributable to common unitholders$(4,732)
$(2,131)  
Net loss per unit: 
  
  
Basic and diluted$(0.12) $(0.13)  
Weighted average common units: 
  
  
Basic and diluted36,881,712
 16,179,492
  
Distributions declared per common unit$0.90
 $0.41
  
 Year Ended December 31,
 2017 2016 2015
Cash Flows from Operating Activities: 
  
  
Net income$39,773
 $31,522
 $12,741
Adjustments to reconcile net income to net cash provided by operating activities     
Depreciation and amortization125,159
 86,589
 45,471
Amortization of deferred financing costs2,299
 2,325
 1,373
Amortization of lease inducements and above/below-market lease intangibles5,083
 3,906
 2,577
Straight-line rental revenue/expense(16,202) (16,226) (9,000)
Amortization of unsecured bond discount277
 
 
Amortization of above-market assumed debt(178) (236) (173)
Gain on sale of investment properties(5,874) 
 (130)
Equity in income of unconsolidated entities(183) (115) (104)
Distribution from unconsolidated entities210
 82
 106
Change in fair value of derivatives150
 (240) (166)
Provision for bad debts123
 2,310
 69
Non-cash share compensation6,695
 5,672
 3,798
Net change in fair value of contingent consideration(472) (840) 
Impairment on investment properties965
 
 
Change in operating assets and liabilities:     
Tenant receivables(2,988) (10,058) (2,836)
Other assets(533) (19,230) (2,630)
Accounts payable6,600
 3,779
 (56)
Accrued expenses and other liabilities19,567
 37,957
 8,312
Net cash provided by operating activities180,471
 127,197
 59,352
Cash Flows from Investing Activities: 
  
  
Proceeds on sales of investment property20,397
 
 3,039
Acquisition of investment properties, net(1,268,442) (1,240,438) (752,807)
Acquisition of non-controlling interests(8,469) (4,690) 
Escrowed cash—acquisition deposits/earnest deposits(1,280) (1,157) 2,000
Capital expenditures on existing investment properties(23,243) (11,304) (4,988)
Pay down of contingent consideration(156) (483) (999)
Real estate loans receivable(39,063) (10,207) (22,359)
Repayment of real estate loan receivable4,711
 11,336
 
Note receivable
 
 (20,545)
Repayment of note receivable16,423
 4,118
 
Leasing commissions(1,449) (1,034) (579)
Lease Inducements(2,067) (8,957) (2,478)
Net cash used in investing activities(1,302,638) (1,262,816) (799,716)
Cash Flows from Financing Activities: 
  
  
Net proceeds from sale of Trust common shares and issuance of common units844,669
 766,841
 545,117
Proceeds from credit facility borrowings927,000
 1,181,000
 620,000
Payment on credit facility borrowings(1,248,000) (925,000) (363,000)
Proceeds from issuance of senior unsecured notes743,060
 225,000
 
Proceeds from issuance of mortgage debt61,000
 39,500
 
Principal payments on mortgage debt(41,503) (10,232) (2,022)
Debt issuance costs(1,589) (4,816) (3,105)
OP Units distributions - General Partner(143,108) (104,908) (63,720)
OP Units distributions - Limited Partner(4,388) (3,162) (3,216)
Preferred OP Units distributions - Limited Partner(600) (1,508) 
Contributions to noncontrolling interest47
 
 
Distributions to noncontrolling interest - partially owned properties(748) (543) (213)
Payments of employee taxes for withheld stock based compensation shares(2,590) (778) (606)
Purchase of Preferred Limited Partner Units(19,961) (9,756) (563)
Purchase of Limited Partner Units(3,886) (3,671) (1,088)
Net cash provided by financing activities1,109,403
 1,147,967
 727,584
Net (decrease) increase in cash and cash equivalents(12,764)
12,348

(12,780)
Cash and cash equivalents, beginning of year15,491
 3,143
 15,923
Cash and cash equivalents, end of year$2,727
 $15,491
 $3,143
Supplemental disclosure of cash flow information - interest paid during the year$38,781
 $17,151
 $9,550
Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements and redeemable equity - property$244
 $13,708
 $
Supplemental disclosure of noncash activity - assumed debt$43,989
 $
 $18,690
Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions$44,978
 $6,769
 $40,376
Supplemental disclosure of noncash activity - contingent consideration$765
 $156
 $2,718
The accompanying notes are an integral part of these consolidated and combined financial statementsstatements.



78


Physicians Realty L.P.Trust and Predecessor
Consolidated and Combined Statements of Changes in Capital
(In thousands, except shares)
 
Predecessor
Equity
 General Partner Limited Partner Total Partners' Capital 
Partially Owned
Properties
Noncontrolling
Interest
 Total Capital
Predecessor Balance 
  
  
    
  
Balance at December 31, 2011$22,503
 $
 $
 $22,503
 $112
 $22,615
Net (loss) income(1,659) 
 
 $(1,659) 125
 (1,534)
Transfer(105) 
 
 $(105) 105
 
Distributions(1,671) 
 
 (1,671) (313) (1,984)
Balance at December 31, 201219,068





19,068
 29

19,097
Net (loss) income(712) 
 
 (712) 136
 (576)
Transfer36
 
 
 36
 (36) 
Distributions(211) 
 
 (211) (209) (420)
Balance at July 24, 201318,181





18,181
 (80)
18,101
Physicians Realty L.P. 
  
  
    
  
Net proceeds from sale of Trust common shares and issuance of common units
 225,920
 
 225,920
 
 225,920
Formation transactions(18,181) 35
 18,181
 35
 (389) (354)
Restricted share award grants
 433
 
 433
 
 433
OP Units - distributions
 (7,009) (1,326) (8,335) 
 (8,335)
Adjustments for Limited Partners ownership in Operating Partnership
 (7,391) 7,391
 
 
 
Contributions
 (5,423) 11,534
 6,111
 1,276
 7,387
Distributions
 
 
 
 (255) (255)
Net (loss) income
 (1,661) (470) (2,131) 71
 (2,060)
Balance at December 31, 2013

204,904

35,310

240,214
 623

240,837
Net proceeds from sale of Trust common shares and issuance of common units
 350,385
 
 350,385
 
 350,385
Trust restricted share award grants, net
 2,060
 
 2,060
 
 2,060
Issuance of Trust common shares and common units in connection with the Ziegler shared service amendment payment
 1,800
 
 1,800
 
 1,800
Purchase of OP Units
 
 (7,546) (7,546) 
 (7,546)
Conversion of OP Units
 13,286
 (13,286) 
 
 
OP Units - distributions
 (39,048) (3,265) (42,313) 
 (42,313)
Adjustments for Limited Partners ownership in Operating Partnership
 5,380
 (5,380) 
 
 
Issuance of OP Units in connection with acquisitions
 
 28,589
 28,589
 
 28,589
Distributions
 
 
 
 (185) (185)
Net (loss) income
 (4,037) (695) (4,732) 314
 (4,418)
Balance at December 31, 2014$

$534,730

$33,727

$568,457
 $752

$569,209
The accompanying notes are an integral part of these consolidated and combined financial statements.


Physicians Realty L.P. and Predecessor
Consolidated and Combined Statements of Cash Flows
(In thousands)
 Year Ended December 31,
     Predecessor
 2014 2013 2012
Cash Flows from Operating Activities: 
  
  
Net loss$(4,418) $(2,636) $(1,534)
Adjustments to reconcile net loss to net cash provided by operating activities 
  
  
Depreciation and amortization16,731
 5,107
 4,150
Amortization of deferred financing costs1,097
 510
 268
Amortization of lease inducements and above/below market lease intangibles571
 141
 70
Straight-line rental revenue/expense(4,366) (675) (100)
(Gain) loss on sale of investment properties(32) 2
 (1,291)
Equity in income of unconsolidated entity(95) 
 
Distribution from unconsolidated entity71
 
 
Change in fair value of derivatives(161) (246) (122)
Provision for bad debts9
 30
 320
Non-cash share compensation2,422
 433
 
Ziegler shared service amendment payment1,800
 
 
Impairment on investment properties1,750
 
 937
Change in operating assets and liabilities: 
  
  
Tenant receivables(986) (184) 33
Other assets(3,518) (1,074) 379
Accounts payable to related parties
 (1,530) 255
Accounts payable(136) 34
 204
Accrued expenses and other liabilities2,556
 1,256
 (56)
Net cash provided by operating activities13,295

1,168

3,513
Cash Flows from Investing Activities: 
  
  
Proceeds on sales of investment properties235
 448
 14,525
Acquisition of investment properties, net(501,127) (125,728) 
Capital expenditures on existing investment properties(900) 
 (845)
Real estate loans receivable(15,386) 
 
Leasing commissions(100) (163) (153)
Lease inducements(1,532) (1,000) 
Net cash (used in) provided by investing activities(518,810)
(126,443)
13,527
Cash Flows from Financing Activities: 
  
  
Net proceeds from sale of Trust common shares and common units350,384
 225,920
 
Formation transactions
 (354) 
Proceeds from credit facility borrowings395,200
 52,350
 
Payment on credit facility borrowings(257,200) (52,350) 
Proceeds from issuance of mortgage debt26,550
 162
 45
Principal payments on mortgage debt(6,549) (41,832) (14,149)
Debt issuance costs(3,887) (1,428) (270)
OP Units distributions - General Partner(28,104) (2,161) 
OP Units distributions - Limited Partner(3,382) (704) 
Distributions to members and partners
 
 (1,671)
Distributions to noncontrolling interest — partially owned properties(185) (464) (313)
Purchase of Limited Partner Units(7,546) 
 
Trust Common shares repurchased and retired(321) 
 
Net cash provided by (used in) financing activities464,960

179,139

(16,358)
Net (decrease) increase in cash and cash equivalents(40,555)
53,864

682
Cash and cash equivalents, beginning of year56,478
 2,614
 1,932
Cash and cash equivalents, end of year$15,923

$56,478

$2,614
Supplemental disclosure of cash flow information — interest paid during the period$5,606
 $3,942
 $5,126
Supplemental disclosure of noncash activity — assumed debt$15,283
 $
 $
Supplemental disclosure of noncash activity — issuance of OP Units in connection with acquisitions$28,589
 $11,535
 $
Supplemental disclosure of noncash activity — contingent consideration$840
 $
 $
The accompanying notes are an integral part of these consolidated and combined financial statements.


Physicians Realty L.P. and Predecessor
Notes to Consolidated and Combined Financial Statements
 
Unless otherwise indicated or unless the context requires otherwise the use of the words “we,” “us” or “our” refers to Physicians Realty Trust and Physicians Realty L.P., collectively.

Note 1—1. Organization and Business
 
Physicians Realty Trust (the "Trust" or“Trust”) was organized in the "General Partner"), astate of Maryland real estate investment trust and general partner of Physicians Realty L.P. (the "Operating Partnership", the "OP", or the "Company"), a Delaware limited partnership, was organized on April 9, 2013 primarily to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.

2013. As of December 31, 2014,2017, the Trust was authorized to issue up to 500,000,000 common shares of beneficial interest, par value $0.01 per share (“common shares”). The Trust filed a Registration Statement on Form S-11 with the Securities and Exchange Commission (the “Commission”) with respect to a proposed underwritten initial public offering (the “IPO”) and completed the IPO of its common shares and commenced operations on July 24, 2013.

The Trust contributed the net proceeds from itsthe IPO to Physicians Realty L.P. (the “Operating Partnership” and together with the Trust and its consolidated subsidiaries, including the Operating Partnership, the “Company”), a Delaware limited partnership, and is the sole general partner of the Operating Partnership. The Trust'sTrust and the Operating Partnership are managed and operated as one entity. The Trust has no significant assets other than its investment in the Operating Partnership. The Trust’s operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership.

Initial Public Offering and Formation Transactions
Pursuant to the IPO, the Trust issued an aggregate of 11,753,597 common shares, including common shares issued upon exercise of the underwriters’ overallotment option, and received approximately $123.8 million of net proceeds (after deducting the underwriting discount and expenses of the IPO and the formation transactions payable by the Trust). The Trust, contributedas the net proceedsgeneral partner of the IPO to the Operating Partnership, in exchange for 11,753,597 common unitscontrols the Operating Partnership and consolidates the assets, liabilities, and results of partnership interest (“OP Units”) on July 24, 2013. Concurrently with the completionoperations of the IPO,Operating Partnership. Therefore, the Company acquired, through a series of contribution transactions, the entities that own the 19 properties that comprised the Company's initial properties from four healthcare real estate funds (the “Ziegler Funds”), as well as certain operating assets and liabilities including the assumption of approximately $84.3 million of debt related to such properties. The Company determined that the Ziegler Funds constitute the Company's accounting predecessor (the “Predecessor”). The Predecessor, which is not a legal entity, is comprised of the four Ziegler Funds that owned directly or indirectly interests in entities that owned the initial 19 properties in the Company's portfolio. The combined historical data for the Predecessor is not necessarily indicative of the Company's future financial position or results of operations. In addition, at the completion of the IPO, the Trust entered into a shared services agreement with B.C. Ziegler & Company (“Ziegler”) pursuant to which Ziegler provides office space, IT support, accounting support and other services to the Trust and the Operating Partnership in exchange for an annual fee.are the same.
 
ToThe Trust is a self-managed real estate investment trust (“REIT”) formed primarily to acquire, the ownership interests in the entitiesselectively develop, own, and manage healthcare properties that own the 19 properties included in the Company's initial properties,are leased to physicians, hospitals, and certain other operating assets and liabilities, from the Ziegler Funds, the Operating Partnership issued to the Ziegler Funds an aggregate of 2,744,000 OP Units, having an aggregate value of approximately $31.6 million based on the price per share to the public in the IPO. These formation transactions were effected concurrently with the completion of the IPO.healthcare delivery systems.
 
Upon closing of the IPO, the Trust owned a 79.6% interest in the Operating Partnership. The Operating Partnership used a portion of the IPO proceeds received from the Trust to purchase the 50% interest in the Arrowhead Commons property not owned by the Ziegler Funds for approximately $850,000, after which the Operating Partnership became the 100% owner of the property, and to pay certain expenses related to debt assumptions and the Trust’s former senior secured revolving credit facility. The balance of the net proceeds was subsequently invested in healthcare properties.
Because the IPO and the formation transactions were completed on July 24, 2013, the Company had no operations prior to that date. References in these notes to the consolidated and combined financial statements of Physicians Realty L.P. signify the Company for the period from July 24, 2013, the date of completion of the IPO and the formation transactions, and of the Predecessor for all prior periods.
Follow-On PublicEquity Offerings

On December 11, 2013,In March 2017, the Trust completed a follow-on public offering of 9,545,00017,250,000 common shares of beneficial interest, including 1,245,0002,250,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds to the Trustit of approximately $103.1$300.8 million. The Trust contributed the net proceeds of this offering to the Operating Partnership in exchange

for 9,545,00017,250,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowings under the Trust’s former senior securedits unsecured revolving credit facility and for general corporate andpurposes, including working capital purposes and funding acquisitions.


On May 27, 2014,In July 2017, the Trust completed a follow-on public offering of 12,650,00021,500,000 common shares of beneficial interest, including 1,650,0001,500,000 common shares issued upon partial exercise of the underwriters’ overallotment option, resulting in net proceeds to the Trustit of approximately $149.9$420.7 million. The Trust contributed the net proceeds of this offering to the Operating Partnership in exchange for 12,650,00021,500,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowings under the former senior securedits unsecured revolving credit facility and for general corporate andpurposes, including working capital purposes and funding acquisitions.

ATM Program

On August 19, 2014, the Trust’s Registration Statement on Form S-3 (File No. 333-197842) (the “Shelf Registration Statement”), filed with the Commission on August 4, 2014, was declared effective by the Commission. The Shelf Registration Statement covers the offering, from time to time, of various securities with an aggregate value of up to $900 million and the secondary offering of common shares by certain selling shareholders.
On August 19, 2014,5, 2016, the Trust and the Operating Partnership entered into separate At Market Issuance Sales Agreements (the “Sales“2016 Sales Agreements”) with each of MLV & Co. LLC, KeyBanc Capital Markets Inc., Credit Agricole Securities (USA) Inc., JMP Securities LLC, Raymond James & Associates, Inc., and RBC Capital Markets, LLCStifel Nicolaus & Company, Incorporated (the “Agents”“2016 Agents”), pursuant to which the Trust may issue and sell, from time to time, its common shares having an aggregate offering price of up to $150$300.0 million, from time to time, through the Agents pursuant to the Shelf Registration Statement (the “ATM“2016 ATM Program”). In accordance with the 2016 Sales Agreements, the Trust may offer and sell its common shares through any of the 2016 Agents, from time to time, by any method deemed to be an “at-the-market“at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended, (the “Securities Act”), which includes sales made directly on the New York Stock Exchange (the “NYSE”),NYSE or other existing trading market, or sales made to or through a market maker. With the Trust’s express written consent, sales may also may be made in negotiated transactions or any other method permitted by law.


During 2014,2016 and 2017, the Trust sold 3,576,010Trust’s issuance and sale of common shares pursuant to the 2016 ATM Program at a weighted average priceis as follows (in thousands, except common shares and price): 
 2017 2016
 Common
shares sold
 Weighted
average price
 Net
proceeds
 Common
shares sold
 Weighted
average price
 Net
proceeds
Quarterly period ended March 31
 $
 $
 
 $
 $
Quarterly period ended June 304,150,000
 20.07
 82,440
 
 
 
Quarterly period ended September 30
 
 
 
 
 
Quarterly period ended December 312,197,914
 18.39
 40,011
 135,531
 19.09
 2,561
Year ended December 316,347,914
 $19.48
 $122,451
 135,531
 $19.09
 $2,561


As of $15.54 per share resulting in total proceeds of approximately $55.6 million, before $0.8 million in commissions and contributed proceeds to the OP for common units.
On September 12, 2014,February 23, 2018, the Trust completed a public offering of 10,925,000 common shares, including 1,425,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds to the Trust of approximately $145.7 million. The Trust contributed the net proceeds of this offering to the Operating Partnership in exchange for 10,925,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowingshas $168.2 million remaining available under the Trust’s former senior secured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.2016 ATM Program.

Note 2—2. Summary of Significant Accounting Policies

Principles of Consolidation
 
Property holding entities and other subsidiaries of which the Operating Partnership owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated in consolidation. For entities in which the OP owns less than 100% of the equity interest, the OP consolidates the property if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, the OP records a non-controlling interest representing equity held by non-controlling interests.
GAAP requires the OPus to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). ASC 810 broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The OP identifiesWe identify the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The OP consolidates investmentsWe consolidate our investment in a VIE when it determineswe determine that the OP iswe are the VIE’s primary beneficiary. The OPWe may change itsour original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposition of all or a portion of an interest held by the primary beneficiary. The OP performsWe perform this analysis on an ongoing basis.


For property holding entities not determined to be VIEs, we consolidate such entities in which the Operating Partnership owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Operating Partnership owns less than 100% of the equity interest, the Operating Partnership consolidates the property if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, the Operating Partnership records a noncontrolling interest representing equity held by noncontrolling interests.

Noncontrolling Interests

The OPCompany presents the portion of any equity it does not own in entities that it controls (and thus consolidates) as noncontrolling interests and classifies such interests as a component of consolidated equity, separate from the OP’sCompany’s total limited partners’ capital,shareholders’ equity, on the consolidated balance sheets.
 
In connection with the closingOperating Partnership: Net income or loss is allocated to noncontrolling interests (limited partners) based on their respective ownership percentage of the IPO,Operating Partnership. The ownership percentage is calculated by dividing the Trustnumber of OP Units held by the noncontrolling interests by the total OP Units held by the noncontrolling interests and the Operating Partnership completed related formation transactions pursuant to whichTrust. Issuance of additional common shares and OP Units changes the Operating Partnership acquired from the Ziegler Funds, the Ziegler Funds’ ownership interests in 19 medical office buildings located in ten states in exchange for an aggregate of 2,744,000 OP Unitsboth the noncontrolling interests and the payment of approximately $36.9 million of debtTrust. Such transactions and the related to such properties.proceeds are treated as capital transactions.
In connection with the acquisition of a surgical center hospital in the New Orleans, Louisiana metropolitan area for approximately $37.5 million, on September 30, 2013, the Operating Partnership partially funded the purchase price by issuing 954,877 OP Units valued at approximately $11.5 million on the date of issuance.

During the year ended December 31, 2014,2017, the Operating Partnership partially funded fiveone property acquisitionsacquisition by issuing an aggregate of 2,042,3132,247,817 OP Units valued at approximately $28.6$44.3 million on the date of issuance. The five acquisitionsacquisition had a total purchase price of approximately $103.6$78.6 million. In addition, the Operating Partnership funded the acquisition of the remaining non-controlling interest on a property by issuing an aggregate of 38,641 OP Units valued at approximately $0.7 million.

During the year ended December 31, 2016, the Operating Partnership partially funded one property acquisition by issuing an aggregate of 174,085 OP Units valued at approximately $2.9 million on the date of issuance. The acquisition had a

total purchase price of approximately $8.5 million. In addition, the Operating Partnership funded the acquisition of the remaining non-controlling interest on a property by issuing an aggregate of 217,549 OP Units valued at approximately $4.0 million.
 
Limited partners' capital representsNoncontrolling interests in the Company include OP Units held by the Predecessor’s prior investors and other investors. As of December 31, 2014,2017 and 2016, the General PartnerTrust held a 94.1%97.1% and 97.5% interest in the Operating Partnership, respectively. As the sole general partner and the majority interest holder, the Trust consolidates the financial position and results of operations of the Operating Partnership.
 
Holders of OP Units may not transfer their units without the General Partners'Trust’s prior written consent.consent, as general partner of the Operating Partnership. Beginning on the first anniversary of the issuance of OP Units, OP Unit holders may tender their units for redemption by the Operating Partnership in exchange for cash equal to the market price of the Trust’s common shares at the time of redemption or for unregistered common shares on a one-for-one basis. Such selection to pay cash or issue common shares to satisfy an OP Unit holder’s redemption request is solely within the control of the General Partner.Trust. Accordingly, the Trust presents the OP Units of the Operating Partnership held by investors other than the Trust as noncontrolling interests within equity in the consolidated balance sheet.
 
Partially Owned Properties: The Trust and OP reflectsreflect noncontrolling interests in partially owned properties on the balance sheet for the portion of properties consolidated by the OPproperties that are not wholly owned by the OP.Company. The earnings or losses from those properties attributable to the noncontrolling interests are reflected as noncontrolling interests in partially owned properties in the consolidated statements of income.

Redeemable Noncontrolling Interests-Series A Preferred Units and combined statementPartially Owned Properties 

On February 5, 2015, the Trust entered into a Second Amended and Restated Agreement of operations.Limited Partnership (the “Partnership Agreement”) which provides for the designation and issuance of the newly designated Series A Participating Redeemable Preferred Units of the Operating Partnership (“Series A Preferred Units”). Series A Preferred Units have priority over all other partnership interests of the Operating Partnership with respect to distributions and liquidation. Holders of Series A Preferred Units are entitled to a 5% cumulative return and upon redemption, the receipt of one common share and $200. Series A Preferred Units are redeemable at the option of the holders; however, the holders of the Series A Preferred Units have agreed not to cause the Operating Partnership to redeem their Series A Preferred Units prior to one year from the issuance date. After such one year period, if the holders of Series A Preferred Units exercise their option to redeem Series A Preferred Units, the Trust may satisfy its redemption obligation, at the Trust’s option, in cash or registered common shares. Instruments that require settlement in registered common shares may not be classified in permanent equity as it is not always completely within an issuer’s control to deliver registered common shares. Due to the redemption rights associated with the Series A Preferred Units, the Trust classifies the Series A Preferred Units in the mezzanine section of its consolidated balance sheets. 

DistributionsThe Series A Preferred Units were evaluated for embedded features that should be bifurcated and separately accounted for as a freestanding derivative. The Company determined that the Series A Preferred Units contained features that require bifurcation. The Company records the carrying amount of the redeemable noncontrolling interests, less the value of the embedded derivative, at the greater of the carrying value or redemption value in the consolidated balance sheets.

Declaration Date Record Date Payment Date 
Cash Distributions
per OP Unit
 
December 30, 2014 January 23, 2015 February 6, 2015 $0.225
 
September 26, 2014 October 17, 2014 October 30, 2014 $0.225
 
June 26, 2014 July 18, 2014 August 1, 2014 $0.225
 
March 27, 2014 April 11, 2014 April 25, 2014 $0.225
 
December 30, 2013 January 24, 2014 February 7, 2014 $0.225
 
September 30, 2013 October 18, 2013 November 1, 2013 $0.18
(1)
On February 5, 2015, the acquisition of the Minnetonka MOB was partially funded with the issuance of 44,685 Series A Preferred Units which were valued at $9.7 million. On December 17, 2015, the acquisition of the Nashville MOB was partially funded with the issuance of 91,236 Series A Preferred Units which were valued at $19.7 million.

On April 1, 2016, the Series A Preferred Units issued in conjunction with the Minnetonka MOB acquisition were redeemed for a total value of $9.8 million. The fair value of the embedded derivative associated with the previously outstanding Series A Preferred Units was $2.7 million which was derecognized in the course of the redemption.
(1)

On January 12, 2017, the Series A Preferred Units issued in conjunction with the Nashville MOB acquisition were redeemed for a total value of $20.0 million. The fair value of the embedded derivative associated with the previously outstanding Series A Preferred Units was $5.6 million which was derecognized in the course of the redemption.

In connection with the acquisition of the Minnetonka MOB, the Trust received a $5 million equity investment from a third party, effective March 1, 2015. This investment earns a 15% cumulative preferred return. At any point subsequent to the third anniversary of the investment, the holder can require the Trust to redeem the instrument at a price for which the investor will realize a 15% internal rate of return. Due to the redemption provision, which is outside of the control of the Trust, the Trust
Prorated cash distribution of $0.18 per OP Unit for the quarterly period from July 19, 2013 (the date of the IPO) through September 30, 2013, which was equivalent to a full quarterly distribution of $0.225 per OP Unit. The distribution was paid on November 1, 2013 to OP Unit holders of record on October 18, 2013, with the exception of the OP Units issued in the acquisition of Crescent City Surgical Centre.

classifies the investment in the mezzanine section of its consolidated balance sheets. The Trust records the carrying amount of the redeemable noncontrolling interests at the greater of the carrying value or redemption value.

In connection with the acquisition on December 29, 2015 of a medical office building located on the campus of the Great Falls Clinic and Hospital in Great Falls, Montana (the “Great Falls Clinic”), physicians affiliated with the seller retained a non-controlling interest which may, at the holders’ option, be redeemed at any time. Due to the redemption provision, which is outside of the control of the Trust, the Trust classifies the investment in the mezzanine section of its consolidated balance sheet. The Trust records the carrying amount of the redeemable noncontrolling interests at the greater of the carrying value or redemption value. As of December 31, 2017, physicians affiliated with the seller redeemed a portion of their non-controlling interest for $1.1 million.

Dividends and Distributions

Dividends and distributions for the years ended December 31, 2017, 2016, and 2015 are as follows:
Declaration Date Record Date Payment Date 
Cash Dividend
per Share/Unit
December 21, 2017 January 3, 2018 January 18, 2018 $0.230
September 21, 2017 October 3, 2017 October 18, 2017 $0.230
June 12, 2017 July 3, 2017 July 18, 2017 $0.230
March 17, 2017 April 5, 2017 April 18, 2017 $0.225
December 22, 2016 January 5, 2017 January 18, 2017 $0.225
September 26, 2016 October 6, 2016 October 18, 2016 $0.225
June 23, 2016 July 5, 2016 July 18, 2016 $0.225
March 18, 2016 April 1, 2016 April 18, 2016 $0.225
December 31, 2015 January 15, 2016 January 29, 2016 $0.225
September 28, 2015 October 16, 2015 October 30, 2015 $0.225
July 1, 2015 July 17, 2015 July 31, 2015 $0.225
April 6, 2015 April 17, 2015 May 1, 2015 $0.225


Our shareholders are entitled to reinvest all or a portion of any cash distribution on their shares of our common stock by participating in our Dividend Reinvestment and Share Purchase Plan (“DRIP”), subject to the terms of the plan.

Tax Status of Dividends and Distributions

Our distributions of current and accumulated earnings and profits for U.S. federal income tax purposes generally are taxable to shareholders as ordinary income. Distributions in excess of these earnings and profits generally are treated as a non-taxable reduction of the shareholders’ basis in the shares to the extent thereof (non-dividend distributions) and thereafter as taxable gain.

Any cash distributions received by an OP Unit holder in respect of its OP Units generally will not be taxable to such OP Unit holder for U.S. federal income tax purposes, to the extent that such distribution does not exceed the OP Unit holder’s basis in its OP Units. Any such distribution will instead reduce the OP Unit holder’s basis in its OP Units (and OP Unit holders will be subject to tax on the taxable income allocated to them by the Operating Partnership in respect of their OP Units when such income is earned by the Operating Partnership, with such income allocation increasing the OP Unit holders’ basis in their OP Units).


The following table sets forth the federal income tax status of distributions per common share and OP Unit for the periods presented:
  Year Ended December 31,
  2017 2016 2015
Per common share and OP Unit:      
Ordinary dividends $0.4529
 $0.5325
 $0.2693
Qualified dividends 
 
 
Capital gain distributions 
 
 
Non-dividend distributions 0.4571
 0.3675
 0.6307
Total $0.9100
 $0.9000
 $0.9000


Purchases of Investment Properties
 
A property acquired not subject to an existing lease is treated as an asset acquisition and recorded at its purchase price, inclusive of acquisition costs, allocated between the acquired tangible assets and assumed liabilities, including identified intangible assets and liabilities, based upon their relative fair values at the date of acquisition. A property acquired with an existing lease is accounted for as a business combination pursuant to the acquisition method in accordance with ASC Topic 805, Business Combinations (“ASC 805”), and assets acquired and liabilities assumed, including identified intangible assets and liabilities, are recorded at fair value.


The determination of fair value involves the use of significant judgment and estimation. The OPCompany makes estimates of the fair value of the tangible and intangible acquired assets and assumed liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence and may includegenerally includes the assistance of a third party appraiser. The OPCompany estimates the fair value of buildings acquired on an as-if-vacant“as-if-vacant” basis and depreciates the building value over the estimated remaining life of the building. The OPCompany determines the allocated value of other fixed assets, such as site improvements, based upon the replacement cost and depreciates such value over the assets���assets’ estimated remaining useful lives as determined at the applicable acquisition date. The fair value of land is determined either by considering the sales prices of similar properties in recent transactions or based on internal analyses of recently acquired and existing comparable properties within the OP’sCompany’s portfolio.
 
In recognizingrecording identified intangible assets and liabilities in connection with a business combination, the value of above-or-below marketabove- or below-market leases is estimated based on the present value (using an interest rate which reflected the risks associated with the leases acquired) of the difference between contractual amounts to be received pursuant to the leases and management’s estimate of market lease rates measured over a period equal to the estimated remaining term of the lease. The capitalized above-market or below-market lease intangibles are amortized as a reduction or addition to rental income over the estimated remaining term of the respective leases.leases plus the term of any renewal options that the lessee would be economically compelled to exercise.
 
In determining the value of in-place leases, and tenant relationships, management considers current market conditions and costs to execute similar leases in arriving at an estimate of the carrying costs during the expected lease-up period from vacant to existing occupancy. In estimating carrying costs, management includes real estate taxes, insurance, other operating expenses, estimates of lost rental revenue during the expected lease-up periods, and costs to execute similar leases, including leasing commissions, tenant improvements, legal, and other related costs based on current market demand. The values assigned to in-place leases and tenant relationships are amortized over the estimated remaining term of the lease.
The values assigned to all lease intangible assets and liabilities are amortizedamortization expense over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.off, net of any required lease termination payments.
 
The OPCompany calculates the fair value of any long-term debt assumed by discounting the remaining contractual cash flows on each instrument at the current market rate for those borrowings, which the OPCompany approximates based on the rate at which it would expect to incur on a replacement instrument on the date of acquisition, and recognizerecognizes any fair value adjustments related to long-term debt as effective yield adjustments over the remaining term of the instrument.
 
Based on these estimates, the OPCompany recognizes the acquired assets and assumed liabilities at their estimated fair values, which are generally determined using Level 3 inputs, such as market rental rates, capitalization rates, discount rates, or other available market data. Initial valuations are subject to change until the information is finalized, no later than 12 months from the acquisition date. The OPCompany expenses transaction costs associated with acquisitions accounted for as business combinations in the period incurred.

Impairment of Intangible and Long-Lived Assets
 
The OPCompany periodically evaluates its long-lived assets, primarily consisting of investments in real estate, for impairment indicators or whenever events or changes in circumstances indicate that the recorded amount of an asset may not be fully recoverable. If indicators of impairment are present, the OPCompany evaluates the carrying value of the related real estate properties in relation to the undiscounted expected future cash flows of the underlying operations. In performing this evaluation, management considers market conditions and current intentions with respect to holding or disposing of the real estate property. The OPCompany adjusts the net book value of real estate properties to fair value if the sum of the expected future undiscounted cash flows, including sales proceeds, is less than book value. The OP recognizesCompany records an impairment loss at the time it makes any such determination. If the OPCompany determines that an asset is impaired, the impairment to be recognizedrecorded is measured as the amount by which the recorded amountbook value of the asset exceeds its fair value. Fair value is typically determined using a discounted future cash flow analysis or other acceptable valuation techniques, which are based, in turn, upon Level 3 inputs, such as revenue and expense growth rates, capitalization rates, discount rates, or other available market data.
 
The OPCompany recorded real estatean impairment charge of $1.0 million on a vacant medical office building in Port Charlotte, Florida during the year ended December 31, 2017. There were no impairment charges of $1.8 million and $0 forin the years ended December 31, 20142016, and 2013, respectively. The Predecessor recognized impairments totaling $0.9 million for the year ended December 31, 2012.2015.

Assets Held for Sale and Discontinued Operations

The OPCompany may sell properties from time to time for various reasons, including favorable market conditions. The OPCompany classifies certain long-lived assets as held for sale once the criteria, as defined by GAAP, has been met. Long-lived assets to be disposed of are reported at the lower of their carrying amount or fair value minus cost to sell, and are no longer depreciated.

In 2014, the FASB issued Accounting Standards Update 2014-8, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-8”), which raises the threshold for disposals to qualify as discontinued operations. A discontinued operation is defined as: (1) a component of an entity or group of components that has been disposed of or No properties were classified as held for sale as of December 31, 2017, 2016, or 2015 and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results; or (2) an acquired business that is classified as held for sale on the acquisition date. ASU 2014-8 also requires additional disclosures regarding discontinued operations, as well as material disposals that do not meet the definition of discontinued operations. The application of this guidance is prospective from the date of adoption and applies only to disposals (or new classifications to held for sale) that have not been reported as discontinued operations in the Trust’s previously issued financial statements. The OP early adopted ASU 2014-8 for the quarter ended March 31, 2014. Such adoption has had no impact on the OP’s financial statements as no dispositions have occurred during the yearyears ended December 31, 2014.
Prior to the adoption of ASU 2014-8, the results of operations for assets meeting the definition of discontinued operations are reflected in the consolidated2017, 2016, and combined statements of operations2015 did not qualify as discontinued operations for all periods presented. The OP allocates estimated interest expense to discontinued operations based on property values and either the weighted average interest rate of the OP or the property’s actual mortgage interest.operations.

Investments in Unconsolidated Entities
 
The OPCompany reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Under this method of accounting, the OP'sCompany’s share of the investee’s earnings or losses is included in its consolidated and combined statements of operations.income. The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the equity interest.

During 2014, the Operating PartnershipCompany completed the acquisition of a 40% limited liability company membership interest in Jeff-OrleansJeff Orleans Medical Development Real Estate, L.L.C,L.L.C., the entity that owns and leases to usthe Company the land on which the Crescent City Surgical Centre is situated, for $1.3 million.

During 2016, the Company completed the acquisition of a 43% limited liability company membership interest in Desert Cove MOB, LLC. During 2017, the Company completed the acquisition of the remaining 57% interest in this facility for a purchase price of approximately $4.6 million and consolidated it effective December 2017. The Company has a total investment in the facility of $5.5 million.

Real Estate Loans Receivable
 
Real estate loans receivable consists of aten mezzanine loans and two term loans. Each mezzanine loan and a term loan which areis collateralized by an equityownership interest in athe respective borrower, while the term loans are secured by equity interests in two medical office building developments. Interest income on the loans are recognized as earned based on the terms of the loans subject to evaluation of collectability risks and are included in the Operating Partnership'sCompany’s consolidated and combined statementstatements of operations.income.
On January 2, 2014, the OP completed a $6.9 million mezzanine loan to affiliates controlled by MedProperties Holdings, LLC, a Dallas, Texas based private investor in medical facilities (“MedProperties”). The mezzanine loan is secured by MedProperties’ ownership interest in two special purpose entities that own a surgical hospital located in San Antonio, Texas and an inpatient rehabilitation facility located in Scottsdale, Arizona. The mezzanine loan has a five year, interest-only term and bears interest at a rate of 9.0% per annum. As part of the consideration for providing the mezzanine loan, the OP has an option to acquire the property at a formula purchase price during year four of the mezzanine loan based on a fixed capitalization rate.
On November 26, 2014, the OP made an $8.6 million term loan to fund the renovations and additions of two re-purposed buildings in Jacksonville, Florida. Upon completion of the expansion and renovations, the properties will be approximately 40,000 square feet in the aggregate. Upon completion of the construction of the buildings and them becoming fully occupied, the Trust has the option to purchase the buildings. The term loan bears interest at a rate of 9.0%.


Cash and cash equivalentsCash Equivalents
 
Cash and cash equivalents consist of cash on hand and short-term investments with maturities of three months or less from the date of purchase.
The OPCompany is subject to concentrations of credit risk as a result of its temporary cash investments. The OPCompany places its temporary cash investments with high credit quality financial institutions in order to mitigate that risk.


Escrow reservesReserves
 
The OPCompany is required to maintain various escrow reserves on certain notes payable to cover future property taxes and insurance and tenant improvements costs as defined in each loan agreement. The total reserves as of December 31, 20142017 and 20132016 are $1.9$2.0 million and $1.6$4.3 million, respectively, which are included in other assets in the consolidated balance sheets.
 
Deferred costsCosts
 
Deferred costs consist primarily of fees paid to obtain financing and costs associated with the origination of long-term leaseleases on real estate properties. After the purchase of a property, lease commissions incurred to extend in-place leases or generate new leaseleases are added to deferred lease costs. Deferred lease costs are included as a component of other assets and are amortized on a straight-line basis over the terms of their respective agreements. Deferred financing costs are shown as a direct reduction from the related debt liability. The OPTrust amortizes deferred financing costs as a component of interest expense over the terms of the related borrowings usingon a method that approximates a level yield.straight-line basis.
 
DerivativesDerivative Instruments

Derivatives consistWhen the Company has derivative instruments embedded in other contracts, it records them either as an asset or a liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, changes in the Company’s derivative instruments’ fair value are recognized currently in earnings. If hedge accounting is applied to a derivative instrument, such changes are reported in accumulated other comprehensive income (“AOCI”) within the equity section of anthe consolidated balance sheets, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income.

To manage interest rate risk for certain of its variable-rate debt, the Company uses interest rate swaps as part of its risk management strategy. These derivatives are designed to mitigate the risk of future interest rate increases by providing a fixed interest rate for a limited, pre-determined period of time. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. As of December 31, 2017, the Company had five outstanding interest rate swap contracts that are designated as cash flow hedges of interest rate risk. For presentational purposes, they are shown as one derivative due to the identical nature of their economic terms. Further detail is provided in Note 7 (Derivatives).

The effective portion of the change in the fair value of derivatives designated and that qualify as cash flow hedges is recognized as a liabilityrecorded in accumulated other comprehensive income (“AOCI”) on the consolidated balance sheets and is measured at fair value. Anysubsequently reclassified into earnings as interest expense for the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in the fair value of the derivatives is recognized immediately in earnings unless the derivative qualified as a hedge. No derivatives have been designated as hedges.
The OP is exposed to certain risks in the normal course of its business operations. One risk relating to the variability of interest on variable rate debt is managed through the use of derivatives. All derivative financial instruments are measured and reported in the consolidated balance sheets at fair value. The OP has elected not to apply hedge accounting to its derivative financial instruments and as such, any changes in the fair values of its derivatives are recognized immediatelydirectly in earnings. Generally,For the OP enters into swap relationships such that changes in the fair value or cash flows of items and transactions being hedged are expected to be offset by corresponding changes in the values of the derivatives. The OP holds one swap to pay fixed/receive variable interest rates with a total notional amount of $7.7 million and $7.9 million as of December 31, 2014 and 2013, respectively. The interest rate swap liability is reported in accrued expenses and other liabilities on the consolidated balance sheet, as of December 31, 2014 and 2013, the interest rate swap liability was $0.2 million and $0.4 million, respectively. Gains recognized on the interest rate swaps of $(0.2) million, $(0.2) million and $(0.1) million were included in interest income on real estate loans and other in the consolidated and combined statements of operations for the yearstwelve months ended months ended December 31, 2014, 2013 and 2012, respectively.2017, the Company recorded a $0.2 million loss as a result of hedge ineffectiveness. The Company expects hedge ineffectiveness to be insignificant in the next 12 months.
 
Tenant receivables, netReceivables, Net
 
Tenant accounts receivable are stated net of the applicable allowance. Rental payments under these contracts are primarily due monthly. The OPCompany assesses the collectability of tenant receivables, including straight-line rent receivables, and defers recognition of revenue if collectability is not reasonably assured. The OPCompany bases its assessment of the collectability of rent receivables on several factors, including, among other things, payment history, the financial strength of the tenant, and current economic conditions. If management’s evaluation of these factors indicates it is probable that the OPCompany will be unable to recover the full value of the receivable, the OPCompany provides a reserve against the portion of the receivable that it estimates may not be recovered. At December 31, 20142017 and 2013,2016, the allowance for doubtful accounts was $0.1 million.$1.6 million and $2.4 million, respectively.


Rental Revenue
 
Rental revenue is recognized on a straight-line basis over the terms of the related leases when collectability is reasonably assured. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue for amounts more or less than amounts currently due from tenants. AmountsAccumulated amounts recognized in excess of amounts currently due from tenants, net of related allowances, are included in other assets and were approximately $6.4$47.6 million and $2.0$32.0 million as of December 31, 20142017 and 2013,2016, respectively. If the OPCompany determines that collectability of straight-line rents is not reasonably assured, the OPCompany limits future recognition to amounts contractually owed and, where appropriate, establishes an allowance for estimated losses. Allowances recognized against straight line rent were approximately $4.9 million

and $0.6 million as of December 31, 2017 and December 31, 2016, respectively. Rental revenue is adjusted by amortization of lease inducements and aboveabove- or below marketbelow-market rents on certain leases. Lease inducements and aboveabove- or below marketbelow-market rents are amortized on a straight line basis over the average remaining life of the lease.
 
Expense Recoveries
 
Expense recoveries relate to tenant reimbursement of real estate taxes, insurance, and other operating expenses that are recognized as expense recovery revenue in the period the applicable expenses are incurred. The reimbursements are recorded at

gross, as the OPCompany is generally the primary obligor with respect to real estate taxes and purchasing goods and services from third-party suppliers, and has discretion in selecting the supplier, and bears the credit risk of tenant reimbursement.
 
The OPCompany has certain tenants with absolute net leases. Under these lease agreements, the tenant is responsible for operating and building expenses. For absolute net leases, the OPCompany does not recognize expense recoveries.
 
Income Taxes

The Trust elected to be taxed as a REIT for federal tax purposes commencing with the filing of its tax return for the short taxable year ending December 31, 2013. The Trust had no taxable income prior to electing REIT status. To qualify as a REIT, the Trust must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of its annual REIT taxable income to its shareholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Trust generally will not be subject to federal income tax to the extent it distributes qualifying dividends to its shareholders. If the Trust fails to qualify as a REIT in any taxable year, it will be subject to federal income tax (including any applicable alternative minimum tax) on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Trust relief under certain statutory provisions. Such an event could materially adversely affect the Trust’s net income and net cash available for distribution to shareholders. However, the Trust intends to continue to operate in such a manner as to continue qualifying for treatment as a REIT. Even if the Trust continues to qualify for taxation as a REIT, the Trust may be subject to state and local taxes on its income and property and federal income and excise taxes on its undistributed income.

As discussed in Note 1 (Organization and Business), the Trust conducts substantially all of its operations through the Operating Partnership. As a partnership, the Operating Partnership generally is not liable for federal income taxes. The income and loss from the operations of the Operating Partnership is included in the tax returns of its limited partners, including the Trust, who are responsible for reporting their allocable share of the partnership income and loss. Accordingly, no provision for income taxes has been made on the accompanying consolidated financial statements.


Management Estimates
 
The preparation of consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated and combined financial statements and the amounts of revenue and expenses reported in the period. Significant estimates are made for the fair value assessments with respect to purchase price allocations, impairment assessments, and the valuation of financial instruments. Actual results could differ from these estimates.
 
Contingent LiabilityLiabilities
 
The OPCompany records a liabilityliabilities for contingent consideration (included in accrued expenses and other liabilities on its consolidated balance sheets) at fair value as of the acquisition date and reassessreassesses the fair value at the end of each reporting period, with any changes being recognized in earnings. Increases or decreases in the fair value of contingent consideration can result from changes in discount periods, discount rates, and probabilities that contingencies will be met.

Related Parties

In 2017, the Company recognized rental revenues totaling $0.6 million and $4.0 million from Aurora Health Care and Baylor Cancer Center, respectively. Both are healthcare facilities affiliated with certain members of the Trust’s Board of Trustees.


Reclassifications
 
Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the previously reported consolidated financial position or consolidated and combined results of operations.
 
Segment reportingReporting
 
Under the provision of Codification Topic 280, Segment Reporting, the OPCompany has determined that it has one reportable segment with activities related to leasing and managing healthcare properties.


New Accounting Pronouncements

In May 2014, the FASB issued ASU No. 2014-9, 2014-09, Revenue from Contracts with Customers, which creates a new Topic, Accounting Standards Codification (Topic 606).Topic 606. The standard is principle-based and provides a five-step model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This standard is effective for interim or annual periods beginning after December 15, 20162017 and allows for either full retrospective or modified retrospective adoption. EarlyThe Company will adopt ASU 2014-09 on January 1, 2018 via the modified retrospective approach. The modified retrospective approach applies the standard in the year of initial application and presents the cumulative effect of prior periods with an adjustment to beginning retained earnings, with no restatement of comparative periods. As leasing arrangements (which are excluded from ASU 2014-09) represent the primary source of revenue for the Company, the impact of adoption will be limited to the Company’s recognition and presentation of non-lease revenues, which are currently reflected as a component of other income. Adoption of ASU 2014-09 will not have a material impact on the amount and timing of the recognition of income subject to this standard isand we do not allowed. The OP is currently evaluating the impact the adoption of Topic 606 will have on its financial statements, if any.intend to further break out income line items with no cumulative effect adjustment to be recognized upon adoption.

In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, to address financial reporting considerations about an entity’s ability to continue as a going concern. ASU 2014-15 is effective for annual periods ending after December 15, 2016 and for interim periods within annual periods beginning after December 15, 2016.

In AprilFebruary 2015, the FASB issued ASU 2015-03, Simplifying2015-02, Amendments to the PresentationConsolidation Analysis. ASU 2015-02 requires entities to evaluate whether they should consolidate certain legal entities. Principally, the new consolidation standard modified the evaluation of Debt Issuance Costs, which changeswhether limited partnerships and similar legal entities are variable interest entities (“VIE”) or voting interest entities. The Company adopted ASU 2015-02 on January 1, 2016. Based on the presentation of debt issuance costs in financial statements. ASU 2015-03 requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. AmortizationCompany’s review and subsequent analysis of the costsstructure of the Company’s legal entities, the Company has concluded that the Operating Partnership is a VIE because the limited partners of the Operating Partnership do not have substantive kick-out or participating rights. The Trust is the general partner and controlling owner of approximately 97.1% of the Operating Partnership and will continue to be reported as interest expense.consolidate the Operating Partnership under this new guidance. With respect to the Company’s investment in unconsolidated joint ventures, the new consolidation standard did not have an impact on previous consolidation conclusions.
In February 2016, the FASB issued ASU 2015-03 is2016-02, Leases. The update amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective for annual reporting periods beginning after December 15, 2016.2018. Early adoption is permitted. As a result of adopting ASU 2016-02, the Company will recognize all of its operating leases for which it is the lessee, including ground leases, on its consolidated balance sheets. The newCompany is evaluating the impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. This update simplifies several aspects of accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, and classification on the statements of cash flows. ASU 2016-09 is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2016. The Company adopted ASU 2016-09 on January 1, 2017, with no material effect on its consolidated financial statements with no adjustments made to prior periods.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses, whichchanges the impairment model for most financial instruments by requiring companies to recognize an allowance for expected losses, rather than incurred losses as required currently by the other-than-temporary impairment model. ASU 2016-13 will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). ASU 2016-13 is effective for reporting periods beginning after December 15, 2019, with early adoption permitted, and will be applied as a cumulative adjustment to retained earnings as of the effective date. We are currently assessing the potential effect the adoption of ASU 2016-13 will have on our consolidated financial statements.


In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payment. ASU 2016-15 clarifies the guidance has beenon the classification of certain cash receipts and payments in the statement of cash flows to reduce diversity in practice with respect to: (i) debt prepayment or debt extinguishment costs; (ii) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (iii) contingent consideration payments made after a business combination; (iv) proceeds from the settlement of insurance claims; (v) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (vi) distributions received from equity method investees; (vii) beneficial interests in securitization transactions; and (viii) separately identifiable cash flows and application of the predominance principle. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017 with early adoption permitted. The Company adopted ASU 2016-15 on January 1, 2018, with no material effect on its consolidated financial statements and no adjustments made to prior periods.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows: Restricted Cash, which will require companies to include restricted cash with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. ASU 2016-18 will require disclosure of a reconciliation between the balance sheet and the statement of cash flows when the balance sheet includes more than one line item for cash, cash equivalents, restricted cash, and restricted cash equivalents. An entity with material restricted cash and restricted cash equivalents balances will be required to disclose the nature of the restrictions. ASU 2016-18 is effective for reporting periods beginning after December 15, 2017, and is required to be applied retrospectively to eachall periods presented. The Company adopted ASU 2016-18 on January 1, 2018, with no material effect on its consolidated financial statements and no adjustments made to prior period presented.periods.



In January 2017, the FASB issued ASU 2017-01, Clarifying the Definition of a Business, that clarifies the framework for determining whether an integrated set of assets and activities meets the definition of a business. The revised framework establishes a screen for determining whether an integrated set of assets and activities is a business and narrows the definition of a business, which is expected to result in fewer transactions being accounted for as business combinations. Acquisitions of integrated sets of assets and activities that do not meet the definition of a business are accounted for as asset acquisitions. ASU 2017-01 will be effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2017. Upon adoption of ASU 2017-01, the Company anticipates it will classify most prospective real estate acquisitions as asset acquisitions, rather than business combinations, and direct acquisition costs associated with these acquisitions will be capitalized. This is due to the fact that substantially all of the fair value of the gross assets the Company acquires are concentrated in a single asset or group of similar identifiable assets.

88


Note 3—3. Acquisitions and Dispositions
 
During 2014,2017, the OPCompany completed acquisitions of 6140 operating healthcare properties, 2 condominium units, and 1 parking deck located in 15 states, for an aggregate purchase price of approximately $543.4$1.37 billion. In addition, the Company completed $39.1 million asof loan investments, $1.1 million of redeemable noncontrolling interest buyouts, and $2.8 million of noncontrolling interest buyouts, resulting in total investment activity of approximately $1.41 billion.

Investment activity for the year ending December 31, 2017 is summarized below:
Property (1)   Location 
Acquisition
Date
 
Purchase Price
(in thousands)
Orthopedic Associates(2)  Flower Mound, TX January 5, 2017 $18,750
Medical Arts Center at Hartford(2)  Plainville, CT January 11, 2017 30,250
Noncontrolling Interest Buyout - New Albany(3)  New Albany, OH January 31, 2017 2,824
CareMount - Lake Katrine MOB(2)(4) Lake Katrine, NY February 14, 2017 41,791
CareMount - Rhinebeck MOB(2)  Rhinebeck, NY February 14, 2017 18,639
Syracuse Condos(2)  Fayetteville & Liverpool, NY February 27, 2017 2,659
Monterey Medical Center - MOB(2)  Stuart, FL March 7, 2017 18,979
Creighton University Medical Center(5)  Omaha, NE March 28, 2017 33,420
Strictly Pediatrics Specialty Center(2)(6) Austin, TX March 31, 2017 78,628
MedStar Stephen's Crossing(2)  Brandywine, MD June 16, 2017 20,900
2017 CHI Portfolio - Tranche 1 (8 MOBs)(5)  AR, MN, ND, NE, TN, TX June 29, 2017 124,181
St. Vincent Portfolio (2 MOBs)(2)  Carmel & Fishers, IN June 29, 2017 93,880
Baylor Charles A. Sammons Cancer Center(2)  Dallas, TX June 30, 2017 290,000
Orthopedic & Sports Institute of the Fox Valley(7)  Appleton, WI June 30, 2017 27,900
Peachtree Dunwoody Medical Center - Parking Deck(7)  Atlanta, GA June 30, 2017 25,000
Clearview Cancer Institute(2)  Huntsville, AL August 4, 2017 53,250
Northside Cherokee/Town Lake MOB(2)  Atlanta, GA August 15, 2017 37,127
HonorHealth Mesa MOB(2)  Mesa, AZ August 15, 2017 4,800
2017 CHI Portfolio - Tranche 2 (5 MOBs)(5)  AR, MN, NE, TX 
August 24, 2017 & August 31, 2017

 33,694
Noncontrolling Interest Buyout - Great Falls Clinic(8)  Great Falls, MT September 21, 2017 1,061
Legends Park MOB & ASC(2)  Midland, TX September 27, 2017 30,000
Franklin MOB & ASC(2)  Franklin, TN October 12, 2017 9,950
Eagle Point MOB(2)  Lake Elmo, MN October 31, 2017 10,949
Edina East MOB(2)  Edina, MN October 31, 2017 7,800
Northside MOB - Center Pointe(2)  Atlanta, GA November 10, 2017 155,986
Gwinnett 500 Building(2)  Lawrenceville, GA November 17, 2017 25,297
Hudgens Professional Building(2)  Duluth, GA November 17, 2017 23,696
St. Vincent Building(2)  Indianapolis, IN November 17, 2017 60,124
Gwinnett Physicians Center(2)(9) Lawrenceville, GA December 1, 2017 51,721
Apple Valley Medical Center(2)  Apple Valley, MN December 18, 2017 21,500
Desert Cove MOB (57% Interest)(2)(10) Scottsdale, AZ December 18, 2017 4,560
Westgate MOB(2)  Glendale, AZ December 21, 2017 15,800

Property(1) Location 
Acquisition
Date
 
Purchase
Price
 (in thousands)
Foundation San Antonio Surgical Hospital(2) San Antonio, TX February 19, 2014 $25,556
Eagles Landing Family Practice 4 MOBs(2) Atlanta, GA February 19, 2014 20,800
21st Century Oncology 4 MOBs(3)
 Sarasota, FL February 26, 2014 17,486
Foundation San Antonio MOB(3) San Antonio, TX February 28, 2014 6,800
Peachtree Dunwoody MOB(3) Atlanta, GA February 28, 2014 36,726
LifeCare LTACH(2) Fort Worth, TX March 28, 2014 27,160
LifeCare LTACH(2) Pittsburgh, PA March 28, 2014 12,840
Pinnacle Health Cardiology Portfolio 2 MOBs (3) Carlisle & Wormleyburg, PA April 22, 2014 9,208
South Bend Orthopedic MOB (3) South Bend, IN April 30, 2014 14,900
Grenada Medical Complex MOB (3) Grenada, MS April 30,2014 7,100
Mississippi Sports Medicine and Orthopaedics Center MOB (2)(4) Jackson, MS May 23, 2014 16,700
Carmel Medical Pavilion MOB (3)(5) Carmel, IN May 28, 2014 4,664
Summit Urology MOB (2) Bloomington, IN June 30, 2014 4,783
Renaissance Center (3) Oshkosh, WI June 30, 2014 8,500
Presbyterian Medical Plaza MOB (3) Monroe, NC June 30, 2014 7,750
Landmark Medical Portfolio (Premier) 3 MOBs (2)(6) Bloomington, IN July 1, 2014 23,837
Carlisle II MOB (3) Carlisle, PA July 25, 2014 4,500
Surgical Institute of Monroe ASC (2) Monroe, MI July 28, 2014 6,000
The Oaks Medical Building MOB (3) Lady Lake, FL July 31, 2014 10,600
Baylor Surgicare ASC — Mansfield (3) Mansfield, TX September 2, 2014 8,500
Eye Center of Southern Indiana (2)(7) Bloomington, IN September 5, 2014 12,174
Wayne State Medical Center and MOB (2) Troy, MI September 10, 2014 46,500
El Paso Portfolio (specialty surgical hospital and 2 MOBs) (3)(8) El Paso, TX September 30, 2014 46,235
The Mark H. Zangmeister Center (3) Columbus, OH September 30, 2014 36,600
Berger Medical Center (3) Orient, OH September 30, 2014 6,785
Orthopedic One 2 MOBs (3) Columbus, OH Westerville, OH September 30, 2014 24,500
Pinnacle Health Portfolio 5 MOBs (3) Harrisburg, PA October 29, 2014 23,100
Columbus Regional Health Portfolio 12 MOBs (3) Columbus Regional Health Portfolio 1 MOB (3) Columbus, GA Phenix City, AL November 20, 2014 27,997
Middletown Medical 2 MOBs (2) Middletown, NY November 26. 2014 14,399
Carle Danville Clinic MOB(3) Danville, IL November 26, 2014 10,300
Napoleon Medical Building MOB (3) New Orleans, LA December 18, 2014 10,500
West Tennessee Bone & Joint 1 MOB 1 ASC (2) Jackson, TN December 30, 2014 9,936
Total     $543,436
Property (1)   Location 
Acquisition
Date
 
Purchase Price
(in thousands)
Loan Investments(11)  Various Various 39,063
        $1,414,179
(1)“MOB” means medical office building. “ASC” means ambulatory surgery center.
(2)The Company accounted for these acquisitions as business combinations pursuant to the acquisition method and expensed total acquisition costs of $16.6 million.
(3)The Company acquired the previously outstanding interest in the New Albany MOB from the predecessor owner. As consideration, the Operating Partnership paid approximately $2.1 million in cash and issued 38,641 OP Units, representing approximately $2.8 million in aggregate.
(4)The Company partially funded this acquisition through the assumption of an existing mortgage valued at approximately $26.4 million.
(5)These acquisitions are part of the CHI Portfolio. The Company accounted for nine of these facilities, consisting of an aggregate purchase price of $143.0 million, as asset acquisitions and capitalized total acquisition costs of $0.4 million. The remaining six facilities, consisting of an aggregate purchase price of $48.3 million, were accounted for as business combinations pursuant to the acquisition method, with acquisition expense totaling $0.1 million.
(6)The Company partially funded the purchase price of this acquisition by issuing a total of 2,247,817 OP Units valued at approximately $44.3 million in the aggregate on the date of issuance.
(7)The Company accounted for these acquisitions as asset acquisitions and capitalized total acquisition costs of $0.5 million.
(8)The Company acquired an additional 3.2% interest in the Great Falls Clinic joint venture from the predecessor owner, increasing the Company’s total interest to 85.0%.
(9)As part of this acquisition, the Company assumed a $17.6 million mortgage on the facility.
(10)The Company acquired an additional 57.0% ownership interest in Desert Cove MOB, LLC increasing the Company’s total interest to 100%.
(11)The loan investments listed here include 8 separate transactions at a weighted average interest rate of 8.1%.

(1)“MOB” means medical office building, “LTACH” means long-term acute care hospital and “ASC” means ambulatory surgical center.
(2)The Operating Partnership accounted for these acquisitions as asset acquisitions and capitalized $1.7 million of total acquisition costs to the basis of the properties.

(3)The Operating Partnership accounted for these acquisitions as business combinations pursuant to the acquisition method and expensed total acquisition costs of $10.9 million.
(4)The Operating Partnership partially funded the purchase price of these acquisitions by issuing a total of 147,659 OP Units valued at approximately $1.9 million in the aggregate on the date of issuance.
(5)The Operating Partnership partially funded the purchase price of these acquisitions by issuing a total of 96,099 OP Units valued at approximately $1.2 million in the aggregate on the date of issuance.
(6)The Operating Partnership partially funded the purchase price of these acquisitions by issuing a total of 576,040 OP Units valued at approximately $8.3 million in the aggregate on the date of issuance.
(7)The Operating Partnership partially funded the purchase price of these acquisitions by issuing a total of 272,191 OP Units valued at approximately $4.0 million in the aggregate on the date of issuance.
(8)The Operating Partnership partially funded the purchase price of these acquisitions by issuing a total of 950,324 OP Units valued at approximately $13.2 million in the aggregate on the date of issuance.

For 2014,2017, the OPCompany recorded revenues and net income of $26.0$49.6 million and $3.7$8.6 million, respectively, from its 20142017 acquisitions.

During 2016, the Company completed acquisitions of 95 properties (including 5 condominium units and the CHI Portfolio) and 1 land parcel, located in 23 states, for an aggregate purchase price of approximately $1.27 billion. In addition, the Company completed $0.9 million of joint venture investments, $10.2 million of loan investments, $2.5 million of redeemable noncontrolling interest buyouts, and $0.6 million of equity buyouts, resulting in total investment activity of approximately $1.29 billion.

This aggregate purchase price does not include near-term capital expenditure commitments of $12.9 million and committed tenant improvement allowances of $8.9 million related to the Company’s acquisition of the CHI Portfolio.

Investment activity for the year ending December 31, 2016 is summarized below:
Property (1)   Location Acquisition
Date
 
Purchase Price
 (in thousands)
Tinseltown - Loan Draws   Jacksonville, FL   $2,192
Randall Road MOB - Suite 380(3)  Elgin, IL January 14, 2016 704
Great Falls Hospital(2)  Great Falls, MT January 25, 2016 29,043
Monterey Medical Center ASC(2)  Stuart, FL February 1, 2016 6,900
Physicians Medical Plaza MOB(2)(4) Indianapolis, IN February 1, 2016 8,500
Mezzanine Loan - Davis   Minnetonka, MN February 4, 2016 500
Park Nicollet Clinic(2)  Chanhassen, MN February 8, 2016 18,600
HEB Cancer Center(2)  Bedford, TX February 12, 2016 13,980
Riverview Medical Center(2)  Lancaster, OH February 26, 2016 12,800
St. Luke's Cornwall MOB(2)  Cornwall, NY February 26, 2016 14,550
HonorHealth Glendale(3)  Glendale, AZ March 15, 2016 9,820
Columbia MOB(2)  Hudson, NY March 21, 2016 18,450

Property (1)   Location Acquisition
Date
 
Purchase Price
 (in thousands)
St Vincent POB 1(2)  Birmingham, AL March 23, 2016 10,951
St Vincent POB 2(2)  Birmingham, AL March 23, 2016 7,945
St Vincent POB 3(2)  Birmingham, AL March 23, 2016 10,455
Emerson Medical Building(2)  Creve Coeur, MO March 24, 2016 14,250
Randall Road MOB - Suite 160(3)  Elgin, IL March 24, 2016 865
Patient Partners Surgery Center(2)  Gallatin, TN March 30, 2016 4,750
Eye Associates of NM - Santa Fe(3)  Santa Fe, NM March 31, 2016 8,739
Eye Associates of NM - Albuquerque(3)  Albuquerque, NM March 31, 2016 10,536
Gardendale Surgery Center(2)  Gardendale, AL April 11, 2016 7,450
HealthEast - Curve Crest(2)  Stillwater, MN April 14, 2016 4,144
HealthEast - Victor Gardens(2)  Hugo, MN April 14, 2016 6,025
NOMS - Clyde(3)  Clyde, OH May 10, 2016 6,342
Blandford MOB(3)(5) Little Rock, AR May 11, 2016 2,580
Cardwell MOB(2)(5) Lufkin, TX May 11, 2016 8,444
Dacono Neighborhood Health(3)(5) Dacono, CO May 11, 2016 5,152
Franciscan Health(3)(5) Tacoma, WA May 11, 2016 9,772
Grand Island Specialty Clinic(3)(5) Grand Island, NE May 11, 2016 2,891
Hot Springs MOB(2)(5) Hot Springs Village, AR May 11, 2016 3,626
Jewish Medical Center East(3)(5) Louisville, KY May 11, 2016 85,000
Jewish Medical Center South MOB - 1(3)(5) Shepherdsville, KY May 11, 2016 17,021
Jewish Medical Plaza I(2)(5) Louisville, KY May 11, 2016 9,650
Jewish Medical Plaza II(2)(5) Louisville, KY��May 11, 2016 6,124
Jewish OCC(3)(5) Louisville, KY May 11, 2016 35,600
Lakeside Three Professional Center(2)(5) Omaha, NE May 11, 2016 1,581
Lexington Surgery Center(2)(5) Lexington, KY May 11, 2016 20,169
Medical Arts Pavilion(2)(5) Lufkin, TX May 11, 2016 6,304
Memorial Outpatient Center(3)(5) Lufkin, TX May 11, 2016 4,958
Midlands Two Professional Center(2)(5) Papillion, NE May 11, 2016 1,341
Parkview MOB(2)(5) Little Rock, AR May 11, 2016 5,060
Peak One ASC(2)(5) Frisco, CO May 11, 2016 6,587
Physicians Medical Center(2)(5) Tacoma, WA May 11, 2016 6,782
St. Alexius - Minot Medical Plaza(3)(5) Minot, ND May 11, 2016 26,570
St. Clare Medical Pavilion(2)(5) Lakewood, WA May 11, 2016 10,617
St. Joseph Medical Pavilion(2)(5) Tacoma, WA May 11, 2016 13,320
St. Joseph Office Park(2)(5) Lexington, KY May 11, 2016 17,228
St. Mary - Caritas Medical II(2)(5) Louisville, KY May 11, 2016 5,603
St. Mary - Caritas Medical III(2)(5) Louisville, KY May 11, 2016 842
Thornton Neighborhood Health(3)(5) Thornton, CO May 11, 2016 3,875
Medical Village at Kissimmee(2)  Kissimmee, FL May 26, 2016 4,923
Medical Village at Leesburg(2)  Leesburg, FL May 26, 2016 4,576
St. Francis MOB(2)(5) Federal Way, WA June 2, 2016 14,287
Children's Hospital MOB(2)  Milwaukee, WI June 3, 2016 5,850
Jewish Medical Center South MOB - 2(2)  Shepherdsville, KY June 8, 2016 4,343
Good Samaritan North Annex Building(3)(5) Kearney, NE June 28, 2016 2,874
NE Heart Institute Medical Building(3)(5) Lincoln, NE June 28, 2016 19,600

Property (1)   Location Acquisition
Date
 
Purchase Price
 (in thousands)
St. Vincent West MOB(3)(5) Little Rock, AR June 29, 2016 14,120
Meridan MOB(3)(5) Englewood, CO June 29, 2016 17,329
St. Mary - Caritas Medical I(2)(5) Louisville, KY June 29, 2016 8,864
St. Alexius - Medical Arts Pavilion(3)(5) Bismarck, ND June 29, 2016 12,983
St. Alexius - Mandan Clinic(3)(5) Mandan, ND June 29, 2016 8,390
St. Alexius - Orthopaedic Center(2)(5) Bismarck, ND June 29, 2016 14,727
St. Alexius - Rehab Center(3)(5) Bismarck, ND June 29, 2016 6,215
St. Alexius - Tech & Ed(3)(5) Bismarck, ND June 29, 2016 16,680
Good Samaritan MOB(2)(5) Kearney, NE June 29, 2016 24,198
Lakeside Two Professional Building(2)(5) Omaha, NE June 29, 2016 13,691
Lakeside Wellness Center(3)(5) Omaha, NE June 29, 2016 10,138
McAuley Center(3)(5) Omaha, NE June 29, 2016 18,382
Memorial Health Center(3)(5) Grand Island, NE June 29, 2016 34,042
Missionary Ridge MOB(2)(5) Chattanooga, TN June 29, 2016 7,635
Pilot Medical Center(3)  Birmingham, AL June 29, 2016 17,351
St. Joseph Medical Clinic(2)(5) Tacoma, WA June 30, 2016 16,444
Woodlands Medical Arts Center(2)(5) The Woodlands, TX June 30, 2016 21,227
FESC MOB(3)(5) Tacoma, WA June 30, 2016 16,748
Mezzanine Loan - Catalyst   Pensacola, FL June 30, 2016 1,340
Prairie Care MOB(2)  Maplewood, MN July 6, 2016 4,886
RE Loan - Chihuahua Development LLC   El Paso, TX July 7, 2016 1,300
Springwoods MOB(2)(5) Spring, TX July 21, 2016 19,925
Equity Buyout - Foundation(6)  TX / OK July 26, 2016 611
Mezzanine Loan - Hazelwood   Minnetonka, MN July 29, 2016 3,375
Jackson, Tennessee Land(3)  Jackson, TN August 2, 2016 1,000
Unity Portfolio (4 MOBs)(2)  West Lafayette, IN August 8, 2016 28,751
Medical Village at Maitland(2)  Orlando, FL August 23, 2016 23,211
Tri-State Orthopaedics MOB(2)  Evansville, IN August 30, 2016 22,000
Maury Regional Healthcare MOB(2)(8) Spring Hill, TN September 30, 2016 18,500
Spring Ridge Medical Center(2)  Wyomissing, PA September 30, 2016 6,100
Doctors Community Hospital POB(2)  Lanham, MD September 30, 2016 26,750
Gig Harbor Medical Pavilion(3)(5) Gig Harbor, WA September 30, 2016 4,766
Midlands One Professional Center(2)(5) Papillion, NE September 30, 2016 14,856
Noncontrolling Interest Buyout - Great Falls Clinic(7)  Great Falls, MT September 30, 2016 1,015
N.W. Michigan Surgery Center - Units #1 & #2(3)(9) Traverse City, MI October 28, 2016 29,448
United Surgical Partners Joint Venture(10)  Scottsdale, AZ October 31, 2016 903
N.W. Michigan Surgery Center - Unit #4(3)(11) Traverse City, MI November 4, 2016 2,715
Syracuse Portfolio (2 MOBs)(2)  Syracuse, NY November 23, 2016 54,239
Cincinnati Eye Institute(3)  Cincinnati, OH November 23, 2016 38,100
Curie Building Loan   El Paso, TX December 2, 2016 1,500
HonorHealth - Scottsdale MOB(3)  Scottsdale, AZ December 2, 2016 6,900
Fox Valley Hematology & Oncology(3)  Appleton, WI December 8, 2016 28,200
Gastrointestinal Associates MOB(2)  Powell, TN December 9, 2016 6,287
Northern Vision Eye Center(3)  Traverse City, MI December 15, 2016 2,777

Property (1)   Location Acquisition
Date
 
Purchase Price
 (in thousands)
Noncontrolling Interest Buyout - Great Falls Clinic(12)  Great Falls, MT December 15, 2016 1,497
Flower Mound Portfolio (3 MOBs)(3)  Flower Mound, TX December 16, 2016 27,800
HonorHealth IRF(3)  Scottsdale, AZ December 22, 2016 25,628

       $1,285,185
(1)“MOB” means medical office building. “ASC” means ambulatory surgical center. “POB” means professional office building. “IRF” means inpatient rehabilitation facility.
(2)The Company accounted for these acquisitions as business combinations pursuant to the acquisition method and expensed total acquisition costs of $14.8 million.
(3)The Company accounted for these acquisitions as asset acquisitions and capitalized total acquisition costs of $3.0 million.
(4)The Company partially funded the purchase price of this acquisition by issuing a total of 174,085 OP Units valued at approximately $2.9 million in the aggregate on the date of issuance.
(5)These acquisitions are part of the CHI portfolio.
(6)The Company acquired the previously outstanding 1% noncontrolling interest retained by the predecessor owner on three properties, El Paso, Texas and Oklahoma City, Oklahoma.
(7)The Company acquired an additional 3% interest in the Great Falls Clinic joint venture from the predecessor owner, increasing the Company’s total interest to 77.3%.
(8)
The Company acquired 99.7% of the ownership interest in this property, the remainder of which was retained by the seller.
(9)
The Company partially funded the purchase price of the acquisition of two condominium units within the Northwest Michigan Surgery Center through unregistered issuance of 947,936 common shares of beneficial interest.
(10)
The Company’s investment in the United Surgical Partners J.V. represents a 43% ownership interest.
(11)
The Company partially funded the purchase price of the acquisition of one additional condominium unit within the Northwest Michigan Surgery Center through the unregistered issuance of 88,602 common shares of beneficial interest.
(12)
The company acquired an additional 4.6% interest in the Great Falls Clinic joint venture from the predecessor owner, increasing the Company’s total interest to 81.8%.

For 2016, the Company recorded revenues and net income of $66.7 million and $14.9 million, respectively, from its 2016 acquisitions.


The following table summarizes the preliminary purchase price allocations of the assets acquired and the liabilities assumed, which the OPCompany determined using Level 2 and Level 3 inputs (in thousands):
 December 31, 2017 December 31, 2016
Land$38,358
 $57,847
Building and improvements1,168,741
 1,112,746
In-place lease intangible128,370
 58,666
Above-market in-place lease intangible18,967
 9,359
Below-market in-place lease intangible(4,270) (4,518)
Above-market in-place ground lease(4,620) (644)
Below-market in-place ground lease17,683
 28,937
Contingent consideration(765) (156)
Receivable434
 104
Debt assumed(43,989) 
Issuance of OP Units(44,978) (2,869)
Investment in unconsolidated entity(2,871) 903
Lease inducement
 8,945
Prepaid expenses
 2,659
Issuance of Common Shares
 (20,980)
Noncontrolling interest
 (50)
Net assets acquired$1,271,060
 $1,250,949
Land$53,687
Building and improvements451,691
In-place lease intangibles35,720
Above market in-place lease intangibles5,270
Below market in-place lease intangibles(2,330)
Above market in-place ground lease(701)
Investment in unconsolidated entity1,300
Issuance of OP units(28,589)
Mortgage debt assumed(15,283)
Lease inducement1,532
Derivative liability assumed(197)
Contingent consideration(840)
Leasehold interest759
Receivable640
Net assets acquired$502,659

 
These preliminary allocations are subject to revision within the measurement period, not to exceed one year from the date of the acquisitions.

Dispositions

On April 7, 2017, the Company closed an agreement to sell a portfolio of four medical office buildings located in Georgia (the “Georgia Portfolio”), for approximately $18.2 million, which reflects a gain of approximately $5.2 million.

On August 15, 2017, the Company completed the disposition of land with a carrying value of $7.7 million in a sale-leaseback at the Peachtree Dunwoody Medical Center. The Company entered into a 90 year term ground lease at closing with all rent prepaid in consideration of the full present value of rent owed. There was no gain or loss recorded as a result of this transaction.

On December 18, 2017, the Company sold one 20,939 square foot medical office building located in Nebraska for approximately $2.5 million, recording a gain of approximately $0.7 million.

The following table summarizes revenues and net income related to the disposition properties for the periods presented (in thousands):
 Year Ended December 31,
 2017 2016 2015
Revenue$823
 $1,967
 $1,666
      
Income before gain on sale of investment properties108
 433
 421
Gain on sale of investment properties5,870
 
 
Net income$5,978
 $433
 $421




Unaudited Pro Forma Financial Information


Physicians Realty LPTrust

The following table illustrates the pro forma combinedconsolidated revenue, net income, and earnings per unit —basic and dilutedshare as if Physicians Realty LPthe Company had acquired the 2017 acquisitions detailed above acquisitions as of January 1, 20132016 (in thousands, except share and per share amounts):
 Year Ended December 31,
 2017 2016
Revenue$405,320
 $352,432
Net income42,149
 39,233
Net income available to common shareholders39,759
 35,614
Earnings per share - basic$0.24
 $0.22
Earnings per share - diluted$0.24
 $0.22
Weighted average number of shares outstanding - basic163,123,109
 163,123,109
Weighted average number of shares outstanding - diluted168,231,299
 168,231,299


Physicians Realty L.P.

The following table illustrates the pro forma consolidated revenue, net income, and earnings per share as if the Company had acquired the 2017 acquisitions detailed above as of January 1, 2016 (in thousands, except unit and per unit amounts):
 Year Ended December 31,
 2017 2016
Revenue$405,320
 $352,432
Net income42,149
 39,233
Net income available to common unitholders40,927
 36,660
Earnings per unit - basic$0.24
 $0.22
Earnings per unit - diluted$0.24
 $0.22
Weighted average number of units outstanding - basic167,963,076
 167,963,076
Weighted average number of units outstanding - diluted168,231,299
 168,231,299

 Year Ended December 31,
 2014 2013
Revenue$81,507
 $71,183
Net income16,883
 11,461
Net income available to common shareholders16,883
 11,461
Earnings per unit - basic and diluted$0.31
 $0.21
Common units issued and outstanding53,831,202
 53,831,202


Note 4—4. Intangibles

The following is a summary of the carrying amount of intangible assets and liabilities as of 2014December 31, 2017 and 20132016 (in thousands):
 December 31, 2017 December 31, 2016
 Cost 
Accumulated
Amortization
 Net Cost 
Accumulated
Amortization
 Net
Assets 
  
  
  
  
  
In-place leases$343,429
 $(85,424) $258,005
 $222,394
 $(55,605) $166,789
Above-market leases54,148
 (11,968) 42,180
 35,478
 (6,909) 28,569
Leasehold interest712
 (183) 529
 712
 (124) 588
Below-market ground lease60,424
 (1,344) 59,080
 42,878
 (539) 42,339
Total$458,713

$(98,919)
$359,794

$301,462

$(63,177)
$238,285
Liabilities 
  
  
  
  
  
Below-market lease$14,344
 $(4,479) $9,865
 $10,297
 $(2,345) $7,952
Above-market ground lease5,965
 (128) 5,837
 1,345
 (44) 1,301
Total$20,309

$(4,607)
$15,702

$11,642

$(2,389)
$9,253
 December 31, 2014 December 31, 2013
 Cost 
Accumulated
Amortization
 Net Cost 
Accumulated
Amortization
 Net
Assets 
  
  
  
  
  
In-place leases$64,777
 $(12,213) $52,564
 $29,056
 $(8,080) $20,976
Above market leases7,449
 (578) 6,871
 2,180
 (48) 2,132
Leasehold interest759
 (5) 754
 
 
 
Total$72,985

$(12,796)
$60,189

$31,236

$(8,128)
$23,108
Liability 
  
  
  
  
  
Below market lease$2,330
 $(156) $2,174
 
 
 
Above market ground lease701
 (4) 697
 
 
 
Total$3,031

$(160)
$2,871

$

$

$

 

The following is a summary of the acquired lease intangible amortization for the years ended December 31, 2014, 20132017, 2016, and 20122015 (in thousands):
 December 31,
 2017 2016 2015
Amortization expense related to in-place leases$37,073
 $28,902
 $15,300
Decrease of rental income related to above-market leases5,357
 4,403
 2,596
Decrease of rental income related to leasehold interests59
 59
 59
Increase of rental income related to below-market leases2,309
 1,835
 643
Decrease of operating expense related to above-market ground leases84
 24
 16
Increase in operating expense related to below-market ground leases810
 471
 68
 December 31,
 2014 2013 2012
Amortization expense related to in-place leases$4,133
 $1,252
 $900
Decrease of rental income related to above-market leases530
 48
 
Decrease of rental income related to leasehold interest5
 
 
Increase of rental income related to below-market leases156
 
 
Decrease of operating expense related to above market ground leases4
 
 

 
For the twelve months ended December 31, 2017, the Company wrote-off in-place lease intangible assets of approximately $3.5 million with accumulated amortization of approximately $2.1 million, resulting in the recognition of $1.4 million in additional amortization expense. The Company also wrote-off above-market lease intangible assets of approximately $0.3 million with accumulated amortization of approximately $0.1 million, resulting in the recognition of $0.2 million in additional amortization expense. In addition, the Company, wrote-off below-market lease intangible of approximately $0.1 million with accumulated amortization of approximately $36.0 thousand, resulting in the recognition of $0.1 million reduction in amortization expense, for a net recognition of approximately $1.5 million reduction in rental income from intangible amortization.

Future aggregate net amortization of the acquired lease intangibles as of December 31, 2014,2017, is as follows (in thousands):
 
 
Net Decrease in
Revenue
 
Net Increase in
Expenses
2018$(3,355) $41,455
2019(3,376) 36,429
2020(3,392) 33,009
2021(3,333) 30,582
2022(2,872) 26,225
Thereafter(16,516) 143,548
Total$(32,844)
$311,248
 
Net Decrease in
Revenue
 
Net Increase in
Expenses
2015$(667) $7,446
2016(689) 7,384
2017(567) 7,165
2018(560) 6,628
2019(458) 4,625
Thereafter(2,511) 18,618
Total$(5,452)
$51,866

 
For the year ended December 31, 2014,2017, the weighted average amortization period for asset lease intangibles and liability lease intangible is nineintangibles are 18 years and 1720 years, respectively.



Note 5—5. Other Assets
 
Other assets consisted of the following as of December 31, 20142017 and 20132016 (in thousands):
 December 31,
 2017 2016
Straight line rent receivable47,599
 32,018
Prepaid expenses18,103
 8,928
Interest rate swap14,693
 13,881
Lease inducements, net14,232
 13,255
Leasing commissions, net4,128
 1,858
Earnest deposits2,780
 1,500
Escrows1,996
 4,334
Notes receivable
 16,618
Other2,771
 2,795
Total$106,302
 $95,187
 December 31,
 2014 2013
Straight line rent receivable$6,431
 $2,018
Lease inducements, net2,845
 1,509
Escrows1,906
 1,552
Earnest deposits2,343
 
Prepaid expenses and other2,281
 822
Total$15,806

$5,901

  

96



Note 6—6. Debt
 
The following is a summary of debt as of December 31, 20142017 and 20132016 (in thousands):
 December 31,
 2014 2013
Mortgage notes, bearing fixed interest from 4.71% to 6.58%, with a weighted average interest rate of 5.26%, and due in 2016, 2017, 2018, 2019, 2021 and 2022 collateralized by nine properties with a net book value of $118,247$73,706
 $38,288
Mortgage note, bearing variable interest of LIBOR plus 2.75% and due in 2017, collateralized by one property with a net book value of $6,2494,399
 4,533
Total mortgage debt78,105

42,821
$400 million unsecured revolving credit facility bearing variable interest of LIBOR plus 1.50%, due September 2018138,000
 
Total Debt$216,105

$42,821
Unamortized deferred financing cost(4,870) (2,105)
Total debt$211,235
 $40,716
 December 31, 
 2017 2016 
Fixed interest mortgage notes$158,171
(1)$90,185
(2)
Variable interest mortgage notes28,509
(3)33,009
(4)
Total mortgage debt186,680
 123,194
 
$850 million unsecured revolving credit facility bearing variable interest of LIBOR plus 1.20%, due September 202080,000
 401,000
 
$400 million senior unsecured notes bearing fixed interest of 4.30%, due March 2027400,000
 
 
$350 million senior unsecured notes bearing fixed interest of 3.95%, due January 2028350,000
 
 
$250 million unsecured term borrowing bearing fixed interest of 2.87%, due June 2023250,000
(5)250,000
 
$150 million senior unsecured notes bearing fixed interest of 4.03% to 4.74%, due January 2023 to 2031150,000
 150,000
 
$75 million senior unsecured notes bearing fixed interest of 4.09% to 4.24%, due August 2025 to 202775,000
 75,000
 
Total principal1,491,680
 999,194
 
Unamortized deferred financing cost(7,808) (8,477) 
Unamortized discount(6,663) 
 
Unamortized fair value adjustment259
 438
 
Total debt$1,477,468
 $991,155
 
(1)Fixed interest mortgage notes, bearing interest from 3.00% to 5.50%, with a weighted average interest rate of 4.45%, and due in 2018, 2019, 2020, 2021, 2022, and 2024 collateralized by nine properties with a net book value of $267.7 million.
(2)Fixed interest mortgage notes, bearing interest from 4.71% to 6.58%, with a weighted average interest rate of 5.44%, and due in 2017, 2018, 2019, 2020, 2021, 2022, and 2032 collateralized by 11 properties with a net book value of $156.7 million.
(3)Variable interest mortgage notes, bearing variable interest of LIBOR plus 2.25% to 3.25%, with a weighted average interest rate of 4.50% and due in 2018, collateralized by three properties with a net book value of $39.2 million.
(4)Variable interest mortgage notes bearing variable interest of LIBOR plus 2.25% to 3.25%, with a weighted average interest rate of 3.68% and due in 2017 and 2018, collateralized by four properties with a net book value of $45.6 million.
(5)The Trust’s borrowings under the term loan feature of the Credit Agreement bear interest at a rate which is determined by the Trust’s credit rating, currently equal to LIBOR + 1.80%. The Trust has entered into a pay-fixed receive-variable interest rate swap, fixing the LIBOR component of this rate at 1.07%.

Effective September 18, 2014, the Credit Agreement, dated as of August 29, 2013 (as amended, restated, increased, extended, supplemented or otherwise modified from time to time, the “Prior Credit Agreement”), among the Operating Partnership, as borrower, the Trust, certain subsidiaries and other affiliates of the Operating Partnership, as guarantors, Regions Bank, as administrative agent, Regions Capital Markets, as sole lead arranger and sole book runner, and the lenders party thereto, and all commitments provided thereunder, were terminated. All amounts due and outstanding under the Prior Credit Agreement were repaid on or prior to such date.
On September 18, 2014,June 10, 2016, the Operating Partnership, as borrower, and the Trust and certain subsidiaries and other affiliates of the Trust, as guarantors, entered into aan amended and restated Credit Agreement with KeyBank National Association, as administrative agent, KeyBanc Capital Markets Inc., RegionsBMO Capital Markets, and BMO Capital Markets,Citizens Bank N.A., as joint lead arrangers and joint bookrunners, Regionsco-book runners, BMO Capital Markets and BMO Capital Markets,Citizens Bank N.A., as co-syndication agents, and the lenders party thereto in connection with(the “Credit Agreement”) which increased the maximum principal amount available under an unsecured revolving credit facility in the maximum principal amount of $400from $750 million (“Credit Agreement”).to $850 million. The Credit Agreement contains a 7-year term loan feature allowing the Operating Partnership to borrow in a single drawing up to $250 million, increasing the borrowing capacity to an aggregate $1.1 billion. The Credit Agreement also includes a swingline loan commitment for up to 10% of the maximum principal amount and provides an accordion feature allowing the OPTrust to increase borrowing capacity by up to an additional $350$500 million, subject to customary terms and conditions, resulting in a maximum borrowing capacity of $750 million. The Credit Agreement replaced$1.6 billion.



On July 7, 2016, the OP’s senior secured revolving credit facility in the maximum principal amount of $200Operating Partnership borrowed $250.0 million under the Prior7-year term loan feature of the Credit Agreement. Borrowings under the term loan feature of the Credit Agreement bear interest on the outstanding principal amount at a rate which is determined by the Trust’s credit rating, currently equal to LIBOR + 1.80%. The Trust simultaneously entered into a pay-fixed receive-variable rate swap for the full borrowing amount, fixing the LIBOR component of the borrowing rate to 1.07%, for an all-in fixed rate of 2.87%. Both the borrowing and pay-fixed receive-variable swap have a maturity date of June 10, 2023.

The Credit Agreement has a maturity date of September 18, 20182020 and includes a one year extension option. Borrowings under the Credit Agreement bear interest on the outstanding principal amount at aan adjusted LIBOR rate, equal to LIBOR plus 1.50% to 2.20% dependingwhich is based on the OP’s consolidated leverage ratio. In addition, the Credit Agreement includes an unused fee equal to 0.15% or 0.25% per annum, which is determined by usageTrust’s investment grade rating under the Credit Agreement. As of December 31, 2014,2017, the weighted averageTrust had an investment grade rating from Moody’s of Baa3 and from S&P of BBB-. As such, borrowings under the revolving credit facility of the Credit Agreement accrued interest on the outstanding principal at a rate on borrowings outstanding was 1.68%of LIBOR plus 1.20%. The Credit Agreement includes a facility fee equal to 0.25% per annum, which is also determined by the Trust’s investment grade rating.


The Credit Agreement contains financial covenants that, among other things, require compliance with leverage and coverage ratios and maintenance of minimum tangible net worth, as well as covenants that may limit the Trust’s and the Operating Partnership’s ability to incur additional debt or make distributions. The OPCompany may, at any time, voluntarily prepay any revolving or swingline loan under the Credit Agreement in whole or in part without premium or penalty. Prepayments of term borrowings require payment of premiums of up to 2.0% of the amount of prepayment, dependent on the date of such prepayment. As of December 31, 2014,2017, the OPCompany was in compliance with all financial covenants.covenants related to the Credit Agreement.


The Credit Agreement includes customary representations and warranties by the Operating Partnership, the Trust and each other guarantorthe Operating Partnership, and imposes customary covenants on the Operating Partnership and the Trust and each other guarantor.Trust. The Credit Agreement also contains customary events of default, and if an event of default occurs and continues, the Operating Partnership is subject to certain actions by the administrative agent, including without limitation, the acceleration of repayment of all amounts outstanding under the Credit Agreement.
 
The Credit Agreement provides for revolving credit and term loans to the Trust and the Operating Partnership. Base Rate Loans, Adjusted LIBOR Rate Loans, and Letters of Credit (each, as defined in the Credit Agreement) will be subject to interest rates, based upon the consolidated leverage ratio of the Operating Partnership and its subsidiariesTrust’s investment grade rating as follows:
Consolidated Leverage
Ratio
Adjusted LIBOR Rate Loans
and Letter of Credit Fee
Base Rate Loans
<35%
LIBOR + 1.50%0.50%
>35% and <45%
LIBOR + 1.65%0.65%
>45% and <45%LIBOR + 1.75%0.75%
>45% and <50%
LIBOR + 1.85%0.85%
>50% and <55%
LIBOR + 2.00%1.00%
>55%LIBOR + 2.20%1.20%
Credit Rating 
Margin for Revolving Loans: Adjusted LIBOR Rate Loans
and Letter of Credit Fee
 Margin for Revolving Loans: Base Rate Loans 
Margin for Term Loans: Adjusted LIBOR Rate Loans
and Letter of Credit Fee
 Margin for Term Loans: Base Rate Loans
At Least A- or A3 LIBOR + 0.85% % LIBOR + 1.40% 0.40%
At Least BBB+ or Baa1 LIBOR + 0.90% % LIBOR + 1.45% 0.45%
At Least BBB or Baa2 LIBOR + 1.00% 0.10% LIBOR + 1.55% 0.55%
At Least BBB- or Baa3 LIBOR + 1.20% 0.20% LIBOR + 1.80% 0.80%
Below BBB- or Baa3 LIBOR + 1.55% 
0.60
% LIBOR + 2.25% 1.25%
 
As of December 31, 2014, there were $1382017, the Company had $80.0 million of borrowings outstanding under its unsecured revolving credit facility, and $250.0 million of borrowings outstanding under the unsecured revolvingterm loan feature of the Credit Agreement. The Company also issued a letter of credit facility and $189for $17.0 million with no outstanding balance as of December 31, 2017. As defined by the Credit Agreement, $753.0 million is available for us to borrow without adding additional properties to the unencumbered borrowing base of assets, as defined byassets.

Notes Payable

On January 7, 2016, the Credit Agreement.Operating Partnership issued and sold $150.0 million aggregate principal amount of senior notes, comprised of (i) $15.0 million aggregate principal amount of 4.03% Senior Notes, Series A, due January 7, 2023, (ii) $45.0 million aggregate principal amount of 4.43% Senior Notes, Series B, due January 7, 2026, (iii) $45.0 million aggregate principal amount of 4.57% Senior Notes, Series C, due January 7, 2028, and (iv) $45.0 million aggregate principal amount of 4.74% Senior Notes, Series D, due January 7, 2031. On August 11, 2016, the note agreement for these notes was amended to make certain changes to its terms, including certain changes to affirmative covenants, negative covenants, and definitions contained therein. Interest on each respective series of the January 2016 Senior Notes is payable semi-annually.

On August 11, 2016, the Operating Partnership issued and sold $75.0 million aggregate principal amount of senior notes, comprised of (i) $25.0 million aggregate principal amount of 4.09% Senior Notes, Series A, due August 11, 2025, (ii)


$25.0 million aggregate principal amount of 4.18% Senior Notes, Series B, due August 11, 2026, and (iii) $25.0 million aggregate principal amount of 4.24% Senior Notes, Series C, due August 11, 2027. Interest on each respective series of the August 2016 Senior Notes is payable semi-annually.

On January 26, 2017, the Company entered into a $300.0 million notional amount forward starting swap to reduce the exposure to fluctuations in interest rates related to the forecasted issuance of the 4.30% senior notes due in 2027. Upon the issuance of the senior notes on March 7, 2017, the forward starting swap was terminated and the Company recorded a $0.8 million loss which will be recognized over the life of the notes utilizing the effective interest method.

On March 7, 2017, the Operating Partnership issued and sold $400.0 million aggregate principal amount of 4.30% Senior Notes which will mature on March 15, 2027. The Senior Notes began accruing interest on March 7, 2017 and began paying interest semi-annually beginning September 15, 2017. The Senior Notes were sold at an issue price of 99.68% of their face value, before the underwriters’ discount. Our net proceeds from the offering, after deducting underwriting discounts and expenses, were approximately $396.1 million.

On December 1, 2017, the Operating Partnership issued and sold $350.0 million aggregate principal amount of 3.95% Senior Notes which will mature on January 15, 2028. The Senior Notes began accruing interest on December 1, 2017 and will begin paying interest semi-annually beginning July 15, 2018. The Senior Notes were sold at an issue price of 99.78% of their face value, before the underwriters’ discount. Our net proceeds from the offering, after deducting underwriting discounts and expenses, were approximately $347.0 million.
 
Certain properties have mortgage debt that contains financial covenants. As of December 31, 2014,2017, the OPTrust was in compliance with all mortgage debt financial covenants.
 
Scheduled principal payments due on debt as of December 31, 2014,2017, are as follows (in thousands):
2018$54,775
201944,631
2020110,122
20218,718
202224,708
Thereafter1,248,726
Total Payments$1,491,680


2015$1,864
20169,421
201728,750
2018139,100
201919,906
Thereafter17,064
Total Payments$216,105
As of December 31, 2017 and 2016, the Company had total consolidated indebtedness of approximately $1.5 billion and $1.0 billion, respectively. The weighted average interest rate on consolidated indebtedness was 3.93% as of December 31, 2017 (based on the 30-day LIBOR rate as of December 31, 2017 of 1.49%). The weighted average interest rate on consolidated indebtedness was 3.09% as of December 31, 2016 (based on the 30-day LIBOR rate as of December 31, 2016 of 0.72%).
 
For the years ended December 31, 20142017 and 2013,2016, the OP incurredCompany paid interest expense on its debt of $5.8$45.1 million and $3.9$21.5 million, respectively.
 
Note 7—7. Derivatives

In the normal course of business, a variety of financial instruments are used to manage or hedge interest rate risk. The Company has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or a liability measured at their fair value unless they qualify for a normal purchase or normal sales exception.

When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Company’s derivative instruments are recorded in the consolidated statements of income if such derivatives do not qualify for, or the Company does not elect to apply for, hedge accounting. If hedge accounting is applied to a derivative instrument, such changes are reported in accumulated other comprehensive income within the equity section of the consolidated balance sheets, exclusive of ineffectiveness amounts, which are recorded as adjustments to net income.



To manage interest rate risk for certain of its variable-rate debt, the Company uses interest rate swaps as part of its risk management strategy. These derivatives are designed to mitigate the risk of future interest rate increases by providing a fixed interest rate for a limited, pre-determined period of time. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. As of December 31, 2017, the Company had five outstanding interest rate swap contracts that are designated as cash flow hedges of interest rate risk. For presentational purposes, they are shown as one derivative due to the identical nature of their economic terms.

The effective portion of the change in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income on the consolidated balance sheets and is subsequently reclassified into earnings as interest expense for the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. For the twelve months ended December 31, 2017, the Company recorded a $0.2 million loss as a result of hedge ineffectiveness. The Company expects hedge ineffectiveness to be insignificant in the next 12 months.

The following table summarizes the location and aggregate fair value of the interest rate swaps on the Company’s consolidated balance sheets (in thousands):
Total notional amount $250,000
Effective fixed interest rate(1)2.87%
Effective date 7/7/2016
Maturity date 6/10/2023
Asset balance at December 31, 2017 (included in Other assets) $14,693
(1)1.07% effective swap rate plus 1.80% spread per Credit Agreement.

Note 8. Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following as of December 31, 2017 and 2016 (in thousands):
 December 31,
 2017 2016
Real estate taxes payable$16,103
 $9,300
Accrued interest11,107
 4,905
Prepaid rent10,496
 5,834
Accrued expenses8,751
 3,453
Tenant improvement allowance3,065
 5,315
Security deposits2,882
 4,506
Accrued incentive compensation1,625
 1,405
Contingent consideration1,454
 1,392
Embedded derivative
 5,571
Other922
 606
Total$56,405
 $42,287


Note 9. Stock-based Compensation
 
The TrustCompany follows ASC 718, Compensation Stock Compensation (“ASC 718”), in accounting for its share-based payments. This guidance requires measurement of the cost of employee services received in exchange for stock compensation based on the grant-date fair value of the employee stock awards. This cost is recognized as compensation expense ratably over the employee’s requisite service period. Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized when incurred. Share-based payments classified as liability awards are marked to fair value at each reporting period. Any common sharesCommon Shares issued by the Trust pursuant to anythe Company’s incentive equity compensation orand employee sharestock purchase plan of the Trust resultsplans will result in the OPOperating Partnership issuing OP Units to the Trust on a one-for-one basis, with the OPOperating Partnership receiving the net cash proceeds of such issuances.


Certain of the Trust'sCompany’s employee stock awards vest only upon the achievement of performance targets. ASC 718 requires recognition of compensation cost only when achievement of performance conditions is considered probable. Consequently, the Trust'sCompany’s determination of the amount of stock compensation expense requires a significant level of judgment in estimating the probability of achievement of these performance targets. Additionally, the TrustCompany must make estimates regarding employee forfeitures in determining compensation expense. Subsequent changes in actual experience are monitored and estimates are updated as information is available.
 
In connection with the IPO, the Trust adopted the 2013 Equity Incentive Plan (“2013 Plan”), which made available 600,000 common shares to be administered by the Compensation and Nominating Governance Committee of the Board of Trustees. On August 7, 2014, at the Annual Meeting of Shareholders of Physicians Realty Trust, the Trust’s shareholders approved an amendment to the 2013 Plan to increase the number of common shares authorized for issuance under the 2013 Plan by 1,850,000 common shares, for a total of 2,450,000 common shares authorized for issuance.

The committee has broad discretion in administering the terms of the 2013 Plan. Restricted Common Shares:

Restricted common shares granted under the 2013 Plan are eligible for dividends as well as the right to vote. The Trust granted to management and the Board of Trustees 250,000 restricted common shares upon completion of the IPO under the Trust’s 2013 Plan at a value per share of $11.50 and total value of $2.9 million with a vesting period of three years. During 2014,2015, a total of 152,987162,522 restricted common shares with a total value of $2.1$2.6 million were granted to Trust employees and the Board of Trustees.Trustees with vesting periods ranging from one to three years. During 2016, a total of 155,306 restricted common shares with a total value of $2.8 million were granted to Company employees with vesting periods ranging from one to three years. During 2017, the Trust granted a total of 143,593 restricted common shares with a total value of $2.8 million to the Company’s officers and certain of its employees, which have a one-year vesting period for senior management award-recipients and a three-year vesting period for employee award-recipients.

AThe following is summary of the status of the Trust’s nonvestednon-vested restricted common shares as of December 31, 2014during 2017, 2016, and changes during the year then ended follow:
2015:
Shares 
Weighted
Average Grant
Date Fair Value
Common Shares 
Weighted
Average Grant
Date Fair Value
Non-vested at December 31, 2013250,000
 $11.50
Non-vested at December 31, 2014319,654
 $12.60
Granted152,987
 13.79
162,522
 15.95
Vested(61,179) 11.50
(170,337) 12.93
Share repurchase(22,154) 14.49
Non-vested at December 31, 2014319,654
 $12.60
Non-vested at December 31, 2015311,839
 14.17
Granted155,306
 17.96
Vested(170,034) 14.16
Forfeited(326) 15.36
Non-vested at December 31, 2016296,785
 16.16
Granted143,593
 19.74
Vested(266,552) 16.00
Forfeited(550) 18.78
Non-vested at December 31, 2017173,276
 $19.36

For all service awards, the OPCompany records compensation expense for the entire award on a straight-line basis (or, if applicable, on the accelerated method) over the requisite service period. For the years ended December 31, 2014,2017, 2016, and 2013,2015 the OPCompany recognized non-cash share compensation of $2.2$3.1 million, $0.4$3.6 million, and $2.9 million, respectively. Unrecognized compensation expense at December 31, 20142017, 2016, and 20132015 was $2.4$1.0 million, $1.2 million, and $2.5$2.1 million, respectively. The OP's compensation expense recorded in connection with grants of restricted stock reflects an initial estimated cumulative forfeiture rate of 0% over the requisite service period of the awards. That estimate will be revised if subsequent information indicates that the actual number of awards expected to vest is likely to differ from previous estimates.
 
Restricted Share Units:

In March 2014,2017, March 2016, and March 2015 under the Trust'sTrust’s 2013 Plan, the Trust granted 55,680(i) restricted share units at a target level of 174,320, 104,553, and 75,250 respectively, to the Trust’s senior management, which are subject to certain performance and market conditions and a three-year service period and (ii) 32,831, 36,784, and 40,957 restricted share units, respectively, to the members of the Board of Trustees, which are subject to a two-year vesting period. In addition, eachEach restricted share unit contains one dividend equivalent. The recipient will accrue dividend equivalents on awarded share units equal to the cash dividend that would have been paid on the awarded share unit had the awarded share unit been an issued and outstanding common share on the record date for the dividend.


Approximately 70% of the restricted share units issued to officers in 2017, and 80% issued to officers in 2016 and 2015, vest based on certain market conditions. The market conditions were valued with the assistance of independent valuation specialists. The OPCompany utilized a Monte Carlo simulation to calculate the weighted average grant date fair valuevalues in 2017, 2016, and 2015 of $19.25$33.43, $28.50, and $20.06 per unit, respectively, using the following assumptions:
 2017 2016 2015
Volatility21.5% 20.3% 20.7%
Dividend assumptionreinvested
 reinvested
 reinvested
Expected term in years2.8 years
 2.8 years
 2.8 years
Risk-free rate1.68% 1.07% 1.14%
Stock price (per share)$19.80
 $17.67
 $15.87


Volatility18.8% - 34.2%
Dividend assumptionreinvested
Expected term in years2.83
Risk-free rate0.65%
Stock price (per share)13.47

 
The remaining 30% of the restricted share units issued to officers in 2017, and 20% issued to officers in 2016 and 2015, vest based upon certain performance conditions. With respect to the performance conditions of the March 2017 grant, the grant date fair value of $13.47$19.80 per unit was calculatedbased on the grant date.share price at the date of grant. The restricted stock units’ combined weighted average grant date fair value of the March 2017 restricted share units issued to officers is $16.94$29.34 per unit. With respect to the performance conditions of the March 2016 grant, the grant date fair value of $17.67 per unit was based on the share price at the date of grant. The combined weighted average grant date fair value of the March 2016 restricted share units issued to officers is $26.33 per unit. With respect to the performance conditions of the March 2015 grant, the grant date fair value of $15.87 per unit was based on the share price at the date of grant. The combined weighted average grant date fair value of the March 2015 restricted share units issued to officers is $19.22 per unit.


The following is a summary of the activity in the Trust'sTrust’s restricted share units during 2014:
2017, 2016, and 2015: 
 Executive Awards Trustee Awards
 
Restricted Share
Units
 
Weighted
Average Grant
Date Fair Value
 Restricted Share
Units
 Weighted
Average Grant
Date Fair Value
Non-vested at December 31, 201455,680
 $16.94
 
 $
Granted75,250
 19.22
 40,957
 15.87
Non-vested at December 31, 2015130,930
 18.48
 40,957
 15.87
Granted104,553
 26.33
 36,784
 17.67
Vested
 
 (20,481) 15.87
Non-vested at December 31, 2016235,483
 21.84
 57,260
 17.03
Granted174,320
 29.34
 32,831
 19.80
Vested(55,680) 16.94
 (38,871) 16.72
Non-vested at December 31, 2017354,123

$26.30
 51,220
 $19.04
 
Restricted Share
Units
 
Weighted
Average Grant
Date Fair Value
Non-vested at December 31, 2013
 $
Granted55,680
 16.94
Vested
 
Forfeited
 
Non-vested at December 31, 201455,680
 $16.94

 
The OPCompany recognized $0.3$3.6 million, $2.1 million, and $0.9 million of non-cash share unit compensation expense for the yearyears ended December 31, 2014.2017, 2016, and 2015, respectively. Unrecognized compensation expense at December 31, 20142017, 2016, and 2015 was $0.7 million.$5.0 million, $2.8 million, and $1.6 million, respectively.
 
Note 8—10. Fair Value Measurements
 
ASC Topic 820, Fair Value Measurement (“ASC 820”), requires certain assets and liabilities be reported and/or disclosed at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value.
 
In general, fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the OPCompany has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. These Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.
 
Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset. These Level 3 fair value measurements are based primarily on management’s own estimates using pricing models, discounted cash flow methodologies, or similar techniques taking into account the


characteristics of the asset or liability. In instances where inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each asset or liability.
 
The Company’s derivative instrument consists solelyinstruments as of oneDecember 31, 2017, consist of five interest rate swap that isswaps. For presentational purposes, the Company’s interest rate swaps are shown as a single derivative due to the identical nature of their economic terms, as detailed in the Derivative Instruments section of Note 2 (Summary of Significant Accounting Policies) and Note 7 (Derivatives).

The Company’s interest rate swaps are not traded on an exchangeexchange. The Company’s derivative assets and isliabilities are recorded at fair value based on a variety of observable inputs including contractual terms, interest rate curves, yield curves, measure of volatility, and correlations of such inputs.
The OPCompany measures its interest rate swapderivatives at fair value on a recurring basis. The fair values are based on Level 2 inputs described above. The Company considers its own credit risk, as well as the credit risk of its counterparties, when evaluating the fair value of its derivatives.
 
The OPCompany also has assets that under certain conditions are subject to measurement at fair value on a non-recurring basis. The following table sets forth by level theThis generally includes assets subject to impairment. There was one asset measured at fair value hierarchy of the OP’s assets that were accounted for on a non-recurring basis as of December 31, 2014.2017.
 

   
Non-recurring Fair Value Measurements At Report
Date using:
  
 
Carrying Value as
of December 31,
2013
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total Losses for Year
Ended December 31,
2014
Investment properties$4,551
 $1,529
 $
 $1,272
 $(1,750)
The following table summarizes the quantitative inputs and assumptions used for items categorized in Level 3 for the fair value hierarchy as of December 31, 2014 (in thousands).
Asset Category 
Fair Value at
December 31, 2014
 Valuation Technique Unobservable Inputs Rate
Investment properties $1,272
 Market comparable/ Discount rate 11.00%
   
 Discounted cash flow Capitalization rate 8.00%
The carrying amounts of cash and cash equivalents, tenant receivables, payables, and accrued interest are reasonable estimates of fair value because of the short term maturities of these instruments. Fair values for real estate loans receivable and mortgage debt are estimated based on rates currently prevailing for similar instruments of similar maturities and are based primarily on Level 2 inputs.
 
The following table presents the fair value of the OP’sCompany’s financial instruments (in thousands).
:
 December 31,
 2017 2016
 
Carrying
Amount
 
Fair
Value
 
Carrying
Amount
 
Fair
Value
Assets:       
Real estate loans receivable$76,195
 $75,288
 $39,154
 $39,154
Notes receivable$
 $
 $16,618
 $16,618
Derivative assets$14,693
 $14,693
 $13,881
 $13,881
Liabilities:       
Credit facility$(330,000) $(330,000) $(651,000) $(651,000)
Notes payable$(975,000) $(970,975) $(225,000) $(214,584)
Mortgage debt$(186,939) $(185,743) $(123,632) $(125,420)
Derivative liabilities$
 $
 $(5,571) $(5,571)
 
December 31,
2014
 
December 31,
2013
 
Carrying
Amount
 
Fair
Value
 
Carrying
Amount
 
Fair
Value
Real estate loans receivable$15,876
 $15,876
 $
 $
Credit facility$(138,000) $(138,000) 
 
Mortgage debt$(78,105) $(78,642) $(42,821) $(44,130)
Derivative liabilities$(233) $(233) $(397) $(397)

 
Note 9—11. Tenant Operating Leases

The Operating PartnershipCompany is lessor of medical office buildings and other healthcare facilities. Leases have expirations from 20152018 through 2028.2045. As of December 31, 2014,2017, the future minimum rental payments on non-cancelable leases, exclusive of expense recoveries, were as follows (in thousands):
2018$292,030
2019291,338
2020285,100
2021278,095
2022265,995
Thereafter1,419,746
Total$2,832,304
2015$65,905
201665,323
201765,179
201862,637
201959,464
Thereafter418,400
Total$736,908

 


103



Note 10—12. Rent Expense
 
The Operating PartnershipCompany leases the rights to a parking structurestructures at one2 of its properties, the air space above 1 property, and the land upon which seven78 of its properties are located from third party land owners pursuant to separate ground and parking leases. In addition, the Company leases 4 individual office spaces. The parking and ground leases require fixed annual rental payments and may also include escalation clauses and renewal options. These leases have terms of up to 6798 years remaining, excluding extension options. As of December 31, 2014,2017, the future minimum lease obligations under non-cancelable parking, air, ground, and groundoffice leases were as follows (in thousands):
2018$2,678
20192,604
20202,549
20212,563
20222,585
Thereafter119,224
Total$132,203

2015$1,426
20161,442
20171,480
20181,521
20191,564
Thereafter23,317
Total$30,750

 
Rent expense for the parking, air, and ground leases of $0.9$2.4 million, $0.02$1.9 million, and $0.02$1.3 million for the years ended December 31, 2014, 20132017, 2016, and 2012,2015, respectively, are reported in operating expenses in the consolidated and combined statements of operations.income. Rent expense for office leases for the year as of December 31, 2017 was $0.1 million and was insignificant for the years ended December 31, 2016, and 2015, and is reported within general and administrative expenses in the consolidated statements of income.


Note 11—13. Credit Concentration

The Company uses annualized base rent (“ABR”) as its credit concentration metric. Annualized base rent is calculated by multiplying contractual base rent for the month ended December 31, 2017 by 12, excluding the impact of concessions and straight-line rent. The following table summarizes certain information about the Company’s top five tenant credit concentrations as of December 31, 2017 (in thousands):
Tenant Total ABR Percent of ABR
CHI - Nebraska $15,906
 5.6%
CHI - KentuckyOne Health 13,120
 4.6%
Baylor Scott and White Health 7,402
 2.6%
US Oncology 6,706
 2.4%
CHI - St. Alexius (ND) 6,239
 2.2%
Remaining portfolio 236,297
 82.6%
Total $285,670
 100.0%


Annualized base rent collected from the Company’s top five tenant relationships comprises 17.4% of its total annualized base rent for the period ending December 31, 2017. Total annualized base rent from CHI affiliated tenants totals 18.7%, including the affiliates disclosed above. Although CHI is not a party to nor a guarantor of the related lease agreements, it controls each of the subsidiaries and the affiliates that are parties to the master lease agreements, which were entered into in connection with the closing of the transactions. Consolidated financial statements of CHI, the parent of the subsidiaries and affiliates of the entities party to master lease agreements, are publicly available on the Catholic Health Initiatives website (http://www.catholichealthinitiatives.org/). Information included on the CHI website is not incorporated by reference within this Annual Report on Form 10-K.



The following table summarizes certain information about the Company’s top five geographic concentrations as of December 31, 2017 (in thousands):
State Total ABR Percent of ABR
Texas $46,850
 16.4%
Georgia 27,457
 9.6%
Indiana 18,283
 6.4%
Nebraska 17,304
 6.1%
Kentucky 16,028
 5.6%
Other 159,748
 55.9%
Total $285,670
 100.0%


Note 14. Earnings Per Share and Earnings Per Unit
 
The following table shows the amounts used in computing the Operating Partnership'sTrust’s basic and diluted earnings per OP Unitshare (in thousands, except share and per share data):
 Year Ended December 31,
 2017 2016 2015
Numerator for earnings per share - basic:     
Net income$39,773
 $31,522
 $12,741
Net income attributable to noncontrolling interests:     
Operating Partnership(1,136) (825) (576)
Partially owned properties(491) (716) (377)
Preferred distributions(731) (1,857) (1,189)
Numerator for earnings per share - basic:$37,415
 $28,124
 $10,599
Numerator for earnings per share - diluted:     
Numerator for earnings per share - basic:37,415
 28,124
 10,599
Operating Partnership net income1,136
 825
 576
Numerator for earnings per share - diluted$38,551
 $28,949
 $11,175
Denominator for earnings per share - basic and diluted:     
Weighted average number of shares outstanding - basic163,123,109
 126,143,114
 72,750,724
Effect of dilutive securities:   
  
Noncontrolling interest - Operating Partnership units4,839,967
 3,692,095
 3,708,494
Restricted shares89,497
 205,036
 190,619
Restricted share units178,726
 426,648
 142,236
Denominator for earnings per share - diluted168,231,299
 130,466,893
 76,792,073
Earnings per share - basic$0.23
 $0.22
 $0.15
Earnings per share - diluted$0.23
 $0.22
 $0.15




The following table shows the amounts used in computing the Operating Partnership’s basic and diluted earnings per unit (in thousands, except unit and per unit data):
 Year Ended December 31,
 2017 2016 2015
Numerator for earnings per unit - basic and diluted:     
Net income39,773
 31,522
 12,741
Net income attributable to noncontrolling interests -
partially owned properties
(491) (716) (377)
Preferred distributions(731) (1,857) (1,189)
Numerator for earnings per unit - basic and diluted$38,551
 $28,949
 $11,175
Denominator for earnings per unit - basic and diluted:     
Weighted average number of units outstanding - basic167,963,076
 129,835,209
 76,459,218
Effect of dilutive securities:   
  
Restricted shares89,497
 205,036
 190,619
Restricted share units178,726
 426,648
 142,236
Denominator for earnings per unit - diluted168,231,299
 130,466,893
 76,792,073
Earnings per unit - basic$0.23
 $0.22
 $0.15
Earnings per unit - diluted$0.23
 $0.22
 $0.15


Note 15. Subsequent Events
Since December 31, 2017, the Trust, through subsidiaries of its Operating Partnership, has completed acquisitions of 2 healthcare properties for an aggregate purchase price of $98.7 million containing an aggregate of 220,140 net leasable square feet and disposed of one property for $1.4 million which resulted in no gain or loss. In addition, the Operating Partnership funded a $2.0 million loan through a separate transaction, resulting in aggregate investment activity of $100.7 million. Property acquisitions are summarized below:
 
Year Ended
December 31,
 2014 2013
Numerator for earnings per unit — basic and diluted: 
  
Net loss$(4,418) $(2,636)
Less: Net loss attributable to Predecessor
 576
Less: Net income attributable to noncontrolling interests — partially owned properties(314) (71)
Numerator for earnings per unit — basic and diluted$(4,732) $(2,131)
Denominator for earnings per unit - basic and diluted units:36,881,712
 16,179,492
Basic and diluted earnings per unit$(0.12) $(0.13)
Property
 Location
Acquisition
Date

Investment
(in thousands)
Hazelwood Medical Commons(1) Maplewood, MN
January 9, 2018
$70,702
Lee's Hill Medical Plaza
 Fredericksburg, VA
January 23, 2018
28,000
Loan Investment
 Pensacola, FL
February 16, 2018
2,000
 
  
 
$100,702
(1)The Company partially funded the purchase price of this acquisition by issuing a total of 104,172 Preferred OP Units valued at approximately $22.7 million in the aggregate on the date of issuance.





106


Note 16. Quarterly Data
 
There were 375,334 and 250,000 restricted common shares and units outstanding related to the 2013 Plan during the years ended December 31, 2014 and 2013, respectively. However, these restricted common shares and units are not dilutive due to the net loss.Physicians Realty Trust
Note 12—Related Party Transactions
The Trust and the OP entered into a shared services agreement with Ziegler pursuant to which Ziegler provides office space, IT support, accounting support and other services to the Operating Partnership in exchange for an annual fee. The shared service fee amounted to $0.4 million and $0.3 million for years ended December 31, 2014 and 2013, respectively, and is recorded in general and administrative expense in the consolidated and combined statements of operations.
Ziegler charged the Predecessor an annual management fee equal to 2 percent of the total capital commitments. Total management fees charged to the Predecessor was $0.5 million and $1.0 million for the years ended December 31, 2013 and 2012, respectively. Total other fees charged to the Predecessor were $0.03 million for the year ended December 31, 2012. The other fees include fees for accounting expenses and other expenses owed to Ziegler. The Trust did not incur a management fee for the year ended December 31, 2014.
The Trust and the Operating Partnership entered into the First Amendment to Shared Services Agreement, dated July 31, 2014 (the “First Amendment”), with Ziegler, which amended certain terms of the shared services agreement. Among other things, the First Amendment reduced the shared services to be provided by Ziegler, the term of the shared services agreement, and the monthly fee to be paid by the OP for the remainder of the term. In consideration of these changes, the OP was obligated to make a one-time payment to Ziegler in the amount of $1.8 million (the “Amendment Payment”), which could be paid in cash or in unrestricted common shares of the OP as determined by the Trust in its sole discretion. On August 19, 2014, the Trust made the Amendment Payment by issuing 124,913 common shares to Ziegler and the OP issued 124,913 units to the Trust. The $1.8 million one-time payment is included in general and administrative expense in the consolidated statement of operations for the year ended December 31, 2014.

Note 13—Subsequent Events
The OP, through subsidiaries, closed on the below acquisitions:
Property(1) Location 
Acquisition
Date
 
Purchase
Price
 (in thousands)
Edina MOB Edina, MN January 22, 2015 $14,190
Savage MOB Savage, MN January 22, 2015 12,800
Crystal MOB Crystal, MN January 22, 2015 14,782
Dell Rd MOB Chanhassen, MN January 22, 2015 6,410
Columbus MOB Columbus, GA January 23, 2015 6,540
Methodist Sports MOB (2) Greenwood, IN January 28, 2015 10,000
Vadnais Heights MOB Vadnais Heights, MN January 29, 2015 18,422
Minnetonka MOB (3)  Minnetonka, MN February 5, 2015 26,000
Jamestown MOB Jamestown, ND February 5, 2015 12,819
Indianapolis South 4 MOBs Greenwood, IN February 13, 2015 17,183
Minnesota Eye MOB Minnetonka, MN February 17, 2015 10,882
Bridgeport Medical Center Lakewood, WA February 27, 2015 13,750
Baylor Cancer Center Dallas, TX February 27, 2015 8,200
      $171,978
(1)“MOB” means medical office building.
(2)The Operating Partnership partially funded the purchase price of this acquisition by issuing a total of 420,963 OP Units valued at approximately $7.3 million in the aggregate on the date of issuance.
(3)The Operating Partnership partially funded the purchase price of this acquisition by issuing a total of 44,685 Series A Preferred Units valued at approximately $9.7 million in the aggregate on the date of issuance.
On February 5, 2015, the OP entered into a Second Amended and Restated Agreement of Limited Partnership (the “Partnership Agreement”) which provides for the designation and issuance of the newly designated Series A Participating Redeemable Preferred Units of the operating partnership (“Series A Preferred Units”). The Series A Preferred Units will have priority over all other partnership interests of the Operating Partnership with respect to distributions and liquidation. In addition, the Series A Preferred Units will be redeemable at the option of the holders on or after the one year anniversary of their issuance, which redemption obligation may be satisfied, at the OP’s option, in cash or shares of the Trust's common stock.
On January 21, 2015, the OP repaid the outstanding balance of $138.0 million on the unsecured revolving credit facility.
On January 21, 2015, the Trust completed a follow-on public offering of 18,975,000 common shares of beneficial interest, including 2,475,000 common shares issued upon exercise of the underwriters’ overallotment option, resulting in net proceeds to it of approximately $297.2 million. The Trust contributed the net proceeds of this offering to the Operating Partnership in exchange for 18,975,000 OP Units, and the Operating Partnership used the net proceeds of the public offering to repay borrowings under its unsecured revolving credit facility and for general corporate and working capital purposes and funding acquisitions.
During 2015, the Trust sold 247,397 common shares pursuant to the ATM Program, at a weighted average price of $16.96 per share resulting in total proceeds of approximately $4.2 million, before $55,696 in commissions. In connection with these shares, the Trust contributed the proceeds to the OP in exchange for 247,397 OP Units. As of the date of this prospectus supplement, the Trust has $90.2 million remaining available under the ATM Program.
See “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Recent Developments” for a further discussion of these acquisitions.


Note 14—Quarterly Data


The following unaudited quarterly data has been prepared on the basis of a December 31 year-end. Amounts are in thousands, except for common unitsshare and per unitshare amounts.
  Quarter Ended
2014 March 31 June 30 September 30 December 31
Total revenues $8,032
 $11,447
 $14,161
 $19,694
Operating (loss) income (3,575) (626) (2,311) 1,967
Net (loss) income (3,558) (600) (2,251) 1,991
Net (loss) income attributable to common unitholders (3,624) (684) (2,327) 1,903
Earnings per unit — basic:  
  
  
  
Net (loss) income available to common unitholder $(0.15) $(0.02) $(0.06) $0.04
Weighted average common units outstanding 24,997,474
 29,962,046
 40,898,015
 51,335,748
Earnings per unit — diluted:  
  
  
  
Net (loss) income available to common unitholder $(0.15) $(0.02) $(0.06) $0.04
Weighted average common units outstanding 24,997,474
 29,962,046
 40,898,015
 51,544,832

As a result of the acquisition activity and equity offerings throughout 2014,2017 and 2016, the quarterly periods are not comparable quarter over quarter.
  Quarter Ended
2013 March 31 (1) June 30 (1) September 30 December 31
Total revenues $3,390
 $3,437
 $3,729
 $6,488
Operating loss (301) (283) (1,414) (638)
Net loss (301) (283) (1,416) (638)
Net loss available to common unitholder 
 
 (1,483) (648)
Earnings per unit — basic and diluted:  
  
  
  
Net income available to common unitsholder $
 $
 $(0.10) $(0.04)
Weighted average common units outstanding 
 
 14,243,850
 17,631,224
  Quarter Ended
2017 March 31 June 30 September 30 December 31
Total revenues $76,666
 $76,599
 $92,999
 $97,320
Operating income 6,688
 4,994
 12,511
 9,523
Net income 6,716
 10,331
 12,539
 10,187
Net income attributable to common shareholders 6,191
 9,670
 12,018
 9,536
Earnings per share – basic:        
Net income available to common shareholders $0.04
 $0.06
 $0.07
 $0.05
Weighted average number of shares outstanding 138,986,629
 155,366,080
 177,847,424
 179,683,948
Earnings per share – diluted:        
Net income available to common shareholders $0.04
 $0.06
 $0.07
 $0.05
Weighted average number of shares outstanding 142,605,930
 161,012,360
 183,298,145
 185,273,236
  Quarter Ended
2016 March 31 June 30 September 30 December 31
Total revenues $44,134
 $53,216
 $70,010
 $73,674
Operating income 5,392
 7,158
 10,267
 8,590
Net income 5,424
 7,184
 10,294
 8,620
Net income available to common shareholders 4,386
 6,486
 9,427
 7,825
Earnings per share – basic:  
  
  
  
Net income available to common shareholders $0.04
 $0.05
 $0.07
 $0.06
Weighted average number of shares outstanding 102,704,008
 131,481,329
 134,608,396
 135,581,976
Earnings per share – diluted:  
  
  
  
Net income available to common shareholders $0.04
 $0.05
 $0.07
 $0.06
Weighted average number of shares outstanding 107,148,380
 135,944,722
 138,880,787
 139,602,349





















(1)Because the IPO and the formation transactions were completed on July 24, 2013, the OP had no operations prior to that date. References in these notes to the consolidated and combined financial statements of Physicians Realty L.P. signify

The following unaudited quarterly data has been prepared on the Companybasis of a December 31 year-end. Amounts are in thousands, except for the period from July 24, 2013, the date of completioncommon unit and per unit amounts.

As a result of the IPOacquisition activity and equity offerings throughout 2017 and 2016, the formation transactions,quarterly periods are not comparable quarter over quarter.
  Quarter Ended
2017 March 31 June 30 September 30 December 31
Total revenues $76,666
 $76,599
 $92,999
 $97,320
Operating income 6,688
 4,994
 12,511
 9,523
Net income 6,716
 10,331
 12,539
 10,187
Net income attributable to common unitholders 6,338
 9,984
 12,380
 9,849
Earnings per unit – basic:        
Net income available to common unitholders $0.04
 $0.06
 $0.07
 $0.05
Weighted average number of units outstanding 142,172,746
 160,765,345
 183,227,405
 185,048,580
Earnings per unit – diluted:        
Net income available to common unitholders $0.04
 $0.06
 $0.07
 $0.05
Weighted average number of units outstanding 142,605,930
 161,012,360
 183,298,145
 185,273,236
  Quarter Ended
2016 March 31 June 30 September 30 December 31
Total revenues $44,134
 $53,216
 $70,010
 $73,674
Operating income 5,392
 7,158
 10,267
 8,590
Net income 5,424
 7,184
 10,294
 8,620
Net income attributable to common unitholders 4,559
 6,687
 9,682
 8,021
Earnings per unit – basic:        
Net income available to common unitholders $0.04
 $0.05
 $0.07
 $0.06
Weighted average number of units outstanding 106,550,467
 135,351,672
 138,227,384
 139,018,183
Earnings per unit – diluted:  
  
  
  
Net income available to common unitholders $0.04
 $0.05
 $0.07
 $0.06
Weighted average number of units outstanding 107,148,380
 135,944,722
 138,880,787
 139,602,349


108


Physicians Realty Trust and Physicians Realty L.P.
Schedule III – Real Estate and Accumulated Depreciation
December 31, 2017
(dollars in thousands)




109


Physicians Realty Trust and Physicians Realty L.P.
Schedule III – Real Estate and Accumulated Depreciation
December 31, 2017
(dollars in thousands)




110


Physicians Realty Trust and Physicians Realty L.P.
Schedule III – Real Estate and Accumulated Depreciation
December 31, 2017
(dollars in thousands)




111


Physicians Realty Trust and Physicians Realty L.P.
Schedule III – Real Estate and Accumulated Depreciation
December 31, 2017
(dollars in thousands)


      Initial Cost to Company Gross Amount at Which Carried as of Close of Period      
Description Location Encumbrances Land 
Buildings and
Improvements
 
Cost Capitalized
Subsequent to
Acquisitions
 Land 
Buildings and
Improvements
 Total 
Accumulated
Depreciation
 
Year
Built
 
Date 
Acquired
 
Life on Which Building
Depreciation in
Income Statement
is Computed
Arrowhead Commons Phoenix, AZ $
 $740
 $2,551
 $730
 $740
 $3,281
 $4,021
 $(563) 2004 5/31/2008 46
Aurora Medical Office Building Green Bay, WI 
 500
 1,566
 
 500
 1,566
 2,066
 (243) 2010 4/15/2010 50
El Paso Medical Office Building El Paso, TX 
 860
 2,866
 406
 860
 3,272
 4,132
 (1,809) 1987 8/24/2006 21
Farmington Professional Pavilion Detroit, MI 
 580
 1,793
 132
 580
 1,925
 2,505
 (1,478) 1972 1/5/2006 15
Firehouse Square Milwaukee, WI 
 1,120
 2,768
 
 1,120
 2,768
 3,888
 (961) 2002 8/15/2007 30
Hackley Medical Center Grand Rapids, MI 
 1,840
 6,402
 64
 1,840
 6,466
 8,306
 (2,381) 1968 12/22/2006 30
MeadowView Professional Center Kingsport, TN 
 2,270
 11,344
 
 2,270
 11,344
 13,614
 (4,054) 2005 5/10/2007 30
Mid Coast Hospital Medical Office Building Portland, ME 7,009
 
 11,247
 81
 
 11,328
 11,328
 (3,614) 2008 5/1/2008 42
New Albany Professional Building Columbus, OH 
 237
 2,767
 621
 237
 3,388
 3,625
 (799) 2000 1/4/2008 42
Remington Medical Commons Chicago, IL 
 895
 6,499
 319
 895
 6,818
 7,713
 (2,228) 2008 6/1/2008 30
Summit Healthplex Atlanta, GA 
 2,633
 15,576
 5,524
 2,633
 21,100
 23,733
 (5,518) 2002 7/3/2008 44
Valley West Hospital Medical Office Building Chicago, IL 4,531
 
 6,275
 620
 
 6,895
 6,895
 (2,357) 2007 11/1/2007 30
East El Paso Medical Office Building El Paso, TX 
 710
 4,500
 
 710
 4,500
 5,210
 (557) 2004 8/30/2013 35
East El Paso Surgical Hospital El Paso, TX 
 3,070
 23,627
 
 3,070
 23,627
 26,697
 (2,844) 2004 8/30/2013 36
LifeCare Plano LTACH Plano, TX 
 3,370
 11,689
 455
 3,370
 12,144
 15,514
 (2,119) 1987 9/18/2013 25
Crescent City Surgical Centre New Orleans, LA 18,750
 
 34,208
 
 
 34,208
 34,208
 (3,029) 2010 9/30/2013 48
Foundation Surgical Affiliates Medical Office Building Oklahoma City, OK 7,101
 1,300
 12,724
 
 1,300
 12,724
 14,024
 (1,258) 2004 9/30/2013 43
Pensacola Medical Office Building Pensacola, FL 
 990
 5,005
 16
 990
 5,021
 6,011
 (437) 2012 10/4/2013 49
Central Ohio Neurosurgical Surgeons Medical Office Columbus, OH 
 981
 7,620
 
 981
 7,620
 8,601
 (707) 2007 11/27/2013 44
Great Falls Ambulatory Surgery Center Great Falls, MT 
 203
 3,224
 67
 203
 3,291
 3,494
 (404) 1999 12/11/2013 33
Eagles Landing Family Practice Medical Office Building McDonough, GA 
 800
 3,345
 1,548
 800
 4,893
 5,693
 (532) 2007 2/19/2014 36
Eagles Landing Family Practice Medical Office Building Jackson, GA 
 800
 3,345
 1,255
 800
 4,600
 5,400
 (475) 2006 2/19/2014 38
Eagles Landing Family Practice Medical Office Building Conyers, GA 
 1,000
 3,345
 
 1,000
 3,345
 4,345
 (360) 2008 2/19/2014 37
Eagles Landing Family Practice Medical Office Building McDonough, GA 
 400
 3,345
 1,741
 400
 5,086
 5,486
 (531) 2010 2/19/2014 37
Foundation San Antonio Surgical Hospital San Antonio, TX 7,691
 2,230
 23,346
 43
 2,230
 23,389
 25,619
 (2,919) 2007 2/19/2014 35
21st Century Radiation Oncology Centers — Sarasota Sarasota, FL 
 633
 6,557
 
 633
 6,557
 7,190
 (969) 1975 2/26/2014 27
21st Century Radiation Oncology Centers - Venice Venice, FL 
 814
 2,952
 
 814
 2,952
 3,766
 (364) 1987 2/26/2014 35
21st Century Radiation Oncology Centers - Englewood Englewood, FL 
 350
 1,878
 
 350
 1,878
 2,228
 (209) 1992 2/26/2014 38
21st Century Radiation Oncology Centers — Port Charlotte Port Charlotte, FL 
 269
 2,326
 (852) 156
 1,474
 1,630
 (262) 1996 2/26/2014 36
Foundation San Antonio Healthplex San Antonio, TX 
 911
 4,189
 
 911
 4,189
 5,100
 (480) 2007 2/28/2014 35
Peachtree Dunwoody Medical Center Atlanta, GA 17,000
 
 27,435
 24,894
 
 52,329
 52,329
 (5,076) 1987 2/28/2014 25
LifeCare LTACH — Fort Worth Fort Worth, TX 
 2,730
 24,639
 
 2,730
 24,639
 27,369
 (3,162) 1985 3/28/2014 30
LifeCare LTACH — Pittsburgh Pittsburgh, PA 
 1,142
 11,737
 
 1,142
 11,737
 12,879
 (1,575) 1987 3/28/2014 30
PinnacleHealth Medical Office Building Harrisburg, PA 
 795
 4,601
 
 795
 4,601
 5,396
 (731) 1990 4/22/2014 25
Pinnacle Health Medical Office Building Carlisle, PA 
 424
 2,232
 
 424
 2,232
 2,656
 (255) 2002 4/22/2014 35
South Bend Orthopaedics Medical Office Building Mishawaka, IN 
 2,418
 11,355
 
 2,418
 11,355
 13,773
 (1,195) 2007 4/30/2014 40
Grenada Medical Complex Grenada, MS 
 185
 5,820
 116
 185
 5,936
 6,121
 (862) 1975 4/30/2014 30
Mississippi Ortho Medical Office Building Jackson, MS 
 1,272
 14,177
 626
 1,272
 14,803
 16,075
 (1,650) 1987 5/23/2014 35
Carmel Medical Pavilion Carmel, IN 
 
 3,917
 99
 
 4,016
 4,016
 (593) 1993 5/28/2014 25
Renaissance Ambulatory Surgery Center Oshkosh, WI 
 228
 7,658
 17
 228
 7,675
 7,903
 (696) 2007 6/30/2014 40
Presbyterian Medical Plaza Monroe, NC 
 1,195
 5,681
 27
 1,195
 5,708
 6,903
 (476) 2008 6/30/2014 45
Summit Urology Bloomington, IN 
 125
 4,792
 
 125
 4,792
 4,917
 (573) 1996 6/30/2014 30
500 Landmark Bloomington, IN 
 627
 3,549
 
 627
 3,549
 4,176
 (370) 2000 7/1/2014 35
550 Landmark Bloomington, IN 
 2,717
 15,224
 
 2,717
 15,224
 17,941
 (1,586) 2000 7/1/2014 35
574 Landmark Bloomington, IN 
 418
 1,493
 
 418
 1,493
 1,911
 (159) 2004 7/1/2014 35
Carlisle II MOB Carlisle, PA 
 412
 3,962
 
 412
 3,962
 4,374
 (317) 1996 7/25/2014 45
Surgical Institute of Monroe Monroe, MI 
 410
 5,743
 
 410
 5,743
 6,153
 (659) 2010 7/28/2014 35
The Oaks @ Lady Lake Lady Lake, FL 
 1,065
 8,642
 
 1,065
 8,642
 9,707
 (710) 2011 7/31/2014 42
Mansfield ASC Mansfield, TX 
 1,491
 6,471
 
 1,491
 6,471
 7,962
 (517) 2010 9/2/2014 46
Eye Center of Southern Indiana Bloomington, IN 
 910
 11,477
 
 910
 11,477
 12,387
 (1,134) 1995 9/5/2014 35
Wayne State Troy, MI 
 3,560
 43,052
 
 3,560
 43,052
 46,612
 (3,921) 1986 9/10/2014 38
Zangmeister Columbus, OH 
 1,610
 31,120
 4
 1,610
 31,124
 32,734
 (2,644) 2007 9/30/2014 40
Ortho One - Columbus Columbus, OH 
 
 16,234
 7
 
 16,241
 16,241
 (1,309) 2009 9/30/2014 45
Ortho One - Westerville Columbus, OH 
 362
 3,944
 
 362
 3,944
 4,306
 (328) 2007 9/30/2014 43
Berger Medical Center Columbus, OH 
 
 5,950
 
 
 5,950
 5,950
 (561) 2007 9/30/2014 38
El Paso - Lee Trevino El Paso, TX 
 2,294
 11,316
 412
 2,294
 11,728
 14,022
 (1,351) 1983 9/30/2014 30
El Paso - Murchison El Paso, TX 
 2,283
 24,543
 1,303
 2,283
 25,846
 28,129
 (2,895) 1970 9/30/2014 30
El Paso - Kenworthy El Paso, TX 
 728
 2,178
 25
 728
 2,203
 2,931
 (230) 1983 9/30/2014 35
Pinnacle - 32 Northeast Harrisburg, PA 
 408
 3,232
 91
 408
 3,323
 3,731
 (352) 1994 10/29/2014 33
Pinnacle - 4518 Union Deposit Harrisburg, PA 
 617
 7,305
 15
 617
 7,320
 7,937
 (803) 2000 10/29/2014 31
Pinnacle - 4520 Union Deposit Harrisburg, PA 
 169
 2,055
 
 169
 2,055
 2,224
 (244) 1997 10/29/2014 28


112


Physicians Realty Trust and Physicians Realty L.P.
Schedule III – Real Estate and Accumulated Depreciation
December 31, 2017
(dollars in thousands)


      Initial Cost to Company Gross Amount at Which Carried as of Close of Period      
Description Location Encumbrances Land 
Buildings and
Improvements
 
Cost Capitalized
Subsequent to
Acquisitions
 Land 
Buildings and
Improvements
 Total 
Accumulated
Depreciation
 
Year
Built
 
Date 
Acquired
 
Life on Which Building
Depreciation in
Income Statement
is Computed
Pinnacle - 240 Grandview Harrisburg, PA 
 321
 4,242
 
 321
 4,242
 4,563
 (411) 1980 10/29/2014 35
Pinnacle - Market Place Way Harrisburg, PA 
 808
 2,383
 6
 808
 2,389
 3,197
 (314) 2004 10/29/2014 35
CRHS - 2000 10th Avenue Columbus, GA 
 380
 2,737
 14
 380
 2,751
 3,131
 (415) 1989 11/20/2014 22
CRHS - 1942 North Avenue Columbus, GA 
 91
 273
 
 91
 273
 364
 (73) 1971 11/20/2014 12
CRHS - 920 18th Street Columbus, GA 
 110
 281
 
 110
 281
 391
 (113) 1982 11/20/2014 8
CRHS - 1900 10th Avenue Columbus, GA 
 474
 5,580
 131
 474
 5,711
 6,185
 (747) 1976 11/20/2014 26
CRHS - 1800 10th Avenue Columbus, GA 
 539
 5,238
 19
 539
 5,257
 5,796
 (615) 1980 11/20/2014 28
CRHS - 705 17th Street Columbus, GA 
 372
 2,346
 278
 372
 2,624
 2,996
 (582) 1994 11/20/2014 15
CRHS - 615 19th Street Columbus, GA 
 75
 113
 
 75
 113
 188
 (107) 1976 11/20/2014 3
CRHS - 1968 North Avenue Columbus, GA 
 89
 32
 
 89
 32
 121
 (26) 1966 11/20/2014 4
CRHS - 633 19th Street Columbus, GA 
 99
 255
 
 99
 255
 354
 (92) 1972 11/20/2014 9
CRHS - 500 18th Street Columbus, GA 
 430
 170
 205
 430
 375
 805
 (111) 1982 11/20/2014 8
CRHS - 2200 Hamilton Road Columbus, GA 
 267
 1,579
 42
 267
 1,621
 1,888
 (248) 1992 11/20/2014 22
CRHS - 1810 Stadium Drive Phenix City, AL 
 202
 149
 26
 202
 175
 377
 (94) 1999 11/20/2014 30
Carle Danville MOB Danville, IL 
 607
 7,136
 
 607
 7,136
 7,743
 (713) 2007 11/26/2014 33
Middletown Medical - 111 Maltese Middletown, NY 
 670
 9,921
 37
 670
 9,958
 10,628
 (909) 1988 11/28/2014 35
Middletown Medical - 2 Edgewater Middletown, NY 
 200
 2,966
 11
 200
 2,977
 3,177
 (272) 1992 11/28/2014 35
Napoleon Medical Office Building New Orleans, LA 
 1,202
 7,412
 763
 1,202
 8,175
 9,377
 (998) 1974 12/19/2014 25
West TN Bone & Joint - Physicians Drive Jackson, TN 
 1,661
 2,960
 
 1,661
 2,960
 4,621
 (269) 1991 12/30/2014 35
West TN Bone & Joint Jackson, TN 
 1,250
 5,210
 
 1,250
 5,210
 6,460
 (543) 1996 12/30/2014 31
Edina MOB Edina MN 
 504
 10,006
 959
 504
 10,965
 11,469
 (1,657) 1979 1/22/2015 24
Crystal MOB Crystal, MN 
 945
 11,862
 
 945
 11,862
 12,807
 (879) 2012 1/22/2015 47
Savage MOB Savage, MN 5,449
 1,281
 10,021
 
 1,281
 10,021
 11,302
 (770) 2011 1/22/2015 48
Dell Road MOB Chanhassen, MN 
 800
 4,520
 29
 800
 4,549
 5,349
 (385) 2008 1/22/2015 43
Columbus MOB Columbus, GA 
 845
 2,708
 7
 845
 2,715
 3,560
 (432) 1980 1/23/2015 22
Methodist Sports MOB Greenwood, IN 
 1,050
 8,556
 
 1,050
 8,556
 9,606
 (795) 2008 1/28/2015 33
Vadnais Heights MOB Vadnais Heights, MN 
 2,751
 12,233
 
 2,751
 12,233
 14,984
 (1,069) 2013 1/29/2015 43
Minnetonka MOB Minnetonka, MN 
 1,770
 19,797
 
 1,770
 19,797
 21,567
 (1,456) 2014 2/5/2015 49
Jamestown MOB Jamestown, ND 
 656
 9,440
 
 656
 9,440
 10,096
 (855) 2013 2/5/2015 43
Indiana American II Greenwood, IN 
 862
 6,901
 600
 862
 7,501
 8,363
 (599) 2008 2/13/2015 38
Indiana American III Greenwood, IN 
 741
 1,846
 185
 741
 2,031
 2,772
 (313) 2001 2/13/2015 31
Indiana American IV Greenwood, IN 
 771
 1,928
 77
 771
 2,005
 2,776
 (205) 2001 2/13/2015 31
Southpointe Indianapolis, IN 
 563
 1,741
 259
 563
 2,000
 2,563
 (284) 1993 2/13/2015 27
Minnesota Eye MOB Minnetonka, MN 
 1,143
 7,470
 
 1,143
 7,470
 8,613
 (592) 2014 2/17/2015 44
Baylor Cancer Center Dallas, TX 
 855
 6,007
 32
 855
 6,039
 6,894
 (427) 2001 2/27/2015 43
Bridgeport Medical Center Lakewood, WA 
 1,397
 10,435
 47
 1,397
 10,482
 11,879
 (899) 2004 2/27/2015 35
Renaissance Office Building Milwaukee, WI 
 1,379
 4,182
 2,834
 1,379
 7,016
 8,395
 (1,078) 1896 3/27/2015 15
Calkins 125 Rochester, NY 
 534
 10,164
 326
 534
 10,490
 11,024
 (1,159) 1997 3/31/2015 32
Calkins 200 Rochester, NY 
 210
 3,317
 32
 210
 3,349
 3,559
 (335) 2000 3/31/2015 38
Calkins 300 Rochester, NY 
 372
 6,645
 24
 372
 6,669
 7,041
 (652) 2002 3/31/2015 39
Calkins 400 Rochester, NY 
 353
 8,226
 34
 353
 8,260
 8,613
 (864) 2007 3/31/2015 39
Calkins 500 Rochester, NY 
 282
 7,074
 28
 282
 7,102
 7,384
 (589) 2008 3/31/2015 41
Avalon Park Florida Hospital MOB Avalon Park, FL 
 1,041
 10,685
 
 1,041
 10,685
 11,726
 (780) 2009 3/31/2015 41
Premier Surgery Center of Louisville Louisville, KY 
 1,106
 5,437
 
 1,106
 5,437
 6,543
 (374) 2013 4/10/2015 43
Baton Rouge MOB Baton Rouge, LA 
 711
 7,720
 
 711
 7,720
 8,431
 (636) 2003 4/15/2015 35
Healthpark Medical Center Grand Blanc, MI 
 
 17,624
 
 
 17,624
 17,624
 (1,434) 2006 4/30/2015 36
Plaza HCA MOB Jacksonville, FL 
 1,112
 12,553
 
 1,112
 12,553
 13,665
 (903) 2007 4/30/2015 39
Northern Ohio Medical Center Sheffield, OH 
 644
 9,162
 
 644
 9,162
 9,806
 (1,225) 1999 5/28/2015 20
University of Michigan - Northville MOB Livonia, MI 
 2,200
 8,627
 166
 2,200
 8,793
 10,993
 (808) 1988 5/29/2015 30
Coon Rapids Medical Center MOB Coon Rapids, MN 
 607
 5,857
 
 607
 5,857
 6,464
 (468) 2007 6/1/2015 35
Premier Landmark MOB Bloomington, IN 
 872
 10,537
 
 872
 10,537
 11,409
 (730) 2008 6/5/2015 39
Palm Beach ASC Palm Beach, FL 
 2,576
 7,675
 
 2,576
 7,675
 10,251
 (507) 2003 6/26/2015 40
Brookstone Physician Center MOB Jacksonville, AL 
 
 1,913
 
 
 1,913
 1,913
 (166) 2007 6/30/2015 31
Jackson Woman's Clinic MOB Jackson, TN 
 555
 3,800
 19
 555
 3,819
 4,374
 (293) 1998 6/30/2015 35
Hillside Medical Center MOB Hanover, PA 
 812
 13,217
 63
 812
 13,280
 14,092
 (941) 2003 6/30/2015 35
Randall Road MOB Elgin, IL 
 1,124
 15,404
 486
 1,124
 15,890
 17,014
 (1,054) 2006 6/30/2015 38
Medical Specialists of Palm Beach MOB Atlantis, FL 
 
 7,560
 6
 
 7,566
 7,566
 (541) 2002 7/24/2015 37
OhioHealth - SW Health Center MOB Grove City, OH 
 1,363
 8,516
 
 1,363
 8,516
 9,879
 (637) 2001 7/31/2015 37
Trios Health MOB Kennewick, WA 
 
 55,178
 3,795
 
 58,973
 58,973
 (3,169) 2015 7/31/2015 45
IMS - Paradise Valley MOB Phoenix, AZ 
 
 25,893
 14
 
 25,907
 25,907
 (1,638) 2004 8/14/2015 43
IMS - Avondale MOB Avondale, AZ 
 1,818
 18,108
 10
 1,818
 18,118
 19,936
 (1,020) 2006 8/19/2015 45
IMS - Palm Valley MOB Goodyear, AZ 
 2,666
 28,655
 
 2,666
 28,655
 31,321
 (1,683) 2006 8/19/2015 43
IMS - North Mountain MOB Phoenix, AZ 
 
 42,877
 495
 
 43,372
 43,372
 (2,372) 2008 8/31/2015 47
Memorial Hermann - Phase I Katy, TX 
 822
 6,797
 19
 822
 6,816
 7,638
 (440) 2005 9/1/2015 39
Memorial Hermann - Phase II Katy, TX 
 1,560
 25,601
 6
 1,560
 25,607
 27,167
 (1,573) 2006 9/1/2015 40
New Albany Medical Center MOB New Albany, OH 
 1,600
 8,505
 216
 1,600
 8,721
 10,321
 (613) 2005 9/9/2015 37
Fountain Hills Medical Campus MOB Fountain Hills, AZ 
 2,593
 7,635
 618
 2,593
 8,253
 10,846
 (502) 1995 9/30/2015 39
Fairhope MOB Fairhope, AL ��
 640
 5,227
 568
 640
 5,795
 6,435
 (349) 2005 10/13/2015 38
      Initial Cost to Company Gross Amount at Which Carried as of Close of Period      
Description Location Encumbrances Land 
Buildings and
Improvements
 
Cost Capitalized
Subsequent to
Acquisitions
 Land 
Buildings and
Improvements
 Total 
Accumulated
Depreciation
 
Year
Built
 
Date 
Acquired
 
Life on Which Building
Depreciation in
Income Statement
is Computed
Foley MOB Foley, AL 
 365
 732
 
 365
 732
 1,097
 (48) 1997 10/13/2015 40
Foley Venture Foley, AL 
 420
 1,118
 
 420
 1,118
 1,538
 (73) 2002 10/13/2015 38
North Okaloosa MOB Crestview, FL 
 190
 1,010
 
 190
 1,010
 1,200
 (61) 2005 10/13/2015 41
Commons on North Davis Pensacola, FL 
 380
 1,237
 
 380
 1,237
 1,617
 (75) 2009 10/13/2015 41
Sorrento Road Pensacola, FL 
 170
 894
 
 170
 894
 1,064
 (55) 2010 10/13/2015 41
Breakfast Point Medical Park Panama City, FL 
 
 817
 
 
 817
 817
 (47) 2012 10/13/2015 42
Panama City Beach Panama City, FL 
 
 739
 
 
 739
 739
 (42) 2012 10/13/2015 42
Perdido Medical Park Pensacola, FL 
 100
 1,147
 
 100
 1,147
 1,247
 (69) 2010 10/13/2015 41
Ft. Walton Beach Ft. Walton Beach, FL 
 230
 914
 
 230
 914
 1,144
 (63) 1979 10/13/2015 35
Panama City Panama City, FL 
 
 661
 
 
 661
 661
 (41) 2003 10/13/2015 38
Pensacola - Catalyst Pensacola, FL 
 220
 1,685
 
 220
 1,685
 1,905
 (104) 2001 10/13/2015 39
Arete Surgical Center Johnstown, CO 
 399
 6,667
 
 399
 6,667
 7,066
 (337) 2013 10/19/2015 45
Cambridge Professional Center MOB Waldorf, MD 
 590
 8,520
 130
 590
 8,650
 9,240
 (590) 1999 10/30/2015 35
HonorHealth 44th Street MOB Phoenix, AZ 
 515
 3,884
 1,320
 515
 5,204
 5,719
 (370) 1988 11/13/2015 28
Mercy Medical Center MOB Fenton, MO 
 1,201
 6,778
 
 1,201
 6,778
 7,979
 (389) 1999 12/1/2015 40
Nashville MOB Nashville, TN 
 1,555
 39,713
 250
 1,555
 39,963
 41,518
 (1,771) 2015 12/17/2015 46
KSF Orthopaedic MOB Houston, TX 
 530
 3,712
 26
 530
 3,738
 4,268
 (430) 1984 12/22/2015 19
Great Falls Clinic MOB Great Falls, MT 
 
 27,402
 441
 
 27,843
 27,843
 (1,482) 2004 12/29/2015 40
Great Falls Hospital Great Falls, MT 
 
 25,262
 
 
 25,262
 25,262
 (1,322) 2015 1/25/2016 40
Monterey Medical Center ASC Stuart, FL 
 380
 5,064
 
 380
 5,064
 5,444
 (240) 2013 2/1/2016 42
Physicians Medical Plaza MOB Indianapolis, IN 
 
 6,703
 17
 
 6,720
 6,720
 (412) 2004 2/1/2016 34
Park Nicollet Clinic Chanhassen, MN 
 1,941
 14,555
 
 1,941
 14,555
 16,496
 (758) 2005 2/8/2016 40
HEB Cancer Center Bedford, TX 
 
 11,839
 
 
 11,839
 11,839
 (548) 2014 2/12/2016 44
Riverview Medical Center Lancaster, OH 
 1,313
 10,243
 63
 1,313
 10,306
 11,619
 (638) 1997 2/26/2016 33
St. Luke's Cornwall MOB Cornwall, NY 9,500
 
 13,017
 
 
 13,017
 13,017
 (761) 2006 2/26/2016 35
HonorHealth Glendale Glendale, AZ 
 1,770
 8,089
 
 1,770
 8,089
 9,859
 (352) 2015 3/15/2016 45
Columbia MOB Hudson, NY 12,000
 
 16,550
 
 
 16,550
 16,550
 (867) 2006 3/21/2016 35
St Vincent POB 1 Birmingham, AL 
 
 10,172
 130
 
 10,302
 10,302
 (1,246) 1975 3/23/2016 15
St Vincent POB 2 Birmingham, AL 
 48
 6,624
 144
 48
 6,768
 6,816
 (853) 1988 3/23/2016 15
St Vincent POB 3 Birmingham, AL 
 75
 9,433
 353
 75
 9,786
 9,861
 (726) 1992 3/23/2016 25
Emerson Medical Building Creve Coeur, MO 
 1,590
 9,853
 114
 1,590
 9,967
 11,557
 (522) 1989 3/24/2016 35
Patient Partners Surgery Center Gallatin, TN 
 203
 3,376
 
 203
 3,376
 3,579
 (163) 2007 3/30/2016 40
Eye Associates of NM - Santa Fe Santa Fe, NM 
 900
 6,604
 
 900
 6,604
 7,504
 (366) 2002 3/31/2016 35
Eye Associates of NM - Albuquerque Albuquerque, NM 
 1,020
 7,832
 
 1,020
 7,832
 8,852
 (384) 2007 3/31/2016 40
Gardendale Surgery Center Gardendale, AL 
 200
 5,732
 
 200
 5,732
 5,932
 (250) 2011 4/11/2016 42
HealthEast - Curve Crest Stillwater, MN 
 409
 3,279
 
 409
 3,279
 3,688
 (148) 2011 4/14/2016 43
HealthEast - Victor Gardens Hugo, MN 
 572
 4,400
 51
 572
 4,451
 5,023
 (209) 2008 4/14/2016 41
NOMS - Clyde Clyde, OH 
 440
 5,948
 
 440
 5,948
 6,388
 (240) 2015 5/10/2016 44
Blandford MOB Little Rock, AR 
 203
 2,386
 
 203
 2,386
 2,589
 (107) 1983 5/11/2016 40
Cardwell MOB Lufkin, TX 
 
 8,348
 138
 
 8,486
 8,486
 (361) 1999 5/11/2016 42
Dacono Neighborhood Health Dacono, CO 
 2,258
 2,911
 20
 2,258
 2,931
 5,189
 (173) 2014 5/11/2016 44
Franciscan Health Tacoma, WA 
 711
 9,096
 65
 711
 9,161
 9,872
 (1,017) 1951 5/11/2016 15
Grand Island Specialty Clinic Grand Island, NE 
 102
 2,802
 150
 102
 2,952
 3,054
 (136) 1978 5/11/2016 42
Hot Springs MOB Hot Springs Village, AR 
 305
 3,309
 65
 305
 3,374
 3,679
 (209) 1988 5/11/2016 30
Jewish Medical Center East Louisville, KY 
 
 81,248
 32
 
 81,280
 81,280
 (3,138) 2003 5/11/2016 45
Jewish Medical Center South MOB - 1 Shepherdsville, KY 
 
 15,861
 225
 
 16,086
 16,086
 (787) 2005 5/11/2016 39
Jewish Medical Plaza I Louisville, KY 
 
 8,808
 172
 
 8,980
 8,980
 (451) 1970 5/11/2016 35
Jewish Medical Plaza II Louisville, KY 
 
 5,216
 1,070
 
 6,286
 6,286
 (592) 1964 5/11/2016 15
Jewish OCC Louisville, KY 
 
 35,703
 108
 
 35,811
 35,811
 (1,767) 1985 5/11/2016 34
Lexington Surgery Center Lexington, KY 
 1,229
 18,914
 363
 1,229
 19,277
 20,506
 (1,074) 2000 5/11/2016 30
Medical Arts Pavilion Lufkin, TX 
 
 6,215
 15
 
 6,230
 6,230
 (337) 2004 5/11/2016 33
Memorial Outpatient Center Lufkin, TX 
 
 4,808
 100
 
 4,908
 4,908
 (206) 1990 5/11/2016 45
Midlands Two Professional Center Papillion, NE 
 
 587
 57
 
 644
 644
 (247) 1976 5/11/2016 5
Parkview MOB Little Rock, AR 
 705
 4,343
 
44

 705
 4,387
 5,092
 (229) 1988 5/11/2016 35
Peak One ASC Frisco, CO 
 
 5,763
 65
 
 5,828
 5,828
 (238) 2006 5/11/2016 44
Physicians Medical Center Tacoma, WA 
 
 5,862
 144
 
 6,006
 6,006
 (376) 1977 5/11/2016 27
St. Alexius - Minot Medical Plaza Minot, ND 
 
 26,078
 
 
 26,078
 26,078
 (1,023) 2015 5/11/2016 49
St. Clare Medical Pavilion Lakewood, WA 
 
 9,005
 
 
 9,005
 9,005
 (535) 1989 5/11/2016 33
St. Joseph Medical Pavilion Tacoma, WA 
 
 11,497
 31
 
 11,528
 11,528
 (591) 1989 5/11/2016 35
St. Joseph Office Park Lexington, KY 
 3,722
 12,675
 3,228
 3,722
 15,903
 19,625
 (1,621) 1992 5/11/2016 14
St. Mary - Caritas Medical II Louisville, KY 
 
 5,587
 23
 
 5,610
 5,610
 (283) 1979 5/11/2016 34
St. Mary - Caritas Medical III Louisville, KY 
 
 383
 194
 
 577
 577
 (266) 1974 5/11/2016 2
Thornton Neighborhood Health Thornton, CO 
 1,609
 2,287
 
 1,609
 2,287
 3,896
 (132) 2014 5/11/2016 43
Medical Village at Kissimmee Kissimmee, FL 
 634
 3,365
 
 634
 3,365
 3,999
 (149) 2006 5/26/2016 39
Medical Village at Leesburg Leesburg, FL 
 802
 3,047
 
 802
 3,047
 3,849
 (213) 1979 5/26/2016 25
St. Francis MOB Federal Way, WA 
 
 12,817
 24
 
 12,841
 12,841
 (615) 1987 6/2/2016 38
Children's Hospital MOB Milwaukee, WI 
 476
 4,897
 
 476
 4,897
 5,373
 (197) 2016 6/3/2016 45
Jewish Medical Center South MOB - 2 Shepherdsville, KY 
 27
 3,827
 
 27
 3,827
 3,854
 (153) 2006 6/8/2016 40
Good Samaritan North Annex Building Kearney, NE 
 
 2,734
 
 
 2,734
 2,734
 (132) 1984 6/28/2016 37
      Initial Cost to Company Gross Amount at Which Carried as of Close of Period      
Description Location Encumbrances Land 
Buildings and
Improvements
 
Cost Capitalized
Subsequent to
Acquisitions
 Land 
Buildings and
Improvements
 Total 
Accumulated
Depreciation
 
Year
Built
 
Date 
Acquired
 
Life on Which Building
Depreciation in
Income Statement
is Computed
NE Heart Institute Medical Building Lincoln, NE 
 
 19,738
 
 
 19,738
 19,738
 (633) 2004 6/28/2016 47
St. Vincent West MOB Little Rock, AR 
 
 13,453
 
 
 13,453
 13,453
 (447) 2012 6/29/2016 49
Meridan MOB Englewood, CO 
 1,608
 15,774
 141
 1,608
 15,915
 17,523
 (717) 2002 6/29/2016 38
St. Mary - Caritas Medical I Louisville, KY 
 
 8,774
 283
 
 9,057
 9,057
 (535) 1991 6/29/2016 25
St. Alexius - Medical Arts Pavilion Bismarck, ND 
 
 12,902
 77
 
 12,979
 12,979
 (624) 1974 6/29/2016 32
St. Alexius - Mandan Clinic Mandan, ND 
 708
 7,700
 74
 708
 7,774
 8,482
 (301) 2014 6/29/2016 43
St. Alexius - Orthopaedic Center Bismarck, ND 
 
 13,881
 363
 
 14,244
 14,244
 (563) 1997 6/29/2016 39
St. Alexius - Rehab Center Bismarck, ND 
 
 5,920
 97
 
 6,017
 6,017
 (380) 1997 6/29/2016 25
St. Alexius - Tech & Ed Bismarck, ND 
 
 16,688
 2
 
 16,690
 16,690
 (679) 2011 6/29/2016 38
Good Samaritan MOB Kearney, NE 
 
 24,154
 72
 
 24,226
 24,226
 (820) 1999 6/29/2016 45
Lakeside Two Professional Building Omaha, NE 
 
 13,358
 144
 
 13,502
 13,502
 (532) 2000 6/29/2016 38
Lakeside Wellness Center Omaha, NE 
 
 10,177
 190
 
 10,367
 10,367
 (397) 2000 6/29/2016 39
McAuley Center Omaha, NE 
 1,427
 17,020
 3
 1,427
 17,023
 18,450
 (927) 1988 6/29/2016 30
Memorial Health Center Grand Island, NE 
 
 33,967
 146
 
 34,113
 34,113
 (1,517) 1955 6/29/2016 35
Missionary Ridge MOB Chattanooga, TN 
 
 7,223
 1,205
 
 8,428
 8,428
 (1,089) 1976 6/29/2016 10
Pilot Medical Center Birmingham, AL 
 1,419
 14,528
 6
 1,419
 14,534
 15,953
 (666) 2005 6/29/2016 35
St. Joseph Medical Clinic Tacoma, WA 
 
 16,427
 32
 
 16,459
 16,459
 (828) 1991 6/30/2016 30
Woodlands Medical Arts Center The Woodlands, TX 
 
 19,168
 198
 
 19,366
 19,366
 (867) 2001 6/30/2016 35
FESC MOB Tacoma, WA 
 
 12,702
 181
 
 12,883
 12,883
 (961) 1980 6/30/2016 22
Prairie Care MOB Maplewood, MN 
 525
 3,099
 
 525
 3,099
 3,624
 (113) 2016 7/6/2016 45
Springwoods MOB Spring, TX 
 3,821
 14,830
 3,492
 3,821
 18,322
 22,143
 (549) 2015 7/21/2016 44
Unity - ASC, Imaging & MOB West Lafayette, IN 
 960
 9,991
 
 960
 9,991
 10,951
 (429) 2001 8/8/2016 35
Unity - Medical Pavilion West Lafayette, IN 
 1,070
 12,454
 
 1,070
 12,454
 13,524
 (535) 2001 8/8/2016 35
Unity - Faith, Hope & Love West Lafayette, IN 
 280
 1,862
 
 280
 1,862
 2,142
 (80) 2001 8/8/2016 35
Unity - Immediate Care & OCC West Lafayette, IN 
 300
 1,833
 
 300
 1,833
 2,133
 (75) 2004 8/8/2016 37
Medical Village at Maitland Orlando, FL 
 2,393
 18,543
 
 2,393
 18,543
 20,936
 (613) 2006 8/23/2016 44
Tri-State Orthopaedics MOB Evansville, IN 
 1,580
 14,162
 
 1,580
 14,162
 15,742
 (553) 2004 8/30/2016 37
Maury Regional Healthcare MOB Spring Hill, TN 
 
 15,619
 
 
 15,619
 15,619
 (503) 2012 9/30/2016 41
Spring Ridge Medical Center Wyomissing, PA 
 28
 4,943
 
 28
 4,943
 4,971
 (177) 2002 9/30/2016 37
Doctors Community Hospital POB Lanham, MD 
 
 23,034
 
 
 23,034
 23,034
 (602) 2009 9/30/2016 48
Gig Harbor Medical Pavilion Gig Harbor, WA 
 
 4,791
 1,768
 
 6,559
 6,559
 (271) 1991 9/30/2016 30
Midlands One Professional Center Papillion, NE 
 
 14,922
 
 
 14,922
 14,922
 (507) 2010 9/30/2016 37
N.W. Michigan Surgery Center
     Units #1, #2, & #4
 Traverse City, MI 
 2,748
 30,005
 
 2,748
 30,005
 32,753
 (909) 2004 10/28/2016 40
Northeast Medical Center Fayetteville, NY 
 4,011
 25,564
 929
 4,011
 26,493
 30,504
 (1,045) 1998 11/23/2016 33
North Medical Center Liverpool, NY 
 1,337
 18,680
 844
 1,337
 19,524
 20,861
 (673) 1989 11/23/2016 35
Cincinnati Eye Institute Cincinnati, OH 
 2,050
 32,546
 
 2,050
 32,546
 34,596
 (1,133) 1985 11/23/2016 35
HonorHealth - Scottsdale MOB Scottsdale, AZ 
 
 4,288
 
 
 4,288
 4,288
 (135) 2000 12/2/2016 45
Fox Valley Hematology & Oncology Appleton, WI 
 1,590
 26,666
 
 1,590
 26,666
 28,256
 (691) 2015 12/8/2016 44
Gastrointestinal Associates MOB Powell, TN 
 937
 3,214
 
 937
 3,214
 4,151
 (129) 1965 12/9/2016 30
Northern Vision Eye Center Traverse City, MI 
 490
 2,132
 
 490
 2,132
 2,622
 (71) 2006 12/15/2016 35
Flower Mound MOB Flower Mound, TX 
 1,945
 8,312
 
 1,945
 8,312
 10,257
 (228) 2011 12/16/2016 43
Carrollton MOB Flower Mound, TX 
 2,183
 10,461
 
 2,183
 10,461
 12,644
 (306) 2002 12/16/2016 40
HonorHealth IRF Scottsdale, AZ 10,000
 
 19,331
 
 
 19,331
 19,331
 (481) 2000 12/22/2016 42
Orthopedic Associates Flower Mound, TX 
 2,915
 12,791
 
 2,915
 12,791
 15,706
 (319) 2011 1/5/2017 43
Medical Arts Center at Hartford Plainville, CT 
 1,499
 24,627
 
 1,499
 24,627
 26,126
 (594) 2015 1/11/2017 44
CareMount - Lake Katrine MOB Lake Katrine, NY 26,039
 1,941
 27,434
 
 1,941
 27,434
 29,375
 (636) 2013 2/14/2017 42
CareMount - Rhinebeck MOB Rhinebeck, NY 
 869
 12,220
 
 869
 12,220
 13,089
 (296) 1965 2/14/2017 41
Monterey Medical Center - MOB Stuart, FL 
 2,292
 13,376
 5
 2,292
 13,381
 15,673
 (323) 2003 3/7/2017 37
Creighton University Medical Center Omaha, NE 
 
 32,487
 
 
 32,487
 32,487
 (575) 2017 3/28/2017 49
Strictly Pediatrics Specialty Center Austin, TX 
 4,457
 62,527
 39
 4,457
 62,566
 67,023
 (1,222) 2006 3/31/2017 40
MedStar Stephen's Crossing Brandywine, MD 
 1,975
 14,810
 
 1,975
 14,810
 16,785
 (190) 2015 6/16/2017 43
CHI Health Clinic Building Omaha, NE 
 
 50,177
 
 
 50,177
 50,177
 (501) 2017 6/29/2017 49
St Gabriel's Centracare Little Falls, MN 
 
 4,944
 
 
 4,944
 4,944
 (110) 1990 6/29/2017 25
Craven-Hagan Clinic Williston, ND 
 
 8,739
 
 
 8,739
 8,739
 (123) 1984 6/29/2017 40
Chattanooga Heart Institute Chattanooga, TN 
 
 18,639
 
 
 18,639
 18,639
 (257) 1993 6/29/2017 37
CHI St. Vincent Mercy Heart & Vascular Center Hot Springs, AR 
 
 11,688
 
 
 11,688
 11,688
 (145) 1998 6/29/2017 45
South Campus MOB Hot Springs, AR 
 
 13,369
 
 
 13,369
 13,369
 (171) 2009 6/29/2017 42
CHI St. Vincent Mercy Cancer Center Hot Springs, AR 
 
 5,090
 
 
 5,090
 5,090
 (72) 2001 6/29/2017 39
St. Joseph Professional Office Building Bryan, TX 
 
 11,169
 
 
 11,169
 11,169
 (129) 1996 6/29/2017 46
St. Vincent Carmel Women's Center Carmel, IN 
 
 31,720
 
 
 31,720
 31,720
 (339) 2014 6/29/2017 48
St. Vincent Fishers Medical Center Fishers, IN 44,000
 
 62,870
 
 
 62,870
 62,870
 (749) 2008 6/29/2017 45
Baylor Charles A. Sammons Cancer Center Dallas, TX 
 
 256,886
 
 
 256,886
 256,886
 (2,994) 2011 6/30/2017 43
Orthopedic & Sports Institute of the Fox Valley Appleton, WI 
 2,003
 26,394
 100
 2,003
 26,494
 28,497
 (406) 2005 6/30/2017 40
Clearview Cancer Institute Huntsville, AL 
 2,736
 43,220
 
 2,736
 43,220
 45,956
 (554) 2006 8/4/2017 34
Northside Cherokee/Town Lake MOB Atlanta, GA 
 
 30,627
 
 
 30,627
 30,627
 (312) 2013 8/15/2017 46
HonorHealth Mesa MOB Mesa, AZ 
 362
 3,059
 
 362
 3,059
 3,421
 (32) 2013 8/15/2017 43
Little Falls Orthopedics Little Falls, MN 
 246
 1,977
 
 246
 1,977
 2,223
 (39) 1999 8/24/2017 28
      Initial Cost to Company Gross Amount at Which Carried as of Close of Period      
Description Location Encumbrances Land 
Buildings and
Improvements
 
Cost Capitalized
Subsequent to
Acquisitions
 Land 
Buildings and
Improvements
 Total 
Accumulated
Depreciation
 
Year
Built
 
Date 
Acquired
 
Life on Which Building
Depreciation in
Income Statement
is Computed
Little Falls Dialysis Center Little Falls, MN 
 
 2,885
 
 
 2,885
 2,885
 (77) 1959 8/24/2017 15
Immanuel One Professional Center Omaha, NE 
 
 16,598
 
 
 16,598
 16,598
 (210) 1993 8/24/2017 35
SJRHC Cancer Center Bryan, TX 
 
 5,065
 
 
 5,065
 5,065
 (47) 1997 8/24/2017 40
St. Vincent Women's Center Hot Springs, AR 
 
 4,789
 
 
 4,789
 4,789
 (41) 2001 8/31/2017 40
Legends Park MOB & ASC Midland, TX 
 1,658
 24,178
 
 1,658
 24,178
 25,836
 (194) 2003 9/27/2017 44
Franklin MOB & ASC Franklin, TN 
 1,001
 7,902
 
 1,001
 7,902
 8,903
 (49) 2014 10/12/2017 42
Eagle Point MOB Lake Elmo, MN 
 1,011
 9,009
 
 1,011
 9,009
 10,020
 (36) 2015 10/31/2017 48
Edina East MOB Edina, MN 
 2,360
 4,135
 
 2,360
 4,135
 6,495
 (26) 1962 10/31/2017 30
Northside MOB - Center Pointe Atlanta, GA 
 
 119,467
 
 
 119,467
 119,467
 (323) 2009 11/10/2017 31
Gwinnett 500 Building Lawrenceville, GA 
 
 22,753
 
 
 22,753
 22,753
 (90) 1995 11/17/2017 45
Hudgens Professional Building Duluth, GA 
 
 21,779
 
 
 21,779
 21,779
 (98) 1994 11/17/2017 40
St. Vincent Building Indianapolis, IN 
 5,854
 42,382
 
 5,854
 42,382
 48,236
 (182) 2007 11/17/2017 45
Gwinnett Physicians Center Lawrenceville, GA 17,609
 
 48,304
 
 
 48,304
 48,304
 (92) 2010 12/1/2017 47
Apple Valley Medical Center Apple Valley, MN 
 1,587
 14,929
 
 1,587
 14,929
 16,516
 (40) 1974 12/18/2017 33
Desert Cove MOB (57% Interest) Scottsdale, AZ 
 1,689
 
5,207

 
 1,689
 5,207
 6,896
 (12) 1991 12/18/2017 38
Westgate MOB Glendale, AZ 
 
 13,379
 
 
 13,379
 13,379
 (27) 2016 12/21/2017 45
    $186,679
 $217,808
 $3,518,259
 $73,655
 $217,695
 $3,591,914
 $3,809,609
 $(201,527)      


The aggregate cost for federal income tax purposes of the Predecessor for all prior periods.real estate as of December 31, 2017 is $3.83 billion, with accumulated tax depreciation of $175.8 million. The cost, net of accumulated depreciation, is approximately $3.65 billion (unaudited).


PHYSICIANS REALTY L.P.
SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION
      Initial Cost to Company Gross Amount at Which Carried as of Close of Period      
Description Location Encumbrances Land 
Buildings and
Improvements
 
Cost
Capitalized
Subsequent
to
Acquisitions
 Land 
Buildings and
Improvements
 Total 
Accumulated
Depreciation
 
Date of
Construction
 Date Acquired 
Life on Which
Building Depreciation
in Income Statement
is Computed
Arrowhead Commons Phoenix, AZ 
 $740
 $2,551
 $1
 $740
 $2,552
 $3,292
 (366) 2004 5/31/2008 46
Aurora Medical Office Building Green Bay, WI 
 500
 1,566
 
 500
 1,566
 2,066
 (149) 2010 4/15/2010 50
Austell Medical Office Building Atlanta, GA 
 289
 1,992
 313
 289
 2,305
 2,594
 (397) 1971 6/30/2008 36
Canton Medical Office Building Atlanta, GA 6,207
 710
 7,225
 97
 710
 7,322
 8,032
 (1,851) 1994 5/25/2007 30
Decatur Medical Office Building Atlanta, GA 
 740
 2,604
 45
 740
 2,649
 3,389
 (679) 1974 10/12/2007 28
El Paso Medical Office Building El Paso, TX 
 860
 2,866
 357
 860
 3,223
 4,083
 (1,293) 1987 8/24/2006 21
Farmington Professional Pavillion Detroit, MI 
 580
 1,793
 87
 580
 1,880
 2,460
 (1,081) 1972 1/5/2006 15
Firehouse Square Milwaukee, WI 2,765
 1,120
 2,768
 
 1,120
 2,768
 3,888
 (684) 2002 8/15/2007 30
Hackley Medical Center Grand Rapids, MI 5,397
 1,840
 6,402
 24
 1,840
 6,426
 8,266
 (1,674) 1968 12/22/2006 30
Ingham Regional Medical Center Lansing, MI 
 310
 2,893
 (1,134) 310
 1,759
 2,069
 (800) 1994 7/26/2006 39
Meadow View Professional Center Kingsport, TN 10,410
 2,270
 11,344
 
 2,270
 11,344
 13,614
 (2,923) 2005 5/10/2007 30
Mid Coast Hospital Office Building Portland, ME 7,869
 
 11,247
 8
 
 11,255
 11,255
 (2,477) 2008 5/1/2008 30
New Albany Professional Building Columbus, OH 
 237
 2,767
 20
 237
 2,787
 3,024
 (472) 2000 1/4/2008 42
Northpark Trail Atlanta, GA 
 839
 1,245
 235
 839
 1,480
 2,319
 (539) 2001 12/28/2005 35
Remington Medical Commons Chicago, IL��4,399
 895
 6,499
 319
 895
 6,818
 7,713
 (1,464) 2008 6/1/2008 30
Stonecreek Family Health Center Columbus, OH 
 459
 1,898
 (153) 459
 1,745
 2,204
 (687) 1996 9/15/2006 23
Summit Healthplex Atlanta, GA 
 2,633
 15,576
 4,412
 2,633
 19,988
 22,621
 (3,735) 2002 7/3/2008 44
Valley West Hospital Medical Office Building Chicago, IL 4,878
 
 6,275
 611
 
 6,886
 6,886
 (1,588) 2007 11/1/2007 30
East El Paso MOB El Paso, TX 
 710
 4,500
 
 710
 4,500
 5,210
 (171) 2004 8/30/2013 35
East El Paso Surgery Center El Paso, TX 
 3,070
 23,627
 
 3,070
 23,627
 26,697
 (875) 2004 8/30/2013 36
LifeCare Plano LTACH Plano, TX 
 3,370
 11,689
 455
 3,370
 12,144
 15,514
 (613) 1987 9/18/2013 25
Crescent City Surgical Centre New Orleans, LA 18,750
 
 34,208
 
 
 34,208
 34,208
 (891) 2010 9/30/2013 48
Foundation Surgical Affiliates MOB Oklahoma City, OK 7,647
 1,300
 12,724
 
 1,300
 12,724
 14,024
 (370) 2004 9/30/2013 43
Pensacola Medical Office Building Pensacola, FL 
 990
 5,005
 6
 990
 5,011
 6,001
 (128) 2012 10/4/2013 49
Central Ohio Neurosurgical Surgeons MOB (CONS) Columbus, OH 
 981
 7,620
 
 981
 7,620
 8,601
 (188) 2007 11/27/2013 44
Great Falls Ambulatory Surgery Center Great Falls, MT 
 203
 3,224
 
 203
 3,224
 3,427
 (102) 1999 12/11/2013 33

Eagles Landing Family Practice Medical Office Building Conyers, GA 
 1,000
 3,345
 
 1,000
 3,345
 4,345
 (78) 2008 2/19/2014 37
Eagles Landing Family Practice Medical Office Building McDonough, GA 
 800
 4,893
 
 800
 4,893
 5,693
 (116) 2007 2/19/2014 36
Eagles Landing Family Practice Medical Office Building McDonough, GA 
 400
 5,086
 
 400
 5,086
 5,486
 (116) 2006 2/19/2014 37
Eagles Landing Family Practice Medical Office Building Jackson, GA 
 800
 4,600
 
 800
 4,600
 5,400
 (103) 2010 2/19/2014��38
Foundation Surgical Hospital of San Antonio San Antonio, TX 9,783
 2,230
 23,346
 
 2,230
 23,346
 25,576
 (634) 2007 2/19/2014 35
Foundation Healthplex of San Antonio San Antonio, TX 
 911
 4,189
 
 911
 4,189
 5,100
 (104) 2007 2/16/2014 35
21st Century Radiation Oncology — Sarasota Sarasota, FL 
 633
 6,557
 
 633
 6,557
 7,190
 (211) 1975 2/26/2014 27
21st Century Radiation Oncology — Venice Venice, FL 
 814
 2,952
 
 814
 2,952
 3,766
 (79) 1987 2/26/2014 35
21st Century Radiation Oncology — Englewood Englewood, FL 
 350
 1,878
 
 350
 1,878
 2,228
 (45) 1992 2/26/2014 38
21st Century Radiation Oncology — Port Charlotte Port Charlotte, FL 
 269
 2,326
 
 269
 2,326
 2,595
 (57) 1996 2/26/2014 36
Peachtree Dunwoody Medical Office Building Center Atlanta, GA 
 6,046
 27,435
 7
 6,046
 27,442
 33,488
 (936) 1987 2/28/2014 25
Lifecare LTACH — Pittsburgh Pittsburgh, PA 
 1,142
 11,737
 
 1,142
 11,737
 12,879
 (315) 1987 3/28/2014 30
Lifecare LTACH — Ft Worth Ft. Worth, TX 
 2,730
 24,639
 
 2,730
 24,639
 27,369
 (632) 1987 3/28/2014 30
Pinnacle Health Medical Office Building Carlisle, PA 
 424
 2,232
 
 424
 2,232
 2,656
 (46) 2002 4/22/2014 35
Pinnacle Health Medical Office Building Harrisburg, PA 
 795
 4,601
 
 795
 4,601
 5,396
 (133) 1990 4/22/2014 25
South Bend Orthopaedics Medical Office Building South Bend, IN 
 2,418
 11,355
 
 2,418
 11,355
 13,773
 (217) 2007 4/30/2014 40
Grenada Medical Complex Grenada, MS 
 185
 5,820
 
 185
 5,820
 6,005
 (151) 1975 4/30/2014 30
Mississippi Ortho Medical Office Building Jackson, MS 
 1,272
 14,177
 
 1,272
 14,177
 15,449
 (248) 1987 5/23/2014 35
Carmel Medical Pavilion Carmel, IN 
 
 3,917
 
 
 3,917
 3,917
 (97) 1993 5/28/2014 25
Presbyterian Medical Plaza Monroe, NC 
 1,195
 5,681
 
 1,195
 5,681
 6,876
 (67) 2008 6/30/2014 45
Renaissance Ambulatory Surgery Center Oshkosh, WI 
 228
 7,658
 
 228
 7,658
 7,886
 (99) 2007 6/30/2014 40
Summit Urology Bloomington, IN 
 125
 4,792
 
 125
 4,792
 4,917
 (82) 1996 6/30/2014 30
500 Landmark Bloomington, IN 
 627
 3,549
 
 627
 3,549
 4,176
 (53) 2000 7/1/2014 35
550 Landmark Bloomington, IN 
 2,717
 15,224
 
 2,717
 15,224
 17,941
 (227) 2000 7/1/2014 35
574 Landmark Bloomington, IN 
 418
 1,493
 
 418
 1,493
 1,911
 (23) 2004 7/1/2014 35
Carlisle II MOB Carlisle, PA 
 412
 3,962
 
 412
 3,962
 4,374
 (39) 1996 7/25/2014 45
Surgical Institute of Monroe Monroe, MI 
 410
 5,743
 
 410
 5,743
 6,153
 (80) 2010 7/28/2014 35
The Oaks at Lady Lake Lady Lake, FL 
 1,065
 8,642
 
 1,065
 8,642
 9,707
 (87) 2011 7/31/2014 42
Mansfield ASC Mansfield, TX 
 1,491
 6,471
 
 1,491
 6,471
 7,962
 (52) 2010 9/2/2014 46
Eye Center of Southern Indiana Bloomington, IN 
 910
 11,477
 
 910
 11,477
 12,387
 (113) 1995 9/5/2014 35

Wayne State Troy, MI 
 3,560
 43,052
 
 3,560
 43,052
 46,612
 (392) 1986 9/10/2014 38
Zangmesiter Columbus, OH 
 1,610
 31,120
 
 1,610
 31,120
 32,730
 (203) 2007 9/30/2014 40
El Paso — Lee Trevino El Paso, TX 
 2,294
 11,316
 183
 2,294
 11,499
 13,793
 (101) 1983 9/30/2014 30
El Paso — Kenworthy El Paso, TX 
 728
 2,178
 
 728
 2,178
 2,906
 (17) 1983 9/30/2014 35
El Paso — Murchison El Paso, TX 
 2,283
 24,543
 
 2,283
 24,543
 26,826
 (211) 1970 9/30/2014 30
Berger Medical Center Columbus, OH 
 
 5,950
 
 
 5,950
 5,950
 (43) 2007 9/30/2014 38
Ortho One — Columbus Columbus, OH 
 
 16,234
 
 
 16,234
 16,234
 (100) 2009 9/30/2014 45
Ortho One — Westerville Westerville, OH 
 362
 3,944
 
 362
 3,944
 4,306
 (25) 2007 9/30/2014 43
Pinnacle — 32 Northeast Hershey, PA 
 408
 3,232
 
 408
 3,232
 3,640
 (18) 1994 10/29/2014 33
Pinnacle — 240 Grandview Camp Hill, PA 
 321
 4,242
 
 321
 4,242
 4,563
 (22) 1980 10/29/2014 35
Pinnacle — 4518 Union Deposit Harrisburg, PA 
 617
 7,305
 
 617
 7,305
 7,922
 (42) 2004 10/29/2014 31
Pinnacle — 4520 Union Deposit Harrisburg, PA 
 169
 2,055
 
 169
 2,055
 2,224
 (13) 1997 10/29/2014 28
Pinnacle — Market Place Way Harrisburg, PA 
 808
 2,383
 
 808
 2,383
 3,191
 (11) 2004 10/29/2014 35
Columbus — 2000 10th Avenue Columbus, GA 
 380
 2,737
 
 380
 2,737
 3,117
 (12) 1989 11/20/2014 22
Columbus — 1942 North Avenue Columbus, GA 
 91
 273
 
 91
 273
 364
 (2) 1971 11/20/2014 12
Columbus — 920 18th Street Columbus, GA 
 110
 281
 
 110
 281
 391
 (3) 1982 11/20/2014 8
Columbus — 1900 10th Ave Columbus, GA 
 474
 5,580
 
 474
 5,580
 6,054
 (19) 1976 11/20/2014 26
Columbus — 1800 10th Ave Columbus, GA 
 539
 5,238
 
 539
 5,238
 5,777
 (17) 1976 11/20/2014 28
Columbus — 705 17th Street Columbus, GA 
 372
 2,346
 
 372
 2,346
 2,718
 (14) 1994 11/20/2014 15
Columbus — 615 19th Street Columbus, GA 
 75
 113
 
 75
 113
 188
 (3) 1976 11/20/2014 3
Columbus — 1968 North Avenue Columbus, GA 
 89
 32
 
 89
 32
 121
 (1) 1966 11/20/2014 4
Columbus — 633 19th Street Columbus, GA 
 99
 255
 
 99
 255
 354
 (3) 1972 11/20/2014 9
Columbus — 500 18th Street Columbus, GA 
 430
 170
 
 430
 170
 600
 (3) 1982 11/20/2014 8
Columbus — 2200 Hamilton Rd Columbus, GA 
 267
 1,579
 
 267
 1,579
 1,846
 (7) 1992 11/20/2014 22
Columbus — 1810 Stadium Drive Phenix City, AL 
 202
 149
 
 202
 149
 351
 (2) 1999 11/20/2014 30
Middletown Medical — 111 Maltese Wallkill, NY 
 670
 9,921
 
 670
 9,921
 10,591
 (24) 1988 11/26/2014 35
Middletown Medical — 2 Edgewater Wallkill, NY 
 200
 2,966
 
 200
 2,966
 3,166
 (7) 1992 11/26/2014 35
Carle Danville MOB Danville, IL 
 607
 7,136
 
 607
 7,136
 7,743
 (20) 2007 11/26/2014 33
Napoleon MOB New Orleans, LA 
 1,202
 7,412
 5
 1,202
 7,417
 8,619
 
 1974 12/18/2014 25
West TN Bone & Joint — Physicians Drive Jackson, TN 
 650
 2,960
 
 650
 2,960
 3,610
 
 1996 12/30/2014 35
West TN Bone & Joint Jackson, TN 
 1,254
 5,215
 
 1,254
 5,215
 6,469
 
 1991 12/30/2014 31
    78,105
 79,334
 643,802
 5,898
 79,334
 649,700
 729,034
 (32,772)      




The cost capitalized subsequent to acquisitions is net of dispositions.


The changes in total real estate for the years ended December 31, 2014, 20132017, 2016, and 20122015 are as follows (in thousands):
 
Year Ended December 31,Year Ended December 31,
2014 2013 20122017 2016 2015
Balance as of the beginning of the year$224,730
 $111,149
 $124,333
$2,606,536
 $1,424,894
 $729,034
Acquisitions505,379
 113,225
 
1,207,098
 1,170,593
 695,693
Additions900
 806
 786
12,243
 11,049
 4,440
Impairment(1,750) 
 (937)(965) 
 
Dispositions(225) (450) (13,033)(15,303) 
 (4,273)
Balance as of the end of the year$729,034
 $224,730
 $111,149
$3,809,609
 $2,606,536
 $1,424,894
 
The changes in accumulated depreciation for the years ended December 31, 2014, 20132017, 2016, and 20122015 are as follows (in thousands):
 Year Ended December 31,
 2017 2016 2015
Balance as of the beginning of the year$118,609
 $61,242
 $32,772
Depreciation87,531
 57,367
 29,958
Dispositions(4,613) 
 (1,488)
Balance as of the end of the year$201,527
 $118,609
 $61,242



113


 Year Ended December 31,
 2014 2013 2012
Balance as of the beginning of the year$20,299
 $16,495
 $14,484
Acquisitions6,575
 694
 
Additions5,898
 3,110
 3,024
Dispositions
 
 (1,013)
Balance as of the end of the year$32,772
 $20,299
 $16,495



ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
 
None.
 
ITEM 9A. CONTROLS AND PROCEDURES

Physicians Realty Trust
 
Evaluation of Disclosure Controls and Procedures.
 
OurThe Trust’s management, with the participation of its Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Trust’s disclosure controls and procedures (as defined in Rules 13a- 15(e) and 15d- 15(e) under the Exchange Act), as of the end of the period covered by this report. Based on such evaluation, the Trust’s Chief Executive Officer and Chief Financial Officer concluded that as of December 31, 2017, the Trust’s disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information it is required to disclose in reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to the Trust’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting.
There have been no changes in the Trust’s system of internal control over financial reporting during the quarter ended December 31, 2017, that have materially affected, or are reasonably likely to materially affect, the Trust’s internal control over financial reporting.
Management’s Report on Internal Control over Financial Reporting.
The Trust’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an assessment of the effectiveness of the Trust’s internal control over financial reporting based on the criteria set forth in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on the assessment, management has concluded that the Trust’s internal control over financial reporting was effective as of December 31, 2017 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP.

The effectiveness of the Trust’s internal control over financial reporting as of December 31, 2017 has been audited by Ernst & Young LLP (“EY”), an independent registered public accounting firm, as stated in their report included in Part II, Item 8 of this Annual Report on Form 10-K.
Limitations on Effectiveness of Controls and Procedures.
In designing and evaluating the disclosure controls and procedures and the Trust’s internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and the Trust’s internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Physicians Realty L.P.

Evaluation of Disclosure Controls and Procedures.
The Operating Partnership’s management, with the participation of the Chief Executive Officer and Chief Financial Officer of ourthe Operating Partnership’s general partner, has evaluated the effectiveness of ourthe Operating Partnership’s disclosure controls and procedures (as defined in Rules 13a- 15(e) and 15d- 15(e) under the Exchange Act), as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer of ourthe Operating Partnership’s general partner concluded that as of December 31, 2014, our2017, the Operating Partnership’s disclosure controls and


procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we areit is required to disclose in reports that we fileit files or submitsubmits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer of ourthe Operating Partnership’s general partner, as appropriate, to allow timely decisions regarding required disclosure.
 
Changes in Internal Control over Financial Reporting.
 
There have been no changes in ourthe Operating Partnership’s system of internal control over financial reporting during the quarter ended December 31, 2014,2017, that have materially affected, or are reasonably likely to materially affect, ourthe Operating Partnership’s internal control over financial reporting.
 
Management’s Report on Internal Control over Financial Reporting.
 
OurThe Operating Partnership’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an assessment of the effectiveness of ourthe Operating Partnership’s internal control over financial reporting based on the criteria set forth in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on the assessment, management has concluded that itsthe Operating Partnership’s internal control over financial reporting was effective as of December 31, 20142017 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP.

Limitations on Effectiveness of Controls and Procedures.
 
In designing and evaluating the disclosure controls and procedures and the Operating Partnership’s internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and the Operating Partnership’s internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

ITEM 9B. OTHER INFORMATION
 
None.




115



PART III
 
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Incorporated herein by reference are “Board“Proposal 1 - Election of Trustees and Nominees,”Trustees”, “Section 16(a) Beneficial Ownership Reporting Compliance,” “Trustee Nomination Procedure”Compliance”, “Audit Committee”“Corporate Governance Matters”, “Executive Officers”, and “Report of the Audit Committee of the Board of Trustees” to be included in the Trust's definitive proxy statement relating to the annual meeting of shareholders held on May 7, 2015,Trust’s 2018 Proxy Statement, which waswill be filed with the SEC on March 25, 2015 (the "2015 Proxy Statement").within 120 days after the end of its fiscal year ended December 31, 2017.
 
Code of Business Conduct and Ethics
 
Information regarding our Code of Business Conduct and Ethics is provided in “Part I., Item 1. Business - Available Information” and is incorporated herein by reference.

ITEM 11. EXECUTIVE COMPENSATION
 
Incorporated herein by reference are “Summary Compensation Table,” “Employment Agreements with NEOs,” “Outstanding Equity Awards at Fiscal Year-End,” “401(k) Plan,” “Trustee“Executive Compensation” and, “2017 Non-Employee Trustee Compensation”, “Compensation Committee Interlocks and Insider Participation”, and “Compensation Committee Report” to be included in the Trust's 2015Trust’s 2018 Proxy Statement, which waswill be filed with the SEC on March 25, 2015.within 120 days after the end of its fiscal year ended December 31, 2017.
 
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
 
Incorporated herein by reference are “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information” to be included in the Trust's 2015Trust’s 2018 Proxy Statement, which waswill be filed with the SEC on March 25, 2015.
Equity Compensation Plan Information
The table below presents information aswithin 120 days after the end of its fiscal year ended December 31, 2014 for the Trust's 2013 Equity Incentive Plan. The Trust does not have any equity compensation plans that have not been approved by its shareholders.
Plan category  
Number of securities to be issued
upon exercise of outstanding options
warrants and rights
 (a)
 
Weighted-average exercise price of
outstanding options, warrants and
rights
 (b)
 
Number of securities remaining
available for future issuance under
equity compensation plans
(excluding securities reflected in
column (a))
 (c)
Equity compensation plans approved by security holders 55,680
(1)
 1,991,333
       
Equity compensation plans not approved by security holders 
 
 
       
(1)  Performance-based restricted stock units at target level granted to the Trust's officers under the 2013 Equity Incentive Plan, which will vest, if at all, based on achievement of performance criteria over a performance period, subject to the terms of the grant.2017.
 
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
 
Incorporated herein by reference are “Certain Relationships and Related Transactions” and “Trustee Independence” to be included in the Trust's 2015Trust’s 2018 Proxy Statement, which waswill be filed with the SEC on March 25, 2015.within 120 days after the end of its fiscal year ended December 31, 2017.
 
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
 
Incorporated herein by reference are “Fees Paid tois “Proposal 2 - Ratification of Independent Registered Public Accounting Firm” and “Audit Committee Pre-Approval Policies and Procedures”to be included in the Trust's 2015Trust’s 2018 Proxy Statement, which waswill be filed with the SEC on March 25, 2015.within 120 days after the end of its fiscal year ended December 31, 2017.



116



PART IV
 
ITEM 15. EXHIBITS, AND FINANCIAL STATEMENT SCHEDULES

(a)The following documents are filed as part of this report:

(1)Financial Statements:

(2)Financial Statement Schedules:
 
 
All other schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are omitted because they are not required under the related instructions or are not applicable, or because the required information is shown in the consolidated financial statements or notes thereto.
 
(3)Exhibits:Exhibits:
 
See the Exhibit Index immediately following the signature page of this report on Form 10-K.

117



ITEM 16. FORM 10-K SUMMARY

None.



SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
PHYSICIANS REALTY L.P.
by: Physicians Realty Trust, its general partner
TRUST
  
Dated: February 24, 2017March 1, 2018/s/ JOHNJohn T. THOMASThomas
 John T. Thomas
 Chief Executive Officer and President
 (Principal Executive Officer)
 
Power of Attorney
 
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John T. Thomas and Jeffrey N. Theiler and each of them severally, his or her true and lawful attorney-in-fact with power of substitution and resubstitution to sign in his or her name, place and stead, in any and all capacities, to do any and all things and execute any and all instruments that such attorney may deem necessary or advisable under the Securities Exchange Act of 1934 and any rules, regulations and requirements of the Securities and Exchange Commission in connection with this Annual Report on Form 10-K and any and all amendments hereto, as fully and for all intents and purposes as he or she might do or could do in person, and hereby ratifies and confirms all said attorneys-in-fact and agents, each acting alone, and his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 




Signature Title Date
     
/s/ JOHN T. THOMAS Chief Executive Officer and February 24, 2017March 1, 2018
John T. ThomasPresident and Trustee (Principal Executive Officer)
/s/ JEFFREY N. THEILERExecutive Vice President andMarch 1, 2018
Jeffrey N. TheilerChief Financial Officer (Principal Financial Officer)
/s/ JOHN W. LUCEYSenior Vice President - Chief Accounting andMarch 1, 2018
John W. LuceyAdministrative Officer (Principal Accounting Officer)
/s/ STANTON D. ANDERSONTrusteeMarch 1, 2018
Stanton D. Anderson
/s/ MARK A. BAUMGARTNERTrusteeMarch 1, 2018
Mark A. Baumgartner
/s/ ALBERT C. BLACK, JR.TrusteeMarch 1, 2018
Albert C. Black, Jr.
/s/ WILLIAM A. EBINGER, M.D.TrusteeMarch 1, 2018
William A. Ebinger, M.D.
/s/ TOMMY G. THOMPSONChairmanMarch 1, 2018
Tommy G. Thompson
/s/ RICHARD A. WEISSTrusteeMarch 1, 2018
Richard A. Weiss
/s/ PAMELA J. KESSLERTrusteeMarch 1, 2018
Pamela J. Kessler



120



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PHYSICIANS REALTY L.P.
by: Physicians Realty Trust, its general partner
Dated:March 1, 2018/s/ John T. Thomas
John T. Thomas
Chief Executive Officer and President
(Principal Executive Officer)
Power of Attorney
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John T. Thomas and Jeffrey N. Theiler and each of them severally, his or her true and lawful attorney-in-fact with power of substitution and resubstitution to sign in his or her name, place and stead, in any and all capacities, to do any and all things and execute any and all instruments that such attorney may deem necessary or advisable under the Securities Exchange Act of 1934 and any rules, regulations and requirements of the Securities and Exchange Commission in connection with this Annual Report on Form 10-K and any and all amendments hereto, as fully and for all intents and purposes as he or she might do or could do in person, and hereby ratifies and confirms all said attorneys-in-fact and agents, each acting alone, and his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



SignatureTitleDate
/s/ JOHN T. THOMASChief Executive Officer andMarch 1, 2018
John T. Thomas President and Trustee (Principal Executive Officer) of Physicians Realty Trust, the general partner of Physicians Realty L.P.  
     
/s/ JEFFREY N. THEILER Executive Vice President and February 24, 2017March 1, 2018
Jeffrey N. Theiler Chief Financial Officer (Principal Financial Officer) of Physicians Realty Trust, the general partner of Physicians Realty L.P.  
     
/s/ JOHN W. LUCEY Senior Vice President - Chief Accounting and February 24, 2017March 1, 2018
John W. Lucey Administrative Officer (Principal Accounting Officer) of Physicians Realty Trust, the general partner of Physicians Realty L.P.  
     
/s/ STANTON D. ANDERSON Trustee of Physicians Realty Trust, the general partner of Physicians Realty L.P. February 24, 2017March 1, 2018
Stanton D. Anderson    
     
/s/ MARK A. BAUMGARTNER Trustee of Physicians Realty Trust, the general partner of Physicians Realty L.P. February 24, 2017March 1, 2018
Mark A. Baumgartner    
     
/s/ ALBERT C. BLACK, JR. Trustee of Physicians Realty Trust, the general partner of Physicians Realty L.P. February 24, 2017March 1, 2018
Albert C. Black, Jr.    
     
/s/ WILLIAM A. EBINGER, M.D. Trustee of Physicians Realty Trust, the general partner of Physicians Realty L.P. February 24, 2017March 1, 2018
William A. Ebinger, M.D.    
     
/s/ TOMMY G. THOMPSON Chairman of the Board of Trustees of Physicians Realty Trust, the general partner of Physicians Realty L.P. February 24, 2017March 1, 2018
Tommy G. Thompson    
     
/s/ RICHARD A. WEISS Trustee of Physicians Realty Trust, the general partner of Physicians Realty L.P. February 24, 2017March 1, 2018
Richard A. Weiss    
/s/ PAMELA J. KESSLERTrustee of Physicians Realty Trust, the general partner of Physicians Realty L.P.March 1, 2018
Pamela J. Kessler






EXHIBIT INDEX
Exhibit No. Title
(1)
(2)
(3)
(1)
(4)
(4)
(4)
(5)
(5)
(6)
(7)
(1)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
(9)
(9)
(9)
(9)
(10)
(11)
(11)
(11)
(8)
(12)
(13)
(14)
(14)
(14)
(14)
(14)
(15)
(15)
(15)
(15)
(15)
(16)


Exhibit
No.
 Title
3.1
(1)
 
Second Amended and Restated Agreement of Limited Partnership of Physicians Realty L.P., dated February 5, 2015
10.1(2)Form of Restricted Shares Award Agreement (Time Vesting) of Physicians Realty Trust
10.2(3)Form of Indemnification Agreement between Physicians Realty Trust and its trustees and officers
10.3
(2)
 
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund I, dated as of June 19, 2013
10.4
(2)
 
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund II, dated as of June 19, 2013
10.5
(2)
 
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund III, dated as of June 19, 2013
10.6
(2)
 
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund IV, LP, dated as of June 19, 2013
10.7
(4)
 
Form of Shared Services Agreement by and among Physicians Realty Trust, Physicians Realty L.P. and B.C. Ziegler and Company
10.8
(4)
 
Membership Interest Purchase Agreement for the Arrowhead Commons property by and among Physicians Realty L.P., Birdie Zone, L.L.C., Ziegler Healthcare Real Estate Fund I and Ziegler-Arizona 23, LLC dated as of June 24, 2013
10.9
(5)
 
Agreement of Sale and Purchase, by and between Physicians Realty L.P. and 6800 Preston Limited dated August 21, 2013
10.10
(6)
 
Assignment and Assumption Agreement of Sale and Purchase by and between Foundation Surgical Hospital Affiliates, L.L.C. and DOC-FSH El Paso Medical Center, LLC, as of August 30, 2013
10.11
(6)
 
Agreement of Sale and Purchase by and between HCRI Texas Properties, Ltd., Health Care REIT, Inc., and Foundation Surgical Hospital Affiliates, L.L.C., as of August 30, 2013
10.12
(6)
 
Membership Interest Contribution Agreement by and among DOC-CCSC Crescent City Surgical Centre, LLC, Crescent City Surgical Centre Facility, LLC, Physicians Realty L.P. and the Members of Crescent City Surgical Centre Facility, LLC, dated as of September 30, 2013
10.13
(7)
 
Assignment and Assumption of Agreement of Sale and Purchase by and between Graymark Healthcare, Inc. and DOC-Greymark HQ OKC MOB, LLC, dated September 30, 2013
10.14
(7)
 
Agreement of Sale and Purchase, dated as of November 7, 2013, by and among Steele Properties I, LLC, Collyn Williams and Physicians Realty L.P.
10.15
(8)
 
Agreement of Sale and Purchase, dated as of January 29, 2014, by and between Octopods, LLC and Physicians Realty L.P.
10.16
(8)
 
Amendment to Agreement of Sale and Purchase, dated as of February 28, 2014, by and between Octopods, LLC and Physicians Realty L.P.
10.17
(8)
 
Second Amendment to Agreement of Sale and Purchase, dated as of April 30, 2014, by and between Octopods, LLC and Physicians Realty L.P.
10.18
(8)
 
Agreement of Sale and Purchase, dated as of February 10, 2014, by and between those Sellers set forth on Exhibit A thereto and Physicians Realty L.P.
10.19
(8)
 
Agreement of Sale and Purchase, dated as of February 19, 2014, by and between Foundation Bariatric Real Estate of San Antonio, LLLP, and DOC-FSH San Antonio Hospital, LLC
10.20
(8)
 
Agreement of Sale and Purchase, dated as of February 28, 2014, by and between North American Property Corporation, and DOC-PDMC Atlanta, LLC
10.21
(8)
 
Agreement of Sale and Purchase, dated as of March 28, 2014, by and between New LifeCare Hospitals of Pittsburgh, LLC, New LifeCare Hospitals of North Texas, LLC, DOC-LifeCare Ft. Worth Ltach, LLC, and DOC-LifeCare Pittsburgh Ltach, LLC
10.22
(9)
 
Amended and Restated Employment Agreement dated as of May 6, 2014, between Physicians Realty Trust and John T. Thomas**
10.23
(9)
 
Amended and Restated Employment Agreement dated as of May 6, 2014, between Physicians Realty Trust and John W. Lucey**
10.24
(9)
 
Amended and Restated Employment Agreement dated as of May 6, 2014, between Physicians Realty Trust and Mark D. Theine**
10.25(9)Physicians Realty Trust Incentive Bonus Plan**
10.26(9)Form of Restricted Share Award Agreement of Physicians Realty Trust- Executive (Time Vesting)**
10.27(9)Form of Restricted Share Award Agreement of Physicians Realty Trust - Trustees (Time Vesting)**
10.28(9)Form of Restricted Share Unit Award Agreement (Performance Units) of Physicians Realty Trust**
Exhibit No. Title
(17)
(17)
(18)
 
 
 
 
 
 
 
 
 
 
 
 
101.INS XBRL Instance Document(†)
101.SCH XBRL Extension Schema Document(†)
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document(†)
101.DEF XBRL Taxonomy Extension Definition Linkbase Document(†)
101.LAB XBRL Taxonomy Extension Label Linkbase Document(†)
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document(†)


10.29(10)Employment Agreement dated as of May 13, 2014, between Physicians Realty Trust and Jeffrey Theiler**
10.30
(11)
 
First Amendment to Shared Services Agreement dated July 31, 2014, among B.C. Ziegler and Company, Physicians Realty Trust, and Physicians Realty L.P.
10.31(12)Physicians Realty Trust 2013 Equity Incentive Plan, as amended effective August 7, 2014**
10.32
(13)
 
Credit Agreement, dated September 18, 2014, among Physicians Realty L.P., Physicians Realty Trust and certain subsidiaries and other affiliates party thereto, KeyBank National Association, KeyBanc Capital Markets Inc., Regions Capital Markets, BMO Capital Markets, and the lenders party thereto
10.33
(14)
 
Agreement of Sale and Purchase, dated as of September 8, 2014, by and between Cassady Gateway Partners, LLC and DOC-3100 Plaza Properties Boulevard MOB, LLC
10.34
(14)
 
Contribution Agreement, dated as of September 8, 2014, by and between Curie Building, LLC, as successor by conversion to Cure Building, Ltd., and DOC-1755 Curie Drive MOB, LLC
10.35
(14)
 
Agreement of Sale and Purchase, dated as of September 8, 2014, by and between University Physician Group, d/b/a Wayne State University Physician Group and DOC-WSUPG Troy MOB, LLC
10.36(15)Agreement of Sale and Purchase, dated as of November 18, 2014, by and between Kennewick Trios 2014 LLC and Physicians Realty L.P.
10.37(15)Contribution Agreement, dated as of February 5, 2015, by and among United Properties Investment, LLC, Minnetonka Medical Building, LLC, and DOC-15450 State Highway 7 MOB, LLC
10.38(15)Employment Agreement dated January 8, 2015, between Physicians Realty Trust and Bradley D. Page**
10.39
(16)
 
Amended and Restated Employment Agreement dated as of February 19, 2015, between Physicians Realty Trust and John Sweet**
10.40(15)Form of Restricted Share Award Agreement of Physicians Realty Trust - Executive (Time Vesting)**
10.41(15)Form of Restricted Share Unit Award Agreement of Physicians Realty Trust- Executive (Performance Vesting)**
10.42(15)Form of Restricted Share Unit Award Agreement of Physicians Realty Trust - Trustees (Time Vesting)**
16.1(17)Letter from Plante & Moran, PLLC to the Securities and Exchange Commission, dated April 4, 2014
21.1 List of Subsidiaries of Physicians Realty L.P.*
23.1 Consent of Plante & Moran, PLLC*
23.2 Consent of Ernst & Young LLP*
24.1 Power of Attorney (included on signature page)*
31.1 Certification of John T. Thomas, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2 Certification of Jeffrey N. Theiler, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1
 
 
Certification of John T. Thomas and Jeffrey N. Theiler, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)*
101.INS XBRL Instance Document(+)
101.SCH XBRL Extension Schema Document(+)
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document(+)
101.DEF XBRL Taxonomy Extension Definition Linkbase Document(+)
101.LAB XBRL Taxonomy Extension Label Linkbase Document(+)
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document(+)
*Filed herewith
**Indicates a management contract or compensatory plan or arrangement.

Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement for purposes of Section 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.
 
(1) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on February 6, 2015.
(2) Incorporated by reference to Amendment No. 3 to Physicians Realty Trust’s Registration Statement on Form S-11 filed with the SEC on June 20, 2013 (File No. 333-188862).
(3) Incorporated by reference to Amendment No. 2 to Physicians Realty Trust’s Registration Statement on Form S-11 filed with the SEC on June 14, 2013 (File No. 333-188862).
(4) Incorporated by reference to Amendment No. 4 to Physicians Realty Trust’s Registration Statement on Form S-11 filed with the SEC on July 3, 2013 (File No. 333-188862).
(5) Incorporated by reference to Physicians Realty Trust’s Quarterly Report on Form 10-Q filed with the SEC on August 30, 2013 (File No. 001-36007).
(6) Incorporated by reference to Physicians Realty Trust’s Quarterly Report on Form 10-Q filed with the SEC on November 12, 2013 (File No. 001-36007).
(7) Incorporated by reference to Physicians Realty Trust’s Annual Report on Form 10-K filed with the SEC on March 21, 2014 (File No. 001-36007).
(8) Incorporated by reference to Physicians Realty Trust’s Quarterly Report on Form 10-Q filed with the SEC on May 7, 2014
(1)Incorporated by reference to Amendment No. 2 to the Registrant’s Registration Statement on Form S-11 filed with the SEC on June 14, 2013 (File No. 333-188862).
(2)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on February 24, 2017 (File No. 001-36007).
(3)Incorporated by reference to the Registrant’s Registration Statement on Form S-3 filed with the SEC on June 17, 2015 (File No. 333-205034).
(4)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on March 7, 2017 (File No. 001-36007).
(5)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017 (File No. 001-36007).
(6)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on February 6, 2015.
(7)Incorporated by reference to Amendment No. 3 to the Registrant’s Registration Statement on Form S-11 filed with the SEC on June 20, 2013 (File No. 333-188862).

(File
(8)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on February 28, 2018 (File No. 001-36007).
(9)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on May 7, 2014 (File No. 001-36007).
(10)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on August 7, 2014 (File No. 001-36007).
(11)Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the SEC on March 12, 2015 (File No. 001-36007).
(12)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on June 13, 2016 (File No. 001-36007).
(13)Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 10, 2015 (File No. 001-36007).
(14)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on January 12, 2016 (File No. 001-36007).
(15)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on August 11, 2016 (File No. 001-36007).
(16)Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the SEC on March 12, 2015 (File No. 001-36007).
(17)Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 6, 2016 (File No. 001-36007).
(18)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on July 7, 2017 (File No. 001-36007).

(9) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on May 7, 2014.
(10) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on May 14, 2014.
(11) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on August 6, 2014.
(12) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on August 7, 2014.
(13) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on September 23, 2014.
(14) Incorporated by reference to Physicians Realty Trust’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2014 (File No. 001-36007).
(15) Incorporated by reference to Physicians Realty Trust’s Annual Report on Form 10-K filed with the SEC on March 21, 2015.
(16) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on February 20, 2015.
(17) Incorporated by reference to Physicians Realty Trust’s Current Report on Form 8-K filed with the SEC on April 7, 2014.

(+) Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement for purposes of Section 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.



97125